- Staat
- FL
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 07.12.2023
- Impfdatum
- 02.03.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: ja
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Biopsy breast abnormal
Breast conserving surgery
Breast mass
Death
Mammogram abnormal
Mastectomy
Syncope
Triple negative breast cancer
Symptomtext
8/2/2022 Hospitalized after fainting spell 2/14/2023 Hospitalized again May 2023 diagnosed with an abnormal mammogram August 2023 lumpectomy for pre-breast cancer diagnosis August 2023 lumpectomy biopsy came back aggressive fast growing cancer triple negative August 2023 double mastectomy November 2023 died complications to cancer
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 07.11.2023
- Impfdatum
- 10.03.2021
- Beginn
- 24.10.2023
- Tage bis Beginn
- 958,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Acute respiratory failure
Anion gap
Aspiration pleural cavity
Auscultation
Blood calcium decreased
Blood chloride normal
Blood creatinine normal
Blood culture negative
Blood glucose normal
Blood magnesium
Blood phosphorus decreased
Blood potassium normal
Blood sodium normal
Blood urea normal
Carbon dioxide increased
Chest X-ray abnormal
Chest tube insertion
Symptomtext
Document Type: Internal Medicine IP Progress Note Document Subject: Progress Note Comprehensive Performed By: MD on November 02, 2023 07:49 Verified By: MD on November 02, 2023 07:49 Encounter Info: Hospital Inpatient, 10/24/23 - 11/04/23 * Final Report * Subjective This patient is an 81 year old female with PMH of a-fib, COPD (on 3L at home), and GERD that presented to the ED on 10/24 for complaints of nausea and confusion. She was found to have a R sided loculated effusion on chest CT and E.coli bacteremia for which she was placed on zosyn. She had a chest tube placed in the effusion which was drained and fluid did not grow any invasive organisms and the effusion was transudative per Light's criteria. She was initially in ICU on BiPAP but was able to be transferred out after a few days. Her chest tube was removed on 10/28 after effusion was improved on CXR. She is back down to her home oxygen but patient continued to complain of chills and generally not feeling well. Another CT chest was obtained which showed increase in bilateral pleural effusions (although still small in volume) which the R side appears loculated. [1] Resting comfortably this morning. Objective Vitals and Measurements Vitals & Measurements most recent past 24 hours T: 36.9 ?C (Oral) BP: 100/83 HR: 96 (Monitored) HR: 96 (Peripheral) RR: 16 SpO2: 99% Oxygen Therapy: OxyMask Oxygen Flow Rate: 3 (L/min) FiO2: 0.40 Hemodynamics Neurologic Glasgow Coma Score: 15 Patient Weight Current Daily Weight: 50.7 kg 10/24/23 Weight for Nutrition: 50.7 kg 10/25/23 BMI: 21.8 10/24/23 Normal Weight (BMI 18.5-24.9) Patient Height Current Height: 152.4 cm 10/24/23 Intake/Output I/O TOTALS ONLY - Last 24 hrs (0600-0559) from 11/01 - 11/02 Total Intake 350.00 mL Total Output 650.00 mL Balance -300.00 mL Physical Exam Chest- Clear to auscultation. CV- RRR. No murmurs, gallops or rubs. ABD- Soft, non-tender. Non-distended. BS present. Ext.- No edema. Assessment/Plan 1. Acute on chronic respiratory failure with hypoxia and hypercapnia J96.21 Probably secondary to bacteremia and loculated pleural effusions. Back to baseline on oxygen supplementation. 2. E coli bacteremia R78.81 Has had 8 days of IV antibiotics. IR asked that we continue with placement of chest tube for now. 3. Pleural effusion, right J90 Planning IR placed chest tube to loculated fluid today. 4. Hypothyroidism E03.9 Continue replacement therapy. 5. Atrial fibrillation I48.91 Slightly tachycardic. On anticoagulation. Continue amiodarone. 6. Acute kidney injury N17.9 Resolved. Potassium replaced. Chronic respiratory failure with hypoxia J96.11 Constipation K59.00 COPD exacerbation J44.1 E-coli UTI N39.0 Emphysema lung J43.9 Hypernatremia E87.0 Hypophosphatemia E83.39 Leucocytosis D72.829 Normocytic anemia D64.9 Palliative care by specialist Z51.5 RML pneumonia J18.9 Septic shock R65.21 Orders: piperacillin-tazobactam, 3.375 GM, IVPB, Injection, Q8H, Indication: Sepsis (Update Indication in 36-48 hrs), 11/02/23 8:00:00 Code Status Resuscitation Status - Ordered -- 10/24/23 17:48:00, Full Code Medications Active Scheduled Inpatient Medications albuterol-ipratropium (albuterol-ipratropium inh soln 2.5 mg-0.5 mg/3 mL), Inhalation SOLN, 3 mL, Neb Inhal, Q6, Start: 10/26/23 09:00:00 amiodarone, Tablet, 200 mg, Orally, Daily, Start: 10/24/23 17:54:00 apixaban, Tablet, 2.5 mg, Orally, BID, Start: 10/24/23 21:00:00 bisacodyl (Dulcolax Laxative), Suppository, 10 mg, Rectally, Daily, Start: 11/01/23 09:00:00 docusate (docusate sodium), Capsule, 100 mg, Orally, Daily, Start: 10/29/23 12:00:00 famotidine, Tablet, 20 mg, Orally, At Bedtime, Start: 10/30/23 21:00:00 levothyroxine (Synthroid), Tablet, 88 mCg, Orally, Before Breakfast, Start: 10/25/23 06:00:00 lidocaine topical (Lidoderm 5% topical film), Patch, 1 Patch, Topical, QAM, Start: 10/25/23 11:00:00 piperacillin-tazobactam (Zosyn), Injection, 3.375 GM, IVPB, Q8H, Indication: Sepsis (Update Indication in 36-48 hrs), Start: 11/02/23 08:00:00 polyethylene glycol 3350, Powder, 17 GM, Orally, Daily, Start: 10/25/23 09:00:00 Sodium Chloride 0.9% 500 mL IV Continuous Other - See Comments 0 10/26/23 Dextrose 5% in Water 500 mL IV Continuous Other - See Comments One-Time Medications Given 11/01/23 00:00:00 TO 11/02/23 07:49:28 metoPROLOL (Lopressor), Injection, 2.5 mg, IV Push, ONCE, (1 DOSE 11/01/23 00:56:00) metoPROLOL (Lopressor), Injection, 5 mg, IV Push, ONCE, (1 DOSE 11/01/23 04:25:00) PRN Medications (0600 - 0559) from 11/01 - 11/02 acetaminophen, 650 mg, Orally, Q4H, 0 Dose(s) albuterol, 2.5 mg, Neb Inhal, Q4H, 0 Dose(s) alteplase, 1 mg, Dwell, Unscheduled, 0 Dose(s) bisacodyl, 10 mg, Rectally, Daily, 0 Dose(s) metoPROLOL, 5 mg, IV Push, Q6H, 2 Dose(s) midodrine, 5 mg, Orally, Q8, 0 Dose(s) ondansetron, 4 mg, IV Push, Q6H, 0 Dose(s) promethazine, 6.25 mg, IVPB, Q6H, 0 Dose(s) Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 10 k/cumm (11/02/23 02:30:00) RBC: 3.38 million/cumm Low (11/02/23 02:30:00) Hgb: 9.4 GM/dL Low (11/02/23 02:30:00) Hct: 29.5 % Low (11/02/23 02:30:00) MCV: 87 fL (11/02/23 02:30:00) MCH: 27.7 pg (11/02/23 02:30:00) MCHC: 31.7 GM/dL Low (11/02/23 02:30:00) RDW: 18.2 % High (11/02/23 02:30:00) Platelet: 215 k/cumm (11/02/23 02:30:00) MPV: 8.7 fL (11/02/23 02:30:00) Chemistry: Sodium SerPl QN: 143 mmol/L (11/02/23 02:30:00) Potassium SerPl QN: 4.6 mmol/L (11/02/23 02:30:00) Chloride SerPl QN: 104 mmol/L (11/02/23 02:30:00) Carbon Dioxide SerPl QN: 37 mmol/L High (11/02/23 02:30:00) Anion Gap: 2 mmol/L Low (11/02/23 02:30:00) BUN SerPl QN: 12 mg/dL (11/02/23 02:30:00) Creatinine SerPl QN: 1.09 mg/dL (11/02/23 02:30:00) Estimated GFR (CKD-EPI, no race): 51 mL/min/1.73m2 Low (11/02/23 02:30:00) Estimated CRCL (CG): 30 mL/min Low (11/02/23 02:30:00) Glucose SerPl QN: 77 mg/dL (11/02/23 02:30:00) Calcium Total SerPl QN: 8 mg/dL Low (11/02/23 02:30:00) Phosphorus SerPl QN: 2.4 mg/dL Low (11/02/23 02:30:00) Magnesium SerPl QN: 2.4 mg/dL (11/02/23 02:30:00) Coagulation: PT: 15.6 seconds High (11/02/23 02:30:00) INR: 1.35 High (11/02/23 02:30:00) Micro - Last 7 days Blood CX: NEG (10/26/23 14:33:00) Blood CX: NEG (10/26/23 14:33:00) Diagnostics Radiology Results - Last 24 hours Across Visits No radiology results found in the last 24 hours. [1] Consult Note; NP 11/01/2023 10:36 Signature Line Electronically Signed on 11/02/23 07:49 ________________________________________________________ MD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 25.07.2023
- Impfdatum
- 01.03.2021
- Beginn
- 02.04.2023
- Tage bis Beginn
- 762,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
Patient Deceased
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- COPD, ILD, Bipolar, RA
- Andere Medikamente
- Albutrol, Flonase, Advair, Seroquel, Tamsulosin, Lisinopril, Metoprolol, Eliquis Digoxin, protonix
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 25.05.2023
- Impfdatum
- 20.02.2021
- Beginn
- 06.03.2021
- Tage bis Beginn
- 14,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
Aortic aneurysm
Asthenia
Chronic respiratory failure
Coagulopathy
Deep vein thrombosis
Respiratory failure
Symptomtext
D68.9 COAGULOPATHY, UNSPECIFIED TYPE 3/14/2021 WEAKNESS I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 12/31/2022 WEAKNESS J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/5/2022 WEAKNESS J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/6/2023 WEAKNESS D68.9 COAGULOPATHY, UNSPECIFIED TYPE 3/14/2021 ABDOMINAL AORTIC ANEURYSM >=5.5 CM W HX OF ENDOVASCULAR REPAIR I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 12/31/2022 ABDOMINAL AORTIC ANEURYSM >=5.5 CM W HX OF ENDOVASCULAR REPAIR J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/5/2022 ABDOMINAL AORTIC ANEURYSM >=5.5 CM W HX OF ENDOVASCULAR REPAIR J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/6/2023 ABDOMINAL AORTIC ANEURYSM >=5.5 CM W HX OF ENDOVASCULAR REPAIR
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 90,0
- Geschlecht
- M
- Eingang
- 27.04.2023
- Impfdatum
- 02.03.2021
- Beginn
- 01.10.2022
- Tage bis Beginn
- 578,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Anticoagulant therapy
COVID-19
Cardiac arrest
Death
Endotracheal intubation
Fall
Life support
SARS-CoV-2 test positive
Troponin increased
Symptomtext
3rd dose of Pfizer COVID vaccine given 10/29/21, #ff8839; pt fell at home and was brought to ED on 10/23/22; elevated troponin; found to be positive for COVID; heparin drip; suffered cardiac arrest; ACLS protocol; intubated; pt remained asystole and passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- LUNG CA, HX OF LOBECTOMY, INTERSTITIAL LUNG DISEASE, CAD
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 14.04.2023
- Impfdatum
- 27.02.2021
- Beginn
- 16.10.2021
- Tage bis Beginn
- 231,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Altered state of consciousness
COVID-19
Cerebral haemorrhage
Chest X-ray abnormal
Computerised tomogram head abnormal
Death
Fall
Head injury
Intensive care
Pneumonia
Respiratory disorder
SARS-CoV-2 test positive
Subarachnoid haemorrhage
Subdural haematoma
Symptomtext
10/15/22 Pt admitted to hospital with altered LOC after falling with head injury; CT showed subarachnoid hemorrhage, subdural hematoma, intraparenchymal hemorrhage; transferred to ICU; found to be positive for COVID; respiratory status worsened; DNR/DNI; CXR showed multifocal PNA; pt transitioned to comfort measures and hospice; pt passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebral haemorrhage
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 06.04.2023
- Impfdatum
- 09.03.2021
- Beginn
- 10.03.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Cerebrovascular accident
SARS-CoV-2 test
Symptomtext
Had 1st stroke; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 63-year-old male patient received BNT162b2 (BNT162B2), on 09Mar2021 at 12:00 as dose 1, single (Lot number: EN6200, Expiration Date: 30Jun2021) at the age of 63 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Sulfa allergy" (unspecified if ongoing); "High BP" (unspecified if ongoing); "Cholesterol abnormal" (unspecified if ongoing); "Neuropathy" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: CEREBROVASCULAR ACCIDENT (hospitalization, disability, life threatening) with onset 10Mar2021 at 13:00, outcome "recovered with sequelae", described as "Had 1st stroke". The patient was hospitalized for cerebrovascular accident (hospitalization duration: 3 day(s)). The event "had 1st stroke" required emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jan2022) Positive; (Jan2023) Negative. Therapeutic measures were taken as a result of cerebrovascular accident. Clinical Course: Patient had 1st dosage of Pfizer Covid 19 vaccine on 09Mar2021, then had 1st stroke 10Mar2021. Went to Hospital Emergency Room. Was advised of stroke, given meds, then med-flighted to a Hospital and was admitted for 3 days. Adverse event treatment: treatment: Medications, testing, observation. Other medications in two weeks: YES, Facility type vaccine: Public Health Clinic.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300143181 Same patient, same product, same event (Dose 2);
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 3,0
- Labordaten
- Test Date: 202201; Test Name: Nasal swab; Test Result: Positive ; Test Date: 202301; Test Name: Nasal swab; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Blood cholesterol abnormal; Blood pressure high; Neuropathy; Sulfonamide allergy
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- U
- Eingang
- 28.03.2023
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- SYR / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Anaemia
Atrophy
B-cell lymphoma
Death
Heart rate increased
Small intestinal obstruction
Symptomtext
B cell lymphoma, atrophy, anemia, blockage in small intestine, fast heart rate, death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 14,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 23.03.2023
- Impfdatum
- 25.02.2021
- Beginn
- 01.09.2022
- Tage bis Beginn
- 553,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
pt had a positive post-mortem PCR COVID test
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 13.03.2023
- Impfdatum
- 24.02.2021
- Beginn
- 01.06.2022
- Tage bis Beginn
- 462,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
COVID-19
Chronic obstructive pulmonary disease
Condition aggravated
Death
Pneumonia
SARS-CoV-2 test positive
Symptomtext
3RD DOSE PFIZER COVID VACCINE GIVEN 10/26/21, #FE3592; Pt had a positive COVID test on 6/27/22; pt had pneumonia, COPD exacerbation, AHRF; was dc'd to nursing home; in nursing home was found without life signes; EMS called; pt taken to Medical Center and pronounced deceased
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- ANEMIA, ARTHRITIS, LUNG CA, CHF, COPD, CAD, GERD, HTN, SEIZURE DISORDER
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 23.02.2023
- Impfdatum
- 18.10.2021
- Beginn
- 15.01.2023
- Tage bis Beginn
- 454,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute respiratory failure
Angiogram pulmonary abnormal
Aspiration pleural cavity
Bacterial test negative
Blood culture positive
Blood glucose increased
C-reactive protein increased
COVID-19
Chills
Chronic kidney disease
Condition aggravated
Cough
Culture negative
Diabetes mellitus management
Dyspnoea
Echocardiogram normal
Fibrin D dimer
Hydronephrosis
Symptomtext
"Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR. Provider d/c note: ""72-year-old divorced male with past medical history significant for longstanding type 1 diabetes complicated by blindness in the setting of proliferative retinopathy, pancreatic insufficiency, hypothyroidism, primary hypertension, Gilbert's disease and hyperlipidemia with recent upper respiratory illness due to influenza A in December 2022 presented with acute onset of cough, worsening shortness of breath and fevers or chills at home found to have sepsis and acute respiratory failure with hypoxia in the setting of a right lower lobe pneumonia with associated right pleural effusion. Of note COVID-19 virus was also detected at time of admission. Procalcitonin was markedly elevated at 26.26. Patient also had marked hyperglycemia in the mid 300s. Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) Patient's sepsis in the setting of pneumonia was treated with IV fluid bolus and then maintenance IV fluids as well as starting antibiotics with IV ceftriaxone and azithromycin. CRP was markedly elevated to 19.3 and D-dimer elevated to 2170. In the setting of COVID 19 CT angiogram of chest was obtained to rule out pulmonary emboli which was ruled out. However a large right pleural effusion was noted associated with near complete consolidation of the right lower lobe and some consolidation in the lateral segment of the right middle lobe and inferior right upper lobe. There was also some characteristics consistent with possible pulmonary necrosis. Patient's ceftriaxone was brought to Unasyn to cover for oral anaerobes. MRSA nares swab was negative. Urine strep pneumoniae and urine Legionella antigens were negative. Interventional Radiology was consulted and performed a right-sided thoracentesis draining 1.2 L of transudative fluid. Pleural fluid cultures were no growth to date. With hypoxia being attributed to bacterial pneumonia it was decided to not treat COVID-19 viral infection. Patient's hypoxia resolved over several days as did his sepsis. Notably patient had 2 sets of blood cultures that both grew staph epidermidis, pansensitive. Collaborated informally with Infectious Diseases and they felt that it would be impossible to rule out this bacteria as a pathogen although it still would be most likely contaminant. Infectious diseases felt treatment for 7 days with Unasyn transition to Augmentin to cover the bacterial pneumonia would be adequate to also treat the staph epidermidis in the blood which cleared quickly with surveillance cultures. Echocardiogram was obtained which showed normal structural heart with no signs of vegetations. Plan was to complete course of antibiotics and then weight 1 additional week and then rechecked 2 sets of blood cultures to confirm no residual signs of bacteremia. Patient was discharged on Augmentin in stable condition. On separate note he was also started on vitamin-D supplementation for vitamin-D deficiency. Patient was also noted to have renal insufficiency which developed some time after October 2022. There was evidence only of minimal left hydronephrosis on imaging with no stones or other obvious pathology. Patient's renal function remained stable which suggested a somewhat chronic component to the kidney disease versus a component of acute tubular necrosis which has delayed renal recovery. Urinalysis was noninflammatory so there was felt to be no need to consult Nephrology. Of note patient was very particular about managing his diabetes because of history of hypoglycemia and so he was allowed to decide how much long and short-acting insulin he took during his hospitalization. He preferred no changes to his outpatient diabetic regimen on discharge Issues Requiring Follow Up: (Who, what, when, and how communicated?) Follow-up resolution of bacterial pneumonia with plan to repeat 2 sets of blood cultures 1 week after completing antibiotics, discussed this with primary care provider who agreed to follow-up with repeat blood cultures; follow-up renal insufficiency, mild left hydronephrosis and other medical issues with primary care provider; follow-up diabetes mellitus with endocrinology; recommend repeat CT of chest in 6-8 weeks to assess resolution of pneumonia with possible component of pulmonary necrosis."""
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 4,0
- Labordaten
- Covid PCR detected on 01/15/2023
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Cardiovascular Primary hypertension Mixed hyperlipidemia Digestive Pancreatic insufficiency Gastroesophageal reflux disease without esophagitis Tubular adenoma of colon Barrett's esophagus Endocrine Blindness due to type 1 diabetes mellitus Type 1 diabetes mellitus with blindness and proliferative retinopathy Hypothyroidism Proliferative diabetic retinopathy of both eyes associated with type 1 diabetes mellitus (*) Type 1 diabetes mellitus with hyperglycemia Musculoskeletal Diaphragmatic hernia Respiratory Right lower lobe pneumonia with possible gram negative and anaerobic involvement Parapneumonic effusion Pulmonary necrosis Urinary Acute kidney injury Hydronephrosis of left kidney - minimal Other History of influenza A - Dec 2022 Gilbert's disease Disorder of bilirubin excretion Family history of prostate cancer Blindness of both eyes Bilateral recurrent inguinal hernia without obstruction or gangrene Medicare annual wellness visit, subsequent Sepsis COVID-19 virus detected
- Andere Medikamente
- amoxicillin-clavulanate (AUGMENTIN) 875-125 mg per tablet Take 1 tablet by mouth 2 (two) times daily. aspirin 81 mg Tab Take 1 tablet by mouth twice a week Takes this Wednesday and sunday. BD ULTRA-FINE MINI PEN NEEDLE 31 gauge x 3/16" nd
- Allergien
- AdhesiveRash Poison Ivy ExtractRash
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 23.02.2023
- Impfdatum
- 24.02.2021
- Beginn
- 01.07.2022
- Tage bis Beginn
- 492,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Abdominal pain lower
Arrhythmia
COVID-19
COVID-19 pneumonia
Colitis
Death
Gastrointestinal haemorrhage
Hyperkalaemia
Hypervolaemia
Hypophagia
Hypotension
Pneumonia
Pneumonia streptococcal
Positive airway pressure therapy
Red blood cell transfusion
Respiratory disorder
SARS-CoV-2 test positive
Sepsis
Symptomtext
#3 DOSE PFIZER COVID VACCINE GIVEN 10/24/21, #FF2593; #4 DOSE COMIRNATY COVID VACCINE GIVEN 6/28/22, #FM0173; pt brought to hospital from rehab on 7/16/22; found to be positive for COVID; COVID pneumonia; streptococcal pneumonia; streptococcal bacteremia; septic shock; volume overload; ABX; "COVID treatment" (specifics not noted in medical record); GI bleed; PRBCs transfused; high flow O2 via NC; dc'd to rehab on 8/6/22; 8/10/22 pt brought back to hospital with lower abdominal cramping and poor oral intake; on BiPAP; ICU; colitis with sepsis; hypotension; hyperkalemic with heart rhythm disturbances; pneumonia and septic shock; pt is DNI; respiratory status worsened; pt transitioned to DNR; she passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 32,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- ESRD
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 09.02.2023
- Impfdatum
- 11.10.2021
- Beginn
- 26.12.2022
- Tage bis Beginn
- 441,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute respiratory failure
Asthenia
COVID-19
COVID-19 pneumonia
Cardiac failure congestive
Fall
Pneumonia bacterial
SARS-CoV-2 test positive
Symptomtext
"Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR. Provider d/c note: ""Reason for Admission: Ground level fall 82 YO female with h/o subarachnoid hemorrhage 2/2 to intracranial aneurysm, Antithrombin 3 deficiency, CKD3, HTN, OA, HLD, T2DM who is presenting to the ED for evaluation of generalized weakness Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) treated for COVID pneumonia, superadded bacterial pneumonia, congestive heart failure transferred to care tel when off COVID isolation Acute hypoxic respiratory failure-resolved, required high-flow nasal cannula oxygen, on admission, in the setting of COVID positive, partially vaccinated On dexamethasone"""
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 11,0
- Labordaten
- Covid PCR detected on 12/26/2022
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Cardiovascular Pure hypercholesterolemia Essential hypertension Aortic valve sclerosis Chronic congestive heart failure Endocrine Type 2 diabetes mellitus with microalbuminuria, with long-term current use of insulin Urinary OAB (overactive bladder) CKD stage G3b/A3, GFR 30-44 and albumin creatinine ratio >300 mg/g (*) Urinary incontinence Nephrotic syndrome Other Antithrombin III deficiency Osteopenia Generalized OA Sciatica associated with disorder of lumbosacral spine At risk for falls Hx of spontaneous subarachnoid intracranial hemorrhage due to cerebral aneurysm History of DVT (deep vein thrombosis) Long term current use of anticoagulant therapy Chronic midline low back pain with right-sided sciatica Weakness Failure to thrive (child) COVID Closed fracture of multiple ribs of right side with routine healing Anemia
- Andere Medikamente
- amLODIPine (NORVASC) 10 mg tablet Take 1 tablet by mouth daily. apixaban (ELIQUIS) 5 mg tablet Take 1 tablet by mouth 2 (two) times daily for 30 days. B complex-vit C-folic acid (NEPHRO-VITE) 0.8 mg tablet Take 1 tablet by mouth daily.
- Allergien
- Ace InhibitorsUnknown
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 30.01.2023
- Impfdatum
- 21.02.2021
- Beginn
- 01.07.2022
- Tage bis Beginn
- 495,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
Anaemia
Atrial fibrillation
Atypical pneumonia
COVID-19
COVID-19 pneumonia
Dialysis
Encephalopathy
Computerised tomogram thorax abnormal
Condition aggravated
Cough
Death
Dyspnoea
Haemoptysis
Leukocytosis
Pyelonephritis
Transfusion
Hypotension
Symptomtext
Pt had a recent hospitalization from 7/27 - 8/5/22 with anemia, COVID 19, and pyelonephritis; tx with O2 supplementation and ABX and transfusion; dc'd back to SNF; back to ED with cough, SOB, blood-tinged sputum; CT chest showed atypical pneumonia/inflammatory process; given ABX and O2 supplementation, Mucinex; AHRF; leukocytosis; Atrial Fibrillation with RVR, treated with medication; DNR/DNI; pt had multiple medical problems and medical instability; was transitioned to comfort care and passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 9,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- right renal CA, Atrial Fibrillation/flutter - on Eliquis, ESRD - on hemodialysis
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 26.01.2023
- Impfdatum
- 20.10.2021
- Beginn
- 18.11.2022
- Tage bis Beginn
- 394,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Abdominal pain
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Hypoxia
Productive cough
SARS-CoV-2 test positive
Symptomtext
Patient was previously seen in the ED on 11/12/22 for abdominal pain. During this visit, she tested positive for COVID-19 by PCR. She returned to the ED on 11/18/22 with continued abdominal pain along with a productive cough. While in the ED, the provider noted that she was intermittently hypoxic, so patient was placed on 2L O2 by nasal cannula. Ultimately patient admitted 11/18/22 - 11/21/22. Discharge diagnosis included acute hypoxic respiratory failure due to COVID-19 pneumonia. Patient was weaned to room air 11/20.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 21.01.2023
- Impfdatum
- 24.02.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 5,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cerebral haemorrhage
Symptomtext
brain bleed after 1st COVID-19 Vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. An 81-year-old female patient received BNT162b2 (BNT162B2), on 24Feb2021 as dose 1, single (Lot number: EN6200, Expiration Date: 30Jun2021) at the age of 81 years intramuscular for covid-19 immunisation; apixaban (ELIQUIS), for anticoagulant therapy. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: CEREBRAL HAEMORRHAGE (hospitalization, medically significant) with onset Mar2021, outcome "unknown", described as "brain bleed after 1st COVID-19 Vaccine". The event "brain bleed after 1st covid-19 vaccine" required emergency room visit. The action taken for apixaban was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300026448 Same patient, same product, different dose, different event;US-PFIZER INC-202300026488 Same patient, same product, different dose, different event;
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebral haemorrhage
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: Other Conditions: No
- Andere Medikamente
- ELIQUIS
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 11.01.2023
- Impfdatum
- 24.03.2021
- Beginn
- 31.10.2022
- Tage bis Beginn
- 586,0
- Dosis
- 1
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Cough
Dyspnoea
Oxygen saturation decreased
Pain
Pyrexia
SARS-CoV-2 test positive
Symptomtext
Patient with history of Alzheimer's. She was seen in the ED on 10/31 with a fever, dry cough, body aches, and mild shortness of breath. Prior to coming to the ED, the patient's daughter was periodically checking the patient's oxygen saturation, and reported it dropped as low as 83%. Patient took an at home COVID test prior to coming to the ED and it was positive. Additionally, she was tested for COVID-19 by PCR in the ED and was positive. While in the ED, her oxygen saturations ranged from the low 90s to high 80s on room air, and she required 2 L O2 via nasal cannula. Patient was admitted 10/31 - 11/2 for acute hypoxic respiratory failure due to COVID-19 pneumonia. At discharge the patient was on room air. Patient has received the primary COVID vaccine series.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 22.12.2022
- Impfdatum
- 08.03.2022
- Beginn
- 01.07.2022
- Tage bis Beginn
- 115,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
3RD DOSE OF PFIZER COVID VACCINE GIVEN 8/16/21, LOT #0698057; pt had a positive COVID test on 7/7/22 and passed away in his home on 7/13/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- ATRIAL FIBRILLATION, COPD, DIFFUST LARGE B CELL LYMPHOMA, VASCULAR DEMENTIA, GERD, BPH
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 99,0
- Geschlecht
- M
- Eingang
- 21.12.2022
- Impfdatum
- 04.03.2021
- Beginn
- 01.07.2022
- Tage bis Beginn
- 484,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Death
Pneumonia
SARS-CoV-2 test positive
Symptomtext
PFIZER COVID VACCINE DOSE #3 GIVE 12/14/21, LOT #FH8027; pt in facility for pneumonia; pt has completed ABX tx; had a positive COVID test on 7/9/22; isolation set up; DNR with comfort measures; family does not want pt sent to hospital; pt passed away 2 days later in the facility
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 21.12.2022
- Impfdatum
- 24.02.2021
- Beginn
- 29.09.2022
- Tage bis Beginn
- 582,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute respiratory failure
Angiogram pulmonary abnormal
Blood gases abnormal
COVID-19
Chronic obstructive pulmonary disease
Condition aggravated
Hypercapnia
Hypoxia
Intensive care
Lung consolidation
Respiratory distress
SARS-CoV-2 test positive
Pleural effusion
Respiratory failure
Symptomtext
85y.o. female presenting with acute on chronic hypoxic respiratory failure. She has history of COPD on home oxygen as well as nocturnal BiPAP. Upon presentation, ABG showed significant CO2 retention. She was begun on broad-spectrum antibiotics. She did require temporary transfer to MICU due to worsening hypoxia. Fortunately, patient did improve and did not require intubation. Further work-up included CTA PE protocol which did not show PE but did show partially loculated effusions as well as near complete consolidation of left lower lobe. Patient was seen by infectious disease as well as pulmonology. Eventually, her oxygenation improved back towards her previous baseline. She completed her courses of antibiotics inpatient. She was also treated with steroid burst due to COPD. She was mobilized with PT/OT and was determined appropriate for home with home care. Following this, she was stable for discharge and was discharged home to complete 1 additional day of her steroid burst. She will follow-up with primary care as well as pulmonology outpatient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- 9/29 SARS-CoV-2 -COVID-19 by NAA, Micro -- detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 15.12.2022
- Impfdatum
- 18.02.2021
- Beginn
- 11.12.2022
- Tage bis Beginn
- 661,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19
Dysphagia
Endotracheal intubation
Extubation
Intensive care
Metabolic encephalopathy
SARS-CoV-2 test positive
Sepsis
Symptomtext
Patient received Pfizer COVID vaccine on 1/27/21 and 2/18/21. On 12/11/22, patient admitted from SNF to our inpatient facility intubated with a positive COVID test. Patient was admitted to our ICU intubated with acute respiratory failure with hypoxia and sepsis due to COVID, acute metabolic encephalopathy, and severe dysphagia. On 12/22/22, patient was extubated and transferred out from ICU to med/surg unit. As of today (12/15/22), patient is still admitted in the med/surg unit.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 4,0
- Labordaten
- COVID status positive 12/11/22.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- SNF resident with history of paraplegia, schizoaffective disorder, drug induced Parkinsonism, CAD, depression, severe dysphagia with gastrostomy tube in place At baseline he is bed bound, depressed mental status, contractured, and paralyzed.
- Andere Medikamente
- acetaminophen, caloric supplement, gabapentin, Jevity, lisinopril, lorazepam, olanzapine, quetiapine, trazodone, valbenazine
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 15.12.2022
- Impfdatum
- 02.03.2021
- Beginn
- 01.06.2022
- Tage bis Beginn
- 456,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acidosis
Atrial fibrillation
COVID-19
Cardiac arrest
Cardio-respiratory arrest
Death
Endotracheal intubation
Hypotension
Intensive care
Leukocytosis
Mechanical ventilation
Resuscitation
SARS-CoV-2 test positive
Unresponsive to stimuli
Urinary tract infection
Symptomtext
PFIZER COVID VACCINE #3 GIVEN 10/19/2021, LOT #320308D; pt to ED via EMS from SNF; pt experienced cardiac arrest at SNF; CPR started; ROSC achieved; coded again in ambulance; intubated with mechanical ventilation in ED; unresponsive; hypotensive, given levophed; found to be positive for COVID; A Fib with RVR, treated with medication; UTI; leukocytosis, lactic acidemia; ICU; family stated pt was DNR; transitioned to comfort measures and she passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 14.12.2022
- Impfdatum
- 04.03.2021
- Beginn
- 01.06.2022
- Tage bis Beginn
- 454,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Cardiomegaly
Chest X-ray abnormal
Death
Dyspnoea
Haemodialysis
Loss of consciousness
Lung infiltration
Pleural effusion
Pulmonary oedema
Pulse absent
Respiratory arrest
Resuscitation
SARS-CoV-2 test positive
Symptomtext
PFIZER COVID VACCINE #3 GIVEN 10/30/21, LOT #32030BD; 6/13/22 pt to ED with SOB; states had a positive COVID test on 6/11/22 from Urgent Care; O2 supplementation; dexamethasone; CXR showed cardiomegaly, central vascular congestion, bilateral infiltrates, small right pleural effusion; while receiving hemodialysis, pt lost consciousness, no pulse or breathing; CPR unsuccessful; pt passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- DM, HTN, HLD GERD, ESRD - on dialysis, anxiety, COPD, asthma, PVD, CAD
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 07.12.2022
- Impfdatum
- 01.03.2021
- Beginn
- 27.05.2021
- Tage bis Beginn
- 87,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Aphasia
Arterial catheterisation
Arterial disorder
Arterial haemorrhage
Arteriosclerosis
Blood test normal
Cancer screening
Cardiac monitoring normal
Carotid artery occlusion
Carotid artery thrombosis
Carotid endarterectomy
Cerebral thrombosis
Cerebrovascular accident
Cytogenetic analysis normal
Demyelination
Dysarthria
Dystrophic calcification
Eosinophilia
Symptomtext
Initial symptoms of blurry vision, dry sweats, loss of limb right slide function, and unable to speak at 4:00pm on 5/25/21. I was found down on the ground at work and brought to hospital at 4:15pm on 5/25/21. I had difficulty with following commands, unable to move the right side of face and entire right side of my body. Also had expressive aphasia and dysarthria. I was taken to the operating room where they found a clot in the left side of my brain (LM2 cutoff) via internal carotid artery. TPA was administered and a catheter was inserted via my femoral artery to remove the clot from the left side of my brain. There was apparent loss of grey matter around the area of the clot. They found a larger clot within the left internal carotid artery. Left-side carotid endarterectomy with use of patch graft was attempted on the morning of 5/26/21 where they removed a 2 cm by 0.5 cm clot. The patch graft procedure failed, and my left internal carotid artery could not be repaired due to the artery having poor tissue quality. After 10 hours in the operating room for a somewhat routine procedure that should have taken 2 hours, they had to sacrifice my left internal carotid artery and rely on the remaining arteries to supply blood/oxygen to my brain. After I awoke the next day, they confirmed occlusion /sacrifice of the Left cervical ICA origin with no persistent embolic source (cephalad contrast column in ICA) and robust collateral circulation via the PCOM and ACOM. The clot was sent to the pathologist and sections show an organizing hemorrhage/thrombus dissecting between layers of an arterial wall with EVG positive elastin fibers on both sides of the dissection. Adjacent to the intramural hemorrhage/thrombus vascular wall architecture consists of anuclear fibrous or hyalinized eosinophilia rather than the laminated concentric layers of myocytes expected in a tunica media. There is also evidence of atherosclerotic plaque with cholesterol crystal cleft spaces in a faintly basophilic anuclear matrix, intramural foamy vacuolated lipid bearing cells, myointimal spindle cells, and dystrophic calcifications. An adjacent thrombus shows early organization with infiltrating fibroblasts. All follow up blood tests, Ehlers Danlos genetic test, cancer screening, blood clot screening, heart monitoring daily for 2 months were negative. This is being labeled as a cryptogenic stroke. Occurred approximately 9 weeks after second vaccine dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 7,0
- Labordaten
- All follow up blood tests, Ehlers Danlos genetic test, cancer screening, blood clot screening, heart monitoring daily for 2 months were negative.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Omeprazole
- Allergien
- Tree nuts, felines
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 22.09.2022
- Impfdatum
- 23.02.2021
- Beginn
- 14.11.2021
- Tage bis Beginn
- 264,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Death
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Patient received two vaccines; admitted with breakthrough case and expired
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 13.09.2022
- Impfdatum
- 26.02.2021
- Beginn
- 05.02.2022
- Tage bis Beginn
- 344,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute kidney injury
Anaemia
Atrial fibrillation
COVID-19
Cough
Death
Dyspnoea
Electrocardiogram abnormal
SARS-CoV-2 test positive
Symptomtext
PFIZER COVID VACCINE #3 GIVEN 11/5/21, LOT #FF8841; pt had a positive COVID test in the nursing home on 2/5/22; 2/7/22 pt to hospital with increasing SOB, cough; acute renal failure, anemia; EKG showed Atrial Fib with RVR, medications given to treat; DNR/DNI; ABX given; family decided to transition to comfort; given Decadron and nebulizer treatments; 2/10/22 pt returned to nursing home where she passed away
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- DEMENTIA, ANEMIA, CVA, DYSPHAGIA, DEPRESSION, ANXIETY, HLD, HTN, GERD
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 04.09.2022
- Impfdatum
- 04.02.2021
- Beginn
- 04.03.2022
- Tage bis Beginn
- 393,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: unbekannt
Back pain
Biopsy bone marrow
Brain oedema
Cerebral haemorrhage
Endotracheal intubation
Fall
Hemiparesis
Magnetic resonance imaging abnormal
Mental status changes
Muscular weakness
Shock
Spinal disorder
Symptomtext
My husband was 42-year-old male with past medical history of ADHD who initially presented to local Medical Center hospital on 04/02 with frequent falls, right arm weakness and altered mental status. Was found to have acute intraparenchymal hemorrhage with surrounding edema in the rt occipital lobe, subsequently was intubated for airway protection, course was complicated by worsening shock requiring vasopressors and transferred to alternate hospital for further care. Patient was dealing with atraumatic back pain since March 2022, eventually obtained an MRI on 03/25/2022 which showed spinal pelvic lesions, and was referred to the cancer center, and a bone marrow biopsy was performed on 03/30/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebral haemorrhage
- Hospital-Tage
- 11,0
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Gout, nose bleeds, ADHD, bulging discs in his back L4 and L5
- Andere Medikamente
- Aderall 20mg, twice a day and ibuprofen as needed for gout
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 02.09.2022
- Impfdatum
- 17.02.2021
- Beginn
- 01.01.2022
- Tage bis Beginn
- 318,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
pt passed away at home; she had a positive COVID test on 1/27/22 from Lab.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 16.08.2022
- Impfdatum
- 21.02.2021
- Beginn
- 01.02.2022
- Tage bis Beginn
- 345,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Abdominal pain
Acidosis
Acute kidney injury
Anaemia
Asthenia
Anticoagulant therapy
COVID-19
Cardiac arrest
Coagulopathy
Computerised tomogram abdomen abnormal
Computerised tomogram thorax abnormal
Decubitus ulcer
Disseminated intravascular coagulation
Death
Diverticulitis
Endotracheal intubation
Extravasation
Diverticulum
Symptomtext
2/15/22 pt to ED with generalized weakness, abdominal pain; new decubitus ulcers; grossly heme positive stool; positive COVID test; hypotensive; given 1 unit of blood; CT of chest, abdomen, pelvis showed multifocal pneumonia, main pulmonary artery pulmonary embolus, severe diverticulitis; vasopressors; ABX; transferred to ICU; pt had a severe drop in hemoglobin and hematocrit; CT abdomen showed acute extravasation from distal duodenum; pt intubated and experienced cardiac arrest during intubation; ROSC achieved after ACS measures; vasopressor support and blood products given; worsening condition; acute renal failure; in DIC; continued to worsen; pt made an intubate only with aggressive measures; continued to be acidotic and anemic; pt passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- 10,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 91,0
- Geschlecht
- F
- Eingang
- 08.08.2022
- Impfdatum
- 23.02.2021
- Beginn
- 05.01.2022
- Tage bis Beginn
- 316,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
COVID-19
Cardiac failure acute
Chronic kidney disease
Death
Dyspnoea
Hypervolaemia
Left ventricular failure
Positive airway pressure therapy
Procalcitonin increased
SARS-CoV-2 test positive
Symptomtext
Patient with a hx of COPD and CHF presented to Medical Center on 12/31/2021 with SOB. In the ED patient was placed on BiPAP. Patient was started on Lasix for volume overload, procalcitonin was elevated, started on empiric meropenem. Patient tested positive for COVID 19 on 01/05/2022. Patient remained in hospital for isolation until 01/17/2022 and discharge to skilled nursing facility with possible hospice. Patient then admitted to Health Center with acute and chronic respiratory failure, acute on chronic systolic heart failure, COPE, CKD IV. Patient expired at facility on 01/28/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 04.08.2022
- Impfdatum
- 21.02.2021
- Beginn
- 01.02.2022
- Tage bis Beginn
- 345,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chest X-ray
Computerised tomogram thorax
Death
Leiomyosarcoma
Magnetic resonance imaging
Metastases to lung
Positron emission tomogram
Symptomtext
Aggressive leiomyosarcoma with METS to the lungs diagnosed 3/2022. Confirmed by Oncology 4/2022. No treatment set up before death. Death 5/12/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- CXR, CT chest, whole body PET scan, and MRI all completed between March and date of death in May 2022.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Arthritis
- Andere Medikamente
- Calcium and vitamin D
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 04.08.2022
- Impfdatum
- 01.03.2021
- Beginn
- 01.10.2021
- Tage bis Beginn
- 214,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
COVID-19 pneumonia
Death
General physical health deterioration
Respiratory failure
SARS-CoV-2 test positive
Symptomtext
pt had a recent hospitalization on 10/8/21 for COVID Pneumonia and respiratory failure; was positive for COVID on 10/8/21; was sent to Hospice; pt progressively declined; DNR; comfort measures only; pt found deceased in hospice facility
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- CLL, THROMBOCYTOPENIA AND ITP
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 86,0
- Geschlecht
- M
- Eingang
- 02.08.2022
- Impfdatum
- 08.12.2021
- Beginn
- 27.07.2022
- Tage bis Beginn
- 231,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Dizziness
Dyspnoea
SARS-CoV-2 test positive
Symptomtext
Patient with a significant past medical history of COPD who presented to the emergency department with his daughter today with a chief complaint of shortness of breath and dizziness in the setting of a positive home COVID-19 test. Patient admitted as observation on 7/27 due to acute respiratory failure with hypoxia due to COVID pneumonia. Patient was tested for COVID-19 and was positive on 7/27.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 02.08.2022
- Impfdatum
- 21.09.2021
- Beginn
- 24.07.2022
- Tage bis Beginn
- 306,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19
SARS-CoV-2 test positive
Symptomtext
Patient admitted as observation on 7/24 due to acute respiratory failure with hypoxia. Patient was tested for COVID-19 and was positive on 7/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 02.08.2022
- Impfdatum
- 18.04.2022
- Beginn
- 21.07.2022
- Tage bis Beginn
- 94,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Cardiac arrest
Cardio-respiratory arrest
Intensive care
SARS-CoV-2 test positive
Symptomtext
Patient is a 75 y.o. year old male with complex medical history including bladder cancer receiving palliative chemo, and percutaneous nephrostomy tubes and urostomy, CKD, CAD with hx of CABG, GERD, admitted after cardiac arrest in the field, coded and ROSC, now in CCU, also found to be covid + on admission.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 01.08.2022
- Impfdatum
- 01.03.2021
- Beginn
- 29.07.2021
- Tage bis Beginn
- 150,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Ataxia
COVID-19
Cerebrovascular accident
Death
SARS-CoV-2 test positive
Symptomtext
Patient was a resident of Siskin Hospital for Physical Rehabilitation, recovering from CVA with ataxia, and tested positive for Covid-19 on 7/29/2021 and transferred to the Covid unit. Patient received Decadron and Monoclonal antibodies, placed on 4.5 liters of O2 NC. Patient expired on 08/13/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 99,0
- Geschlecht
- F
- Eingang
- 26.07.2022
- Impfdatum
- 25.02.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 249,0
- Dosis
- 1
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Death
Endotracheal intubation
Intensive care
Mechanical ventilation
Mental status changes
Respiratory distress
SARS-CoV-2 test positive
Shock
Symptomtext
11/2/21 pt had a positive COVID test; 11/7/21 pt to ED with AMS and in respiratory distress requiring intubation with mechanical ventilation upon arrival; positive COVID test; developed worsening shock; transferred to ICU; pt expired in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- CLL, A Fibrillation, COPD, HTN, hypothyroidism
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 88,0
- Geschlecht
- M
- Eingang
- 12.07.2022
- Impfdatum
- 05.03.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- 149,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Cerebral haemorrhage
Computerised tomogram head abnormal
Death
Face injury
Fall
General physical health deterioration
SARS-CoV-2 test positive
Subarachnoid haemorrhage
Symptomtext
8/25/21 pt admitted to hospital after a fall at home where he hit the right side of his face; CT showed acute IPH and SAH; found to be positive for COVID on admission; O2 supplementation; dexamethasone; pt's condition worsened; he refused PEG tube or any advanced measures; condition declined; inpatient hospice care; pt expired in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebral haemorrhage
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HTN, CKD stage 3
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 23.06.2022
- Impfdatum
- 24.02.2021
- Beginn
- 22.01.2022
- Tage bis Beginn
- 332,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Atrial fibrillation
COVID-19
Cardio-respiratory arrest
Condition aggravated
Death
Hypotension
Respiratory distress
SARS-CoV-2 test positive
Unresponsive to stimuli
Symptomtext
Pt to ED 1/22 for hypotension, respiratory distress and AFib, upon arrival pt is not alert to any stimuli. COVID+ 1/22, on Vancomycin. Pt coded twice, first time for 5 minutes second for 1 minute, pt received antibiotics and multiple boluses. Family changed code status to comfort care, pt expired 1/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardio-respiratory arrest
- Hospital-Tage
- 1,0
- Labordaten
- see above
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Pulmonary emphysema (CMS/HCC) ... Pulmonary emphysema (CMS/HCC) Obstructive sleep apnea syndrome C. difficile colitis, 11/26/21 Endocrine Hypothyroidism Diabetes mellitus (CMS/HCC) Chronic pulmonary embolism (CMS/HCC) Renal failure Lymphedema of both lower extremities BMI 50.0-59.9, adult (CMS/HCC) Debility General weakness AKI (acute kidney injury) (CMS/HCC) Chronic atrial fibrillation (CMS/HCC) Atrial fibrillation (CMS/HCC) Essential hypertension Mixed hyperlipidemia Venous insufficiency, peripheral Xerosis of skin Traumatic hematoma of left lower leg Ulcer of left lower extremity with fat layer exposed (CMS/HCC) Leg edema Chronic venous hypertension with ulcer involving left side Venous ulcer of left leg (CMS/HCC) Varicose veins of l low extrem w ulcer oth part of lower leg (CMS/HCC) Macrocytic anemia Inability to walk Acute bilateral ankle pain CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min (CMS/HCC) Closed fracture of multiple ribs of right side with routine healing Hypertensive heart disease without heart failure At risk for falls At risk for impaired skin integrity Pulmonary nodule Venous stasis Acute on chronic congestive heart failure (CMS/HCC) CKD (chronic kidney disease) Recurrent cellulitis of right lower extremity Urinary retention Swelling Gluteal abscess Supratherapeutic INR Necrotizing soft tissue infection Paroxysmal atrial fibrillation (CMS/HCC) Functional quadriplegia (CMS/HCC) Left wrist sprain Respiratory distress
- Andere Medikamente
- atorvastatin (LIPITOR) 10 MG PO Tab ... atorvastatin (LIPITOR) 10 MG PO Tab colchicine (COLCRYS) 0.6 MG PO Tab collagenase (SANTYL) 250 UNIT/GM EXTERNAL Ointment fluticasone (FLONASE) 50 MCG/ACT NASAL Suspension levothyroxine (SYNTHROID, LE
- Allergien
- hydrochlorothiazide, sulfa antibiotics
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 22.06.2022
- Impfdatum
- 04.09.2021
- Beginn
- 30.05.2022
- Tage bis Beginn
- 268,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute kidney injury
COVID-19
Clostridium difficile infection
Death
Enterococcal infection
General physical health deterioration
Pneumonia
Respiratory failure
Symptomtext
Pt presented to hospital with covid hypoxic failure, pnuemonia, cdiff, VRE in urine, and acute renal failure. Pt continued to delcine with treatment and famliy signed withdrawal of care, pt deceased.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- breast cancer with mets, chemo, hypothyrodism, cervical cancer, bone cancer diverticulitis.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 17.06.2022
- Impfdatum
- 23.02.2021
- Beginn
- 03.06.2022
- Tage bis Beginn
- 465,0
- Dosis
- 2
- Route/Site
- UN / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Atrial fibrillation
Blood lactic acid
Brain injury
Brain natriuretic peptide increased
Cardiac arrest
Chest X-ray abnormal
Condition aggravated
Death
Dyspnoea
Echocardiogram abnormal
Ejection fraction decreased
Electrocardiogram abnormal
Endotracheal intubation
Haemorrhage intracranial
Hypervolaemia
Hypoxia
Jugular vein distension
Laboratory test
Symptomtext
Patient seen in ED at the Hospital. Patient presented to ED with worsening shortness of breath and hypoxia. Patient was hypoxic at home. Patient had recent admission with sepsis secondary to lumbar spine infection with MSSA bacteremia and intracranial hemorrhage discharged to rehab on IV cefazolin. Patient was initially tachycardic. Lactic acid 1.92, white blood cell count 9.01. Noted to have elevated troponin. He appeared fluid overloaded with JVD and peripheral edema. BNP was elevated and chest x-ray appeared to show no focal infiltrates to suggest pneumonia. Cardiac enzymes were very mildly elevated. His EKG showed A. fib. He has no chest pain and no shortness of breath at rest. Chest xray with Rt pleural effusion. Patient was treated with Lasix. Patient was scheduled to have an MRI to further assess his infection and lumbar spine. This was performed in the emergency department and showed worsening of the fluid collection than previously noted. He had been on IV antibiotics with no acute surgical intervention, but the areas needed to be drained by interventional radiology. Patient was admitted for further management. Patient developed PEA arrest. No PE or significant rise in troponin level. Echocardiogram did show significant decrease of LVE F, from 40% to 20%. Suspect viral cardiomyopathy. He was intubated and started on Decadron protocol. Mentally, he was unresponsive off sedation. Head imaging with MRI was negative for acute process. Suspected anoxic brain injury. Treatment was continued but no meaningful mental recovery. POA elected to pursue comfort/hospice care. Discharge to inpatient hospice service 6/6/22 Pt was on comfort cares and transitioned to in hospital hospice. He time of death was 1610.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- -
- Labordaten
- Lab, chest x-ray, MRI-L-spine, Ekg
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- systolic and diastolic heart failure, L2 compression fracture, chronic lower back pain, CKD st age III, CAD with previous stenting, paroxysmal atrial fibrillation, hypertension, hyperlipidemia, chronic anemia, gout, Alzheimer's disease, BPH,
- Andere Medikamente
- unknown
- Allergien
- Ambien Morphine
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 13.06.2022
- Impfdatum
- 17.02.2021
- Beginn
- 09.06.2022
- Tage bis Beginn
- 477,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute myocardial infarction
Asthenia
COVID-19
COVID-19 pneumonia
Encephalopathy
Dehydration
Diarrhoea
SARS-CoV-2 test positive
Syncope
Symptomtext
He presented to the ED on 06/08/22 after a syncopal episode at home, likely due to dehydration and diarrhea. He was found to be COVID-19 positive.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 13.06.2022
- Impfdatum
- 17.02.2021
- Beginn
- 09.06.2022
- Tage bis Beginn
- 477,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute myocardial infarction
Asthenia
COVID-19
COVID-19 pneumonia
Encephalopathy
Dehydration
Diarrhoea
SARS-CoV-2 test positive
Syncope
Symptomtext
He presented to the ED on 06/08/22 after a syncopal episode at home, likely due to dehydration and diarrhea. He was found to be COVID-19 positive.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 08.06.2022
- Impfdatum
- 23.02.2021
- Beginn
- 11.01.2022
- Tage bis Beginn
- 322,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenia
COVID-19
Chest X-ray abnormal
Death
Failure to thrive
General physical health deterioration
Impaired self-care
Lung opacity
Pulmonary embolism
Urinary tract infection
Symptomtext
Patient presented to ED on 03/05/2022 with generalized weakness. Patient was previously hospitalized at facility on 01/11/2022 to 02/09/2022 with failure to thrive and Covid-19, Right segmental PE. Since discharge from the facility, the patient has became progressively worse, and unable to care for himself. In ED chest xray revealed bibasilar airspace opacities, and UTI, started on antibiotics. Patient was discharged on 03/14/2022 to hospice. Patient expired on 04/02/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 9,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 08.06.2022
- Impfdatum
- 05.03.2021
- Beginn
- 05.01.2022
- Tage bis Beginn
- 306,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute kidney injury
Blood test
COVID-19
Death
Enterococcus test positive
Hypotension
Presyncope
SARS-CoV-2 test positive
Staphylococcus test positive
Syncope
Urine analysis
Symptomtext
Patient tested positive for covid-19 on 01/05/2022. Patient then presented to ED on 03/19/2022 with presyncope/syncope complicated by past medical history of AMS, recent VRE/MRSA in urine and blood, GERD, CAD s/p CABG, HTN. Patient was discharged to SNF on 03/23/22. Discharge diagnosis included Hypotension, Near syncope, AKI. Patient expired on 03/29/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 03.06.2022
- Impfdatum
- 15.09.2021
- Beginn
- 15.05.2022
- Tage bis Beginn
- 242,0
- Dosis
- 2
- Route/Site
- UN / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Blood product refusal
COVID-19
COVID-19 pneumonia
Chest X-ray
Complication associated with device
Death
Dyspnoea
Electrocardiogram
Endotracheal intubation
Enteral nutrition
Gastric haemorrhage
Gastritis erosive
Hypoxia
Laboratory test
Melaena
Normocytic anaemia
Oesophagogastroduodenoscopy abnormal
Pneumonia bacterial
Symptomtext
This patient had an extensive past medical history including breast cancer, lymphoma, CAD s/p stents. Patient was vaccinated with Pfizer vaccine x3. She presented to the hospital with shortness of breath, hypoxia after being evaluated at urgent care. Patient had tested positive for COVID-19 approximately 3 weeks prior to Hospital on 5/15/2022. The patient had a prolonged and complex hospitalization, with numerous consultants during her stay including infectious disease, intensivist/pulmonology, nephrology, gastroenterology, palliative care teams. She was treated for COVID-19 pneumonia with steroids, duo nebs at the at the direction of infectious disease. This patient was also thought to have superimposed bacterial pneumonia and completed a course of ceftriaxone and doxycycline. She was suspected to have post COVID pneumonitis/pulmonary fibrosis as well contributing to worsening shortness of breath and respiratory decline. Patient was DNR. She was initially hesitant to be intubated but did elect intubation. Patient did not improve, and her respiratory status continued to decline. Hospitalization was complicated by acute on chronic normocytic anemia. She also had melena and underwent EGD with findings of slow oozing blood likely from NG tube gastric erosions. She was treated with APC. Of note, patient would not accept blood products. Nephrology followed closely and assisted with volume management during her stay. Patient had aggressive treatment by pulmonologist/intensivist, multiple consultants input, but patient respiratory continued to decline. Palliative care followed and family elected to transition the patient to comfort measures. Family was able to visit and she was compassionately extubated at 11 AM and given IV morphine for comfort. Time of death was 11:14.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 15,0
- Labordaten
- lab chest Xray EKG
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Lymphoma CHF CAD with stents Anemia
- Andere Medikamente
- unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 31.05.2022
- Impfdatum
- 30.09.2021
- Beginn
- 21.05.2022
- Tage bis Beginn
- 233,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Confusional state
Crepitations
Dementia
Full blood count abnormal
Hypoxia
Lung infiltration
Lymphopenia
Nasopharyngitis
SARS-CoV-2 test positive
Symptomtext
He had a "cold" starting on Thursday. Treated with Alka-Seltzer. Noted he was having increasing crackles with breathing and started to have some increasing confusion off of his baseline dementia. Wife stated his senses did not make sense are were irrelevant. Patient has had a history of TIAs in the past but she said that was not exactly the same. Otherwise has not been ill recently. In the emergency department was found to be hypoxic requiring 2 L of oxygen. a chest x-ray was obtained and read as an infiltrate. Was started on ceftriaxone and azithromycin. With fluids and antibiotics the patient's mental status improved. Following this however his COVID-19 testing returned positive. Of note he does have lym phopenia on his CBC. Admitted for further cares. Patient admitted to GHS for observation on 05/21/2022 due to Acute respiratory failure with hypoxia, secondary to COVID-19 pneumonia and possibly secondary bacterial pneumonia.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 8,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 26.05.2022
- Impfdatum
- 27.02.2021
- Beginn
- 11.08.2021
- Tage bis Beginn
- 165,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenia
COVID-19
Death
Fall
Fatigue
Hypersomnia
Intensive care
Muscular weakness
Pleural effusion
Pneumonia
SARS-CoV-2 test positive
Symptomtext
Patient was recently discharged from Hospital on July 30, 2021 after receiving treatment for community acquired PNA and pleural effusion. Sent home on ABX and completed that course on August 5th. Daughter reports since discharge patient has been very fatigued with no energy and sleeps most of day, with increasing bilateral lower extremity weakness and has fallen which prompted a call to EMS. On arrival to ED patients BP was 79/42 and HR in 50's. A sepsis bundle was initiated and was started on Levophed with an ICU admission. Patient tested positive for Covid 19 on 8/11/2021. Patient expired on 08/19/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 22.05.2022
- Impfdatum
- 09.03.2021
- Beginn
- 13.10.2021
- Tage bis Beginn
- 218,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Angina pectoris
Back injury
Coronary arterial stent insertion
Coronary artery disease
Electrocardiogram abnormal
Myocardial infarction
Symptomtext
Sudden painful, almost paralyzing, Heart Attack - Coronary Artery Disease, Drug eluding Stent in Left Anterior ( Widow-Maker ) descending artery Sudden Onset when on my second or third lap swimming in the daily Swimming program the morning of Wed, Oct 13, 2021. Was on a course of Prednisone for a Back injury suffered the week before. I thought I was having a bad case of Angina/Chest Pain since I had a similar (NOT Heart Attack ) documented event in 2013. I managed to get myself home and take the prescribed Prednisone hoping that would give me relief...but it did NOT. Had son take me to ER who then transferred me the the Medical Center.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocardial infarction
- Hospital-Tage
- 2,0
- Labordaten
- EKG, Oct 13, 2021
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Ruptured Feet Fibromas, Neuropathy, Paresthesia, Numbness, Loss of Smell, Random Paralyzing Back-neck Spasms-Cramps, Osteoarthritis, Sleep Apnea, Allergies
- Andere Medikamente
- Flexirol-5mg/day, Flonase-2 sprays each nostril \day, Claritin-10mg/day, Zytec, 10mg/day, Celebrex-100mg x 4/day, Prolisec-100mg/day, Centrum Silver, Gingko Biloba, Fish Oil, Vita E, Flaxseed, Calcium, Tonic Water, B6, Probiotics, Melatonin
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 20.05.2022
- Impfdatum
- 02.03.2021
- Beginn
- 01.09.2021
- Tage bis Beginn
- 183,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Death
Inappropriate schedule of product administration
SARS-CoV-2 test positive
Symptomtext
pt had a positive COVID test on 9/14/2021; requested med records; the wrong pt's records were sent; refaxed for records and they were not received by this time; per death certificate, a positive COVID test was listed as a contributing factor; death certificate sent per VAERS request
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 15.02.2021
- Beginn
- 19.01.2022
- Tage bis Beginn
- 338,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
Blood albumin decreased
Blood alkaline phosphatase increased
Blood glucose normal
Blood lactic acid
Brain natriuretic peptide normal
COVID-19
Cough
Death
Dyspnoea at rest
Dyspnoea exertional
Headache
Hyperhidrosis
Influenza A virus test negative
Nausea
Pain
Pyrexia
SARS-CoV-2 test positive
Symptomtext
Patient presents to medical center with complaints of dyspnea. On 1/17/2022 patient started having a nonproductive cough and fever and ongoing UTI, which she was prescribed antibiotics by PCP. During ED presentation she reports sweats, headache, body aches, dyspnea at rest and with activity and nonproductive cough, nausea, and vomiting. Patient received Zithromax 500 mg IV, cefepime 2 g IV, and Decadron 6mg IV. Admitted to COVID unit with acute respiratory failure. Started on dexamethasone, remdesivir, and oxygen. Pulmonary started patient on baricitnib. Patient did not respond to treatment favorably. Patient family decided to proceed with comfort care measures. Patient expired on 1/26/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 7,0
- Labordaten
- ER workup; Glucose 139, albumin 3, total alkaline phosphatase 152, lactic 1, BNP 26, Influenza A negative, Covid 19 positive.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 04.05.2022
- Impfdatum
- 26.02.2021
- Beginn
- 20.08.2021
- Tage bis Beginn
- 175,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Anticoagulant therapy
Atrial fibrillation
COVID-19
Cardiac arrest
Confusional state
Death
Dysarthria
Imaging procedure abnormal
Intensive care
Magnetic resonance imaging normal
Mental status changes
Pneumonia
Respiratory failure
Symptomtext
Patient admitted to hospital, from her rehab facility for AMS and slurred speed after a recent hospitalization for COVID. She had an MRI which was negative for new CVAs. Initially her mental status started to improve with supportive measures and IV fluids. Her hospital course was com/plicated by A.fib /with RVR which EP was consulted, she was resumed carefullyo on systemic anticoagulation with Eliquis and fortunately did not show any s/s of recurrent GIB. EP was debating whether or not she was stable enough for TEE/DCCV; however she developed worsening confusion and hypoxemic respiratory failure. Repeat chest imaging showed signs of multifocal PNA. Admitted to hospital, and respiratory status continued to decline. Patient was made DNR/DNI. She went into asytolic arrest and expired on 09/15/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- 10,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 02.05.2022
- Impfdatum
- 23.02.2021
- Beginn
- 21.08.2021
- Tage bis Beginn
- 179,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cardio-respiratory arrest
Death
Pulse absent
Respiratory arrest
Resuscitation
SARS-CoV-2 test positive
Unresponsive to stimuli
Symptomtext
Patient is resident of a facility, tested positive for Covid 19 on 08/21/2021, and started on isolation at facility. On 08/296/2021, nurse entered room and patient was found laying on his back and non responsive, with no pulse or respiration. CPR was initiated, and CODE blue called overhead. Patient expired.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardio-respiratory arrest
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 29.04.2022
- Impfdatum
- 01.03.2021
- Beginn
- 30.08.2021
- Tage bis Beginn
- 182,0
- Dosis
- 2
- Route/Site
- SYR / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
COVID-19
COVID-19 pneumonia
Cardiac failure congestive
Confusional state
Death
Dyspnoea
Encephalopathy
Haematochezia
Haematuria
Hypertension
Hypoxia
Inappropriate schedule of product administration
Oropharyngeal pain
Posture abnormal
SARS-CoV-2 test positive
Shock haemorrhagic
Troponin increased
Symptomtext
This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Pfizer product on 02/08/2021 and 03/10/2021. They first presented to Emergency Department on 08/30/2021 for sore throat, where they first tested positive for COVID-19. The primary reason for presenting to Emergency Department was to get a COVID-19 test. They were not admitted to hospital at that time. They were brought to hospital on 09/03/2021 for weakness, after staff at the facility noticed the individual was "sliding out of their chair." They were admitted at that time, and were discharged on 09/06/2021. During this hospital stay, they were diagnosed with COVID-19 pneumonia. They were then brought to Emergency Department on 09/11/2021 with primary concern of hematuria. They were not admitted to hospital at that time. They were then brought to emergency department again on 09/20/2021 via ambulance with a primary concern of shortness of breath; staff noted confusion and hypoxia. They were admitted to hospital at this time. They were found to be having complications of hematochezia, hypertension, mild troponin elevation, encephalopathy, congestive heart failure, COVID-19 pneumonia, and hemorrhagic shock. They died on 09/25/2021. An additional COVID-19 test was positive on a specimen collected on the day of death but was not resulted until 09/27/2021 after the individual had died.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 10,0
- Labordaten
- Positive COVID-19 tests x2 on 08/30/2021 and an additional one on 09/25/2021 despite being vaccinated.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Congestive Heart Failure, Liver Cirrhosis (non-alcoholic), Steatohepatitis (non-alcoholic), Senile Osteoporosis, Hypothyroidism, Dysphagia The individual was a resident of the facility noted in the address portion of this form.
- Andere Medikamente
- -
- Allergien
- Cefdinir (reaction: unknown) Trimcinolone Acetonide (reaction: anaphylaxis) Codeine (reaction: anaphylaxis) Influenza Virus Vaccines, Specific (reaction: unknown) Pneumococcal Vaccine (reaction: unknown) Sulfa/Sufonamide Antibiotics (reaction: unknown) Steroids: reaction: throut [sic] closes
- Vorherige Impfungen
- The individual has listed allergies to the Influenza Virus Vaccine and Pneumococcal Vaccine but the reaction or effect of these
- Staat
- -
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 27.04.2022
- Impfdatum
- 24.02.2021
- Beginn
- 01.10.2021
- Tage bis Beginn
- 219,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Asthenia
Confusional state
Death
Diarrhoea
Dyspnoea
General physical health deterioration
Positive airway pressure therapy
Symptomtext
pt brought to ED for c/o worsening SOB, confusion, generalized weakness, diarrhea; O2 supplementation ;admitted; given steroids, remdesivir, baricitinib; pt's condition worsened; family decided upon comfort measures for pt; BiPAP removed and pt expired in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 9,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 27.04.2022
- Impfdatum
- 16.03.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- 138,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Bradycardia
COVID-19
Death
Dyspnoea
General physical health deterioration
Immunoglobulin therapy
Positive airway pressure therapy
SARS-CoV-2 test positive
Symptomtext
8/2/21 pt had a positive COVID test; reports sx 1 wk prior to test; admitted to hosp on 8/9 - 8/10/21 and was treated with dexamethasone and dc'd to home on RA; 8/22/21 presents to ED with worsening SOB; admitted; AKI; developed bradycardia; O2 need increased to BiPAP; given steroids and baricitinib; given IVIG infusion; pt continued to worsen and needed more O2, Vapotherm and NRB; pt's condition continued to decline; family transitioned pt to comfort measures and he passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 27,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- chronic lymphocytic leukemia B cell type (not in remission), paroxysmal A Fib, DMT2, OSA on CPAP, HTN
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 20.04.2022
- Impfdatum
- 27.02.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- 155,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Death
Dyspnoea
General physical health deterioration
Pneumonitis
Respiratory symptom
SARS-CoV-2 test positive
Symptomtext
pt to ED with c/o respiratory sx off and on x 1 wk; worsening SOB; found to be positive for COVID; admitted; bilateral pneumonitis; O2 supplementation; dexamethasone and tocilizumab given; pt's condition worsened and he passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 13,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 19.04.2022
- Impfdatum
- 09.03.2021
- Beginn
- 16.08.2021
- Tage bis Beginn
- 160,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Death
Dyspnoea
Electroencephalogram abnormal
Epilepsy
Pneumonia
Respiratory failure
SARS-CoV-2 test positive
Sepsis
Vaccine breakthrough infection
White blood cell count increased
Symptomtext
This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Pfizer product on 02/16/2021 and 03/09/2021. They presented to emergency department on 08/16/2021 via ambulance, after being sent over from an urgent care facility with primary complaints of elevated white count and shortness of breath. They were admitted to hospital 08/16/2021 and tested positive for COVID-19 upon admission (on 08/16/2021). They experienced complications of pneumonia, respiratory failure, sepsis, and epileptiform activity on EEG. They remained hospitalized until their death on 09/11/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 26,0
- Labordaten
- Positive COVID-19 test on 08/16/2021 despite being vaccinated.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Asthma, Obstructive Sleep Apnea, Chronic Lymphocytic Leukemia, bronchiectasis, Depression, Bipolar Disorder, Borderline Personality Disorder, Hypothyroidism
- Andere Medikamente
- -
- Allergien
- Latex (reaction: unknown) Levofloxacin (reaction: nausea and vomiting) Omeprazole (reaction: unknown) Rabeprazole (reaction: unknown)
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 94,0
- Geschlecht
- M
- Eingang
- 11.04.2022
- Impfdatum
- 18.02.2021
- Beginn
- 11.12.2021
- Tage bis Beginn
- 296,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute kidney injury
Anaemia
Anxiety
Asthenia
Autoimmune lung disease
Blood creatinine abnormal
C-reactive protein increased
COVID-19
COVID-19 pneumonia
Cardiac failure congestive
Chest X-ray abnormal
Clostridium test negative
Condition aggravated
Coronary artery disease
Death
Decreased appetite
Diarrhoea
Dyspnoea
Symptomtext
Patient with 2 Pfizer vaccinations who admitted with positive COVID test and was found to be positive for COVID during admission testing. Patient admitted for four days and discharged home with provider discharge note below: "95 year old man with a history of pulmonary fibrosis and COPD, not chronically on oxygen who is vaccinated for Covid-19 presented with generalized weakness. He was found to be Covid-19 positive, deferred Regeneron, but was thankfully relatively asymptomatic presenting with no respiratory symptoms. He was also found to have bilateral upper and lower lobe infiltrates on CXR and empirically treated for CAP. He was assessed by therapy and deemed appropriate to return home with therapy and assist at the time of discharge. After observing patient in a hospital setting, he was able to improve in strength with a notable improvement in appetite as well. Patient was discharged to home with remaining doses of antibiotics for CAP coverage. Of note, patient was found to have ESR and CRP elevation. Though it is likely that these inflammatory markers are elevated due to Covid-19, repeat labs were ordered in the outpatient setting and if they continue to be elevated, patient will need additional work up/follow up with PCP and Rheumatology to assess for possible PMR. " Of note - patient readmitted 12/30/21 was admitted to hospice services and ultimately died on 01/09/2022. 12/30/21 provider discharge note below: "Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) These were his acute medical issues addressed at home. Pneumonia due to COVID-19 12/11/21 - was not hypoxic at rest initially, but dropped severely with ambulation and needs O2, recovers very slowly. - received rocephin and doxy initially with elevated procal (has ckd) D7. - was treated for CAP as well Last 12/11/21 hospitalization. - MRSA nares was negative. - Cefepime restarted. SOB -- persistent, despite treatment. -- multifactorial cause: Post COVID, CHF, ?HCAP, prob ILD, ?Autoimmune lung dse; certainly has an anxiety component. -- fluid positive. -- Given Lasix BID. O2 via nasal canula -- appreciate Dr. input. We are treating everything: Lasix/ Cefepime/ Steroids. -- will add low dose Ativan or Xanax. -- long term steroids planned (3-4 weeks) per Dr. -- will d/w CARDS whether a component of PM dysynchrony can be contributing? AKI -- overdiuresed. DC diuretics. Check daily BMP. -- SCr rising RF positive serology -- ?has RA lung. This may be non specific per Dr. -- anti --CCP ordered Diarrhea- Has made him more fatigued/weak. start probiotic and Imodium. - C diff was negative. CKD- at baseline CAD HLD HTN Anemia Today 1/9/22: Has not improved in the last several days despite ongoing treatment above. Now drowsy and more somnolent. D/W family his non improving state. They are interested in a Hospice info visit. This is most appropriate and I support this. Hospice RN visit made. Family signed Hospice papers discussion with Hospice RN. Patient is discharged to IP Hospice for end of life care and will remain GIP at Hospital."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 4,0
- Labordaten
- COVID detected PCR on 11/30/22.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Dyslipidemia Degenerative joint disease of spine Arthritis Benign prostatic hyperplasia GERD (gastroesophageal reflux disease) CKD (chronic kidney disease) stage 4, GFR 15-29 ml/min Carotid artery stenosis Pulmonary fibrosis HTN (hypertension) Coronary artery disease of native artery of native heart with stable angina pectoris Diverticulosis with history of diverticulitis, no clinical signs of diverticulitis currently, equivocal imaging Chronic tension versus migaine headaches DNS (deviated nasal septum) Squamous cell carcinoma of skin of face Low back pain with sciatica Trochanteric bursitis of left hip Trigger finger Sensory hearing loss, bilateral Pacemaker HLD (hyperlipidemia) ETD (eustachian tube dysfunction) Subjective tinnitus Moderate protein-calorie malnutrition (*) Peptic ulcer disease AV block, 3rd degree (*) Severe protein-calorie malnutrition (*) Secondary hyperparathyroidism of renal origin (*) Chronic obstructive pulmonary disease (*) Compression fracture of T12 vertebra (*)
- Andere Medikamente
- Norvasc Aspirin Lipitor Drisdol Bio-K Plus Ultram
- Allergien
- Xylocaine
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 08.04.2022
- Impfdatum
- 06.03.2021
- Beginn
- 03.01.2022
- Tage bis Beginn
- 303,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Angiogram pulmonary abnormal
Atypical pneumonia
COVID-19 pneumonia
Cardiomegaly
Chest X-ray abnormal
Death
Deep vein thrombosis
Dyspnoea
General physical health deterioration
Lethargy
Lung opacity
Pleural effusion
Pneumonia aspiration
Subdural haematoma evacuation
Symptomtext
Recent admission for COVID pneumonia and left lower extremity DVT at Medical Center was brought into another medical center due to lethargy and concern for aspiration. Patient with severe dementia and is unable to provide any additional history. Reports that she was admitted at the hospital for antibiotics and discharged with 3 days of cefdinir. She was diagnosed with COVID pneumonia. She was also found to have a left lower extremity DVT but not treated with any anticoagulation due to history of subdural hematoma which had to be drained in September of last year. After discharge patient was doing much belter and In her usual state of health. However, began to have more difficulty breathing and has been lethargic. Pt was admitted at the hospital for further evaluation. Pt was noticed to have acute hypoxic respiratory failure likely secondary to COVID pneumonia vs. aspiration pneumonia. For the rest of her medical condition, home medication resumed. Pt's condition declined during the hospitalization. Pt was placed on IV steroids, breathing treatment, high amount of oxygen/ vapotherm. Palliative care was consulted. Per daughter who Is the POA, pt was placed on comfort care. Patient expired on January 16, 2022 at 2:15.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 5,0
- Labordaten
- Chest xoray with patchy peripheral alveolar opacities suggestive of atypical pneumonia. CT angiogram no visible pulmonary embolism. Small bilateral pleural effusions right greater than left. Interval development of extensive bilateral ground-glass opacities compatible with COVID pneumonia. Mild cardiomegaly.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- non-Hodgkin's lymphoma, severe dementia, subdural hematoma in September 2021, CAD status post CABG
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 07.04.2022
- Impfdatum
- 01.03.2021
- Beginn
- 01.01.2022
- Tage bis Beginn
- 306,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Anticoagulant therapy
Asthenia
COVID-19
Death
Dyspnoea
Fatigue
General physical health deterioration
Malaise
Productive cough
SARS-CoV-2 test positive
Symptomtext
admitted to hosp with worsening SOB, weakness, malaise, fatigue, progressive dyspnea; states had a positive COVID test on 1/3/21; home pulse ox showed O2 sats at 82%; placed on O2 supplementation; COVID test positive also in the hospital; productive cough; placed on Decadron and Lovenox; O2 requirements increased to requiring Vapotherm with additional NRB; DNR/DNI; pt's condition worsened; placed on comfort care and passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 10,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 05.04.2022
- Impfdatum
- 19.02.2021
- Beginn
- 10.09.2021
- Tage bis Beginn
- 203,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Death
Symptomtext
Information unavailable. Patient diet at home. Covid 19 listed as a cause of death on death certificate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 04.04.2022
- Impfdatum
- 26.02.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- 156,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Arteriosclerosis coronary artery
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
no medical records received; pt died at home; pt had a positive COVID test on 8/27/21; per death certificate pt died at home with causes of death being COVID 19 and Acute Atherosclerotic Coronary Vascular Event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 92,0
- Geschlecht
- M
- Eingang
- 23.03.2022
- Impfdatum
- 01.03.2021
- Beginn
- 25.03.2021
- Tage bis Beginn
- 24,0
- Dosis
- 2
- Route/Site
- SYR / UN
Tod: ja
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Death
Dysstasia
Fall
General physical health deterioration
Influenza like illness
Oedema peripheral
Urinary incontinence
Symptomtext
He felt like he was having flu-like symptoms and his primary care physician gave him vitamin B. His health began to decline and on his birthday he had begun to have fluid build-up in the legs. Shortly thereafter he complained of urinating himself. He was taken to the hospital when he fell and could not get up. My husband knows more about the symptoms because he carried him into several hospitals which all discharged him until he finally died in the third hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 10,0
- Labordaten
- Trying to pull together medical records.
- Aktuelle Erkrankungen
- Was overall in good health as the conditions he had were under control.
- Vorgeschichte
- Diabetes and he had a stent in his heart.
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 21.03.2022
- Impfdatum
- 10.03.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 294,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Malaise
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Pfizer product on 02/17/2021 and 03/10/2021. They became symptomatic for COVID-19 disease approx 12/27/2021 and tested positive via PCR test on 12/29/2021. They were hospitalized 12/29/2021-01/06/2022. They died at home on 01/12/2022. The individual had numerous underlying medical conditions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 8,0
- Labordaten
- Positive COVID-19 test on 12/29/2021 despite being vaccinated.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Previous traumatic spinal cord injury, paralysis below T7 (paraplegic), bilateral leg amputation, ankylosing spondylitis, coronary artery disease, obstructive sleep apnea (treated with C-PAP); hypertension, depression, hyperlipidemia, Type II Diabetes Mellitus with peripheral neuropathy, indwelling urinary catheter present,
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 11.03.2022
- Impfdatum
- 22.02.2021
- Beginn
- 10.03.2022
- Tage bis Beginn
- 381,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: ja
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Symptomtext
COVID-related death, hospital admission 2/19/22-3/4/22, readmitted 3/8/22, expired 3/10/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 17,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 09.03.2022
- Impfdatum
- 01.03.2021
- Beginn
- 24.08.2021
- Tage bis Beginn
- 176,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Anticoagulant therapy
Atrial fibrillation
Blood creatinine increased
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Cough
Death
Dyspnoea
Endotracheal intubation
Gastrostomy
General physical health deterioration
Heart rate decreased
Hyperkalaemia
Hypoxia
Infusion
Intensive care
Lung infiltration
Symptomtext
Admit date 08/24/21 HPI: pt presented to the ER complaining of shortness of breath; pt stated he had URI symptoms for 1 week; tested COVID negative 1 week prior; home health nurse says he is now positive for COVID; hypoxic at home, oxygenating in 70s; placed on nasal cannula; dry cough Creatinine of 1.9; chest xray showed patchy infiltrates concerning for COVID; pt has hx of asthma Treatment plan: oxygen prn, lovenox 40 mg subq bid, albuterol prn, Tylenol prn, dexamethasone 6 mg qd, remdesivir, normal saline 75 cc/hour Transferred to icu on 08/27 with COVID pneumonia and worsening respiratory failure with hypoxemia; started on baricitinib; intubated on 08/29/2021; sedated; prone positioning; amiodarone infusion for atrial fibrillation with rapid ventricular response; 09/02/21 hyperkalemia; Eliquis to replace lovenox; versed on 09/03; tracheostomy and PEG tube placed on 09/08/21; patient deteriorated throughout the day; received maximal pressor therapy and was noted to have decreasing heart rate; pt was dnr and passed away the afternoon of 09/09/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 16,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 08.03.2022
- Impfdatum
- 24.02.2021
- Beginn
- 08.09.2021
- Tage bis Beginn
- 196,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Asthenia
COVID-19
Death
Decreased appetite
General physical health deterioration
Nausea
SARS-CoV-2 test positive
Vomiting
Symptomtext
pt brought to ED with increase in weakness, N/V, anorexia; had a positive COVID test on 9/8/21; admitted 10/26/21 with AKI; transitioned to in-hospital hospice care with comfort focused care; pt's condition worsened and she died in the hospital; per death certificate, hx of COVID infection listed as a contributing factor to death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 10,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- breast CA
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 07.03.2022
- Impfdatum
- 23.02.2021
- Beginn
- 06.01.2022
- Tage bis Beginn
- 317,0
- Dosis
- 2
- Route/Site
- UN / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute respiratory failure
Alkalosis
Blood gases
Brain natriuretic peptide increased
COVID-19
COVID-19 pneumonia
Cardiac failure congestive
Chest X-ray abnormal
Condition aggravated
Death
Dyspnoea
Echocardiogram
Electrocardiogram normal
Fraction of inspired oxygen
Hypertension
Hypoxia
Intensive care
Laboratory test
Symptomtext
Patient was seen in ED on 1/6/22 presenting with shortness of breath that began on 1/5/22. Patient resulted positive for covid-19 and was admitted on 1/6/22 admission. Patient was discharged, presented to ED on 1/11/22 for evaluation of alerted mental status and hypoxia. Patient thought to have had an acerbation of CHF however symptoms did not improve with treatment and was suspected to have pneumonitis. Dexamethasone 10 mg was given per protocol and patient was monitored. Patient was hypertensive, and a Nitro drip was initiated. Patient?s BNP was elevated up compared to prior and high-sensitivity troponin was also elevated due to hypoxia. EKG was unchanged to prior and No STEMI. ABG indicated mild respiratory Alkalosis and hypoxia. While in ED patient blood pressure in ED improved on nitro-drip. Her breathing effort improved on vapoterm 40LPM and 100%FI02. Patient was admitted to ICU for further management. Patient was determined to have an illness or injury (acute hypoxic respiratory failure) that acutely impairs one or more vital organ systems such that there is a high probability of imminent or life-threatening deterioration in the patient's condition. Chest Xray demonstrated significant interval deterioration in the appearance of the chest radiograph as compared to 1/6/2022 and a pattern with significant progression of COVID19 T pneumonia. Broad-spectrum antibiotic was initiated for sepsis secondary to COVID-19 pneumonia with hospital-acquired pneumonia. Patient was DNR and DNI. Web report 1/31/22 stated patient died 1/27/22 at 19:32 of covid-19 illness.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- LAB WORK CHEST XRAY ECHO-CARDIOGRAM EKG
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- CHF Aortic Stenosis- non rheumatic CAD DM Depression Hypothyroidism Type 2 diabetes mellitus with diabetic neuropathy Hypercholesterolemia Hypertension Iron deficiency anemia Paroxysmal atrial fibrillation CKD (chronic kidney disease) stage IV Peripheral arterial disease
- Andere Medikamente
- unknown
- Allergien
- Hydrochlorothiazide - ANAPHYLAXIS - SEVERE - IMMEDIATE fainting Amlodipine- Itching Biaxin [Clarithromycin]- GI UPSET Doxazosin- itching Lipitor [Atorvastatin ]- MUSCLE ACHES Losartan- Swelling of tongue, mouth Valsartan- Tongue swelling Verapamil- Muscle aches Zocor [Simvastatin ]- Muscle aches
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 07.03.2022
- Impfdatum
- 08.10.2021
- Beginn
- 10.01.2022
- Tage bis Beginn
- 94,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Dyspnoea
Fatigue
SARS-CoV-2 test positive
Symptomtext
Patient tested positive at hospital on 01/07/2022. Admitted to hospital on 01/10/2022 with symptoms: Fatigue, difficulty breathing. Patient has multiple underlying health conditions: obesity, diabetes and hypertension. He may have been transferred to bigger hospital as he was tested again for Covid on 01/23/2022: positive. Patient died on 01/24/2022. This charting of information comes from case profile.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- 2019 Novel Coronavirus RNA: 01/07/2022 and 01/23/2022 Both Detected.
- Aktuelle Erkrankungen
- diabetes, hypertension, obesity
- Vorgeschichte
- diabetes, hypertension, obesity
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 03.03.2022
- Impfdatum
- 26.02.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 305,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Coronavirus test positive
Death
SARS-CoV-2 RNA
Symptomtext
Patient tested positive on 12/20/2021. No charting of symptoms or pre-existing condition in ODRS. Patient died 12/28/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- 2019 Novel Coronavirus RNA Detected 12/20/2021
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- No health conditions charted in ODRS.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 03.03.2022
- Impfdatum
- 01.03.2021
- Beginn
- 05.02.2022
- Tage bis Beginn
- 341,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Coronavirus test
Death
COVID-19
Coronavirus test positive
SARS-CoV-2 RNA
Symptomtext
Patient tested positive for Covid on 01/23/2022. Not hospitalized. No symptoms or health conditions listed in the disease reporting system Medical unknown
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- 2019 Novel Coronavirus RNA Detected 01/23/2022
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- There are no entries charted in disease reporting system for this patient for pre-existing health conditions
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 18.02.2022
- Impfdatum
- 16.03.2021
- Beginn
- 08.02.2022
- Tage bis Beginn
- 329,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19
Coronavirus pneumonia
Cough
Dyspnoea
SARS-CoV-2 test positive
Wheezing
Symptomtext
76-year-old female, who presents to Hospital on 2/8/22 with cough, shortness of breath, wheezing. The patient was diagnosed with coronavirus pneumonia and found to have acute hypoxic respiratory failure. She has a history of atrial fibrillation for which she is on Xarelto 20 mg per day. She has a history of chronic obstructive pulmonary disease for which she takes albuterol as needed. She has a history also of diabetes mellitus, last hemoglobin A1c of 6.4. Discharged 2/11/22 Pfizer 2/22/21, 3/16/21
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 4,0
- Labordaten
- COVID 19 PCR + 2/8/22
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- COPD, a-fib, diabetes type 2, osteoarthritis, breast carcinoma, anemia, CAD, hypercholesterolemia, hypertension, obesi
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 15.02.2022
- Impfdatum
- 25.02.2021
- Beginn
- 22.12.2021
- Tage bis Beginn
- 300,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Cerebrovascular accident
Death
Dyspnoea
Mental status changes
SARS-CoV-2 test positive
Symptomtext
tested positive for COVID in ED on 12/22/21; dc'd to home with Tessalon and Zofran; back to ED on 12/26/21 via EMS with worsening SOB, O2 sats 80% on RA; NRB mask; dexamethasone, baricitinib, remdesivir; experienced change in mental status, suspected CVA, unable to obtain MRI; DNR: transferred to hospice; comfort measures; pt died in hospice
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- DM, HTN, PVD, chronic kidney disease
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 15.02.2022
- Impfdatum
- 19.02.2021
- Beginn
- 14.02.2022
- Tage bis Beginn
- 360,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Vaccine breakthrough infection
Symptomtext
COVID RELATED DEATH; BREAKTHROUGH CASE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 14.02.2022
- Impfdatum
- 25.02.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Anticoagulant therapy
Aspiration pleural cavity
Asthenia
Atelectasis
Atrial fibrillation
Blood bicarbonate decreased
Blood thyroid stimulating hormone decreased
COVID-19
Cardiac valve disease
Chest X-ray abnormal
Death of relative
Diastolic dysfunction
Dyspepsia
Dyspnoea
Dysuria
Echocardiogram abnormal
Electrocardiogram abnormal
Exposure to SARS-CoV-2
Symptomtext
89 yo F with PMH of HTN, borderline T2DM, GERD, hypothyroidism (on armour thyroid d/t prev synthetic T4 alone ineffective), and intermittent phentermine use x the past few years "to help with energy." She p/w the onset of rhinorrhea, ShOB, orthopnea, occ palpitations, nausea, and increasing weakness approx 10 days ago. She developed BLE edema x 2 days ago. She was found to be in new onset afib w/ RVR in the ED. She has had increased heartburn with nausea esp. after eating over the past week with associated increased stress from the death of her daughter from biliary cancer on 1/31/22--her daughter had tested positive for COVID (as have ot recent family members) but the pt feels her death was more related to the advanced cancer. The pt denies chest pain, dizziness, syncope, HA, hemoptysis, fever, cough, vomitting, hematemesis, hematochezia or melena. Denies NSAID or asa use. She denies a hx of CAD, CHF, atrial fib, or edema. She reports a preop stress test years ago showed no ischemia. HRs were up to 140s on presentation. She received cardizem 15mg IVP followed by 5mg/h drip, IVP lasix followed by a drip, and a heparin drip was started in the ED. Denies ETOH use; she is a prev smoker In the ED, she is afebrile. She has visible tachypnea with increased WOB with speech, no hypoxia on RA but 2L NC O2 placed for ease of breathing. HR 110-120 afib while seen --dilt drip increased to 10mg/h with stable BP. Pertinent Labs: CBC unremarkable. bicarb 20 w/ nl gap, pro BNP 2,358, TSH <0.01; FT3 and FT4 nl levels. 5G TNT flat x2 (14<-16). She is COVID positive. EKG showed afib w/o acute changes. Pertinent Imaging: CXR: "Pulmonary edema with small to moderate bilateral pleural effusions and associated bibasilar atelectasis." Though still dyspneic , she feels her breathing is improving. Hospital Medicine has been asked to admit the patient. DISCHARGE:Patient was admitted to the hospital medicine service and placed in the COVID isolation unit. For atrial fibrillation with RVR cardiology was consulted. She had echocardiogram which showed diastolic dysfunction and abnormal mitral and aortic valves. Cardiology was consulted. Ultimately she was rate controlled with diltiazem and carvedilol. She is anticoagulated with Eliquis. She will follow-up in the cardiology clinic for further monitoring and treatment of her atrial fibrillation and diastolic heart failure. She also was found to have significant bilateral pleural effusions. She underwent right and left-sided thoracentesis. She has significant improvement after her bilateral thoracentesis were performed. She did require oxygen initially with 2 L and this was believed to be secondary to her effusions and diastolic heart failure and not due to COVID so she did not require COVID treatment. She overall did very well during hospital stay. She has follow-up with PCP next week to have a basic metabolic panel checked to monitor her electrolytes and kidney function since she has been discharged on Lasix 40 mg daily and potassium 20 mEq daily. Again she will follow in the cardiology clinic as well. She also had dysuria during hospital stay and urinalysis was consistent with UTI and she completed treatment with antibiotics during hospital stay. Overall she is significantly improved and will be discharged home in stable condition.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death of relative
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- 530484
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 14.02.2022
- Impfdatum
- 17.02.2021
- Beginn
- 13.10.2021
- Tage bis Beginn
- 238,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Symptomtext
Death related to COVID 19 as OSC.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- OSC:Parkinson's disease; COPD; CKD stage 3; HTN; HLD; TIA
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 14.02.2022
- Impfdatum
- 19.03.2021
- Beginn
- 03.02.2022
- Tage bis Beginn
- 321,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Atrial fibrillation
COVID-19
Chest X-ray abnormal
Death
Encephalopathy
Feeding disorder
Lung opacity
Mental status changes
Pneumococcal sepsis
Positive airway pressure therapy
SARS-CoV-2 test positive
Symptomtext
Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/26/21 and 3/19/21. Previously admitted in 12/2021 for K. pneumoniae septicemia d/c'd. Tested Covid+ 1/10/22 at facility. Transferred from facility and admitted 1/21/22 altered mental status with acute encephalopathy and pos Covid test again. CXR with patchy bilateral opacities. Placed on bipap, AMS never improved. Unable to eat 2/2 AMS, placed on PPN. Hospital course c/b AFib in RVR, started on amiodarone gtt. Treated with dexamethasone, actemra, and baricitinib. Transitioned to DNAR, expired 2/3/22. Pt transitioned to DNAR. Patient expired 2/3/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 15,0
- Labordaten
- 1/22/22 Covid +: This sample was analyzed using the Luminex Aries platform using PCR or equivalent Nucleic Acid Amplification (NAA) technology.
- Aktuelle Erkrankungen
- K.pneumoniae septicemia 12/2021
- Vorgeschichte
- HTN, GERD, HLD, DM, hypothyroid, s/p kidney transplant 2010 and TVH with L salpingectomy 2020
- Andere Medikamente
- tylenol/codeine, allopurinol, atorvastatin, B complex, budesonide, carvedilol, coleselevam, donepezil, epoetin alfa, folic acid, hydralazine, insulin glargine,insulin lispro, levothyroxine,loperamide,multivitamin, mycophenolate,ondansetron
- Allergien
- amlodipine, ethylene, adhesive
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 13.02.2022
- Impfdatum
- 03.03.2021
- Beginn
- 30.01.2022
- Tage bis Beginn
- 333,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute kidney injury
Acute respiratory failure
Blood bicarbonate decreased
Blood creatinine increased
Blood sodium normal
COVID-19
COVID-19 pneumonia
Chronic kidney disease
Emphysema
Extra dose administered
Fibrin D dimer
Hypercoagulation
Hypertension
Hypothyroidism
Leukopenia
Metabolic function test
Renal impairment
SARS-CoV-2 test positive
Symptomtext
Patient was hospitalized due to breakthrough infection. Patient appears to have received three doses of both the Pfizer and Moderna vaccine per chart review in the EMR. Patient was hospitalized from 01/30/22 - 02/02/22. Below is copied from discharge summary: Patient is a 74 y.o. female patient who is being discharged today. Hospital Course: Acute on chronic respiratory failure due to COVID-19 pneumonia Hypercoagulable state due to above History of COPD/lung cancer remission D-dimer 2046, patient has a history of hemorrhagic pancreatitis while on Eliquis, will avoid anticoagulation at this time, unable to do CTA due to renal function NM perfusion scan indeterminate, scattered areas of decreased perfusion present, likely related to pulm emphysema Dexamethasone 6 milligram X 10 days Albuterol q.4 hours Symbicort b.i.d. Robitussin p.r.n. Nasal cannula 3 liters AKI on chronic kidney disease Cr improving 25/1.41 Bicarb 20 BMP daily a.m. Hyponatremia 139 Hypothyroidism Levothyroxine 125 micrograms daily Arterial hypertension Toprol 12.5 milligram p.o. daily History of PE NM perfusion scan indeterminate, scattered areas of decreased perfusion present, likely related to pulm emphysema Leukopenia - Resolved Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP, MD within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 3,0
- Labordaten
- SARS-COV-2, NAA, Detected: 01/30/22
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- COPD, Lung Cancer
- Andere Medikamente
- albuterol (PROVENTIL) (5 MG/ML) 0.5% Inhalation Nebulization Solution Take 5 mg by nebulization 3 times daily as needed for wheezing or shortness of breath. Yes Information, Historical buPROPion HCl (WELLBUTRIN) 100 MG Oral Tablet Take
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 93,0
- Geschlecht
- M
- Eingang
- 11.02.2022
- Impfdatum
- 24.02.2021
- Beginn
- 02.02.2022
- Tage bis Beginn
- 343,0
- Dosis
- 1
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Asthenia
COVID-19
COVID-19 pneumonia
Chest X-ray normal
Chills
Cough
Delirium
Drainage
Gait disturbance
General physical condition abnormal
Hypertension
Metabolic encephalopathy
Oropharyngeal pain
Oxygen saturation decreased
PO2 decreased
Pyrexia
Symptomtext
94 yr old fully vaccinated (3 shots) patient present back to the ED after his son states he got him home and he was too weak to ambulate on his own and noted his pulse oximetry was low. Began having sore throat and drainage w cough 1/31, then developed fever that next am. Son states the patient does not leave his home and he and other family members have had mild URI symptoms for a couple weeks so they are getting tested, assuming they gave it to him. CXR does not look bad but paO2 is <60 and looks ill. Was prescribed Paxlovid last night but son has not filled yet. 1. Acute respiratory failure with hypoxia 2. Pneumonia due to COVID-19 virus 3. Acute delirium, acute metabolic encephalopathy 4. Fever and chill symptoms 1/31 and febrile so pretty acute fully vaccinated CXR not bad started Dex, RDSV - both completed day 3 on 2/4 - considered initiating IL-6 inhibitor if O2 needs increasing but is now on room air will not continue RDSV or Dex as room air and any risk > benefit at this point 5. HTN resume his ARB and amlodipine at higher doses PT recommended SNF but also acknowledges he has a very supportive family in the the home He has no interest in SNF and he and son both feel they can manage at home
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- 544269
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 11.02.2022
- Impfdatum
- 05.02.2021
- Beginn
- 11.01.2022
- Tage bis Beginn
- 340,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Patient death from breakthrough COVID S/P COVID-19 vaccination
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 5,0
- Labordaten
- Positive COVID-19 test 01/11/2022
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- non-Hodgkin's lymphoma Severe dementia Hypertension History of subdural hematoma History of DVT CAD post CABG
- Andere Medikamente
- Galantamine Losartan xanax Citalopram Keppra Seroquel Docusate Magnesium Polyethylene Glycol Senokot-s Melatonin
- Allergien
- Sulfonylureas Carbonic Anhydrase Inhibitors Thiazides Penicillins Sulonamide antibiotics Codeine Pyrithione zinc meperidine
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 10.02.2022
- Impfdatum
- 22.12.2021
- Beginn
- 24.12.2021
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Lung infiltration
Oxygen saturation decreased
SARS-CoV-2 test positive
Symptomtext
Discharge Diagnosis Acute hypoxic respiratory failure with Covid pneumonitis. PAC -9 beat run. Evaluated by cardiology service Diabetes mellitus Essential hypertension Hyperlipidemia unspecified Hospital Course 70F PMHx DM and hypertension presents via EMS for evaluation. Patient diagnosed with Covid on 12/24 by home Covid test, confirmed later by rapid at immediate care. patient oxygen saturation at home dipped and advised by pulmonologist to come to ED for evaluation for low O2 saturations. Chest x-ray shows bilateral infiltrate patient admitted for further management .Patient on remdesivir and steroids pulmonary following, seen by cardio for pac. today pt On room air Completing remdesivir course. Clinically asymptomatic cleared by pulmonary service and discharge home patient and family agree with the discharge plan patient denies fever, cough, chest pain, abdominal pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- Past Medical History DM hypertension
- Andere Medikamente
- UNKNOWN
- Allergien
- no known drug allergy
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 10.02.2022
- Impfdatum
- 20.02.2021
- Beginn
- 08.02.2022
- Tage bis Beginn
- 353,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19 pneumonia
Hospitalisation
Infection
Symptomtext
Patient was admitted 02/08/2022 for acute hypoxic respiratory failure secondary to covid-19 pneumonia. This is considered a breakthrough case.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 09.02.2022
- Impfdatum
- 26.02.2021
- Beginn
- 19.05.2021
- Tage bis Beginn
- 82,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19
Cardiac failure acute
Cardiac failure congestive
Cardiomyopathy
Ischaemic hepatitis
Left ventricular failure
Non-small cell lung cancer metastatic
Pulmonary hypertension
SARS-CoV-2 test positive
Type 2 diabetes mellitus
Symptomtext
Cause: Complications of metastatic non-small cell lung cancer; OSC: positive COVID-19 test on 05/17/2021; shock liver; pulmonary HTN; acute on chronic respiratory failure; DM2; cardiomyopathy; acute on chronic diastolic CHF
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 02.02.2022
- Impfdatum
- 12.01.2022
- Beginn
- 19.01.2022
- Tage bis Beginn
- 7,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Acute myocardial infarction
Amnesia
Electroencephalogram
Encephalitis
Encephalomyelitis
General physical health deterioration
Hallucination
Hypertension
Imperception
Lumbar puncture
Magnetic resonance imaging head normal
Paranoia
Symptomtext
7 days following booster, high blood pressure 200/90plus. Unaware of surroundings. Hospital admission stroke suspected. No stroke. Head MRI normal. blood pressure normalized, admitted to hospital. Next day increasing paranoia, halucinations, short term memory loss. Spinal tap not conclusive. EEG not conclusive. Anti seizure medication no improvment. Deteriation of condition until iv steroids day 3 in hospital. Immediate improvment of symptoms. oral steroids for 5 days improved symptoms. 2 weeks later apparent full recovery. being monitored by cardiologist. Never fever.Encephalitis and encephalomyelitis following immunization procedure (Discharge Diagnosis) - 1/23/22 NSTEMI (non-ST elevated myocardia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 02.02.2022
- Impfdatum
- 24.02.2021
- Beginn
- 30.01.2022
- Tage bis Beginn
- 340,0
- Dosis
- 1
- Route/Site
- UN / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Abnormal behaviour
Acute coronary syndrome
Anticoagulant therapy
Anuria
Azotaemia
Blood bicarbonate normal
Blood creatinine increased
Blood culture
Blood gases abnormal
Blood lactic acid
Blood potassium increased
Blood urea increased
Bradycardia
Brain natriuretic peptide increased
COVID-19
Cardiac arrest
Cardiac failure
Chest X-ray abnormal
Symptomtext
Please note this patient has a duplicate medical record. I have asked for admissions to combine these records. Patient is a 76-year-old gentleman with complex past medical history significant a end-stage renal disease on dialysis Tuesday, Thursday, Saturday, COPD on 2-3 liters of home oxygen nasal cannula, heart failure with reduced ejection fraction (45-50%), coronary artery disease, hypertension and diabetes mellitus type 2 who presents to the emergency department via EMS from home for altered mental status. Most history is obtained from the medical record. This patient is known to our services he was previously discharged from this facility on January 18th. At that time the patient had presented on At that time the patient had presented on January 6th with altered mental status thought to be secondary to uremia and potentially exacerbated by a new prescription for baclofen in addition to his regular hydrocodone. His mental status improved with hemodialysis and cessation of alternate agents. During that hospitalization he also had was believed to be aspiration pneumonia and completed treatment with a course of Zosyn. He had an elevated 5th generation troponin without anginal symptoms and was started on a heparin drip. Cardiology evaluated the patient and ultimately felt that his troponins were not related to acute coronary syndrome but rather his end-stage renal disease. While on a heparin drip his platelets at that time dropped from 194,000 to 37,000 so heparin was discontinued and he was evaluated for HIT. His heparin antibody test was negative. He did present at that time with a BNP greater than 70,000 with an acutely reduced ejection fraction of 30 to 35%. Cardiology added metoprolol to his heart failure medication regimen and his EF improved to 45 to 50% by time of discharge. The patient was discharged to facility. The patient is alert and oriented x3 although he is generally a poor historian. He tells me he returned home from rehab "3 or 4 days ago" and thought he was doing fine. When I asked him why he ended up in the emergency department he said that his wife called EMS because she was worried about him although he could not elaborate as to what prompted her to think this. The wife is not present at the bedside, is actually being evaluated in the emergency department herself so is unavailable to help give history. Nonetheless when EMS arrived the patient was noted to have an oxygen saturation of 73% on room air, with a temperature of 101.9?. They had a difficult time a getting reliable SpO2 readings while the patient was on 8 liters nasal cannula so they ended up placing him on a non-rebreather mask. His initial blood pressure was 73/41 so EMS gave patient a 300 milliliters bolus of normal saline. On arrival to the emergency department the patient remained hypotensive with a systolic blood pressure reading in the 60s. He was also tachycardic with heart rate above 100 and had a temperature of 100 ?. Blood cultures were obtained and patient was treated with broad-spectrum antibiotics including vancomycin, Levaquin, cefepime. Patient is anuric so urine culture not obtained. A right internal jugular central line was placed by the emergency room physician and the patient was started on a norepinephrine drip. The patient tested positive for COVID-19. He does state that he completed a COVID-19 vaccine series with a booster but could not elaborate when. A chest radiograph was performed which showed a right lower lobe infiltrate. He was taken for a CT of the chest which demonstrated emphysematous changes, bilateral patchy opacities consistent with COVID-19 as well as a moderate left lower lobe pleural effusion. Other notable findings from his initial evaluation included a white blood cell count of 1,800, hemoglobin 8.1, potassium 5.5, creatinine/BUN 4.2/40, BNP 37000, lactic acid 4.7, procalcitonin 12 and a 5th generation troponin 116. His initial ABG was apparently performed on room air and was 7.31, pCO2 44, PO2 44, HC03 22. During time of exam I turned his oxygen down from 8 liters to 4 liters and he was able to maintain an acceptable oxygen saturation for the several minutes I was present. He does have bilateral rhonchi and is dyspneic with conversation. He is still tachycardic with a heart rate of 105 and had a systolic blood pressure in the 80s while on 8 micrograms/minute of norepinephrine. He denies having any fever chills at home, denies nausea, vomiting, diarrhea. Denies sick contacts. He denies worsening shortness of breath, cough or sputum production. DISCHARGE: Admitted 1/30 after wife called EMS about him "not acting right" at home. Had recent admission for CHF and discharged to facility On admission, was felt to have sepsis with septic shock, lactic acidosis with hypotension, tachypnea, tachycardia and fever. He did have positive COVID-19 test but given toxic appearance felt this was more bacterial infection such as bacterial pneumonia, and patient had completed the 3 shot mRNA vaccination series. Blood cultures obtained, Started on vancomycin and cefepime, and metronidazole for aspiration pneumonia given history. Unfortunately, declined quickly, requiring Levophed drip, ventilator support and 100% fIo2 CPR was initiated earlier in the day and Palliative care was of assistance with goals of care with his wife. He had another bradycardic rhythm into asystole and elected not to revive, he passed comfortably at that time. He was pronounced at 1725 and I spoke with his wife at bedside shortly after. Expired at 1725
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- 8125302
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 01.02.2022
- Impfdatum
- 17.02.2021
- Beginn
- 20.01.2022
- Tage bis Beginn
- 337,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
COVID-19
Death
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Received Pfizer vaccines on 1/27, 2/17/21 COVID-19 positive by PCR on 1/20/22 hospitalized 1/20-1/31/22 Expired 1/31/22 d/t COVID-19 infection, acute hypoxic respiratory failure Underlying COPD, lung cancer, pulmonary arterial HTN Previous VAERS report ID 780938
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 12,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 01.02.2022
- Impfdatum
- 17.02.2021
- Beginn
- 20.01.2022
- Tage bis Beginn
- 337,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
COVID-19
Death
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Received Pfizer vaccines on 1/27, 2/17/21 COVID-19 positive by PCR on 1/20/22 hospitalized 1/20-1/31/22 Expired 1/31/22 d/t COVID-19 infection, acute hypoxic respiratory failure Underlying COPD, lung cancer, pulmonary arterial HTN Previous VAERS report ID 780938
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 12,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 27.01.2022
- Impfdatum
- 01.12.2021
- Beginn
- 25.01.2022
- Tage bis Beginn
- 55,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Symptomtext
Death related to complications of COVID-19 infection
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- OSC: CHF; HTN; obesity
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 25.01.2022
- Impfdatum
- 15.10.2021
- Beginn
- 14.01.2022
- Tage bis Beginn
- 91,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Abdominal distension
Acute kidney injury
Acute respiratory failure
Anticoagulant therapy
Aortic dissection
Aortic valve repair
Arterial catheterisation
Atelectasis
Back pain
Blood lactic acid normal
Bronchoscopy
COVID-19
Cardiac tamponade
Chest pain
Computerised tomogram abdomen abnormal
Computerised tomogram thorax abnormal
Distributive shock
Dysphagia
Symptomtext
Hospitalized (1.14.22 - PRESENT - in ICU; intubated, sedated; s/p pericardial window 1.23.22); COVID-19 positive (1.14.22); fully vaccinated PLUS booster HISTORY OF PRESENT ILLNESS: Patient is a 58 y.o. male who presents today with acute substernal chest pain radiating to his back that started this morning while he was working on his desk. He presented to the ED and further w/u inc a CT chest is corroborative for a type A dissection. He denies any focal weakness, weakness or abdominal pain. He is alert and oriented with no signs of focal deficit. He denies any previous such pain. He does endorse family h/o similar dissection in his father that required emergent surgery. ASSESSMENT / PLAN: 58 yr old male with no known past medical or surgical history presenting with acute ascending aortic dissection extending up to iliacs. Remains hypertensive in the ED: nicardipine gtt ordered ( brady with HR in 50s). No signs of mal-perfusion; Equal pulses bilaterally. To OR for emergent repair of type A dissection. 1.15.22 - arterial line insertion; 1.16.22 - intubation; 1.16.22 - bronchoscopy; 1.17.22 - corpack placed under fluoroscopy for dysphagia; 1.23.22 - intubation; 1.23.22 - bronchoscopy Progress note from 1.24.22: Plan: 58 year old male p/w type A aortic dsxn s/p emergent repair - elephant trunk and total arch 1/14/22 whose course c/b acute hypoxic resp failure requiring reintubation 1/16/22, pericardial effusion w tamponade s/p pericardial window 1/23/22. Given abdo distension, CT a/p obtained today after which our service was contacted. Evidence of ileus and non specific enterocolitis. Imaging limited to eval bowel ischemic given lack of IV contrast (in setting of AKI) however given normal lactic, patient stability and soft abdomen w/o peritonitis, this is not an active concern. No acute indication for operative intervention. Continue non op management of ileus w gastric decompression via NGT, NPO status. Given the non sp bowel thickening of the sm and large bowel, recommend a 7 day course of abx to cover risk of translocation esp in setting of new aortic graft - zosyn or ceft/flagyl would suffice. Hold PR bowel regimen at this time. Progress Note 1.25.22: The patient was visited at bedside. His wife was also present for visit. He is sedated and intubated on 35 ugr/kg/min of propofol and 0.02 ugr/kg/min of norepinephrine. He does not open his eyes to verbal or noxious stimuli. Anasarca with 3-4+ edema on 4 extremities. Abdomen distended tympan on palpation. Unable to assess tenderness due to sedation. Surgery will continue to follow. Problem List: - Type A Aortic Dissection s/p Elephant Trunk Repair w/ AV resuspension 1/14/22 - Pericardial Tamponade s/p Window 1/23/22 - Distributive shock, NE PRN. Discuss antihypertensive meds an needed. - Hypoxemic respiratory failure s/p failed extubation attempt 1/15/22 - Ileus, NPO, OG to LIS - Nonspecific small and large bowel thickening, zosyn x 7 days - Leukocytosis, increasing - AKI, follow, appreciate nephrology recommendations - Left IJ DVT, SQH prophylaxis Daily Events/Procedures: 1/14: admit Type A dissection, COVID-19 positive, OR for Type A dissection repair/elephant trunk/total arch and resuspension of aortic valve with Dr. 1/15: extubated, CTCC 1/16: worse hypoxia, repeat COVID negative, hypotension, 2 units of blood, ETT, CTA H/C/A/P: Nothing acute. B/l pleural effusions and atelectasis, echo with underfilling and normal EF, small pericardial effusion 1/17: 2 units blood, 2 FFP, TEE neg for tamponade 1/18: Extubated; bipap overnight; enteral BB and hydralazine initiated 1/19: Increasing PO antihypertensives; bilateral IJ DVT noted on UE US, VAD heparin started; cardene changed to labetalol (pulmonary shunting) 1/20: USV w/ LIJ DVT 1/23: Febrile, leukocytosis, hypotensive, worsening AKI. Anti-htn held, diuretics held. Afib; Amiodarone. Tamponade, emergent pericardial window; ETT. 1/24: ongoing abdominal distention, CT thorax/abdomen/pelvis with mediastinal hemoatoma (post-pericardial drain), small and large bowel wall thickening, left posas hematoma, Gen surg recommend NPO, holding enema, continue PO bowel regimen 1/25: Strict NPO; serial abdominal exams, tenuous ileus
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 11,0
- Labordaten
- LIMITED ECHOCARDIOGRAPHY REPORT Study Date: 01/23/2022 Interpretation Summary A two-dimensional transthoracic echocardiogram with color flow and spectral flow Doppler was performed in limited views only. Due to limited acoustic windows, Definity was administered. The left ventricular cavity is small. The left ventricular ejection fraction is 55%. Right ventricle function is moderately decreased. There is large circumferential pericardial effusion. There is no tamponade by 2D criteria. There is respirophasic changes of the mitral and tricuspid valve inflow which is pobably due to underlying AFib with RVR. Today's study was compared to one performed on 1/17/2022. Interpretation Summary Limited Echocardiogram: Small, echolucent space adjacent to the right ventricular free wall, possibly representing epicardial fat versus small anterior pericardial effusion. There is no evidence for significant tricuspid or mitral valve respirophasic inflow variation by Doppler interrogation. No Doppler signs consistent with tamponade. The left ventricular ejection fraction is 60%. Today's study was compared to one performed on 1/23/22. The LVEF was 55% on the prior report.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Diagnoses listed during hospitalization: Hospital Ascending aortic dissection (HCC) Essential hypertension COVID-19 virus detected Acute hypoxemic respiratory failure (HCC) Paroxysmal atrial fibrillation with RVR (HCC) AKI (acute kidney injury) (HCC) Pericardial tamponade
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG tablet Ascorbic Acid (VITAMIN C PO) Cholecalciferol (VITAMIN D3 PO) Omega-3 Fatty Acids (OMEGA-3 FISH OIL) 1200 MG CAPS
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 25.01.2022
- Impfdatum
- 23.11.2021
- Beginn
- 14.01.2022
- Tage bis Beginn
- 52,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Acute left ventricular failure
Acute respiratory failure
Angiogram abnormal
Angiogram pulmonary abnormal
Anticoagulant therapy
Asthenia
Atrial fibrillation
Bacteraemia
Biopsy adrenal gland
Blood bilirubin increased
Blood creatinine normal
Blood glucose normal
Blood pH decreased
Blood test
Breast cancer female
Breast cancer stage I
CHA2DS2-VASc-score
Symptomtext
Hospitalized (1.17.22 - present); COVID-19 positive (1.14.22); fully vaccinated (3 doses) ASSESSMENT / PLAN: Patient is a 64 y.o. female with a past medical history of left breast cancer on chemotherapy presented with fatigue found to be in shock, undifferentiated requiring norepinephrine, covid-19 pna, pancytopenia, new onset afib with RVR Brief History and Medical Decision-Making: This is a 64 year old female patient with past medical hx significant for left breast cancer (stage 1A) s/p left partial mastectomy and SLNB performed on 10/4/21. She is currently receiving adjuvant chemotherapy. She recently underwent CT guided left adrenal biopsy which was complicated by hemothorax and pseudoaneurysm of left T1 intercostal artery, s/p IR embolization of T10, T11 and T12 and pleural drain placement. She was diagnosed with COVID-19 Pneumonia on 1/14/2022, she presented to ED today with feeling of generalized weakness and not feeling well. Noted to be in acute hypoxemic respiratory failure and shock requiring pressors to maintain MAP more than 65. She was also noted to be in acute kidney injury ( suspect pre-renal in etiology). In regards to the shock, the main differential currently is septic shock given neutropenia and findings on CT chest of With increasing left sided pleural effusion that is mostly likely related to recent hemothorax and differential include empyema, She also has nodule opacities in left upper lobe. We will contine broad spectrum Abx ( cefepime and vancomycin) pending blood culture results and consult ID. We will add stress dose steroids. Obtain echo to assess for LV function and presence of pericardial effusion. Consult IR for potential drain placement in the left chest and send diagnostic samples to rule out empyema ( her platelets are low and given recent bleeding, we need to transfuse before any intervention, She might also require thoracic surgery consult). No active signs of bleeding but we will continue to follow serial Hemoglobin, anticipate the drop in hemoglobin is related to chemotherapy given findings of neutropenia and thrombocytopenia. Start Amiodarone given Atrial fibrillation with RVR on presentation. For the COVID-19 pneumonia, we will hold off on remedisivr given AKI and she is currently on stress dose steroids. Check D--dimer and obtain DVT US of both lower extremities. Progress Note from 1.25.22: ASSESSMENT / PLAN: 64-year-old female with past medical history of left breast cancer stage IA, status post left partial mastectomy and sentinel lymph node biopsy on 10/04/2021, currently receiving adjuvant chemo with curative intent, who recently underwent CT-guided left adrenal biopsy was complicated by hemothorax and pseudoaneurysm of left T1 intercostal artery, status post IR embolization of T10, T11, and T12, with pleural drain placement. Patient also recently diagnosed with COVID on 1/14. Patient presented with generalized weakness and not feeling well. Admitted to intensive care unit with shock, acute hypoxic respiratory failure. 1. Acute hypoxic respiratory failure Multifactorial in setting COVID-19 PCR, left empyema, Staph aureus pneumonia and bacteremia. Had acute tachypneic and hypoxic event on 1/24 requiring increased vent settings and further sedation. Plan: - Wean vent settings as tolerated - Lasix 40 IV qd, goal net negative - goal O2 sat 88% and above 2. Shock - resolved - multifactorial in setting of left empyema, multifocal bilateral pneumonia, Staph aureus pneumonia and bacteremia. Plan: - Off Pressors - Solumedrol taper - 40, 30, 20, 10 per day 3. Left empyema IR placed left chest tube on 01/18. Pleural fluid exudative with pH 6.72, glucose less than 2. IR recommended tPA / dornase. However, initially held off on tPA / dornase given recent hemothorax requiring emoblization and also pancytopenia. CT scan of the chest 1/19 showed improving left-sided empyema, however, with minimal drainage on 1/20. Drainage likely will be limited due to loculated infection. - 1/20: s/p trial tPA / dornase at 1/2 dose (5 mg) x 1 on 1/20. - 1/21: started on tPA / dornase at normal dose, plan for 5 total doses - 1/23: receiving final doses/ CXR appears well improved, no further drainage from chest tube, no signs of bleeding - 1/24: Completed tPA / dornase therapy, no immediate complications, stable and improved left lower consolidation on CXR - 1/25: significant drainage from L chest tube 355cc over last 24 hours 4. Febrile Patient became febrile during the night of 1/24-1/25. This was in the setting of recently starting Precedex and following return from IR procedure. This is likely 2/2 medication effects however superimposed new bacterial infection cannot be ruled out on exam alone. Plan: - Follow-up culturers - Discontinued Precedex - Continue to monitor temperature 5. Multifocal bilateral pneumonia Left lower lobe Staph aureus pneumonia Staph aureus bacteremia 1/18 respiratory cultures positive for MSSA, with left pleural fluid cultures positive for Staph aureus, and blood cultures positive for GPC in clusters. CT chest 1/19 (obtained for re-evaluation of left empyema) showed new multifocal pneumonia in right side, suspected to be a progression of left-sided Staph aureus pneumonia. Plan: - Escalated current abx based on repeat fever with CXR and clinical course concerning for HAP/VAP, continue Zosyn + Vanc for empiric coverage pending cultures and ID recommendations - Obtain sputum culture, if unable patient will need bronchoscopy w/ BAL - Given Staph aureus bacteremia, will need to consider future TEE for rule out infective endocarditis when stabilized - IR successfully removed R portacath evening of 1/24, will need replaced once discharged for continued chemotherapy 6. Acute systolic heart failure / heart failure with reduced ejection fraction 22% New reduced EF 22%, compared to EF 65% in 12/14/2021. Cardiology consulted, and discussed case with Cardiology Oncology, who thinks that overall less likely due to anthracycline therapy, but possible. Patient's new reduced systolic function likely due to stress-induced cardiomyopathy in setting of shock. Plan: - could consider future repeat echo 7. Loose Stools - prolonged illness with tube feeds, unlikely to be infectious at this time, will continue to monitor temperature and for other signs of infection. Plan: - remove rectal tube as soon as possible, high risk for adverse sequela including pressure ulcers - monitor rectal tube output - follow-up C. Diff and enteric pathogens - bowel regiment changed from standing to PRN 8. Atrial fibrillation with RVR - resolved No history of atrial fibrillation, likely 2/2 shock in the setting of stress cardiomyopathy. Converted to sinus rhythm while on amiodarone drip on 1/20, has remained in sinus rhythm since. Plan: - On PO amiodarone 400mg BID, decrease dosing once received entire 10g loading dose - Patient is high risk for thromboembolic event based on CHADS-VASC2 > 3, for that reason we are starting therapeutic heparin drip - Patient also plans on receiving chemotherapy on discharge causing transient thrombocytopenia, this puts her at high risk for bleeding sequela, this issue will have to be addressed on discharge for further anticoagulation planning - plan to resume BB as able now that shock resolved 9. Pancytopenia - stable In the setting of active chemotherapy for breast cancer. On arrival had significant neutropenia, now improved but is on stress dose steroids for shock. Hb and Plt stable. Plan: - transfuse if platelets less than 10 or less than 50 if active bleeding - transfuse if hemoglobin less than 7 10. AKI - resolved Likely prerenal in setting of shock on presentation. Based on chart review, patient has a baseline creatinine of 0.5-0.7. Plan: - patient continues to be at baseline following resuscitation - continue to trend on daily CMP 11. Elevated liver enzymes - resolved RUQ US 1/19 obtained due to gradually rising bilirubin. Negative for biliary obstruction, cholelithiasis, cholecystitis. Showed heterogeneous liver which may be due to hepatic steatosis. Consider dedicated liver screening with patient more stable. 12. Metastatic breast cancer Stage IA, status post left partial mastectomy and sentinel lymph node biopsy on 10/04/2021, currently receiving adjuvant chemo with curative intent, who recently underwent CT-guided left adrenal biopsy was complicated by hemothorax and pseudoaneurysm of left T1 intercostal artery, status post IR embolization of T10, T11, and T12, with pleural drain placement. Plan: - holding chemotherapy pending clinical course - palliative care consult, for supportive care for husband who is patient's sole caregiver and management of chronic conditions
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 8,0
- Labordaten
- -
- Aktuelle Erkrankungen
- 12.20.21-12.24.21 - hospital admission - Hemothorax on left - HOSPITAL COURSE: Patient is a 64 year old female with PMH significant for invasive ductal breast carcinoma, HTN, rosacea, who presented to the ED following a CT guided adrenal bx due to acute bleeding. After procedure pt c/o pain and shortness of breath, BP was found to be 74/38, pt received fluid bolus and a CT was obtained with findings of hemothorax, Pseudoaneurysm of left T11 intercostal artery with extravasation into left pleural space. Pt was taken to IR and underwent intercostal angios (T 10, 11, and 12) with microcoil embolizations. Left internal mammary angio; left pleural drain placement. Her blood counts where closely monitored throughout hospitalization. She received 1 unit PRBC in ED but did not require any further transfusions. Cardiothoracic team was consulted for evaluation and recommended continuing current conservative managment with drain. The patient did have one episode of near-syncopal episode which resolved after fluid bolus. Her antihypertensive medications where briefly held and all restarted before discharge.
- Vorgeschichte
- Family history of coronary artery disease Essential hypertension Class 2 obesity due to excess calories without serious comorbidity with body mass index (BMI) of 39.0 to 39.9 in adult Psoriasis Family history of leukemia Pain in joint, multiple sites Family history stroke in brother and father in early 60s Leukocytosis Chronic pain of left knee Rosacea, acne Encounter for consultation Carcinoma of upper-outer quadrant of left breast in female, estrogen receptor positive (HCC) Hemothorax on left
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG tablet amLODIPine (NORVASC) 5 MG tablet atenolol-chlorthalidone (TENORETIC) 100-25 MG per tablet B Complex Vitamins (VITAMIN B COMPLEX) tablet Cholecalciferol 2000 units CAPS diphenhydrAMINE (BENADRYL) 25 MG t
- Allergien
- Contrast Dye [Ivp Dye, Iodine Containing]Itching TramadolDizziness CephalexinRash Ciprofloxacin CyclobenzaprineRash EtodolacOther, Palpitations Fish Flu Virus VaccineSwelling Lisinopril MacrolidesRash, Swelling Neomycin-bacitracin-polymyxinRash Nickel Nitrofuran DerivativesRash Nitrous Oxide PenicillinsRash Sulfa DrugsRash Taxotere [Docetaxel]Rash
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 25.01.2022
- Impfdatum
- 26.02.2021
- Beginn
- 11.08.2021
- Tage bis Beginn
- 166,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Asthenia
Atrial fibrillation
COVID-19
Death
Dehydration
Diarrhoea
Dyspnoea
Facial paralysis
General physical health deterioration
Headache
Hemiparesis
Hypotension
Mental status changes
Pain
Respiratory disorder
SARS-CoV-2 test positive
Vomiting
Symptomtext
to ED with c/o body aches, weakness, increasing SOB, headache, vomiting, diarrhea; sx have worsened over the last week since he was diagnosed positive for COVID 1 wk ago at primary care provider's office; in ED found to be hypotensive and dehydrated; treated for both; admitted to hosp; developed A Fib with RVR; respiratory status quickly declined; on Vapotherm; pt's condition worsened and he was found with altered mental state and right sided weakness with facial droop; unable to perform MRI due to AICD to confirm stroke; DNI/DNR; status deteriorated and he was made comfort measures; he passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- systolic heart failure post AICD, CAD, HTN
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 24.01.2022
- Impfdatum
- 25.02.2021
- Beginn
- 14.01.2022
- Tage bis Beginn
- 323,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Abdominal pain
Acute respiratory failure
Bacterial infection
Blood gases abnormal
Blood pressure increased
C-reactive protein increased
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Chronic obstructive pulmonary disease
Computerised tomogram abdomen normal
Computerised tomogram thorax abnormal
Condition aggravated
Cough
Depression
Dyspnoea
Hilar lymphadenopathy
Hypercapnia
Symptomtext
DISCHARGE DIAGNOSES: 1. Acute hypoxic hypercapnic respiratory failure d/t COVID-19 pneumonia 2. Secondary bacterial RLL CAP 3. Acute exacerbation of suspected COPD 4. Abdominal pain and vomiting, resolved 5. HTN 6. Tobacco dependency 7. History stroke 8. Depression 9. Peripheral neuropathy, chronic pain 10. Mediastinal and hilar lymphadenopathy HOSPITAL COURSE: This is a 74 y.o. female with a history of probable COPD, ongoing tobacco use, HTN, chronic pain syndrome, depression who presented with cough, SOB, abdominal pain. Acute hypoxic hypercapnic respiratory failure d/t COVID-19 pneumonia: Vaccinated and boosted. Symptom onset gradual over a couple weeks. Cough started ~1/12. Tested positive 1/15. Secondary bacterial RLL CAP: RLL consolidation on top of coarse bilateral infiltrates and procal elevated so empirically treated. Acute exacerbation of suspected COPD: No prior formal diagnosis of COPD, suspected given symptoms and tobacco use. - CXR and CT PE study negative for PE but with bibasilar coarse interstitial opacities with a RLL consolidation, small R pleural effusion and suggestion of pulmonary vascular congestion. - Treated with Solu-medrol 40mg IV daily (for COVID-19 PNA and COPD). Transitioned to Prednisone 40mg daily with a short taper prescribed on d/c. - Procalcitonin 0.58. Completed Zithromax therapy and was transitioned from ceftriaxone to cefdinir to complete 10 total days for CAP. - Tocilizumab / baricitinib not indicated d/t secondary bacterial infection and not requiring high flow oxygen - CRP normalized 8.7 -- > less than 1 - Hypercapnic, improved on VBGs with supplemental O2 - Required up to 2L NC. Weaned to RA at rest. - Home O2 eval done recommending 2L with exertion otherwise RA. - Scheduled and prn bronchodilators provided. Incruse started for suspected COPD. - Encouraged use of IS, aerobika. She was ambulatory and up in chair. - PTA Dyazide held, Lasix 20 mg IV given a couple days in place of PTA Lasix 20mg - On d/c resumed Lasix 20mg daily. Did NOT resume Dyazide. - Recommend outpt Pulmonary referral once recovered from Covid to obtain formal PFTs Abdominal pain, vomiting: Resolved. CT A/P unremarkable for acute intra-abdominal pathology. Tolerating a regular diet. HTN: BPs elevated throughout much of her stay, SBPs in the 160s primarily. Her dyazide was held while on IV Lasix. Amlodipine 5mg daily continued; did not want to increase d/t risk of increased peripheral edema (mild edema at baseline). Metoprolol 25mg BID was added but BPs dropped quite quickly and significantly from 180s to 109 systolic and HRs 80-90s to low 60s. It was felt safest to d/c on amlodipine 5mg daily, Lasix 20mg daily and have her f/u with her PCP. She plans to purchase a BP cuff and monitor at home. She will hold the Dyazide for now as two diuretics not felt necessary (and not hyponatremic during stay, e-lytes stable). Tobacco use disorder - Encouraged ongoing cessation. NRT available during stay. History stroke: No acute neurologic concerns - Continue BP meds as above, atorvastatin and Plavix Depression - PTA Lexapro Peripheral neuropathy - PTA gabapentin, Robaxin, hydroxyzine, oxycodone Mediastinal and hilar lymphadenopathy: Noted on CT, presumably benign per Radiologist. - Recommend f/u with PCP
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 6,0
- Labordaten
- COVID PCR POSITIVE 1/16/2022
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- 74-year-old woman with history of COPD and hypertension Past Medical History: Diagnosis Date ? Depression ? Essential hypertension ? GERD (gastroesophageal reflux disease) ? H/O lithotripsy ? Hiatal hernia ? HLD (hyperlipidemia) ? Iron deficiency anemia ? Kidney stone ? Osteoarthritis chronic left knee pain ? Pulmonary vascular congestion 7/27/2021 ? TIA (transient ischemic attack)
- Andere Medikamente
- -
- Allergien
- Acetaminophen, Ibuprofen, Librium [chlordiazepoxide hcl], Olmesartan, and Chlordiazepoxide
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 19.01.2022
- Impfdatum
- 15.10.2021
- Beginn
- 11.01.2022
- Tage bis Beginn
- 88,0
- Dosis
- 2
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute kidney injury
Acute respiratory failure
Brain natriuretic peptide increased
COVID-19 pneumonia
Cardiac failure congestive
Chest X-ray abnormal
Electrocardiogram abnormal
Lung infiltration
Pulmonary congestion
Troponin
Symptomtext
Hospitalized 01/11/2022-still currently admitted; COVID-19 positive 01/11/2022; fully vaccinated plus booster CHIEF COMPLAINT: Acute respiratory failure with hypoxia (HCC) Assessment/Plan ASSESSMENT / PLAN: Acute Respiratory failure with hypoxia Pneumonia due to COVID 19 Virus Immunosuppressed status Vaccinated: 2 doses and booster Symptom onset: 1/4 CXR w/ scattered scattered left peripheral infiltrates and vascular congestion with possible small bilateral effusions Decadron Check procal, consider abx if elevated Not candidate for remdisivr due to renal disease Already on coumadin, check INR to ensure therapeutic Wean O2 as tolerated Acute CHF exacerbation, unspecified type and chronicity Elevated Troponins Hx of CAD s/p stenting Hx of Aortic Valve stenosis s/p TAVR (bioprosthetic) Hx of Complete Heart Block s/p PPM Hx of Subclavian Veinoplasty Trop 143-- >142 BNP 5790 ECG is ventricular paced but does appear to have some increased ST elevation No previous Hx of CHF Will obtain Echo, Consider cardiology consult pending results He was started on coumadin after TAVR, although it is bioprosthetic valve Will monitor off lasix tonight due to AKI. Low threshold to initiate if decompensates overnight Continue Toprol, ASA, statin, coumadin (pharmacy to dose) 01/14/2022 notes: Assessment and Plan Severe acute respiratory failure with hypoxia COVID19 PNA Immunosuppressed state -Currently O2 need increased from 6L-> HFNC @ 95% and 45L to maintain sats -is s/p vaccination and booster but immunosuppressed from transplant meds -procal normal -supra therapeutic INR makes suspicion for clot low -patient confirmed to be full code Plan: -decadron -> solumedrol 60mg BID with eventual slow taper if he improves -titrate O2 as able -warfarin for anticoagulation -repeat CXR 01/18/2022 notes: Severe acute respiratory failure with hypoxia COVID19 PNA Immunosuppressed state -Currently O2 need stable today at 80% FIO2 @ 50L/min -is s/p vaccination and booster but immunosuppressed from transplant meds -procal normal -supra therapeutic INR makes suspicion for clot low -patient confirmed to be full code Plan: -solumedrol 60mg BID for 7-14 days (day 5 today) with slow prednisone taper afterwards -titrate O2 as able -warfarin for anticoagulation -repeat CXR Disposition: DC timing unclear given severe hypoxia though hopefully DC in next week given lack of improvement over last few days
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 8,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- CAD in native artery Hypertension Dyslipidemia Liver disease Severe aortic stenosis Subclavian vein obstruction, right (HCC) Acquired cystic kidney disease Alcoholic cirrhosis (HCC) Anemia of chronic renal failure Obesity End stage renal failure on dialysis (HCC) Gout Hyperlipidemia Renal transplant recipient Monoclonal gammopathy of unknown significance (MGUS) Renal osteodystrophy Impaired fasting glucose GERD (gastroesophageal reflux disease) CKD (chronic kidney disease) AV block, Mobitz 1 Complete heart block (HCC) Chronic diastolic heart failure (HCC) Cardiac pacemaker in situ Long term (current) use of anticoagulants
- Andere Medikamente
- amLODIPine (NORVASC) 10 MG tablet aspirin 81 MG enteric coated tablet atorvastatin (LIPITOR) 40 MG tablet B Complex Vitamins (VITAMIN B COMPLEX) TABS cholecalciferol (CHOLECALCIFEROL) 25 MCG (1000 UT) tablet clindamycin (CLEOCIN) 300 MG cap
- Allergien
- Penicillins Clarithromycin Erythromycin Fluconazole Itraconazole Ketoconazole Minocycline Tetracycline Vancomycin
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- 89,0
- Geschlecht
- F
- Eingang
- 18.01.2022
- Impfdatum
- 08.10.2021
- Beginn
- 25.12.2021
- Tage bis Beginn
- 78,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Fall
General physical health deterioration
SARS-CoV-2 test positive
Surgery
Vaccine breakthrough infection
Symptomtext
This is an instance of COVID-19 breakthrough disease after which death occurred. The individual was vaccinated on 01/27/2021, 02/17/2021, and 10/08/2021. The individual was admitted to hospital on 12/25/2021 for an emergency surgical procedure after a fall (the reason for admission and surgery were not related to COVID-19 or respiratory disease). They were transported via ambulance. It is not known if they experienced COVID-19 specific symptoms. They were found to be COVID-19 positive during the hospital stay. The positive specimen was collected on 12/25/2021. Their health declined rapidly during this hospital stay and they passed away on 12/26/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 1,0
- Labordaten
- Positive for COVID-19 via PCR despite being fully vaccinated.
- Aktuelle Erkrankungen
- Cardiopulmonary arrest, hypovolemic shock
- Vorgeschichte
- Hypertension, coronary artery disease, hyperlipidemia, hypothyroidism, gastroesophageal reflux disease
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 18.01.2022
- Impfdatum
- 19.02.2021
- Beginn
- 11.01.2022
- Tage bis Beginn
- 326,0
- Dosis
- 2
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute respiratory failure
Blood pH decreased
C-reactive protein increased
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Culture
Dyspnoea
Encephalopathy
Endotracheal intubation
Fibrin D dimer increased
Hypertension
Intensive care
International normalised ratio increased
Lung opacity
Mechanical ventilation
PCO2 increased
PO2 decreased
Symptomtext
Hospitalized (1.11.22 - present - currently in ICU); COVID-19 positive 1.11.22; fully vaccinated (no booster) HISTORIES: (1.11.22) HPI: This is a 75 y/o female with past medical history significant for HTN, persistent Afib on Coumadin, prior DVT, cardiomyopathy with normalization of LV function, obesity, OSA, chronic lymphedema. She presented to ED this evening with complaints of SOB. Evidently patient's caregiver came to her residence today at which time the patient complained of shortness of breath. It is unclear as to the duration of the patient's symptoms. EMS was ultimately called and it is reported that patient was saturating around 50% on room air upon their arrival. She was thus placed on oxygen and transferred to the ED. Upon arrival to the ED, patient was urgently intubated. VBG following intubation noted pH-7.17, pCO2-64.5, pO2 <20. Basic labs were significant for positive COVID PCR (patient vaccinated with Pfizer in 1/2021 but has not received booster), pro-bnp of 1858, normal troponin, WBC-11.5, INR-2, normal renal function, and UA which was abnormal and possibly suggestive of infection. CXR with dense bilateral airspace opacities. Patient received 80 mg of IV lasix along with 20 mg of labetalol due to post-intubation hypertension/tachycardia. She also received empiric Vanc/Zosyn, as well as IV Solumedrol. She is currently paralyzed with vecuronium and is receiving sedation with fentanyl/propofol. Assessment and Plan Acute hypoxic respiratory failure secondary to COVID-19 PNA Status post both Pfizer vaccines Feb 21 Symptom onset unknown Positive testing in ER 1/11 Intubated upon arrival to ED on 1/11 Currently sedated and paralyzed Current respiratory support: Device (Oxygen Therapy): ventilator Vent Settings: FIO2 (%): 100 % Type of Mechanical Vent: Vela Mechanical Rate: 26 breaths/min Set/Target Tidal Volume: 400 PEEP (cm H2O): 12 cm H2O Lung mechanics: Plateau Pressure: 26 cmH2O REC Continue sedation and chemical paralysis Lung protective ventilation - tidal volume should be closer to 310 ml - currently 400 ml Adjust resp rate first to get pH > 7.3 - then proceed with tidal volume reduction Follow ABG's - for sustained PF ratios less than 150 consider proning Continue weight based IV solumedrol at 75 mg q 12 hours Remdesivir Empiric Abx with Vanc, Zosyn; collect and follow cultures and de-escalate Abx as appropriate Monitor fluid balance, prn lasix for goal net even Progress note from 1.17.22: #COVID-19 -uncertain date of symptom onset, tested positive 01/11/2022 -given high-dose methylprednisolone in the emergency department, now on methylprednisolone 60 mg q.12 hours, day 7 of steroids -continuing on remdesivir -maintain enhanced isolation precautions for now # Acute hypoxic respiratory failure with pneumomediastinum -likely secondary to COVID-19 -initial chest x-ray showed bilateral airspace opacities consistent with viral pneumonia -patient emergently intubated in the ER, hard to ventilate, quickly paralyzed and sedated -initial D-dimer 2010, C-reactive protein 65 -currently saturating 92% on AC volume, 65% FiO2, tidal volume 350, rate of 30, peep 8, plateau pressure of 18 -overall net fluid status negative, -1292 mL, continuing on furosemide 40 mg IV q.12 -doing well off paralytics but still encephalopathic, will discontinue fentanyl and utilize Ativan as needed for agitation -if Ativan is not working for agitation, will start dexmedetomidine -will attempt pressure support ventilation today and monitor -appreciate input from Critical Care Service, Dr. -monitor pneumomediastinum on repeat imaging with use of positive-pressure ventilation # Pneumomediastinum -in the setting of acute hypoxic respiratory failure from COVID-19 -monitor follow-up imaging
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HTN (hypertension) Hypothyroidism GERD (gastroesophageal reflux disease) Hypercholesterolemia Arthritis Anxiety Permanent atrial fibrillation Urinary incontinence CHF (congestive heart failure) Status post bariatric surgery BMI 60.0-69.9, adult Warfarin anticoagulation Abnormal chest CT Cardiomyopathy, nonischemic History of MRSA infection Decreased mobility and endurance Prediabetes Sleep apnea Dyslipidemia Fibromyalgia IBS (irritable bowel syndrome) Neuropathy Osteopenia Colon polyps Diverticulosis Hyperparathyroidism Osteoporosis, unspecified osteoporosis type, unspecified pathological fracture presence Depression, recurrent
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG tablet atorvastatin (LIPITOR) 40 MG tablet B Complex Vitamins (VITAMIN B COMPLEX) TABS Biotin 10 MG TABS calcium citrate-vitamin D (CITRACAL MAXIMUM) 315-250 MG-UNIT TABS carvedilol (COREG) 12.5 MG tablet chol
- Allergien
- chlorhexidine
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 17.01.2022
- Impfdatum
- 27.03.2021
- Beginn
- 15.12.2021
- Tage bis Beginn
- 263,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Myocardial infarction
Symptomtext
I suffer major heart attack months after the vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocardial infarction
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 12.01.2022
- Impfdatum
- 26.02.2021
- Beginn
- 04.09.2021
- Tage bis Beginn
- 190,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
COVID-19 pneumonia
Chest pain
Death
Dyspnoea
Endotracheal intubation
General physical health deterioration
Mechanical ventilation
Pulseless electrical activity
SARS-CoV-2 test positive
Sepsis
Symptomtext
pt presents to ED with c/o increasing SOB (over past week) and chest pain; diagnosed positive for COVID 5 days prior; treated with remedesivir, baricitinib, steroids, O2 supplementation, antibiotics; pneumonia due to COVID, sepsis; while in hospital experienced pulseless electrical activity, ACLS protocol followed, obtained ROSC; pt intubated and on mechanical ventilation; pt's condition worsened, poor prognosis; comfort measures and pt extubated; he died in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- PAD, HTN, hyperlipidemia, DM, dementia, CKD3, BPH, A FIB, anemia
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 12.01.2022
- Impfdatum
- 23.03.2021
- Beginn
- 01.01.2022
- Tage bis Beginn
- 284,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Abstains from alcohol
Acute kidney injury
Acute left ventricular failure
Acute respiratory failure
Alanine aminotransferase increased
Anaemia
Anion gap
Anticoagulant therapy
Aortic dilatation
Aspartate aminotransferase normal
Atrial fibrillation
Atrial flutter
Blood albumin decreased
Blood alkaline phosphatase normal
Blood bicarbonate normal
Blood bilirubin normal
Blood calcium decreased
Blood chloride decreased
Symptomtext
Hospitalized (1.1.22 - still admitted currently); COVID-19 positive (12.31.21); Fully vaccinated - pfizer x2 H&P: CHIEF COMPLAINT: Acute respiratory insufficiency Assessment/Plan ASSESSMENT / PLAN: # Acute on Chronic Respiratory Insufficiency with COVID-19 -CXR personally reviewed and noted very mild opacity at right lung base with cardiac enlargement -completed vaccination series for COVID-19 (3/2021) but no booster -CXR personally reviewed and noted cardiac enlargement with faint opacity in right lower lobe -Decadron (6 mg PO daily), trend CRP, continuous pulse oximetry for now -check pro-calcitonin in AM (in hopes renal function improved) and if elevated start Abx -VTE prophylaxis with Eliquis (resume if Hgb stable in AM) # History of Cryptogenic Organizing PNA # History of Tobacco Us -quit tobacco in 1997 and diagnosed with COP (8/2020) and evaluated by pulmonary at that time -continue home albuterol and Spiriva # Acute on Chronic Kidney Disease Stage 3b -baseline creatinine 1.4-1.6 and increased to 1.8 last month -treated with 1 liter bolus of NS in the ED and suspect pre-renal from diuresis & possible diarrhea -IVF (NS 75 cc/hr) and monitor respiratory status closely given CHF history -daily renal panel, avoid nephrotoxins and dose medications renally # Hypokalemia -potassium 2.9 noted on admission and treated with 20 mEq IV and 20 mEq PO KCl by ED -suspected secondary to diarrhea and diuretic use and recheck potassium along with Mg in AM # Chronic Diastolic Heart Failure -patient unsure of how much Lasix he actually takes and reports dry weight to be around 212 lbs/96kg -Echo (10/2021) with preserved LVEF, mild aortic root dilation and mild bilateral atrial dilation -standing daily weight (97.2kg today), I/O, fluid restriction to 2 liters -holding lasix given AKI and hypokalemia, daily renal panel # Permanent Atrial Fibrillation # Prolonged QTC -diagnosed 3/2020 with DCCV (2/2020) and EKG on presentation with QTc >500 ms -CHA2DS2-VASc score of at least 3 (CHF, HTN, age) -evaluated by cards (12/2/21) and plan for rate control only due to intolerance to Amiodarone -telephone notes report that Amiodarone was started (12/9) -hold Amiodarone given prolonged QT and if rate controlled would not restart -rate control: Metoprolol succinate (50 mg BID) and Diltiazem (360 mg daily) -anticoagulation: Eliquis (5 mg BID) resume in AM if hematoglobin stable # Essential HTN -holding home Lasix given AKI and hypokalemia, also holding Lisinopril -continue Metoprolol succinate (50 mg BID) and Diltiazem (360 mg daily) # Acute Anemia -baseline Hgb 13-14 and presented with a Hgb of 9.5 -noted to be on Eliquis for atrial fibrillation and hold for now (resume in AM if Hgb stable) # Hypothyroidism -TSH 99.3 with free T4 0.2 (10/8/21) -Levothyroxine (50 mcg daily) # HLD -Crestor (20 mg daily) # Depression -holding Effexor given prolonged QT Telemetry: prolonged QT VTE prophylaxis: Eliquis (restart 1/2/21 if Hgb stable) Nutrition: general diet (2 liter fluid restriction) Code Status: full code Subjective HISTORY OF PRESENT ILLNESS: Patient is a 73 y.o. male who presented to ED with complaints of fatigue, cough and dyspnea. Reported to the ED he has had these symptoms for the past year but worsened over the last 2 days. He presented to UC on 12/31 for the previous stated symptoms including fever and diarrhea. At the time he tested positive for COVID-19 and per ED note family requested patient present to ED tonight. Patient is somewhat of a poor historian. He initially states dyspnea occurred today before being informed of UC presentation and then states dyspnea started the day he went to UC. He states dyspnea assocaited with productive cough and "low grade fevers". He denies diarrhea (although reported by UC) and states he has a good appetite. Patient states he lives alone and does take lasix daily, but unsure of how much he takes. He tells me his typical weight is 212 lbs and reports he checks his weights daily. He quit tobacco in 1997 and states no used alcohol in last year since he is on Eliquis. Patient Active Problem List Diagnosis ? Left basilar pulmonary infiltrate ? Acute exacerbation of CHF (congestive heart failure) (HCC) ? Acute respiratory failure with hypoxia (HCC) ? Atrial fibrillation and flutter (HCC) ? Dyspnea ? Acute respiratory failure (HCC) ? Cryptogenic organizing pneumonia (HCC) ? History of tobacco abuse ? Postprocedural pneumothorax ? Pleural effusion, left ? Cardiomyopathy (HCC) ? Acute diastolic (congestive) heart failure (HCC) ? Hypokalemia ? COVID-19 ? Acute renal failure superimposed on stage 3b chronic kidney disease (HCC) ? Acute renal failure superimposed on stage 3b chronic kidney disease, unspecified acute renal failure type (HCC) ? Acute respiratory insufficiency Review of Systems Constitutional: Positive for fever. Negative for appetite change and chills. HENT: Negative for congestion and rhinorrhea. Respiratory: Positive for cough and shortness of breath. Cardiovascular: Positive for leg swelling. Negative for chest pain, palpitations and orthopnea. Gastrointestinal: Positive for vomiting (non-bloody). Negative for nausea, abdominal pain, constipation, diarrhea and blood in stool. Genitourinary: Negative for difficulty urinating, dysuria and hematuria. Musculoskeletal: Positive for falls (slipped on ice 5 days ago, no head trauma). Neurological: Negative for headaches, dizziness and light-headedness. Psychiatric/Behavioral: Negative for anxiety and sleep disturbance. Skin: Negative for rash and wound. Objective OBJECTIVE: BP 121/68 | Pulse 64 | Temp 36.7 ?C (Oral) | Resp 18 | Ht 1.702 m | Wt 97.2 kg | SpO2 100% | BMI 33.56 kg/m? Physical Exam Vitals reviewed. Constitutional: General: He is not in acute distress. Appearance: He is obese. He is not ill-appearing or diaphoretic. HENT: Head: Normocephalic and atraumatic. Mouth/Throat: Mouth: Mucous membranes are moist. Eyes: General: No scleral icterus. Cardiovascular: Rate and Rhythm: Normal rate. Rhythm irregular. Pulmonary: Effort: Pulmonary effort is normal. No respiratory distress. Breath sounds: No wheezing, rhonchi or rales. Abdominal: Tenderness: There is no abdominal tenderness. There is no guarding or rebound. Comments: Somewhat firm Musculoskeletal: Right lower leg: No edema. Left lower leg: No edema. Skin: General: Skin is warm and dry. Neurological: Mental Status: He is alert. Psychiatric: Mood and Affect: Mood normal. Behavior: Behavior normal. 1/11/22 General Medicine Progress Note: Attestation signed by MD at 1/11/2022 6:00 PM I have personally interviewed and examined the patient on 1/11/2022. Management was discussed with the provider below. I agree with the documented findings and plan of care in his/her note. Brief exam: alert, oriented sat SpO2: 95 % O2 Flow Rate (l/min): 5 l/min no accessory mm use and appears comfortable, sinus, cta, no peripheral edema, pleasant Brief history and medical decision making: 73yo recovering from covid pna on IV steroids. Wean to po steroids in next 24-48 hours. Currently on solumedrol bid-- > solumedrol daily then prednisone taper. Expected Discharge date: Jan 13, 2022 Expand All Collapse All Hide copied text Hover for details Progress Note CHIEF COMPLAINT: Acute respiratory insufficiency Assessment/Plan ASSESSMENT / PLAN: Principal Problem: Acute respiratory insufficiency Active Problems: COVID-19 Acute renal failure superimposed on stage 3b chronic kidney disease (HCC) Acute renal failure superimposed on stage 3b chronic kidney disease, unspecified acute renal failure type (HCC) COVID 19 PNA Acute Hypoxic Respiratory Failure secondary to above-stable Symptom onset 12/30, positive test 12/31 at urgent care. Vaccinated, but did not receive booster. - CXR 1/4: progressing mixed interstitial and airspace opacities - Remdesivir completed 1/3-1/7 - Repeat CXR 1/9 with interval improvement - Will start weaning steroids now that back on NC. Decreasing to salumdrol 50mg IV daily - Lasix changed back to home dose 60mg PO daily - Continuous pulse ox, IS, prone as tolerated - Checking US bilateral LE due to L>R lower extremity edema New Anemia,stable - Baseline Hgb 13-14 - hgb now stable in 9s - Denies hematemesis, hematochezia, melena. No EGD or colonoscopy in our system->would likely benefit from outpt eval - Ferritin 1,292, IBC 229, Fe 38, Fe sat WNL; B12/folate WNL - PPI Leukocytosis; improving - likely reactive to steroid - monitor off abx Transaminitis, improving - likey secondary to COVID - continue to trend History of Cryptogenic Organizing PNA History of Tobacco Use - Quit tobacco in 1997 and diagnosed with COP (8/2020) and evaluated by pulmonary at that time - Continue home albuterol and Spiriva AKI on Chronic Kidney Disease-resolved - creatinine now back to baseline (1.4-1.6) - Trend - avoid nephrotoxins and renally dose medications Chronic Diastolic Heart Failure - Echo (10/2021) with preserved LVEF, mild aortic root dilation and mild bilateral atrial dilation - Lasix as above - daily weights, strict I&Os - 2 gm Na and 2 L fluid restriction Permanent Atrial Fibrillation Prolonged QTC ,resolved Diagnosed 3/2020 with DCCV (2/2020) and EKG on presentation with QTc >500 ms. CHA2DS2-VASc score of at least 3 (CHF, HTN, age). Evaluated by cards (12/2/21) and plan for rate control only due to intolerance to Amiodarone - repeat EKG: afib nonspecific t wave abnormalities; qtc 443 - amio originally held due to prolonged QTc, now normalized, will continue to hold for now as pt HR remains stable - rate control: Metoprolol succinate (50 mg BID) and Diltiazem (360 mg daily) - anticoagulation: Eliquis (5 mg BID) Essential HTN, stable - continue lasix, lisinopril, metoprolol succinate, diltiazem Hypothyroidism - TSH 99.3 with free T4 0.2 (10/8/21). TSH now 8.85 - Continue Levothyroxine (50 mcg daily) Steroid induced hyperglycemia - A1c 6.2 - glucose levels improved on lantus 6u with low dose corrective, continue Hyperlipidemia - continue statin Depression - continue effexor DVT prophylaxis: On eliquis Code status Full code Dispo: Weaned to 6L O2, continue to wean as able. Starting to taper IV steroids. Lasix transitioned back to PO. Likely ready for discharge once stable on 3-4L and not requringin more than 6L O2 with ambulation. The above stated assessment and plan was discussed with Dr. and reflect her input. SUBJECTIVE: Patient reports breathing feels well but he feels more foggy than prior. Denies any chest pain, SOB, n/v/d or abdominal pain. When asked about LE edema endorses that his left is normally more swollen than right but does not know why and has not had any prior US for it. Review of Systems Constitutional: Negative for chills and fever. Respiratory: Positive for cough. Negative for shortness of breath. Cardiovascular: Negative for chest pain. Gastrointestinal: Positive for constipation. Negative for nausea and abdominal pain. Musculoskeletal: Positive for edema. Neurological: Negative for dizziness. Objective OBJECTIVE: BP 128/86 | Pulse 72 | Temp 36.4 ?C (Oral) | Resp 16 | Ht 1.702 m | Wt 93.7 kg | SpO2 97% | BMI 32.35 kg/m? FIO2 (%): 50 % Physical Exam Vitals and nursing note reviewed. Constitutional: General: He is not in acute distress. Appearance: Normal appearance. He is well-developed. He is not toxic-appearing. HENT: Head: Normocephalic and atraumatic. Eyes: Conjunctiva/sclera: Conjunctivae normal. Pupils: Pupils are equal, round, and reactive to light. Neck: Trachea: No tracheal deviation. Cardiovascular: Rate and Rhythm: Normal rate and regular rhythm. Pulses: Normal pulses. Heart sounds: Normal heart sounds. No murmur heard. No friction rub. No gallop. Pulmonary: Effort: Pulmonary effort is normal. No respiratory distress. Breath sounds: Normal breath sounds. No wheezing or rales. Comments: Crackles at bilateral lung bases Abdominal: General: Bowel sounds are normal. There is no distension. Palpations: Abdomen is soft. Tenderness: There is no abdominal tenderness. There is no guarding or rebound. Musculoskeletal: General: Normal range of motion. Cervical back: Normal range of motion and neck supple. Right lower leg: No edema. Left lower leg: Edema (trace pitting) present. Skin: General: Skin is warm and dry. Findings: No erythema. Neurological: Mental Status: He is alert and oriented to person, place, and time. Psychiatric: Behavior: Behavior normal. Thought Content: Thought content normal.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 11,0
- Labordaten
- Comprehensive Metabolic Panel (CMP) (Abnormal) Collected: 01/12/22 0945 Order Status: Completed Specimen: Blood, Venous Updated: 01/12/22 1026 Sodium Level 132 Low 134 - 146 mmol/L Potassium Level 4.1 3.4 - 5.0 mmol/L Chloride 93 Low 98 - 112 mmol/L HCO3 27 21 - 29 mmol/L Anion Gap 12 9 - 18 mmol/L Glucose Level 325 High 70 - 99 mg/dL Blood Urea Nitrogen 43 High 8 - 20 mg/dL Creatinine 1.19 0.60 - 1.30 mg/dL MDRD eGFR 60 >=60 mL/min/1.73 m2 CG eCrCl 52 mL/min/1.73 m2 Calcium Level Total 8.1 Low 8.6 - 10.4 mg/dL Protein Total 5.6 Low 6.0 - 8.0 g/dL Albumin Level 2.8 Low 3.5 - 5.0 g/dL Bilirubin Total 0.4 0.2 - 1.0 mg/dL Alkaline Phosphatase 72 40 - 129 IU/L Alanine Aminotransferase 53 High 10 - 40 IU/L Aspartate Aminotransferase 12 10 - 40 IU/L Complete Blood Count without Differential (Abnormal) Collected: 01/12/22 0945 Order Status: Completed Specimen: Blood, Venous Updated: 01/12/22 1006 White Blood Cell 17.90 High 4.00 - 10.80 x10*3/uL Red Blood Cell 3.22 Low 4.60 - 6.00 x10*6/uL Hemoglobin 10.7 Low 14.0 - 18.0 g/dL Hematocrit 32.1 Low 42.0 - 52.0 % Mean Cell Volume 99.7 80.0 - 100.0 fL Mean Cell Hemoglobin 33.2 High 27.0 - 33.0 pg NRBC Absolute Count 0.02 High 0.00 - 0.01 x10*3/uL NRBC Automated 0.1 0.0 - 0.1 %WBC Mean Cell Hemoglobin Concentration 33.3 32.0 - 37.0 g/dL Red Cell Diameter Width 13.7 11.0 - 16.0 % Platelet 312 140 - 400 x10*3/uL Mean Platelet Volume 10.2 7.4 - 11 fL
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Past Medical History: Diagnosis Date ? Atrial fibrillation (HCC) 03/2020 ? Depression ? Essential hypertension, benign ? History of tobacco abuse ? HLD (hyperlipidemia) ? Kidney stones stones ? Systolic heart failure (HCC) 03/2020 EF 45% BNP 2K
- Andere Medikamente
- Albuterol Sulfate 108 (90 Base) MCG/ACT 2 puffs Inhalation Every 4 hours PRN Amiodarone HCl 200 mg Oral Daily, Apixaban 5 mg Oral 2 times daily Cholecalciferol 50 mcg Oral Daily dilTIAZem HCl ER Beads 360 mg Oral Daily Furosemide 20 mg Oral
- Allergien
- Allergen Reactions ? Contrast Dye [Ivp Dye, Iodine Containing] MRI Contrast Dye Nausea, Dizziness
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 11.01.2022
- Impfdatum
- 17.02.2021
- Beginn
- 21.11.2021
- Tage bis Beginn
- 277,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Anticoagulant therapy
Atrial fibrillation
Blood bicarbonate decreased
Blood pH decreased
COVID-19
Candida test positive
Cardioversion
Condition aggravated
Confusional state
Culture urine positive
Death
Diabetic ketoacidosis
Encephalopathy
Fall
Haematoma
Haematoma infection
Haemorrhage
Symptomtext
Patient is now deceased (1.4.22); Hospitalized (1.3.22); COVID positive (11.21.21 AND 1.3.22); fully vaccinated (prior hospitalizations - see section one for recent history / illness) Admission Date: 1/3/2022 Deceased: 1/4/2022 Discharge Disposition: Deceased DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Shock Septic shock HOSPITAL COURSE: Patient s our 80 y.o. female who resides at assisted living facility with pmhx of insulin-dependent diabetes (presumed type 1), history of DKA, Parkinson's disease and dementia, CKD 3a, hx of DVT and PE on eliquis who presented to the ED via EMS after she was found to be confused this morning and hypotensive. She had mild AKI, leukocytosis, and bicarb of 6 with pH of 7.4. Upon our evaluation, patient was requiring vasopressor support with norepinephrine. She was tachypneic into the 40s. HR continued to increase, patient in afib with RVR rates in the 200s. We attempted DCCV 1 time without success. She was given fentanyl of 50mcg and 2mg of versed for this. She did not tolerate this well. pH returned down to 7.16. Pressor requirements escalated and goals of care discussion had with DPOA (son) and daughter. Eventually it was decided for code status to change to comfort care. The patient had blood pressure MAPs in the 40s-50s overnight. Patient passed at 12:04 on 1/4/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- 10.21.21 - Infectious Disease appt - after recent hospital admission for follow up of:surgical site infection of R hip s/p recent hemiarthroplasty with intraoperative findings demonstrating infected hematoma. (and 11.8.21 - with Ortho Trauma) 11.16.21 - ED visit to hospital admission - 11.16.21 - 11.22.21 - from extended care facility - increasingly confused over 24 hours. Diabetic Ketoacidosis (DKA) - admitted to ICU; urine cultures positive for candida, shingles. Found to be COVID positive on DC. 11.23.21 - ED visit - Scalp hematoma - FALL (fall out of bed, hit head on side table, blood on back left- bleeding controlled, on eliquis, - LOC, A & O x 1-2 (baseline), COVID +) 12.5.21 - 12.9.21 - hospitalized - UTI, severe sepsis, encephalopathy
- Vorgeschichte
- Type 1 diabetes mellitus with diabetic polyneuropathy (HCC) Obesity Osteopenia of multiple sites Parkinson disease (HCC) Cord compression (HCC) Carpal tunnel syndrome REM sleep behavior disorder CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min (HCC) Primary hypothyroidism Hypoglycemia unawareness associated with type 2 diabetes mellitus (HCC) Essential hypertension Mixed hyperlipidemia Coronary artery disease involving native coronary artery of native heart without angina pectoris Diabetic peripheral neuropathy associated with type 2 diabetes mellitus (HCC) Left carpal tunnel syndrome Right carpal tunnel syndrome Renal cysts, acquired, bilateral Shortness of breath History of deep venous thrombosis (DVT) of distal vein of left lower extremity Pulmonary nodule Other iron deficiency anemia Closed left hip fracture (HCC) Mixed anxiety depressive disorder Imbalance of constituents of food intake History of urinary tract infection Dyslipidemia Uncontrolled type 2 diabetes mellitus with peripheral neuropathy (HCC) Venous thromboembolism (VTE) At risk for falls Advanced care planning/counseling discussion Multiple comorbid conditions Parkinson's disease dementia (HCC) Acute encephalopathy Unspecified severe protein-calorie malnutrition (HCC) Candiduria Shingles UTI (urinary tract infection) Shock (HCC)
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG tablet acetaminophen (TYLENOL) 500 MG tablet atorvastatin (LIPITOR) 10 MG tablet Blood Glucose Monitoring Suppl MISC Calcium Carb-Cholecalciferol (CALCIUM-VITAMIN D) 500-400 MG-UNIT TABS carbidopa-levodopa (SI
- Allergien
- Ativan [Lorazepam]Confusion CodeineGI Upset Haldol [Butyrophenones]Nausea Only, Other Penicillin G Potassium
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 11.01.2022
- Impfdatum
- 26.02.2021
- Beginn
- 19.03.2021
- Tage bis Beginn
- 21,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Anticoagulant therapy
Computerised tomogram thorax abnormal
Dyspnoea
Fibrin D dimer increased
Pain in extremity
Asthma
Condition aggravated
Electrocardiogram
Fibrin D dimer
Gait disturbance
Pulmonary thrombosis
Thrombosis
Ultrasound Doppler abnormal
Peripheral swelling
Pulmonary embolism
Ultrasound scan abnormal
Wheezing
Symptomtext
After the first dose I began having problem with what I thought was my asthma. I wen to my dr for refill of my inhaler. They also thought it was my asthma and additionally prescribed a packet of prednisone for one week. I was told if no fever to have the second vaccine. I did not have a fever but the morning after the second shot I couldn't walk on my left foot when getting out of the bed. It was like a pulled muscle. It continued to get worse . By the time I saw my physician on 3/23 I could barely walk. I was sent to the ER for an ultrasound on my left leg where blood clots were discovered. A CT Scan revealed I had them in my lungs as well. I stayed one night in Hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 1,0
- Labordaten
- D-Dimer at physicians office, ultrasound on left leg and CT Scan at Hospital. An EKG was also done on my heart at the hospital. I have had to repeat the ultrasound and CT Scans periodically. The clots in lung are gone, but one clot still remains behind my left knee.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Restless Leg, slight case of controlled asthma, endometriosis, migraines
- Andere Medikamente
- NP Thyroid 60 MG, rOPINIRole HCl 4 MG TAKE 1-3 TABLETS AT BEDTIME 30, Atenolol 50 MG TAKE ONE TABLET BY MOUTH DAILY 90 Cyclobenzaprine HCl 5 MG 1-2 p.o. three times a day (tid)/prn 90 days ,Ambien 10 take one tablet by mouth every night at
- Allergien
- Sulfur drugs
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 11.01.2022
- Impfdatum
- 26.02.2021
- Beginn
- 19.03.2021
- Tage bis Beginn
- 21,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Anticoagulant therapy
Computerised tomogram thorax abnormal
Dyspnoea
Fibrin D dimer increased
Pain in extremity
Asthma
Condition aggravated
Electrocardiogram
Fibrin D dimer
Gait disturbance
Pulmonary thrombosis
Thrombosis
Ultrasound Doppler abnormal
Peripheral swelling
Pulmonary embolism
Ultrasound scan abnormal
Wheezing
Symptomtext
After the first dose I began having problem with what I thought was my asthma. I wen to my dr for refill of my inhaler. They also thought it was my asthma and additionally prescribed a packet of prednisone for one week. I was told if no fever to have the second vaccine. I did not have a fever but the morning after the second shot I couldn't walk on my left foot when getting out of the bed. It was like a pulled muscle. It continued to get worse . By the time I saw my physician on 3/23 I could barely walk. I was sent to the ER for an ultrasound on my left leg where blood clots were discovered. A CT Scan revealed I had them in my lungs as well. I stayed one night in Hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 1,0
- Labordaten
- D-Dimer at physicians office, ultrasound on left leg and CT Scan at Hospital. An EKG was also done on my heart at the hospital. I have had to repeat the ultrasound and CT Scans periodically. The clots in lung are gone, but one clot still remains behind my left knee.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Restless Leg, slight case of controlled asthma, endometriosis, migraines
- Andere Medikamente
- NP Thyroid 60 MG, rOPINIRole HCl 4 MG TAKE 1-3 TABLETS AT BEDTIME 30, Atenolol 50 MG TAKE ONE TABLET BY MOUTH DAILY 90 Cyclobenzaprine HCl 5 MG 1-2 p.o. three times a day (tid)/prn 90 days ,Ambien 10 take one tablet by mouth every night at
- Allergien
- Sulfur drugs
- Vorherige Impfungen
- -
- Staat
- WV
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 10.01.2022
- Impfdatum
- 19.11.2021
- Beginn
- 20.12.2021
- Tage bis Beginn
- 31,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Abnormal behaviour
Activated partial thromboplastin time normal
Alanine aminotransferase normal
Angiogram cerebral abnormal
Anion gap
Anticoagulant therapy
Antiplatelet therapy
Aphasia
Aspartate aminotransferase normal
Basophil count
Basophil percentage
Blood albumin normal
Blood alkaline phosphatase normal
Blood bilirubin normal
Blood calcium decreased
Blood chloride normal
Blood creatinine normal
Blood glucose normal
Symptomtext
12/20/21 ED note from RN-Pt's wife reports that last known well was last night. She states that he woke her up this AM and was unable to talk. She states that he had a TIA in November. Pt is unable to make intelligible conversation.12/20/21 ED note from Dr. -Chief Complaint: Stroke Symptoms.HISTORY OF PRESENT ILLNESS:Date of birth 6/19/1950, is a 71 y.o. male who presents to the Emergency Department complaining of stroke symptoms. According to the nurses report, the patient's wife states that the patient started to develop difficulties speaking and increased confusion starting at around 10:00 am today (12/20/21). The wife of the patient states that she woke up the patient this morning and was unable to verbally communicate with her. The wife states that at baseline the patient does not have significant speech deficit, so he was brought to the ED for evaluation. The patient's wife does note that the patient has recently suffered a TIA in November 2021, but states that the patient is acting much different than he did during his previous episode. The patient has went to speech therapy for previous symptoms suffered from a TIA. Patient is unable to verbally communicate with the medical staff at this time due to his condition. The patient has a past medical history of hypercholesterolemia, bladder cancer hypertension, anxiety, and headaches. The patient is currently taking a baby aspirin and Plavix.Update from the patient's wife states that the patient was last seen well yesterday night at 21:00 (12/19/21). Therefore the patient is not a candidate for tPA at this time. Caveat: Full history of present illness is unobtainable from patient secondary to condition. 12/20/21 H&P from Dr. -PCP: APRN:Chief Complaint: Aphasia.HPI: is a 71 y.o., male with medical history significant for previous CVA in 11/2021 on aspirin and Plavix, nicotine dependence, bladder cancer and anxiety who presents with aphasia .patient's wife states that the patient started to develop difficulties speaking and increased confusion starting at around 10:00 am today (12/20/21). she woke up the patient this morning and was unable to verbally communicate with her. wife states that at baseline the patient does not have significant speech deficit, so he was brought to the ED for evaluation. patient's wife does note that the patient has recently suffered a TIA in November 2021, but states that the patient is acting much different than he did during his previous episode. The patient has went to speech therapy for previous symptoms suffered from a TIA. Patient is unable to verbally communicate with the medical staff at this time due to his condition. patient is not a candidate for tPA due to unknown onset of time ( after ER attending had tele stroke consult). CT angiogram of head showed left ICA occlusion . MRI of head requested and patient is now being admitted for acute stroke. NIH stroke scale of 8.Active Hospital Problems (*Primary Problem).Diagnosis Acute CVA (cerebrovascular accident) (CMS HCC).12/21/21 consult note from Dr. Chief Complaint: speech problems ;History of Present Illness: History was obtained from a review of the electronic record and discussion with the patient and family. is a 71 y.o. male is a 71-year-old gentleman who presented to the hospital on 12/20/2021 after having significant speech problems and right-sided weakness. The patient recently had a stroke in November at which point he was found to have occluded left ICA and he was treated with best medical management and he was discharged on dual antiplatelet therapy and high-dose statin. The patient does have extensive history of smoking. The patient presented back on 12/20/2021 after having worsening weakness and speech problems. The patient had repeat CT angiogram which did not reveal any acute abnormalities but MRI brain showed new embolic appearing strokes in the left MCA territory. These were new compared to the previous MRI in November. The patient was evaluated at bedside. He was clinically improving. He continued to have significant speech problems.Follow up with PCP.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- EXAM:Temperature: 37 ?C (98.6 ?F); Heart Rate: 76; BP (Non-Invasive): (!) 160/75; Respiratory Rate: 15; SpO2: 94 %; Labs: Results for orders placed or performed during the hospital encounter of 12/20/21. COMPREHENSIVE METABOLIC PANEL, NON-FASTING; Result; Value; Ref Range SODIUM 134 (L) 136 - 145 mmol/L; POTASSIUM 4.5 3.5 - 5.1 mmol/L; CHLORIDE10496 - 111 mmol/L; CO2 TOTAL 22 (L) 23 - 31 mmol/L;ANION GAP 8 4 - 13 mmol/L BUN 16 8 - 25 mg/dL; CREATININE 1.09 0.75 - 1.35 mg/dL; BUN/CREA RATIO 15 6 - 22 ESTIMATED GFR 68 >=60 mL/min/BSA; ALBUMIN 3.7 3.4 - 4.8 g/dL; CALCIUM 8.5 (L) 8.8 - 10.2 mg/dL; GLUCOSE 94 65 - 125 mg/dL; ALKALINE PHOSPHATASE 114 45 - 115 U/L; ALT (SGPT) 13 10 - 55 U/L; AST (SGOT) 17 8 - 45 U/L; BILIRUBIN TOTAL0.40.3 - 1.3 mg/dL; PROTEIN TOTAL 6.9 6.0 - 8.0 g/dL; PT/INR; Result; Value; Ref Range PROTHROMBIN TIME 11.8 9.4 - 12.5 seconds INR 1.02 PTT (PARTIAL THROMBOPLASTIN TIME)Result Value Ref Range APTT 31.7 24.0 - 36.5 secondsTROPONIN-IResult Value Ref Range TROPONIN I <7 (L) 7 - 30 ng/LDRUG SCREEN, NO CONFIRMATION, URINEResult ValueRef Range AMPHETAMINES, URINE Negative Negative BARBITURATES URINE Negative Negative BENZODIAZEPINES URINE Negative NegativeBUPRENORPHINE URINE Negative Negative CANNABINOIDS URINE Negative NegativeCOCAINE METABOLITES URINENegativeNegative METHADONE URINE Negative NegativeOPIATES URINE (LOW CUTOFF) Negative Negative OXYCODONE URINE Negative Negative ECSTASY/MDMA URINE Negative Negative FENTANYL, RANDOM URINE Negative NegativeCREATININE RANDOM URINE 107 (H) 50 - 100 mg/dLCBC WITH DIFFResultValue Ref RangeWBC 4.1 3.7 - 11.0 x10?3/uLRBC 5.08 4.50 - 6.10 x10?6/uL HGB 15.2 13.4 - 17.5 g/dLHCT 46.4 38.9 - 52.0 %MCV 91.3 78.0 - 100.0 fLMCH 29.9 26.0 - 32.0 pgMCHC 32.831.0 - 35.5 g/dLRDW-CV 12.8 11.5 - 15.5 % PLATELETS 190 150 - 400 x10?3/uLMPV11.0 8.7 - 12.5 fLNEUTROPHIL % 76 %LYMPHOCYTE % 16%MONOCYTE % 5 %EOSINOPHIL % 2 %BASOPHIL % 1 %NEUTROPHIL # 3.11 1.50 - 7.70 x10?3/uLLYMPHOCYTE # 0.66 (L) 1.00 - 4.80 x10?3/uLMONOCYTE # 0.20 0.20 - 1.10 x10?3/uL EOSINOPHIL # <0.10 <=0.50 x10?3/uLBASOPHIL # <0.10 <=0.20 x10?3/uLIMMATURE GRANULOCYTE % 0 0 - 1 %IMMATURE GRANULOCYTE # <0.10 <0.10 x10?3/uL POC FINGERSTICK GLUCOSE - BMC/JMC (RESULTS). Result; Value Ref Range; GLUCOSE, POC138 (H)60 - 100 mg/dl. Labs reviewed and interpreted by me.Radiology: XR AP MOBILE CHEST. Final Result. No acute radiographic findings.Radiologist location ID: B02945.CT ANGIO INTRA-EXTRA CRANIAL W IV CONTRAST.Final Result.1. Redemonstration of occluded left ICA.2. Asymmetric intracranial perfusion, as a consequence of the aforementioned occluded left ICA with out evidence of intracranial occlusion or severe focal stenosis.3. Diminutive left vertebral artery. There is mild narrowing in the V1 segment of the right vertebral artery with the right vertebral artery otherwise widely patent.Radiologist location ID:
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Past Medical History: Diagnosis Date: Anxiety; Bladder cancer (CMS HCC); Headache; Hypercholesterolemia; Hypertension;Past Surgical History: Procedure Laterality; Date; Cystectomy w/ Ureteroileal Conduit hx Carpal Tunnel Release Right; Hx other. 7/14/2016 - Robotic assisted Lap Radical cystoprostatectomy, bilateral pelvic lymph Node dissection and ileal loop urinary diversion. Social History: Tobacco Use; Smoking status:Current Every Day Smoker; Packs/day:0.50;Years:50.00; Pack years; 25.00 Types: Cigarettes; Smokeless tobacco: Current User;Types: Chew Tobacco comment: Formerly smoked 1 ppd x50 years. Substance Use Topics Alcohol use:Not Currently.
- Andere Medikamente
- Aspirin; Atorvastatin (LIPITOR); ClopidogreL (PLAVIX); Levetiracetam (KEPPRA)Llisinopril (PRINIVIL); Nicotine (NICODERM CQ);Transdermal Patch; Sertraline (ZOLOFT).
- Allergien
- No Known Allergies
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 07.01.2022
- Impfdatum
- 11.03.2021
- Beginn
- 12.12.2021
- Tage bis Beginn
- 276,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
COVID-19 pneumonia
Death
Respiratory failure
SARS-CoV-2 test positive
Septic shock
Vaccine breakthrough infection
Symptomtext
This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Pfizer product on 02/18/2020 and 03/11/2021. The individual tested positive on 12/12/2021. It is not specifically known if the individual had symptoms or when symptom onset was. They were admitted to hospital on 12/12/2021 and remained hospitalized until their death on 12/23/2021. Death Certificate details are as follows: Part I: Cause of Death: A. Septic Shock & Respiratory Failure B. COVID-19 Pneumonia Part II: Other Significant Conditions: Atrial Fibrillation, Thrombocytopenia, Hyperglycemia, Obstructive Sleep Apnea, Obesity, Coronary Artery Disease
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 9,0
- Labordaten
- Positive COVID-19 test despite being fully vaccinated for COVID-19
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- History of atrial fibrillation, hyperglycemia, obstructive sleep apnea, obesity, coronary artery disease
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 07.01.2022
- Impfdatum
- 18.02.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 314,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute respiratory failure
Asthenia
Bradycardia
C-reactive protein normal
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Fibrin D dimer
Hypotension
Pneumonia
Pulmonary congestion
Pulmonary oedema
SARS-CoV-2 test positive
Weight decreased
Symptomtext
Hospitalized 12/29/2021; COVID-19 positive 12/29/2021; fully vaccinated BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: , MD Admission Date: 12/29/2021 Discharge Date: Jan 6, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia Generalized weakness COVID-19 HOSPITAL COURSE: Patient is an 81-year-old man with history of coronary artery disease, CABG, pulmonary embolism, atrial fibrillation, seizure, type 2 diabetes, diastolic congestive heart failure. Patient presents to the hospital secondary to weakness. He is identified to have COVID-19. He had a similar hospitalization in November with weakness requiring a subacute rehab stay, and he did improve following that rehabilitation stint. In the emergency department he is found to have hypotension, he received 2 L of fluids, he was also noted to have O2 saturations of 88% requiring 2 L of oxygen. COVID-19 PCR tested positive. Chest x-ray revealed moderate pulmonary vascular congestion and suspicious alveolar edema versus superimposed pneumonia. He was admitted to the general medicine service for further workup and management. Patient was suspected to have COVID-19 pneumonia with acute hypoxemic respiratory failure, with possible superimposed pulmonary edema. He was placed on dexamethasone 6 mg daily. He completed 5 days of remdesivir. His CRP normalized and his D-dimer was negative. His acute hypoxemic respiratory failure resolved, and was doing well on room air. In regards to his chronic heart failure with preserved ejection fraction, it did not seem that he was decompensated on presentation. His weight was stable from his last cardiology appointment. He was resumed on torsemide, and weight decreased to 93.5 kg. Torsemide was adjusted to attempt to avoid over-diuresis. Patient did tolerate this well, and his discharge weight is 94.2 kg and discharge torsemide dose is 30 mg. He was noted to have some resting bradycardia, his metoprolol XL was decreased to 75 mg daily. Patient was seen in consultation with PT and OT, and subacute rehabilitation was recommended. Discharge was delayed due to transportation issues on 1/5 with plans for discharge today at 1/6. No issues overnight. Patient continues to remain in stable condition on room air with no abnormal vitals signs. Patient is comfortable with plan for discharge to facility.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 8,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Obstructive sleep apnea (adult) NSTEMI 2012 Arteriosclerosis of coronary artery vein bypass graft Mitral regurgitation Hypertension Atrial fibrillation (HCC) Chronic systolic congestive heart failure (HCC) Pulmonary embolism (HCC) Coronary artery disease Seizures (HCC) Hyperlipidemia S/P CABG x 2 2009 S/P mitral valve repair 2009 Generalized weakness
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG tablet amoxicillin (AMOXIL) 500 MG capsule dexamethasone (DECADRON) 6 MG tablet diphenhydramine-acetaminophen (TYLENOL PM EXTRA STRENGTH) 25-500 MG TABS empagliflozin (JARDIANCE) 25 MG tablet gabapentin (NEUR
- Allergien
- Lipitor Metformin
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 88,0
- Geschlecht
- M
- Eingang
- 06.01.2022
- Impfdatum
- 18.02.2021
- Beginn
- 03.03.2021
- Tage bis Beginn
- 13,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Death
Symptomtext
Narrative: Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Death occurred out of state and no details were provided. Patient was 86 with CHF and requiring a pacemaker. Call to nurse on 2/17/21 showed complaints of SOB with sats in the 80s but declined suggestions to go to ER
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 06.01.2022
- Impfdatum
- 18.02.2021
- Beginn
- 25.02.2021
- Tage bis Beginn
- 7,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Death
Symptomtext
Narrative: Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 85 but no other contributors to death can be determined. No clinical notes/history available on patient in system listing comorbidities or pertinent medical history. Patient did not appear to receive medical care through facility system, so no apparent comorbidities are on record.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 05.01.2022
- Impfdatum
- 18.02.2021
- Beginn
- 24.02.2021
- Tage bis Beginn
- 6,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute respiratory failure
Blood bicarbonate decreased
Blood creatinine increased
Blood gases abnormal
Blood lactic acid
Blood pH increased
Blood urea increased
Cardiac arrest
Chills
Chronic obstructive pulmonary disease
Condition aggravated
Death
Dyspnoea
PCO2 normal
PO2 decreased
Pneumonia
Positive airway pressure therapy
Pulseless electrical activity
Symptomtext
Narrative: Patient died after COVID vaccination dose #1. 11/06 hospitalization 12/20 hospitalization: COPD exacerbation with acute respiratory failure requiring bipap 12/29 hospitalization for SOB, acute on chronic hypoxic respiratory failure 12/31 discharged to home 01/02 hospitalization after hearing something "pop" near the groin area and associated SOB; Per patient stated that he woke up with increasing shortness of breath not improved with his nebulizer treatment. He also said that the night before had fever associated with chills, pain and swelling of his scrotum. At the hospital he was found to be tachycardic, tachypneic, febrile with initial labs showing white count of 21.0, lactic acid 1.4, BUN 38, creat 1.6, ABG with pH 7.451. bicarbonate 7.0 pCO2 38.7, PO2 49. 01/14 discharged from hospital 01/25 admitted to hospital w/ SOB; dx pneumonia and copd exacerbation 02/02 transferred to different hospital 02/18 COVID vaccine dose #1 02/18 discharged from hospital on hospice care 02/20 admitted to hospital via ambulance with diagnosis MI, noted that patient presented in asystole, then PEA, then ROSC 02/24 patient passed away
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 90,0
- Geschlecht
- M
- Eingang
- 04.01.2022
- Impfdatum
- 23.02.2021
- Beginn
- 23.03.2021
- Tage bis Beginn
- 28,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Death
Symptomtext
Narrative: PT DIED AFTER RECEIVING 1ST DOSE OF COVID VACCINE 02/23 COVID vaccine dose #1 03/01 Pt's daughter trying to get parents into ALF 03/15 advised pt is in health and rehab facility, unknown reason, skilled nursing facility, discharged from PC 03/23 pt died No death note or bereavement note or autopsy to indicate cause of death. Appears patient was on hospice at time of vaccine, so likely that vaccine did not contribute to death, but likely due to advanced age (88 y/o) and comorbidities. No prior positive covid infection. No recent hospitalizations noted. No ADR immediately after vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 92,0
- Geschlecht
- M
- Eingang
- 04.01.2022
- Impfdatum
- 18.02.2021
- Beginn
- 06.04.2021
- Tage bis Beginn
- 47,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Death
Ejection fraction decreased
Hypotension
Intensive care
Peripheral swelling
Symptomtext
Narrative: Patient was not previously COVID-19 positive and did not have any predisposing(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt was 90 years of age, with a PMH significant for HF, AF, DM, vitamin d deficiency, neoplasm of skin, obesity, hyperlipidemia. Pt was previous admitted for worsening leg swelling. EF less than 20%. Hypotensive, and transferred to SDU on 3/29. Transferred to micu on 4/2. Transferred to hospice care on 4/3.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 04.01.2022
- Impfdatum
- 26.02.2021
- Beginn
- 12.04.2021
- Tage bis Beginn
- 45,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Death
Symptomtext
Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt has PMH significant for CAD, t2dm, CKD, hyperlipidemia, HTN, Carcinoma of Bladder, Anemia. Patient deceased on 4/12/2021 of unknown cause, no note listed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 04.01.2022
- Impfdatum
- 26.02.2021
- Beginn
- 11.03.2021
- Tage bis Beginn
- 13,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Adverse drug reaction
Cardio-respiratory arrest
Death
Dyspnoea
Malaise
Symptomtext
Narrative: Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was admitted to Hospital and coded twice before passing away on 3/11/21. Daughter reports that patient began not feeling well and having difficulty breath shortly after receiving his second Pfizer COVID-19 vaccine on 2/26/21. Death occurred at outside facility and suspected cause of death not apparent. Patient was 78 and PMH included chronic hypoxemic respiratory failure, HTN, T2DM, COPD.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardio-respiratory arrest
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 03.01.2022
- Impfdatum
- 23.02.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Death
Hyperkalaemia
Renal impairment
Symptomtext
Narrative: Patient received two covid vaccines. Patient died 3 weeks after second dose. Unclear if death was related to vaccine. PMH included stage IIIC (T3N3M0) adenocarcinoma of the R lung (s/p carboplatin, pretrexed, durcalumab, XRT), RA 2/2 durvalumab, PE with recurrent epicardial/pleural effusions s/p pericardial window, now c/b worsening renal function and hyperkalemia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 03.01.2022
- Impfdatum
- 24.02.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Death
Symptomtext
Narrative: Patient received two doses of covid vaccine. death over a month after last dose. Unclear documentation of cause of death and no further investigation documented. PMH includes lung SCC, hypothyroidism, carotid artery disease.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 94,0
- Geschlecht
- M
- Eingang
- 03.01.2022
- Impfdatum
- 24.02.2021
- Beginn
- 11.03.2021
- Tage bis Beginn
- 15,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
Death during the night two weeks after second dose
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Dizziness
- Andere Medikamente
- Aspirin, Tylenol
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 02.01.2022
- Impfdatum
- 24.05.2021
- Beginn
- 23.02.2021
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Death
Dementia
Failure to thrive
Symptomtext
Narrative: Patient received one dose of the covid vaccine. Patient died approx. one month after first dose. Cause of death noted to be end stage dementia and failure to thrive. Reporting per instruction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 02.01.2022
- Impfdatum
- 22.02.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Death
Hepatic cancer
Symptomtext
Narrative: patient received two doses of covid vaccine. Death reported on 3/9/2021 with death cert stating cause of death liver cancer. patient has no other documentation of death relating to vaccination. reporting per instructions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 96,0
- Geschlecht
- M
- Eingang
- 02.01.2022
- Impfdatum
- 24.02.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Death
Respiratory failure
Symptomtext
Narrative: Patient with one covid vaccine. Patient passed from respiratory failure before second dose due. unclear the underlying cause from respiratory failure. No other death details recorded. reporting with Regulatory Authority instructions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- F
- Eingang
- 30.12.2021
- Impfdatum
- 19.02.2021
- Beginn
- 10.10.2021
- Tage bis Beginn
- 233,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Asthenia
COVID-19
COVID-19 pneumonia
Decreased appetite
Dyspnoea
Fatigue
Nausea
Pyrexia
Symptomtext
Fully vaccinated patient with a booster as well was diagnosed with Covid 9 days ago. States she has had no appetite since then, very nauseous, some dyspnea and profound weakness and fatigue. SOB and fever. Pneumonia due to COVID-19 virus and acute hypoxic respiratory failure. Not candidate for remdesivir/decadron. Cefepime/vancomycin. Stable and discharged to home.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 6,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 97,0
- Geschlecht
- M
- Eingang
- 29.12.2021
- Impfdatum
- 13.03.2021
- Beginn
- 13.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Death
Symptomtext
Narrative: A 96yo male with PMH of Prostatic Carcinoma, Adjustment Disorder with Depressed mood, HTN, Hyperlipidemia, Chronic Low Back Pain, Arthritis, GERD, Hiatal Hernia and other Bursitis Disorder Per Nurse's documentation; He received Pfizer Covid-19 vaccine per policy and protocol without complication First dose on February 20, 2021 and the second dose on March 13, 2021 No ADE was reported Per May 4, 2021 Geriatric Telephone note, the patient passed away on April 24, 2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 29.12.2021
- Impfdatum
- 23.02.2021
- Beginn
- 23.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Death
Symptomtext
Narrative: A78yo Bed-ridden male with PMH of Cerebral Infraction, Depression, Chronic Kidney Disease, Peripheral Arterial Occlusive Disease, Parkinson's Disease, Slurred Speech, DM II, GI hemorrhage, Aspiration Pneumonia, Dysphagia as a late effect of Cerebral Infraction, transition from Home Health Care to Hospice Received Pfizer Covid - 19 vaccine per protocol and policy without complication No ADE was reported System showed this patient passed away on April 1, 2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 80,0
- Geschlecht
- U
- Eingang
- 26.12.2021
- Impfdatum
- 17.02.2021
- Beginn
- 22.12.2021
- Tage bis Beginn
- 308,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Symptomtext
Fully vaccinated-covid death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HTN, COPD, Chronic venous insufficiency
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 25.12.2021
- Impfdatum
- 15.11.2021
- Beginn
- 25.12.2021
- Tage bis Beginn
- 40,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute myocardial infarction
Arterial disorder
Catheterisation cardiac abnormal
Chest discomfort
Coronary angioplasty
Coronary arterial stent insertion
Coronary artery dilatation
Coronary artery stenosis
Intensive care
Symptomtext
70-year-old man with no significant cardiac history. He was visiting relatives for the holidays today when he developed acute onset chest discomfort. He presented to the local ER and was found to have inferior STEMI. He was emergently transferred directly to the Hospital. There was noted to be a subtotal lesion in the distal right coronary artery. The right coronary artery is a moderate caliber dominant vessel which supplies a moderate area of myocardium and is 99% stenosed in the distal segment. The lesion was predilated with a 2.5 mm balloon, stented with a 2.5 mm drug-eluting stent, and postdilated with a 2.75 mm noncompliant balloon with multiple inflations to burst rated atmospheres. There was excellent angiographic result with reduction in stenosis from 99% to 0% residual and continued TIMI-3 flow down the vessel. Admitted to ICU for recovery.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 22.12.2021
- Impfdatum
- 28.01.2021
- Beginn
- 12.12.2021
- Tage bis Beginn
- 318,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Symptomtext
Patient hospitalized on 12/12/21 and died 1on 2/13/21, after being diagnosed with COVID on 12/12/21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Parkinson's Disease.
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 20.12.2021
- Impfdatum
- 17.02.2021
- Beginn
- 19.12.2021
- Tage bis Beginn
- 305,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Symptomtext
Fully vaccinated Covid-19 related death.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Asthma; HLD; morbid obesity
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 15.12.2021
- Impfdatum
- 25.03.2021
- Beginn
- 10.10.2021
- Tage bis Beginn
- 199,0
- Dosis
- 1
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Asthenia
Blood culture positive
COVID-19
COVID-19 pneumonia
Cardio-respiratory arrest
Cough
Death
Dizziness
Dyspnoea
Endotracheal intubation
Hypervolaemia
Mechanical ventilation
Polyuria
Pseudomonas infection
Resuscitation
SARS-CoV-2 antibody test
SARS-CoV-2 test positive
Sepsis
Symptomtext
Patient presented to the emergency department on 10/10/2021 for evaluation of worsening weakness, cough, and shortness of breath that started in the past week. He was recently hospitalized for 2 days for fluid overload, diuresed, and discharged to home on 09/27/2021 and was feeling completely fine. In the past week he started to have dizziness, lightheadedness, vision problems, shortness of breath, and cough. He was admitted with COVID pneumonia. He received 2 doses of COVID vaccine in Feb and March 2021. He is on baseline oxygen of 2L via NC. He was placed on 10L HFNC on admission. Oxygen requirements continued to increase and he was intubated, ventilated on 10/17/2021. Patient received remdesivir, dexamethasone, and 1 dose of tocilizumab. He developed sepsis, and received IV fluids, vasopressors, and broad spectrum antibiotics. A code blue was called on 10/18/2021 and the patient expired despite resuscitation efforts. The patient stated that he was fully vaccinated for COVID-19. He explained that
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardio-respiratory arrest
- Hospital-Tage
- 8,0
- Labordaten
- COVID 19 positive on 10/11/2021 COVID 19 IgM and IgG antibodies were positive on 10/11/2021 Blood cultures on 10/18/2021 grew Pseudomonas aeruginosa
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 14.12.2021
- Impfdatum
- 22.03.2021
- Beginn
- 24.10.2021
- Tage bis Beginn
- 216,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
COVID-19 pneumonia
Chest pain
Death
Fall
Hypoxia
Positive airway pressure therapy
SARS-CoV-2 test positive
Symptomtext
PMH: asthma, MS; states fell 2 wks ago @ home and has had pain in chest area since; tested positive for COVID; COVID pneumonia; hypoxic; on 6 L O2 via NC saturating @ 92%; treated with decadron, antibiotics, remdesivir; placed on BIPAP; DNR; condition continued to decline; comfort measures; BIPAP was dc'd and pt died in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 11,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 10.12.2021
- Impfdatum
- 28.02.2021
- Beginn
- 15.11.2021
- Tage bis Beginn
- 260,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
Anticoagulant therapy
COVID-19
COVID-19 pneumonia
Dyspnoea
Erythema
Fibrin D dimer increased
Inflammation
Inflammatory marker test
Liver function test increased
SARS-CoV-2 test positive
Scar
Skin injury
Upper respiratory tract infection
Symptomtext
Date of Admission: 11/15/2021 Date of Discharge: 11/17/2021 Reason for Hospital Admission (Admitting Diagnosis): Acute hypoxemic respiratory failure from COVID Pneumonia 81 yo lady from home, s/p COVID vaccine x 2 in 02/2021, with known HTN, preDM, chronic bronchitis developed URI s/s on 11/08/21, found to be COVID positive on 11/11/21, presented to ED on 11/15/21 due to 3 days duration of worsening sob with hypoxemia. 1. Acute hypoxemic respiratory failure from COVID pneumonia. Elevated ddimer likely due to inflammatory process from COVID infection rather than VTE. Clinically not consistent with acute CHF or COPD exacerbation. - now on NC 2-3 L.min. Goal SpO2 >92%. Consider ICU evaluation if requiring >40LPM and 60% FiO2 for SpO2 >/= 90% - Self-proning as tolerated for O2 req >3L - Decadron 6mg IV or PO qday for up to 10 days (started on 11/15/2021) or until no longer hypoxic. - Remdesivir 200mg IV x1 on 11/15/21, followed by 100mg IV daily until clinical improvement or 5 days. - Daily LFTs. Noted slight elevated, likely due to remdesivir, will cont to trend, will hold Remdesivir if ALT >10xULN or CrCl<30 - GI prophylaxis with pepcid - trend inflammatory markers every other day - Lovenox 40mg SQ BID (BMI>40) and hold for Plt <25k, Fibrinogen <100, active bleeding - enhanced isolation in hospital per Regional/Local ID guidance. 2. PreDM - ssi in house while on steroid 3. HTN/HLD - cont PTA lisinopril/HCTZ - cont PTA lipitor 4. Moisture Associated Skin Damage to the buttocks/cleft, groin, labia with erythema + Scar tissue to the right distal lower leg from previous ulcers related to lipodermatosclerosis. No open ulcers at this time. - To the buttocks, cleft, bilateral groin, peri area and labia, clean with warm water cleansing cloths and pat dry. Apply Critic Aid Anti Fungal ointment BID and PRN soiling. Protect Sacrum/buttocks with Mepilex sacrum border dressing, changing every 3 days and PRN soiling - To the right lower leg, clean with warm water cleansing cloths and apply Atrac Tain Superior Moisturizer BID - appreciate wound nurse iput Condition on Discharge: Stable to be transfer to another acute hospital for continue care. Code Status at Time of Discharge: Full Code Discharge Disposition: Another acute hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hypertension, pre-diabetes mellitus, chronic bronchitis
- Andere Medikamente
- Atorvastatin, Lisinopril-Hydrochlorothiazide
- Allergien
- nkda
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 10.12.2021
- Impfdatum
- 21.02.2021
- Beginn
- 17.10.2021
- Tage bis Beginn
- 238,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
COVID-19 pneumonia
Death
Dyspnoea
Pain
Dementia
Polyuria
Positive airway pressure therapy
SARS-CoV-2 test positive
Seizure
Wheezing
Symptomtext
pt brought to ED by daughter with c/o worsening SOB, dyspnea, wheezing, pain; hx of CHF, gouty arthritis, CKDIII, recent new onset of seizure, dementia; started on BiPAP and diuretics, comfort measures; pt died in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 10.12.2021
- Impfdatum
- 21.02.2021
- Beginn
- 17.10.2021
- Tage bis Beginn
- 238,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
COVID-19 pneumonia
Death
Dyspnoea
Pain
Dementia
Polyuria
Positive airway pressure therapy
SARS-CoV-2 test positive
Seizure
Wheezing
Symptomtext
pt brought to ED by daughter with c/o worsening SOB, dyspnea, wheezing, pain; hx of CHF, gouty arthritis, CKDIII, recent new onset of seizure, dementia; started on BiPAP and diuretics, comfort measures; pt died in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 08.12.2021
- Impfdatum
- 24.02.2021
- Beginn
- 05.09.2021
- Tage bis Beginn
- 193,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Anticoagulant therapy
COVID-19
COVID-19 pneumonia
Death
Dyspnoea
Hypoxia
Respiratory failure
SARS-CoV-2 test positive
Symptomtext
pt presents to hosp with hypoxemia and SOB; positive for COVID; started on remdesivir, steroids, antibiotics, n-acetylcysteine, Lovenox and Mucinex; DNI; only wants medications; refusing shocking and compressions; pt's condition worsened and she died in the hosp; AHRF secondary to COVID pneumonia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 17,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 03.12.2021
- Impfdatum
- 18.02.2021
- Beginn
- 29.11.2021
- Tage bis Beginn
- 284,0
- Dosis
- 2
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
Angiogram pulmonary abnormal
Blood pressure abnormal
Breast neoplasm
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Chest pain
Cough
Dehydration
Dyspnoea
Hypophagia
Lung disorder
Lung opacity
Oxygen saturation decreased
Pyrexia
SARS-CoV-2 test positive
Sinus congestion
Symptomtext
Patient currently inpatient admission at (4) days. Acute hypoxemic respiratory failure due to COVID pneumonia: Symptom onset 11/17, started with sinus congestion. She was found to be COVID positive 11/19. She started having fevers 11/24. o Trend appropriate labs daily o Prone patient TID for 1 hour if they can tolerate o Dexamethasone for 10 day course o Continuous pulse oximetry. Goal SpO2 >92%. Dehydration: Likely due to poor PO intake o LR at 100 mL an hour o Hold home HCTZ Anxiety/depression Seasonal allergic rhinitis Morbidity obesity HTN Asthma GERD o Continue essential home medications unless otherwise stated above o VTE Prophylaxis: This patient is high risk per the VTE risk assessment tool, pharmacologic prophylaxis is indicated. Lovenox has been ordered. Diet: General Code Status: Full HPI CHIEF COMPLAINT: SHORTNESS OF BREATH (Covid + 11/19 worsening cough the last 3 days. persistent dry cough was found hypoxic when fire arrived. patient reports 86% on home pulse ox. chest pain with movement and cough. ) HISTORY OF PRESENT ILLNESS: Patient is a 50 y.o. female with a pertinent past medical history for anxiety, depression, asthma, HTN, GERD who presented to the ED primarily with shortness of breath. She denies a history of tobacco or alcohol abuse. She states that she started having symptoms of 11/17 with congestion similar to previous episodes of sinusitis, she was found to be positive 11/19, she started having fevers 11/24, last few days she has been dealing with increased cough and shortness of breath. She has also been having chest pains with cough, mostly dry cough. In the emergency department she desatted to 81% on room air, with improvement in saturations with 2 L of oxygen. Her blood pressure was soft in the emergency department and she received 1 L of IV fluids with improvement in her blood pressure. She was given Decadron 6 mg IV. Chest x-ray showed ?prominent diffuse airspace disease consistent with COVID pneumonia.?
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 4,0
- Labordaten
- CT ANGIO THORAX WITH IV CONTRAST [355884113] Resulted: 12/01/21 1900 Order Status: Completed Updated: 12/01/21 1907 Narrative: EXAMINATION: CT Angiography of the Thorax EXAM DATE: 12/1/2021 6:42 PM TECHNIQUE: Standard protocol CT angiogram images were obtained through the chest following the administration of intravenous contrast. Coronal and axial MIP 3-D reformations were performed. IV Contrast: The amount and type of contrast are recorded in the medical record. QPP DOCUMENTATION: At least one of the following dose reduction techniques was utilized: Iterative reconstruction, and/or Automatic Exposure Control, and/or mA/kV adjustment based on body size. INDICATION: Respiratory failure, hypoxia COMPARISON: None ENCOUNTER: Not applicable ____________________ CHEST FINDINGS: Base of Neck & Axillae: There is no adenopathy. Mediastinum & Hila: There is no mediastinal or hilar adenopathy. Cardiovascular: The heart has a normal size. There is no evidence of right heart strain. There is no pericardial effusion. The thoracic aorta is normal in caliber. Pulmonary Arteries: No pulmonary embolism is present. Lungs and Airways: There are moderate groundglass and consolidative opacities in a predominantly peripheral distribution bilaterally. Pleural Space: There are no pleural effusions. There is no pneumothorax. Upper Abdomen: Included portions of the upper abdomen are unremarkable. Chest Wall & Musculoskeletal: No suspicious bone lesions. There is an incidental nodular appearing lesion in the lower, slightly outer left breast at mid depth measuring 13 mm. ____________________ Impression: 1. No evidence of an acute pulmonary embolism or an acute aortic syndrome. 2. Moderate bilateral pulmonary opacities are consistent with COVID-19 pneumonia in this COVID-19 positive patient. 3. Incidental 13 mm left breast lesion. Recommend nonemergent breast imaging (mammogram plus/minus ultrasound), if not recently performed. DR CHEST 2 VIEWS FRONTAL AND LATERAL [355461104] Resulted: 11/29/21 1459 Order Status: Completed Updated: 11/29/21 1501 Narrative: EXAMINATION: Frontal and Lateral View Chest EXAM DATE: 11/29/2021 1:55 PM TECHNIQUE: Frontal and lateral views INDICATION: Cough and shortness of breath. COMPARISON: 12/20/2019 ENCOUNTER: Not applicable _________________________ FINDINGS: Heart size is normal. No mediastinal pathology. Development of moderate to marked patchy airspace disease of both lungs, most prominent in the periphery of the mid to upper lungs bilaterally. No pneumothorax or pleural effusion. _________________________ Impression: Prominent diffuse airspace disease consistent with COVID pneumonia.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Anxiety Depression Allergic rhinitis
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG tablet albuterol (ACCUNEB) 0.63 MG/3ML nebulizer solution albuterol (PROAIR HFA) 108 (90 BASE) MCG/ACT inhaler ALPRAZolam (XANAX) 0.5 MG tablet dexamethasone (DECADRON) 6 MG tablet escitalopram (LEXAPRO) 5 MG
- Allergien
- Contrast Dye [Ivp Dye, Iodine Containing]Shortness of Breath PhenobarbitalAgitation Dilaudid [Hydromorphone]Anxiety Droperidol Metoclopramide
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 93,0
- Geschlecht
- M
- Eingang
- 03.12.2021
- Impfdatum
- 23.02.2021
- Beginn
- 27.10.2021
- Tage bis Beginn
- 246,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Hypotension
Mental status changes
SARS-CoV-2 test positive
Symptomtext
Patient presented to emergency department from a long term care facility on 10/27/2021 for altered mental status and hypotension. He was diagnosed with COVID-19 on 10/11/2021 and was treated for infection. He was positive during presentation on 10/27/2021. He had a complicated hospital stay and expired on 11/17/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 21,0
- Labordaten
- COVID-19 test positive on 10/27/2021
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- acetaminophen (TYLENOL EXTRA STRENGTH) 500 MG tablet amiodarone (CORDARONE) 200 MG tablet aspirin (HALFPRIN) 81 MG tablet atorvastatin (LIPITOR) 20 MG tablet furosemide (LASIX) 40 MG tablet losartan (COZAAR) 50 MG tablet magnesium hydroxide
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 30.11.2021
- Impfdatum
- 20.02.2021
- Beginn
- 24.11.2021
- Tage bis Beginn
- 277,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Symptomtext
fully vaccinated covid related death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- CAD, HTN, DM2, CKD4
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 23.11.2021
- Impfdatum
- 19.03.2021
- Beginn
- 19.11.2021
- Tage bis Beginn
- 245,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Cerebrovascular accident
Cough
Vaccine breakthrough infection
Symptomtext
This case meets criteria for vaccine breakthrough review. SxS include, continued cough. Possible COVID infection weeks ago but was not tested. Was admitted for CVA, no specific COVID related symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- PMH/Chronic conditions include celiac, COPD, DM, CAD.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 22.11.2021
- Impfdatum
- 29.03.2021
- Beginn
- 21.11.2021
- Tage bis Beginn
- 237,0
- Dosis
- 2
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
COVID-19
Dyspnoea
Symptomtext
Acute hypoxemic respiratory failure due to COVID-19; Shortness of breath; History of COPD;
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 17.11.2021
- Impfdatum
- 21.03.2021
- Beginn
- 04.11.2021
- Tage bis Beginn
- 228,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Contusion
Cough
Death
Dyspnoea
Fall
Hypoxia
Loss of consciousness
SARS-CoV-2 test positive
Walking aid user
Symptomtext
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/28/2021 and 3/21/2021. Presented to ED on 11/4/2021 complaining of passing out at daughters house around 9am today. Patient said it lasted for a few seconds. + previous in rehab 3 weeks ago. Had a fall and did rehab recently where she left on October 1st. Lives with daughter. SOB all the time due to COPD. Uses walker. Bruised on her left knee and right ankle but improving. Patient treated with remdesivir, baricitinib, antibiotics. Patient began to experience more cough on 11/7, patient developed hypoxia on 11/9 started on oxygen NC. Patient expired on 11/13/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 9,0
- Labordaten
- COVID-19 Positive on 11/4/2021 using one or a combination of Real-Time PCR based methods and multiplex reagents including that utilize primer/probe sets specific for the detection
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- H/O Breast Cancer, COPD, Hypertenison, Macular degeneration, arthritis
- Andere Medikamente
- Allbuterol MDI PRN, Furosemide 20 mg QD, Gabapentin 300 mg TID, Olmesartan 40 mg QD, Potassium Chloride 8 meq QD, Viroptic 1 drop Q4H, Preservision Vitamin QD, Carvedilol 6.25 mg BID, Symbicort QD
- Allergien
- Codeine
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 16.11.2021
- Impfdatum
- 18.02.2021
- Beginn
- 04.11.2021
- Tage bis Beginn
- 259,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
Blood creatinine increased
Blood potassium normal
Blood sodium normal
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Condition aggravated
Cough
Dyspnoea
Dyspnoea exertional
Echocardiogram
Fatigue
Glomerular filtration rate decreased
Lung infiltration
Myalgia
Platelet count decreased
Polymerase chain reaction positive
Symptomtext
Hospitalized (10.7.21- still admitted currently); COVID-19 positive (11.4.21); Fully vaccinated CHIEF COMPLAINT: COVID HISTORY OF PRESENT ILLNESS Patient is a 83 y.o. male who presents today with COVID. The patient has a PMHx significant for CAD, HTN and CKD stage lll. The patient started having symptoms of COVID on 11/1, which included extreme fatigue, cough and SOB. The patient tested positive on 11/4. The patient has been having cough and SOB with increased exertional dyspnea. Today a portable pulse ox was placed on the patient and he was 85% on room air so he was brought to the ED. The patient otherwise denies N/V/D/C and dysuria. Patient states his last vaccine was in Feb. Upon arrival to the ED CXR pending. Na 136. K 4.5. Cr 2.20. GFR 29. Platelet 122. WBC 5.21. The patient is requiring 2L NC but otherwise remains hemodynamically stable. The patient is being admitted to the SHMG for further management and evaluation. PLAN: COVID Pneumonia Acute Hypoxic Respiratory Failure Symptom onset 11/1 + PCR 11/4. Vaccinated. CXR pending Decadron x 10 days Unable to do remdesivir at this time with kidney function. Could consider if kidney function improves. Trend labs Supportive care Progress Note / PLAN from 11.17.21: ASSESSMENT / PLAN: Acute respiratory failure COVID-19 pneumonia Vaccinated Symptom onset 11 1 Chest x-ray 11 14 showing left-sided infiltrate Continued on high-flow nasal cannula Lasix 40 mg daily Completed Rocephin and doxycycline Decadron switched to Solu-Medrol 60 IV 2 times a day 11/14 If no improvement with high-dose steroids would recommend CT scan without contrast to rule out fibrotic changes
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 10,0
- Labordaten
- -
- Aktuelle Erkrankungen
- 10.8.21: TEE Procedure 11.4.21: Urgent Care visit - Patient is a 83 y.o. male who complains of fatigue, myalgias, congestion, dry cough and fever. The symptoms have been present for 4 day(s). He denies a history of nausea, vomiting, diarrhea and rash. He has tried acetaminophen for his symptoms. Sick Contacts: contacts w/ similar symptoms, went to lunch with his sister last week and she was having similar symptoms, but did not tell him about her cold at that time. Patient has received both COVID immunizations, but they were greater than 6 months ago and he has not received the booster. He has received his influenza vaccine. He has significant cardiac history including ascending aortic aneurysm that is being monitored by Cardiology. He had a TEE performed the beginning of October.
- Vorgeschichte
- Hospital Acute hypoxemic respiratory failure due to COVID-19 (HCC) Paroxysmal A-fib (HCC) Elevated troponin level CAD (coronary artery disease) Transaminitis Primary hypertension Ascending aortic aneurysm (HCC) Pneumonia due to COVID-19 virus Nonrheumatic aortic valve insufficiency AKI on stage 3b CKD Constipation Non-Hospital Stage 3b chronic kidney disease (HCC)
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG tablet allopurinol (ZYLOPRIM) 100 MG tablet amlodipine (NORVASC) 10 MG tablet aspirin 81 MG enteric coated tablet atenolol (TENORMIN) 25 MG tablet chlorthalidone (HYGROTEN) 25 MG tablet Cholecalciferol (VITAMI
- Allergien
- Gabapentin Hives Penicillin G Hives
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 90,0
- Geschlecht
- F
- Eingang
- 16.11.2021
- Impfdatum
- 26.02.2021
- Beginn
- 27.08.2021
- Tage bis Beginn
- 182,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
COVID-19 pneumonia
Death
Encephalopathy
Unresponsive to stimuli
Symptomtext
pt admitted to hosp with severe COVID pneumonia, AHRF; on high flow O2; DNR; placed on comfort care; encephalopathy and her condition continued to worsen; no response to verbal or tactile stimuli for 2 days prior to her death in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 15.11.2021
- Impfdatum
- 28.02.2021
- Beginn
- 07.11.2021
- Tage bis Beginn
- 252,0
- Dosis
- 1
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19 pneumonia
Chest X-ray abnormal
Death
Dyspnoea
Symptomtext
Pt received pfizer vaccines on 02/28/21 and 03/21/21. ON 11/07 pt presented to the ED with complaints of SOB. Pt required supplemental oxygen. CXR showed COVID pneumonia. Pt was DNR comfort and expired on 11/12/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- NSTEMI, Dyspnea, CLL
- Andere Medikamente
- -
- Allergien
- Avandia, hydralazine
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 09.11.2021
- Impfdatum
- 24.02.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 254,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
fully vaccinated-covid releated death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- CLL; DM2; CAD; a-fib; HTN; HLD; Hx of CVA
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 09.11.2021
- Impfdatum
- 19.03.2021
- Beginn
- 27.10.2021
- Tage bis Beginn
- 222,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute respiratory failure
COVID-19 pneumonia
Catheterisation cardiac
Chronic obstructive pulmonary disease
Computerised tomogram thorax abnormal
Condition aggravated
Pulmonary fibrosis
Symptomtext
10/27 Pt presents to ER via EMS with c/o DIB x 5hrs PTA. Per EMS, pt SpO2 was 70% on RA, pt normally on 2L NC at home, Hx COPD. 10/28 A/P: COVID 19 Pneumonia, Acute Hypoxic Resp Failure, COPD Exacerbation. on high-flow oxygen with increasing O2 demand. 10/29 Advised patient to lay on sides and rotate as much as tolerated. The patient was started on Decadron 6 mg q.12. The patient also started on remdesivir.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- 10/27 CT Chest: Chronic obstructive pulmonary disease and fibrotic scarring. 11/2 CT Chest: Chest Stable.
- Aktuelle Erkrankungen
- heart catheterization on 03/29/2021
- Vorgeschichte
- Cellulitis of knee, left Traumatic joint effusion COPD, severe S/P laparoscopic cholecystectomy Acute superficial gast Cellulitis COPD laparoscopic cholecystectomy Acute superficial gastritis Diverticulosis of large intestine Cervical radicular pain Paresthesia of left arm Abdominal pain Chronic respiratory failure with hypoxia Anxiety Dizziness
- Andere Medikamente
- atorvastatin, metoprolol, omeprazole, predniSONE, Psyllium raloxifene SYNTHROID traMADol TRELEGY ELLIPTA 1
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 92,0
- Geschlecht
- F
- Eingang
- 09.11.2021
- Impfdatum
- 25.02.2021
- Beginn
- 04.11.2021
- Tage bis Beginn
- 252,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
Angiogram abnormal
Arterial occlusive disease
COVID-19
COVID-19 pneumonia
Death
Intensive care
Peripheral ischaemia
Positive airway pressure therapy
SARS-CoV-2 test positive
Streptococcus test positive
Symptomtext
COVID-19 pneumonia 93-year-old female who was admitted to Hospital for acute hypoxic respiratory failure. Patient found to be Covid positive and had a positive urine antigen for strep pneumonia. She also had ischemic appearing limbs and was found to have arterial occlusions in bilateral lower extremities on CT angio. On arrival, patient was on BiPAP and stated that she wanted to be DNR/DNI. She was started on broad-spectrum antibiotics and remdesivir. In the morning on 11/5, it was explained to the patient that she would require antibiotics, anticoagulation, and continued respiratory support. She decided that she would prefer to go on comfort care measures of these were initiated. Patient died at 1313 on 11/5.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 2,0
- Labordaten
- SARS-COV2 PCR+11/4/21
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 05.11.2021
- Impfdatum
- 22.02.2021
- Beginn
- 05.09.2021
- Tage bis Beginn
- 195,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Death
Dyspnoea
General physical health deterioration
Mental status changes
Positive airway pressure therapy
Symptomtext
pt was seen in ED and diagnosed with COVID; pt refused hospitalization and was dc'd to home; pt presented again today in ED with worsening symptoms; reports altered mental status and O2 sats in 80s @ home, increasing SOB; placed on 100% high flow via NC and alternating between BiPAP; pt's condition continued to deteriorate; placed on comfort care only; pt died in the hosp
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 9,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 05.11.2021
- Impfdatum
- 22.02.2021
- Beginn
- 05.09.2021
- Tage bis Beginn
- 195,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Death
Dyspnoea
General physical health deterioration
Mental status changes
Positive airway pressure therapy
Symptomtext
pt was seen in ED and diagnosed with COVID; pt refused hospitalization and was dc'd to home; pt presented again today in ED with worsening symptoms; reports altered mental status and O2 sats in 80s @ home, increasing SOB; placed on 100% high flow via NC and alternating between BiPAP; pt's condition continued to deteriorate; placed on comfort care only; pt died in the hosp
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 9,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 03.11.2021
- Impfdatum
- 24.02.2021
- Beginn
- 14.09.2021
- Tage bis Beginn
- 202,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Death
Hyporesponsive to stimuli
Hypothermia
Intensive care
Pneumonia
Renal failure
SARS-CoV-2 test positive
Symptomtext
pt diagnosed positive for COVID in nursing home,11 days prior to hosp admission; admitted to hosp with hypothermia, left sided pneumonia and renal insufficiency; family states she's requiring more O2 and is less interactive; hx of Alzheimer's, DM; COVID test is positive; treated with steroids and antibiotics; DNR/DNI; sent to ICU where she shortly passed away
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 02.11.2021
- Impfdatum
- 28.01.2021
- Beginn
- 17.09.2021
- Tage bis Beginn
- 232,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Body temperature increased
COVID-19
Cardiac failure congestive
Chills
Death
Delirium
Hypoxia
Mental status changes
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Narrative: Breakthrough COVID case. Pt had COVID confirmed non-facility, test was done 9/14. Sx on 9/17 included altered mentation, delirium, hypoxia, chills, temp elevated 1 degree from baseline (per PCP not technically a fever). Monoclonal infusion 9/16 at 1:30 pm. EMS called to take pt to non-facility hospital 9/17 and husband confirmed that patient had passed away Sept. 17th of CHF.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 29.10.2021
- Impfdatum
- 27.02.2021
- Beginn
- 09.08.2021
- Tage bis Beginn
- 163,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Bronchopleural fistula
COVID-19
Death
Dyspnoea
Endotracheal intubation
Intensive care
SARS-CoV-2 test positive
Symptomtext
pt presented to ED with 3 days of increasing SOB; positive for COVID in ED; treated with dexamethasone, remdisivir, tocilizumab; on 15 L O2 via NC; oxygenation worsened requiring ICU and intubation; bronchopleural fistula secondary to heavy hx of vaping and cigarette use; was eventually made a DNR; comfort measures; extubated and patient expired in the hosp
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 30,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 89,0
- Geschlecht
- F
- Eingang
- 29.10.2021
- Impfdatum
- 21.02.2021
- Beginn
- 19.09.2021
- Tage bis Beginn
- 210,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Condition aggravated
Cough
Death
Dyspnoea
Malaise
Positive airway pressure therapy
SARS-CoV-2 test positive
Symptomtext
pt diagnosed COVID positive 2 days before hospital admission; admitted with increasing SOB and malaise; O2 saturations @ home were 85%; placed on O2, 8L via NC; cough, treated with dexamethasone and baricitinib; has AKI therefore didn't treat with remdesirvir; COVID pneumonia and ARF with hypoxia; placed on Vapotherm and eventually BiPAP; pt's condition worsened; palliative care was consulted; pt was taken off BiPAP and she was kept comfortable; pt expired in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 8,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 28.10.2021
- Impfdatum
- 24.02.2021
- Beginn
- 23.08.2021
- Tage bis Beginn
- 180,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
COVID-19
Cardiac arrest
Cough
Death
Dyspnoea
Endotracheal intubation
Hypoxia
Oxygen saturation decreased
Positive airway pressure therapy
SARS-CoV-2 test
Symptomtext
pt admitted to the hosp with increasing SOB over past 2 days; hx COPD; positive test for COVID; placed on BiPAP due to increasing O2 requirements; acute on chronic respiratory failure with hypoxemia; cough continued to worsen and O2 requirements increased requiring intubation; cardiac arrest occurred and pt died in the hospital despite aggressive measures to prolong life
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 27,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 28.10.2021
- Impfdatum
- 15.03.2021
- Beginn
- 21.10.2021
- Tage bis Beginn
- 220,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Angiogram pulmonary abnormal
Anticoagulant therapy
Aortic dilatation
COVID-19
Chest X-ray abnormal
Computerised tomogram thorax abnormal
Condition aggravated
Cough
Dyspnoea
Echocardiogram abnormal
Left ventricular hypertrophy
Lung opacity
Pain in extremity
Pulmonary embolism
SARS-CoV-2 test positive
Scan with contrast abnormal
Symptomtext
Hospitalized (10.21.21); COVID-19 positive (10.21.21); Fully vaccinated Admission Date: 10/21/2021 Discharge Date: 10/24/2021 DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: 83 y.o. male who presented with worsening cough, shortness of breath found to be COVID 19 positive on date 10/21 with pulmonary embolism. He was treated with decadron, 4 day course of remdesivir as well as home inhalers. He initially required 2L NC but was weaned to room air. He improved both clinically and in lab findings. He was discharged home in stable condition to complete decadron course. CT as above regarding PE. Patient initially started on heparin for PE for suspicion of failed anticoagulation with Xarelto. Home xarelto had been held for upcoming biopsy prior to admission, indicating PE not due to treatment failure. Patient transitioned to loading dose of Xarelto. Echo limited in quality but did not show clear evidence of right heart strain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 4,0
- Labordaten
- PROCEDURES 10/21/21: - CT angio thorax w/ contrast: 1. Segmental and subsegmental pulmonary emboli involving the right upper, middle, and lower lobes as well as the lingula. No CT evidence of right heart strain. 2. Similar appearance of a spiculated density within the right upper lung near the apex. This remains concerning for lung cancer and the patient is currently scheduled for CT-guided biopsy. 3. There are scattered areas of groundglass opacity are nonspecific but can be seen with Covid-19 pneumonia. 4. Ectasia of the ascending thoracic aorta measuring up to 44 mm. -CXR: 1. No acute cardiopulmonary process. 2. Redemonstration of an area of architectural distortion in the peripheral right upper lung zone corresponding to a solid spiculated density on the recent comparison CT. This remains concerning for lung cancer. 10/22/21 Echocardiogram: Technical quality limited. LV normal in size. Mild concentric LVH. LV systolic function normal. RV not well visualized. RV systolic pressure normal
- Aktuelle Erkrankungen
- 9.23.21: ED: Leg pain 9.24.21: ED: Left leg pain
- Vorgeschichte
- CAD (coronary artery disease) PVD (peripheral vascular disease) with claudication (HCC) Diabetes mellitus, type II (HCC) Dyslipidemia Left Diaphragm paralysis OSA (obstructive sleep apnea) COPD, severe (HCC) Preop cardiovascular exam CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min (HCC) Right inguinal hernia Abscess, intra-abdominal, postoperative History of Recurrent Pulmonary Embolism Edema, unspecified type Ascending aorta dilatation (HCC) Abnormal CT of the chest
- Andere Medikamente
- albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler allopurinol (ZYLOPRIM) 300 MG tablet aspirin 81 MG EC tablet atenolol (TENORMIN) 50 MG tablet colchicine (COLCRYS) 0.6 MG tablet dexamethasone (DECADRON)
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 28.10.2021
- Impfdatum
- 26.03.2021
- Beginn
- 20.10.2021
- Tage bis Beginn
- 208,0
- Dosis
- 2
- Route/Site
- IM / AR
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
Anaemia
Anticoagulant therapy
Anticoagulation drug level above therapeutic
Asthenia
COVID-19
COVID-19 pneumonia
Computerised tomogram head normal
Condition aggravated
Death
Decreased appetite
Endotracheal intubation
Fall
Gait disturbance
Gastrointestinal endoscopic therapy
Gastrointestinal polyp haemorrhage
International normalised ratio increased
Mental status changes
Symptomtext
Deceased (10.23.21); Hospitalized (10.20.21); COVID-19 positive (10.20.21); fully vaccinated Primary Care Physician at Discharge Admission Date: 10/20/2021 Date of Death: 10/23/21 Time of Death: 5:47 PM Preliminary Cause of Death: Pneumonia due to COVID-19 virus DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Supratherapeutic INR Acute on chronic anemia Acute respiratory failure due to COVID-19 HOSPITAL COURSE: 86yo Afib on coumadin, trip/fall on 10/20, admitted to IM for INR-7.3, recent GIB (9/13 EGD with coag, 10/1 21 friable polyps resected for oozing and need for anticoagulation), found to be COVID + (full vax with Pfizer and booster), symptoms of weakness, poor appetite since 10/14, 10/22 Azith/Rocephin started for CAP, pt mentation declining, taking off his oxygen, not following commands, early AM 10/23 pt removed oxygen, went into PEA arrest. ROSC obtained after 15min. Intubated, cooled to prevent fever, no target temp. CT head done and NEG, EEG ordered however son came in to see patient, held a family mtng and decided to go comfort care. Therefore pt was extubated this afternoon, sedation off and passed away peacefully.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- 10.1.21: Procedure: ENDOSCOPIC MUCOSAL RESECTION (EMR), UPPER GI. Friable bleeding gastric polyps. Multiple friable polyps in the stomach. Benign appearing. These were treated by cold BAS (band and slough) EMR.
- Vorgeschichte
- Rheumatic aortic insufficiency Rheumatic mitral insufficiency CHF (congestive heart failure) Permanent atrial fibrillation Elevated prostate specific antigen (PSA) Cardiomyopathy, nonischemic HDL deficiency VT (ventricular tachycardia) Cardiac resynchronization therapy defibrillator (CRT-D) in place Mixed hyperlipidemia Essential hypertension Macular degeneration Orthostatic hypotension Diabetes mellitus type 2 with complications GERD (gastroesophageal reflux disease) S/P aortic valve replacement S/P mitral valve repair Exudative age-related macular degeneration, unspecified laterality, unspecified stage Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side Thoracic aortic aneurysm, without rupture Supratherapeutic INR Shock Acute respiratory failure with hypoxia Cardiac arrest COVID-19 AKI (acute kidney injury)
- Andere Medikamente
- acetaminophen (TYLENOL) 325 MG tablet aspirin 81 MG tablet Blood Glucose Monitoring Suppl MISC carvedilol (COREG) 25 MG tablet Ferrous Sulfate (IRON) 325 (65 Fe) MG TABS glucose blood VI test strips (ONE TOUCH ULTRA TEST) strip insulin glar
- Allergien
- Lipitor [Atorvastatin] Statins [Hmg-coa-r Inhibitors]Myalgia
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 27.10.2021
- Impfdatum
- 13.03.2021
- Beginn
- 22.10.2021
- Tage bis Beginn
- 223,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cerebrovascular accident
Death
Symptomtext
death I63.9 - Cerebrovascular accident (CVA), unspecified mechanism
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 25.10.2021
- Impfdatum
- 13.03.2021
- Beginn
- 21.09.2021
- Tage bis Beginn
- 192,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute kidney injury
Acute respiratory distress syndrome
Acute respiratory failure
Asthenia
COVID-19
COVID-19 pneumonia
Condition aggravated
Death
Diarrhoea
Dyspnoea
Fatigue
Malaise
Metabolic encephalopathy
Oropharyngeal pain
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
This is a case of breakthrough COVID-19 disease that resulted in death. The patient became symptomatic while on a trip out of state. Several other people on this trip were also ill with COVID-19. This case was vaccinated with the Pfizer product on 02/19/2021 and 03/13/2021. The case became symptomatic for COVID-19 on 09/21/2021 and experienced symptoms of diarrhea, general weakness, fatigue, and sore throat. The exact timeline here is not clear, but over the course of the following days, the case developed difficulty breathing and was admitted to the hospital on 09/27/2021.. The case subsequently died on 10/01/2021. The death certificate details are as follows: Part I Cause of Death A: Acute Hypoxic Respiratory Failure B: COVID 19 Pneumonia; Adult Respiratory Distress Syndrome Part II Other Significant Conditions: Acute Kidney Failure; Acute Metabolic Encephalopathy
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 5,0
- Labordaten
- PCR positive for COVID-19 on 09/27/2021 despite being fully vaccinated against COVID-19.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Acute kidney failure; acute metabolic encephalopathy
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 21.10.2021
- Impfdatum
- 21.02.2021
- Beginn
- 03.08.2021
- Tage bis Beginn
- 163,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Asthenia
Blood calcium decreased
COVID-19
Death
Electrolyte imbalance
General physical health deterioration
Pain
Pyrexia
Renal impairment
SARS-CoV-2 test positive
Symptomtext
pt sent to ED by PCP due to low Calcium & multiple electrolyte abnormalities; during hospital stay he complained of body aches and weakness; tested positive for COVID; began running fever; renal function declined; pt's condition worsened; DNR; comfort measures instituted; pt passed away in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 38,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 21.10.2021
- Impfdatum
- 01.03.2021
- Beginn
- 13.10.2021
- Tage bis Beginn
- 226,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Death
Systemic inflammatory response syndrome
Symptomtext
death R65.10 - SIRS (systemic inflammatory response syndrome) N17.9 - AKI (acute kidney injury)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 20.10.2021
- Impfdatum
- 08.03.2021
- Beginn
- 10.09.2021
- Tage bis Beginn
- 186,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Death
Dyspnoea
Hypotension
Hypoxia
Oxygen saturation decreased
Symptomtext
pt presented with SOB and hypoxia despite being on 3L O2 via NC; placed on nonrebreather; oxygen requirement increased; hypotension occurred; O2 sats dropped; pt was a DNR/DNI; condition declined and she died in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 19.10.2021
- Impfdatum
- 17.01.2021
- Beginn
- 13.10.2021
- Tage bis Beginn
- 269,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Parkinson's disease; COPD; CKD Stage 3; HTN; HLD, TIA
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 91,0
- Geschlecht
- M
- Eingang
- 19.10.2021
- Impfdatum
- 12.02.2021
- Beginn
- 16.08.2021
- Tage bis Beginn
- 185,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
COVID-19
Cough
Death
Dyspnoea
General physical health deterioration
Hypoxia
Pyrexia
SARS-CoV-2 test positive
Symptomtext
pt presented to Ed with worsening cough, fever and SOB, sx X 4 days; hypoxic, placed on a non-rebreather; mucoid sputum, tested positive for COVID; pt declined intubation; acute respiratory failure with hypoxia; pt's condition declined and he died in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 6,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 18.10.2021
- Impfdatum
- 17.02.2021
- Beginn
- 10.10.2021
- Tage bis Beginn
- 235,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute respiratory failure
Asthenia
Brain natriuretic peptide normal
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Hypokalaemia
Hypoxia
Lung infiltration
Nausea
Pulmonary oedema
SARS-CoV-2 test positive
Spinal fusion surgery
Spinal laminectomy
Urine analysis abnormal
Vomiting
Symptomtext
Hospitalized 10.10.21; COVID-19 positive (10.10.21); fully vaccinated Admission Date: 10/10/2021 Discharge Date: Oct 12, 2021 PRESENTING PROBLEM: Hypoxemia Hypokalemia Acute hypoxemic respiratory failure due to COVID-19 COVID-19 HOSPITAL COURSE: Patient is a 68-year-old female who presented for evaluation of nausea, vomiting and weakness. The patient has a history of Addison's disease, hypothyroid, GERD and recent lumbar lami and spinal fusion. In the ER the patient was found to have a positive UA, no leukocytosis and hypokalemia. She was treated with rocephin. She was also hypoxic and a CXR showed possible edema vs infectious process. Her BNP was normal and she was found to be COVID positive. She was started on dexamethasone and given a dose of IV hydrocortisone and admitted to the hospitalist for further management. She was quickly weaned from oxygen and not treated with further dexamethasone or remdesivir. Her nausea and vomiting resolved however she continued to feel very weak. She was treated with additional stress dose steroids. PT/OT evaluated the patient and felt she was appropriate to return home to resume home health. On the day of discharge she was feeling better. She was encouraged to follow up with her PCP for continued monitoring after discharge and to quarantine for 10 days after symptom onset. She verbalized understanding of these instructions and discharged home in stable condition. * Pneumonia due to COVID-19 virus Assessment & Plan Symptoms began 1 day before admission Patient is fully vaccinated CXR showing pulmonary edema vs infectious infiltrates BNP normal and COVID positive Hypoxic in the ER on room air requiring 2L NC initially, weaned to room air today Will stop dexamethasone and remdesivir Monitor daily CRP, CMP, CBC, D dimer Lovenox for VTE prophylaxis Supportive care Wean oxygen as tolerated Acute hypoxemic respiratory failure due to COVID-19 Assessment & Plan Resolved Now on room air Weakness Assessment & Plan Patient feeling weaker than baseline Will continue to monitor today and ask PT/OT to eval Will treat with stress dose steroids given Addison's disease
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- 9.15.21: consult pre-operatively - Patient was not able to reach her endocrinologist regarding steroid use in perioperative. Going off which she has done with previous spinal procedure (2009) I would recommend she receive hydrocortisone 100 mg just prior to her procedure. Monitor blood pressure and fluid status closely during surgery and administer hydrocortisone 50 mg and her home Florinef immediately after the surgery 9.20.21: Admitted for surgery 9.20.21 - 9.24.21: posterior lumbar 1-4 decompressive last. Interbody fusion. Local bone, bone morphogenic protein crest calcinosis allograft bone on 09/20/21.
- Vorgeschichte
- benzodiazapine dependent Anxiety Addison's disease Adrenal insufficiency Low back pain Eczematous dermatitis GERD (gastroesophageal reflux disease) Tinnitus Hypothyroidism due to acquired atrophy of thyroid Dyspnea Family history of colon cancer Insomnia Thoracic spine pain Osteoarthritis of multiple joints, unspecified osteoarthritis type Post-menopausal bleeding Osteopenia Osteoarthritis of lumbar spine Accidental medication error Incisional hernia GAD (generalized anxiety disorder) Recurrent major depressive disorder, in full remission Lumbar stenosis with neurogenic claudication Acute hypoxemic respiratory failure due to COVID-19 Pneumonia due to COVID-19 virus UTI (urinary tract infection) Hypokalemia Nausea and vomiting Weakness
- Andere Medikamente
- benzocaine-menthol (CEPACOL) 15-3.6 MG LOZG benzonatate (TESSALON) 100 MG capsule cephalexin (KEFLEX) 500 MG capsule fludrocortisone (FLORINEF) 0.1 MG tablet fluoxetine (PROZAC) 40 MG capsule guaiFENesin (MUCINEX) 600 MG 12 hr tablet hydroc
- Allergien
- LatexRash Norco [Hydrocodone-acetaminophen]Rash Shellfish AllergyItching, Rash
- Vorherige Impfungen
- -
- Staat
- DE
- Alter
- 47,0
- Geschlecht
- M
- Eingang
- 18.10.2021
- Impfdatum
- 31.01.2021
- Beginn
- 22.06.2021
- Tage bis Beginn
- 142,0
- Dosis
- 2
- Route/Site
- SYR / AR
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Back pain
Blood cholesterol increased
Blood triglycerides increased
Cardiac arrest
Laboratory test
Pain
Resuscitation
Stent placement
Symptomtext
Received the second shot as of 2/21/21. In June of that summer woke up with back pain between the shoulder blades. Could not relieve the back pain. Suffered Cardiac Arrest on drive to hospital. Revived by wife and EMT using CPR compressions and an AED device. Received a stent at hospital. Have recovered with no side effects other than soreness from compressions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- 3,0
- Labordaten
- Medical test showed elevated numbers of cholesterol, triglycerides, and other labs.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 15.10.2021
- Impfdatum
- 31.01.2021
- Beginn
- 28.09.2021
- Tage bis Beginn
- 240,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
COVID-19 pneumonia
Chills
Computerised tomogram head normal
Cough
Dyspnoea
Fall
Pyrexia
Symptomtext
88-year-old woman with significant past medical history of COPD/asthma, pulmonary hypertension, atrial fibrillation on Coumadin, coronary artery disease and prediabetes presents on transfer from Hospital for Covid pneumonia. Patient had been previously vaccinated and contracted Covid from her daughter. Started developing fevers and chills with cough and progressive shortness of breath. Went to Hospital today where she was found to have Covid pneumonia with acute hypoxemic respiratory failure. While at hospital patient fell and a CT scan of the head was obtained which was negative for bleed. Patient was placed on 4 L of oxygen with improvement in her oxygen saturation. Patient currently feels comfortable without shortness of breath on 4 L of oxygen by nasal cannula. Denies chest pain, nausea vomiting, diarrhea, abdominal pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 15.10.2021
- Impfdatum
- 01.03.2021
- Beginn
- 04.10.2021
- Tage bis Beginn
- 217,0
- Dosis
- 1
- Route/Site
- SYR / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
Adenovirus test
Asthenia
COVID-19
Chills
Cough
Exposure to SARS-CoV-2
Fall
Mycoplasma test negative
Respiratory viral panel
SARS-CoV-2 test positive
Symptomtext
10/07/2021Patient presents with o Covid-19 Screening + covid exposure, cough and chills x 3 days. no otc meds taken. Pt is a 86 y.o. male presents to UC for chief complaint of possible covid. Wife is covid positive. Started with cough/chills 3 days ago (10/4/2021). No OTC medication needed. Is COVID vaccinated No hx of covid. ED to Hosp-Admission Current 10/10/2021 - present (5 days) local Hospital Acute respiratory failure with hypoxia (CMS/HCC) Patient presents with o Fall o Weakness - Generalized o COVID + Pt is an 86 y.o. male with medical history sig for hypertension, CAD s/p catheterization, atrial fibrillation, long-term anticoagulant use, dyslipidemia, a
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 5,0
- Labordaten
- 10/10/2021 1305 Respiratory virus detection panel Collected: 10/10/21 1305 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Dete
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 89,0
- Geschlecht
- F
- Eingang
- 14.10.2021
- Impfdatum
- 01.03.2021
- Beginn
- 22.09.2021
- Tage bis Beginn
- 205,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19 pneumonia
Death
SARS-CoV-2 test
Symptomtext
Developed covid pneumonia and hospitalized on 9/22/21; Died on 10/2/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- SARS-CoV-2 Antigen specimen collected 9/22/2021
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 89,0
- Geschlecht
- F
- Eingang
- 14.10.2021
- Impfdatum
- 01.03.2021
- Beginn
- 22.09.2021
- Tage bis Beginn
- 205,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19 pneumonia
Death
SARS-CoV-2 test
Symptomtext
Developed covid pneumonia and hospitalized on 9/22/21; Died on 10/2/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- SARS-CoV-2 Antigen specimen collected 9/22/2021
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 09.10.2021
- Impfdatum
- 23.02.2021
- Beginn
- 26.02.2021
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Cerebrovascular accident
Death
Symptomtext
Major stoke three days after injection. He was unable to recover and subsequently passed away after one month.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 28,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- copd
- Andere Medikamente
- -
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 90,0
- Geschlecht
- M
- Eingang
- 08.10.2021
- Impfdatum
- 12.03.2021
- Beginn
- 28.08.2021
- Tage bis Beginn
- 169,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
COVID-19 pneumonia
Cardiac arrest
Cough
Death
Dyspnoea
Oxygen saturation decreased
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough COVID-19 case with unknown symptom onset date: Shortness of breath/difficulty breathing, Cough. Hospitalized 8/28/2021-9/10/2021, SOB and low O2 stats (86%) reported, developed pneumonia. Death 9/20/2021. From Records COD= CARDIAC ARREST, COVID-19 PNEUMONIA. Per records, Other Significant Conditions include: None listed. Place of death: HOSPITAL-INPATIENT; certified by: PRONOUNCING AND CERTIFYING PHYSICIAN; occ/ind: MIDDLE MANAGEMENT, TELECOMMUNICATIONS .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- 13,0
- Labordaten
- 08/28/2021 PCR+ COVID-19 test at Hospital; 09/10/2021 PCR+ COVID-19 test at Hospital; 09/17/2021 PCR+ COVID-19 test at Hospital
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 98,0
- Geschlecht
- F
- Eingang
- 08.10.2021
- Impfdatum
- 20.03.2021
- Beginn
- 30.08.2021
- Tage bis Beginn
- 163,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Death
Symptomtext
Fully vaccinated COVID-19 death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 88,0
- Geschlecht
- M
- Eingang
- 07.10.2021
- Impfdatum
- 22.02.2021
- Beginn
- 04.10.2021
- Tage bis Beginn
- 224,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19
COVID-19 pneumonia
SARS-CoV-2 test positive
Symptomtext
Patient admitted under observation on 10/04/2021 due to Acute respiratory failure with hypoxia 2/2 COVID pneumonia. Patient was tested for COVID-19 and was positive on 10/04/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- finasterie, furosemide, gabapentin, losartan, lovastatin, metFORMIN, metoprolol succinate , nitroglycerin, tamsulosin
- Allergien
- Vytorin 10-80 [Ezetimibe-simvastatin]
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 06.10.2021
- Impfdatum
- 16.03.2021
- Beginn
- 16.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Aphasia
Dyskinesia
Neurological symptom
Peripheral swelling
Respiratory arrest
Unresponsive to stimuli
Symptomtext
Mouth twisted like having stroke, couldn't breath, couldn't respond to name being called, couldn't talk. Used epipen, and nitroglycirin, and alled ambulance Swelling in legs
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Respiratory arrest
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Born with polio, COPD, sleep apnea, Mini strokes, sinuses, fused vertibrate, multiple surgeries
- Andere Medikamente
- Albuterol, Amlodipine, Carbamazepine, Ciprofloxacin, Anoro, Ellipta, Aciphex, Cyclobenzaprine, Dexamethasone, Diclofenanac Sodium, Epinephrine Sluoxetine, Fluticasone, Furosemide, Gabapentin, Multivitamin, Levetiracetam, Nethadone, Losartan
- Allergien
- Asa Buff, Azithromycin, Bee Venom, Covid 19 vaccine, Hydrocondone, IV Contrast, Lisinopril, Lyrica, Nutritional suppliment, Rilpax, shellfish, Sulfa drugs, cross reactors, Tramadol, Wasp vemon, blackberries, Strawberry extract.
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 90,0
- Geschlecht
- M
- Eingang
- 06.10.2021
- Impfdatum
- 10.03.2021
- Beginn
- 19.08.2021
- Tage bis Beginn
- 162,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
COVID-19
Death
Fall
Fatigue
SARS-CoV-2 antibody test positive
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough COVID-19 case with unknown symptom onset date: Fatigue or tiredness and weakness. Patient presented to ED on 08/19/2021 after a fall with weakness and feeling tired. Patient death reported by hospital. Patient was admitted on 08/20/2021 and died on 08/24/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 4,0
- Labordaten
- 08/19/2021 PCR+ COVID-19 test at hospital; 08/21/2021 IGG+ COVID-19 test at hospital
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Patient had a hx of diabetes, hypertension, cardiovascular disease, and prostate cancer
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 46,0
- Geschlecht
- M
- Eingang
- 05.10.2021
- Impfdatum
- 17.02.2021
- Beginn
- 20.02.2021
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
Death within 7 days of receiving vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- sleep apnea, asthma, hypertension
- Andere Medikamente
- Unknown
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 04.10.2021
- Impfdatum
- 20.02.2021
- Beginn
- 19.09.2021
- Tage bis Beginn
- 211,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Adenovirus test
Angiogram pulmonary abnormal
Anticoagulant therapy
Aortic arteriosclerosis
Arteriogram coronary abnormal
Arteriosclerosis
Arteriosclerosis coronary artery
Bordetella test negative
COVID-19
Cardiac telemetry
Chest X-ray abnormal
Chlamydia test negative
Chronic left ventricular failure
Computerised tomogram
Condition aggravated
Coronavirus test negative
Cough
Diastolic dysfunction
Symptomtext
ED to Hosp-Admission Discharged 9/19/2021 - 9/21/2021 (2 days) Last attending ? Treatment team COVID-19 Presenting Problem/History of Present Illness/Reason for Admission Hypoxia [R09.02] Pulmonary embolism associated with COVID-19 (CMS/HCC) [U07.1, I26.99] COVID-19 [U07.1] Chronic combined diastolic and systolic heart failure Hospital Course 77-year-old male admitted to the hospital with findings of acute pulmonary embolism in the setting of COVID-19 without significant pneumonia. Was found to have respiratory insufficiency with hypoxia acute present on admission. Was started on heparin infusion as well as remdesivir, monitored overnight with some improvement. This morning upon evaluating him he appeared stable for discharge home. He was taken off of heparin, converted to Eliquis which she will continue for 3 months. We will stop acute interventions for COVID-19 given that he does not show signs of viral pneumonia. Hypoxia is likely related to VTE. He was instructed to isolate until October 3. He will follow-up with PCP within 7 to 10 days. Supplemental oxygen was provided at discharge as patient did qualify. If there are complications regarding cost and affordability of Eliquis it would be recommended that patient's physician bridge him with Eliquis to Coumadin over the next month. I stopped his Plavix, he should not be on triple therapy at this time, he will be on Eliquis, and aspirin and after 3 months if taken off of Eliquis could be then put back on Plavix. ED to Hosp-Admission Current 10/1/2021 - present (3 days)hospital Last attending ? Treatment team Ventricular tachycardia (CMS/HCC) Chief Complaint Patient presents with ? Irregular Heart Beat 1. Ischemic cardiomyopathy status post BiV ICD, now with recurrent V. tach. Admit to general medical floor. Monitor on telemetry. Patient to be admitted for initiation of sotalol therapy, cardiology to follow. Monitor QTC per protocol. Check TSH. 2. Elevated troponins. Likely due to demand ischemia in the setting of V. tach. Trend troponins to peak, check 2D echocardiogram. 2D echocardiogram from September 7, 2021 shows reduced EF 40 to 45%, grade 2 diastolic dysfunction. Await cardiology recommendations. 3. Subacute PE. Patient on Eliquis therapy, continue for now. Check D-dimer to evaluate for worsening PE, given that he is now having recurrent V. tach episodes. 4. Type 2 diabetes. Hold oral hypoglycemics. Will place on insulin sliding scale Accu-Cheks per protocol. 5. CAD status post PCI. Continue aspirin, statin, beta-blocker 6. COVID-19 infection. Patient is tolerating room air, monitor clinically. Continue supportive care with as needed albuterol inhaler, Mucinex.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 5,0
- Labordaten
- Updated Procedure 10/01/21 1213 COVID-19 (SARS CoV-2,RNA Molecular Amplification) Collected: 10/01/21 1103 | Final result | Specimen: Swab from Nasopharynx COVID-19 SARS-CoV-2 Overall Result Detected Critical 10/01/21 1213 COVID-19 PCR - Asymptomatic screening for admission Collected: 10/01/21 1103 | Final result | Specimen: Swab from Nasopharynx 09/19/21 1431 Respiratory virus detection panel Collected: 09/19/21 1205 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Detected Chlamydophila pneumoniae Not Detected Parainfluenza Not Detected COVID-19 SARS-CoV-2 Overall Result Detected Critical Enterovirus/Rhinovirus Not Detected Coronavirus Not Detected Respiratory Syncytial Virus Not Detected Influenza A Not Detected Bordetella pertussis Not Detected Influenza B Not Detected Bordetella parapertussis Not Detected Metapneumovirus Not Detected Procedure Component Value Ref Range Date/Time Ultrasound lower extremity venous bilateral Resulted: 09/19/21 1612 Order Status: Completed Updated: 09/19/21 1612 Narrative: PROCEDURE INFORMATION: Exam: US Duplex Lower Extremity Veins, Bilateral Exam date and time: 9/19/2021 3:05 PM Age: 77 years old Clinical indication: Condition or disease; Other: P. E. ; Additional info: R/O dvt TECHNIQUE: Imaging protocol: Real-time duplex ultrasound of the extremities with 2-D gray scale, color Doppler flow and spectral waveform analysis with image documentation. Complete exam focused on the bilateral lower extremity veins. COMPARISON: PT PET SKULL TO THIGH ONCOLOGIC SCAN W CT 20/02/2017 09:02 FINDINGS: Right deep veins: Unremarkable. The common femoral, femoral, proximal profunda femoral and popliteal veins are patent without thrombus. Normal Doppler waveforms. Normal compressibility and/or augmentation response. Right superficial veins: Saphenofemoral junction is patent without thrombus. Left deep veins: Unremarkable. The common femoral, femoral, proximal profunda femoral and popliteal veins are patent without thrombus. Normal Doppler waveforms. Normal compressibility and/or augmentation response. Left superficial veins: Saphenofemoral junction is patent without thrombus. Soft tissues: Unremarkable. IMPRESSION: No evidence of deep vein thrombosis. THIS DOCUMENT HAS BEEN ELECTRONICALLY SIGNED BY MD X-ray chest 1 view - Portable Resulted: 09/19/21 1436 Order Status: Completed Updated: 09/19/21 1436 Narrative: XR CHEST 1 VW PORT IMPRESSION: 1. No acute findings. 2. Chronic interstitial lung disease. 3. Pacemaker and coronary stent in situ. END OF IMPRESSION: INDICATION: Cough Sepsis. TECHNIQUE: Portable AP lordotic projection of the chest was acquired. COMPARISON: 8/9/2021. FINDINGS: EKG wires project over the thorax. A dual-chamber pacemaker enters via the left subclavian vein. 3 leads are present in total. A coronary stent is seen. The heart size is normal. The vascular distribution is normal. There is chronic prominence of the central pulmonary arteries. The hilar and mediastinal silhouettes appear unremarkable. Bilateral interstitial thickening is present No pleural effusion is identified. There is no evidence of pneumothorax. There are no significant bony findings. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT angiogram chest pulmonary embolism with and without contrast Resulted: 09/19/21 1434 Order Status: Completed Updated: 09/19/21 1434 Addenda: Correction to voice recognition transcription error in the first 2 bullets in the impression: 1. Left posterior basal pulmonary arterial thromboembolism. 2. Irregular fibrosis or atypical pneumonitis in the left lower lobe, encompassing the area of the embolism. Cannot exclude small acute infarct as well. Recommend follow-up to exclude unmasking of possible small pulmonary nodule. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Signed: 09/19/21 1434 MD Narrative: CTA CHEST PULMONARY EMBOLISM W WO CONTRAST IMPRESSION: 1. Left posterior basal pulmonary thromboembolism. 2. Irregular fibrosis or atypical pneumonitis in the left lower lobe, encompassing the area of the embolism. Cannot exclude due to small acute infarct as well. Recommend follow-up to exclude unmasking of possible small pulmonary nodule. 3. Scattered fibrosis elsewhere. Suspected underlying emphysema. 4. Stable mildly thickened mediastinal lymph nodes, greatest in the right hilum. 5. Stable 20 mm perihilar RLL nodule, unchanged since 2017, which therefore appears to be benign. 6. ASCVD. Pulmonary arterial hypertension. Pacemaker and coronary stent in situ. Discussed with Dr 9/19/2021, 2:25 PM. END OF IMPRESSION: INDICATION: pt states persistent cough x 2 months with SOB; hx COPD and CHF; hx coronary stent dyspnea. Assess for pulmonary artery embolism. TECHNIQUE: Enhanced helical CTA scan of the chest was performed from the lung apices to below the diaphragm, including the pulmonary artery. 1 mm axial reconstruction with MPR and MIP coronal, oblique and sagittal images were created. 3D post processing imaging were obtained and stored. CONTRAST: 80mL of IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION administered INTRAVENOUS. Quality of contrast opacification was adequate. COMPARISON: CTA 3/4/2019. CT 10/27/2017. FINDINGS: Cardiovascular: Filling defect in distal segmental and subsegmental posterior basal branches of the left lower lobe artery. Chronic central pulmonary arterial ectasia, unchanged since 2017. For example, the main pulmonary artery measures 4 cm in diameter; the ascending aorta at the same level measures 3.5 cm. Normal heart size. No septal deviation. No pericardial effusion. No aortic aneurysm. No dissection identified, taking into account pulmonary arterial phase imaging. Aortic and coronary calcifications. LAD stent. Dual-chamber pacemaker entering via the left subclavian vein. Mediastinum: Stable mildly thickened mediastinal lymph nodes. Stable thickening of the right hilar lymph node measuring 11 mm along the short axis. Small hiatus hernia. Lungs: Scattered fibrosis at the bases. Greatest in the posterior basal left lower lobe, where acute atypical pneumonitis is possible, and small nodules could be obscured. Note that this contains the area affected by the PE, subacute infarct is possible although no pleural-based wedge-shaped opacity is identified. Stable right perihilar 20 mm nodule with rim vascularity. This was FDG negative on PET/CT of 2017. Centrilobular emphysema. No pleural effusion or pneumothorax. Central airways clear. Neck base: No significant findings. Chest Wall: Implanted pacemaker on the left. Upper abdomen: No focal abnormality. Atherosclerotic calcifications. Bones: Mild spondylosis.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Osteoarthritis of neck V-tach (CMS/HCC) Former smoker Essential hypertension Ischemic cardiomyopathy Chronic systolic heart failure (CMS/HCC) Type 2 diabetes mellitus, without long-term current use of insulin (CMS/HCC) Biventricular implantable cardioverter-defibrillator in situ CAD in native artery S/P drug eluting coronary stent placement Shortness of breath COVID-19
- Andere Medikamente
- albuterol 0.63 mg/3 mL nebulizer solution apixaban (ELIQUIS) 5 mg tablet apixaban 5 mg (74 tabs) tablets,dose pack aspirin 81 mg tablet atorvastatin (LIPITOR) 80 mg tablet cholecalciferol, vitamin D3, (VITAMIN D3) 50 mcg (2,000 unit) c
- Allergien
- Grass Pollen-, Standard Mold Penicillins EtomidateNausea and Vomiting
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 04.10.2021
- Impfdatum
- 23.02.2021
- Beginn
- 03.10.2021
- Tage bis Beginn
- 222,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
PATIENT TESTED POSITIVE FOR COVID-19 ON 8/27/2021; EXPIRED ON 10/3/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 30,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 88,0
- Geschlecht
- M
- Eingang
- 01.10.2021
- Impfdatum
- 16.02.2021
- Beginn
- 25.09.2021
- Tage bis Beginn
- 221,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
Asthenia
COVID-19
COVID-19 pneumonia
Cough
Diarrhoea
Pyrexia
SARS-CoV-2 test positive
Sepsis
Symptomtext
Patient finished COVID-19 vaccine series on 2/16/21. Patient arrived at reporting hospital with reports of weakness and cough. Other symptoms included fever and diarrhea. Patient was admitted on 9/23/21 with COVID-19 pneumonia with acute hypoxemic respiratory failure and discharged 4 days later on 9/27/21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 4,0
- Labordaten
- COVID 19 NP Swab positive 9/23/21
- Aktuelle Erkrankungen
- CAD s/p PCI, aortic stenosis s/p TAVR in October 2020, HFrEF with EF 45%, chronic kidney disease stage 3, spinal stenosis on chronic low dose prednisone
- Vorgeschichte
- CAD s/p PCI, aortic stenosis s/p TAVR in October 2020, HFrEF with EF 45%, chronic kidney disease stage 3, spinal stenosis on chronic low dose prednisone, two admissions for sepsis this year (April and July 2021)
- Andere Medikamente
- Albuterol 108, aspirin low dose 81mg, Lipitor 40mg, Coreg 25mg, Plavix 75mg, Voltaren 1% Gel, Lisinopril 10mg, melatonin 10mg, multi-vitamin, Spiriva 18mcg, Nitroglycerin 0.4mg
- Allergien
- Zolpidem, Ceftriaxone, Niacin, oxycodone, vancomycin
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 30.09.2021
- Impfdatum
- 03.03.2021
- Beginn
- 25.06.2021
- Tage bis Beginn
- 114,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Asthenia
COVID-19
COVID-19 pneumonia
Cough
Death
Fatigue
General physical health deterioration
Hypoxia
Respiratory failure
SARS-CoV-2 test positive
Symptomtext
pt presented to ED with hx of positive COVID test earlier in the week from a dr's office, cough, weakness, fatigue x 1 wk; hypoxic, placed on nonrebreather; in respiratory failure due to COVID pneumonia; pt's condition worsened and she died in the hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 15,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 30.09.2021
- Impfdatum
- 18.03.2021
- Beginn
- 24.08.2021
- Tage bis Beginn
- 159,0
- Dosis
- 2
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Acute myocardial infarction
Angina unstable
Angiocardiogram
Arthralgia
COVID-19
Cardiac stress test abnormal
Condition aggravated
Ejection fraction
Ischaemia
SARS-CoV-2 test positive
Symptomtext
Patient found to be COVID-19 positive on 8.24.21 - went to ED (not admitted); fully vaccinated Later hospitalized (9.21.21); found to be COVID-19 positive at DC (9.26.21); Fully vaccinated Admission Date: 9/21/2021 Discharge Date: 09/26/2021 Presenting Problem: Unstable angina (HCC) DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: PT is a 82 y.o. female with history of hypertension, dyslipidemia, obstructive sleep apnea, obesity, chronic kidney disease stage 3 and coronary artery disease with previous PCI to her circumflex x2 in 2006 and her LAD in 2010. She presented 9/21 with complaints of posterior left shoulder pain which was reminiscent of prior angina. She ruled out for ACS. She was risk stratified with Lexiscan nuclear stress test that was abnormal with peri-infarct ischemia along with distal inferior lateral wall. LV EF calculated at 52%. Coronary angiography revealed stable CAD, no angiographic culprit to account for presentation symptoms. She was started on amlodipine for additional antianginal therapy. PT/OT evaluated and recommended SAR for ongoing care. Of note she was incidentally COVID-19 + on day of discharge but was not symptomatic.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- 6,0
- Labordaten
- NA
- Aktuelle Erkrankungen
- COVID positive 8..24.21; COVID positive 9.26.21
- Vorgeschichte
- Coronary artery disease Dyslipidemia Essential hypertension CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min Unstable angina (HCC) NSTEMI 2019
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG tablet amlodipine (NORVASC) 2.5 MG tablet amoxicillin (AMOXIL) 500 MG capsule aspirin 81 MG tablet atorvastatin (LIPITOR) 40 MG tablet Cholecalciferol (EQL VITAMIN D3) 1000 UNITS TABS clopidogrel (PLAVIX) 75 M
- Allergien
- Hydrocodone-acetaminophenDiarrhea, Nausea and Vomiting, Swelling Imdur [Isosorbide]Headache Nabumetone Oxaprozin RamiprilCough Spironolactone Tramadol Triamterene Zyrtec [Cetirizine]
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 86,0
- Geschlecht
- M
- Eingang
- 27.09.2021
- Impfdatum
- 19.02.2021
- Beginn
- 25.02.2021
- Tage bis Beginn
- 6,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: unbekannt
Erholt: nein
Blindness
Cerebrovascular accident
Laboratory test abnormal
Symptomtext
Card says Pfizer 1-29-2021 ELA264 Pfizer EN6200 2-19-2021 please note the six might be the letter G. I cannot differentiate the handwriting Approximately one week after the second Covid 19 vaccine, patient was seen by a doctor, sent home and returned to doctor a few days later when he was referred to the E.R . for a stroke work up. He was diagnosed Mar 1, 2021 with a stroke and has partial permanent vision loss.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 1,0
- Labordaten
- Hospitalized for stroke March 1, 2021 Labs and Radiology reports confirmed stroke with partial but permanent vision loss. The card only says Pfizer for the name of vaccine Patient visited his eye doctor doctor. Doctor referred patient to the emergency room for stroke workup.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- intermittent asthma
- Andere Medikamente
- synthroid Breo Elipta inhaler
- Allergien
- grass trees
- Vorherige Impfungen
- 2 Pfizer Covid 19 vaccines followed by a stroke listed previously
- Staat
- TX
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 27.09.2021
- Impfdatum
- 19.05.2021
- Beginn
- 02.09.2021
- Tage bis Beginn
- 106,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Chills
Death
Diarrhoea
Dyspnoea
Exposure to SARS-CoV-2
Illness
Nausea
Oxygen saturation decreased
Pyrexia
SARS-CoV-2 test positive
Vomiting
Symptomtext
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 4/28/2021 and 5/19/2021. Presentes to ED on 9/2/2021 with complaints of illness for 5 days with symptoms of nausea, vomiting, diarrhea, chills and subjective fever. Also reports COVID-19 exposure. Patient admitted. At time of admission no respiratory symptoms, SpO2 of 98%. Patient reports dyspnea on 9/6, with need for O2 via nasal cannula. Patient experiences desturation on 9/11 requiring 7 L/min (SpO2 = 93%). On 9/12 requiring 60L FiO2 70%. On 9/13 60L FiO2 86% with an SpO2 of 100%. On 9/14, while receiving HFNC at 50L 80% patient desats to 80%. Patient transitioned to comfort care. Patient expired on 9/16/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 15,0
- Labordaten
- COVID-19 Positive on 9/2/2021 using PCR or other technology.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- CLL, Acute cystitis without hematuria, Acute kidney injury, Chemotherapy induced neutropenia, Anemia, Sepsis, UTI, DM
- Andere Medikamente
- Amlodipine, Aspirin, Carvedilol, Furosemide, Ibrutinib, insulin glargine, metoprolol.
- Allergien
- Adhesive, Codeine, Penicillin, Promethazine, Sulfa, Novacare, Tetracycline
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 27.09.2021
- Impfdatum
- 24.02.2021
- Beginn
- 29.08.2021
- Tage bis Beginn
- 186,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Aspiration
Asthenia
COVID-19
Chest X-ray abnormal
Cough
C-reactive protein increased
Death
Hypoxia
Intensive care
Decreased appetite
Infection
Lung opacity
Oxygen saturation decreased
Malaise
Polyuria
Positive airway pressure therapy
Respiratory failure
Pyrexia
Symptomtext
***ADDENDUM: Pt previously reported to VAERS under ID #641016. Adding information. Pt died on 9/26/2021 Hospital Course: PT is a 84 y.o. male with history of CAD (s/p CABG x 4), HTN, pancytopenia, and PUD who was admitted on 9/4 after presenting with hypoxia in the context of recently diagnosed COVID-19 infection. He completed vaccination in March, developed symptoms of COVID 8/26, was diagnosed 8/29, and was admitted to the hospital on 9/4. He was started on dexamethasone and remdesivir. His O2 needs rapidly increased after admission and he had a marked elevation of his CRP to 15.6, prompting administration of tociluzimab. He was treated for a possible concurrent bacterial pneumonia with 5 days of cefepime and 3 days of azithro with last dose of antbx on 9/13. Diuresis was also attempted on several occasions in an attempt to improve his very poor oxygenation. Despite these measures his resp failure progressed to point that PT was transferred to the ICU and required maximal noninvasive resp support with HFNC and BiPAP. BiPAP was poorly tolerated. He ultimately decided to be DNR but stabilized to an extent and was transferred back to HVU where he continued to require HFNC w/ FiO2 80-100% for many days. On the evening of 9/24 his respiratory status worsened. BiPAP was again attempted but he was not able to tolerate it. A family meeting was held on 9/25 with discussions regarding end-of-life. On the morning of 9/26 he had worsening respiratory status and indicated that he wanted transition to comfort care measures. His family members were at the bedside when he passed away.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 24.09.2021
- Impfdatum
- 25.01.2021
- Beginn
- 16.09.2021
- Tage bis Beginn
- 234,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 2,0
- Labordaten
- unknown
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 23.09.2021
- Impfdatum
- 02.03.2021
- Beginn
- 25.08.2021
- Tage bis Beginn
- 176,0
- Dosis
- 2
- Route/Site
- IM / AR
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute hepatic failure
Acute kidney injury
Ammonia normal
Arthralgia
Arthritis bacterial
Asthenia
Asymptomatic COVID-19
Bacteraemia
Blindness
Blindness unilateral
Blood bilirubin abnormal
COVID-19
Cerebrovascular accident
Computerised tomogram head normal
Confusional state
Death
Dyspnoea
Echocardiogram
Symptomtext
Hospitalized (9.2.21); Deceased (9.17.21); COVID-19 positive; Fully Vaccinated Discharge Provider Primary Care Physician at Discharge Admission Date: 9/2/2021 Date of Death: 9/17/21 Time of Death: 3:30 PM Preliminary Cause of Death: Bacteremia Discharge Disposition: death DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hyponatremia Loss of vision AKI (acute kidney injury) HOSPITAL COURSE: Patient is a 70 y.o. male with a pertinent past medical history for chronic diastolic heart failure, cirrhosis, non-insulin-dependent type 2 diabetes, who presented to the ED primarily with generalized weakness and left vision sided loss. The patient's wife is at bedside and provides aspects of history. 8/19 he started having some confusion and generalized weakness and went to the ED due to wife concern for hepatic encephalopathy, however ammonia normal. He went back to the ED 8/25 and was found to be COVID positive but did not have any symptoms, he received monoclonal antibodies the next day. He presented to the ED again 8/31 for right knee pain and swelling and thought that he may have twisted his knee, he has had a prior arthroplasty there. Radiograph was negative for fracture or other acute abnormality at that time. He then returned with left eye vision loss that started 5-6 days prior to admission that he had never mentioned until day of admission. He was noted to have hyponatremia and mild AKI both of which corrected while hospitalized. CT orbits negative for globe issue. Ophthalmology evaluated him and stated this was Iritis and started patient on prednisolone and atropine drops (the atropine caused left eye pupillary dilation). He was evaluated by ortho and had his right knee tapped which returned septic and grew MSSA. On Ancef with plan to continue 6 weeks course. His hospitalization was complicated by his lethargy and confusion likely related to pain medications and liver function. He had a stroke rap called which did not show concern for a stroke. He was found to have MSSA bacteremia as well and was seen by ID. TTE negative for vegetations. Unfortunately patient developed worsening LFTs and bilirubin. Gastroenterology was consulted. It is noted that patient had cirrhosis have baseline etiology unclear. Hepatitis-C and hepatitis-B workup were negative. Imaging did not show thrombus. Acute liver failure was initially attributed to recent anesthesia exposure and Ancef use as well as Tylenol. These medications were discontinued but LFTs continue to trend up. There was also concern for Bilateral endogenous endophthalmitis. IV Ancef was discontinued and patient was started on IV vancomycin and linezolid. Unfortunately this led to acute kidney injury with high vancomycin trough level. Given that his LFTs have continued to worsen despite stopping ancef, id felt the Ancef is less likely to be the cause of Abnormal LFTs, hence; he was placed back on Ancef and Vanco was discontinued. Unfortunately patient continued to decline and have further elevation in bilirubin levels. Ultimately after consultation with various consultants it was felt that the liver failure was more attributable to sepsis. Renal function also continued to decline with subsequent noted hyperkalemia. Given patient's overall decline and lack of options for possible medical intervention to reverse liver failure (patient deemed not to be a transplant candidate per Gastroenterology in setting of bacteremia) patient and family ultimately decided to pursue comfort care and patient was transitioned to inpatient comfort care on 09/16. Palliative Care was consulted and assisted with medication. Patient was placed on a fentanyl drip. Physician was called that patient passed away at 3:30 p.m. 09/17/2021. Patient officially pronounced on 15:50 on 09/17/2021. Family present in room.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 16,0
- Labordaten
- -
- Aktuelle Erkrankungen
- 8.19.21: Acute Hepatic Encephalopathy (Office Visit) 8.25.21: ED visit - COVID-19 positive; fatigue 8.26.21: ED visit - shortness of breath; antibody infusion 8.30.21: Office visit 8.31.21: ED - knee injury; COVID; weakness
- Vorgeschichte
- Acute on chronic diastolic heart failure Elevated LFTs Colonic polyp OSA (obstructive sleep apnea) Diabetes mellitus type 2, uncontrolled, without complications Squamous cell skin cancer, upper arm Tubular adenoma of colon Other cirrhosis of liver Thrombocytopenia, unspecified Type 2 diabetes mellitus with hyperglycemia Morbid (severe) obesity due to excess calories Body mass index (BMI) 45.0-49.9, adult Mixed hyperlipidemia Gastro-esophageal reflux disease without esophagitis Essential (primary) hypertension Long term (current) use of insulin Primary open-angle glaucoma, bilateral, mild stage Mild intermittent asthma without complication Pancytopenia Delta beta thalassemia Unspecified severe protein-calorie malnutrition Multiple comorbid conditions Counseling regarding advanced directives and goals of care End of life care
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG tablet Blood Glucose Monitoring Suppl MISC ceFAZolin (ANCEF) 2 g/20mL SOSY syringe Insulin Pen Needle (BD ULTRA-FINE SHORT PEN NEEDLE 8 MM X 31G) lactulose (CHRONULAC) 10 GM/15ML solution Lancets (ONETOUCH DEL
- Allergien
- NA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 21.09.2021
- Impfdatum
- 21.03.2021
- Beginn
- 10.09.2021
- Tage bis Beginn
- 173,0
- Dosis
- 2
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
Anticoagulant therapy
Atrial fibrillation
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Cough
Dyspnoea
Evidence based treatment
Fibrin D dimer increased
Full blood count
Headache
Hypoxia
Lung opacity
Nasopharyngitis
Procalcitonin decreased
Respiratory tract congestion
Rhinorrhoea
Symptomtext
Hospitalized (9.11.21 - present); COVID-19 positive; Fully Vaccinated History of Present Illness Patient is a 85 y.o. male with a history of HTN, paroxysmal atrial tachycardia and prostate cancer s/p prostatectomy who presents today with cough and shortness of breath. Symptoms started about a week ago and patient thought he had a mild head cold with congestion, rhinorrhea, and headaches. His symptoms continued throughout the week, but he noted they were "up and down" and he initially felt he was improving. However, he then began to have more shortness of breath and coughing. He tested positive for COVID on 9/10. Shortness of breath worsened, prompting ED presentation. Initially planned for monoclonal antibodies, but he then became hypoxic and was placed on 3 L NC. CXR showing bilateral groundglass opacities suggestive of COVID. WBC 14.3. He was given decadron and hospitalists were asked to admit for further care. Chief complaint COVID-19 Assessment and Plan Covid-19 pneumonia Acute respiratory insufficiency with hypoxia - symptom onset about 1 week ago - (+) PCR 09/10 - fully vaccinated with Pfizer (2/25/21 and 3/25/21) - Chest xray consistent with COVID pneumonia - started on decadron - start remdesivir - supportive measures - prone positioning - daily labs Leukocytosis - WBC 14.3 - will check procal - trend CBC - hold off on antibiotics for now Progress note 9.20.21: This is a 85 y.o. who has a past medical history significant for remote history of Prostate Cancer s/p Resection, HTN, who presented to the ED 9/11 with dyspnea, testing positive for COVID on 9/10, was admitted for hypoxia and started on dexamethasone/remdesevir 9/11, and empiric antibiotics on 9/13. His oxygen requirement has worsened and Pulm/Crit Care was asked to see for his respiratory failure. He ultimately worsened and required transfer to the MICU. D-Dimer significantly elevated, superficial clots seen in upper extremities. Key Plan for Today September 20: Continue high-flow nasal cannula oxygen/non-rebreather face mask At high risk for requiring intubation/mechanical ventilation Begin amiodarone for atrial fibrillation with RVR Decadron day 10/14 tentative course Continue empiric heparin drip given superficial clots and markedly elevated D-dimer Status post empiric ceftriaxone/azithromycin through September 17 Fluid balance -400/24 hours -- > goal even to negative fluid balance, as tolerated Advanced diet, as tolerated Add Pepcid, given steroids and anticoagulation Acute respiratory failure with hypoxia Assessment & Plan 2/2 COVID Pneumonia despite vaccination. Question additional issues, maybe some reticular changesin the bases bilaterally - Continue HFNC + NRB Mask and wean for goal sats>90%. At significant risk of decompensation requiring intubation - Completed empiric antibiotics, started 9/13 for 5d course. Procal is low - UE dopplers with superficial clots, question PE given elevated D-Dimer, starting empiric heparin gtt. Echo Pending. Hold on CTPE for now given tenuous status - Continue intermittent lasix for euvolemia Pneumonia due to COVID-19 virus Assessment & Plan - despite vaccination, very ill, no evidence of immunocompromise. Tested positive 9/10 - Continue dexamethasone, started 9/11, expecting 10d course, will extend depending on his trajectory - s/p remdesevir 5d, started 9/11
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 11,0
- Labordaten
- -
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- Hospital Osteoarthritis of left hip Paroxysmal atrial tachycardia Essential hypertension COVID-19 Pneumonia due to COVID-19 virus Acute respiratory failure with hypoxia Acute thrombosis of superficial vein of both upper extremities Obesity Non-Hospital Malignant neoplasm of prostate-RRP 9/2005,Gleason 3+3=6, pT2a, negative margins, nerve sparing Epididymal head cyst. Palpable area appears correspond to a more prominent left epididymal head cyst measuring 10 mm Meniere's disease Status post total hip replacement, left
- Andere Medikamente
- Outpatient Medications cephALEXin (KEFLEX) 250 MG capsule metoprolol succinate-XL (TOPROL-XL) 25 MG 24 hr tablet Psyllium (METAMUCIL FIBER PO) triamterene-hydrochlorothiazide (MAXZIDE) 37.5-25 MG per tablet
- Allergien
- Penicillins Rash Celecoxib Rash Sulfa Drugs Swelling
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 20.09.2021
- Impfdatum
- 19.02.2021
- Beginn
- 18.09.2021
- Tage bis Beginn
- 211,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asymptomatic COVID-19
Cardiac arrest
Overdose
SARS-CoV-2 test positive
Symptomtext
ASYMPTOMATIC. PATIENT ADMITTED FOR CARDIAC ARREST / OVERDOSE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- -
- Labordaten
- POSITIVE COVID TEST 9/18/21
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 17.09.2021
- Impfdatum
- 18.02.2021
- Beginn
- 29.07.2021
- Tage bis Beginn
- 161,0
- Dosis
- 1
- Route/Site
- SYR / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chest pain
Death
Dyspnoea
Fatigue
Symptomtext
Shortness of breath or difficulty breathing Chest pain Fatigue or tiredness Hospitalization and death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 15,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Diabetes Hypertension Cardiovascular condition
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 16.09.2021
- Impfdatum
- 28.02.2021
- Beginn
- 14.08.2021
- Tage bis Beginn
- 167,0
- Dosis
- 1
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
COVID-19
Chills
Cough
Diarrhoea
Dyspnoea
Infusion
Pyrexia
SARS-CoV-2 test positive
Symptomtext
positive COVID test on 8/14/21; presented to ED from infusion center where she's been receiving antibody infusions since 8/18/21; presented with increasing fever, chills, cough, SOB, and diarrhea; hx of diabetes mellitus type 2; acute hypoxemic respiratory failure due to COVID
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 13,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 38,0
- Geschlecht
- M
- Eingang
- 16.09.2021
- Impfdatum
- 16.02.2021
- Beginn
- 30.07.2021
- Tage bis Beginn
- 164,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Angiogram pulmonary abnormal
Protein C
Protein S normal
Pulmonary embolism
Symptomtext
Patient developed a pulmonary embolism on 30 July 2021, 5 months following his 2nd dose of COVID-19 vaccine. He did have mild COVID-19 infection on 12 August 2020.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- -
- Labordaten
- CT pulmonary angiogram on July 30, 2021 demonstrated a subsegmental left lower lobe pulmonary embolism with developing lung infarct. Negative COVID-19 test in July 2021. Normal Protein C and S levels in August 2021.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 15.09.2021
- Impfdatum
- 12.03.2021
- Beginn
- 01.06.2021
- Tage bis Beginn
- 81,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Blood test normal
Cardiac arrest
Cardiac stress test
Catheterisation cardiac normal
Electrocardiogram ambulatory
Impaired driving ability
Implantable defibrillator insertion
Intensive care
Magnetic resonance imaging normal
Presyncope
Syncope
Ventricular fibrillation
Ventricular tachycardia
Symptomtext
I started having syncope and near-syncope episodes in June 2021. And this was intermittent, random, unprovoked and just happened. Wasn't sure if it was blood pressure, heart or seizures. I was worked up by Cardiology and they had me wear a heart monitor at the end of august because this thing went in overdrive at the end of July. They stopped me from driving because they weren't sure what was causing me to pass out. After a report in August, I was immediately hospitalized because I was having runs of ventricular fibrillation and ventricular tachycardia. Max heart rate was 387bpm. I was in ICU cardiac arrest - mind you I am a very healthy person. No body knows what's going on, my diagnosis is idiopathic ventricular fibrillation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- 7,0
- Labordaten
- Heart catherization which was normal, Cardiac stress test, S-ICD, MRI -- everything was normal. Blood test was normal.
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Raynauds syndrome
- Andere Medikamente
- -
- Allergien
- Latex
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 15.09.2021
- Impfdatum
- 27.02.2021
- Beginn
- 04.09.2021
- Tage bis Beginn
- 189,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Acute respiratory failure
Bordetella test negative
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Cough
Diarrhoea
Dysphagia
Dyspnoea
Human metapneumovirus test
Human rhinovirus test
Hypoxia
Influenza A virus test negative
Influenza B virus test
Malaise
Mycoplasma test negative
Nausea
Oxygen therapy
Symptomtext
FEVER, DRY COUGH, CONGESTION, DIARRHEA - OUTPATIENT PROGRESS NOTE 09/13/21 ASSESSMENT AND PLAN Diagnoses and all orders for this visit: Pneumonia due to COVID-19 virus Patient was hypoxemic to 8 7% on 2 L of oxygen on my exam today. He was also in mild respiratory distress due to hypoxia and tachypnea. 991 was called in for urgent transfer of the patient to the hospital. SUBJECTIVE Patient is a 70 y.o. male who presented with his wife for evaluation of cough, shortness of breath, nausea, vomiting and positive Covid test results. Patient has been having the symptoms for past few days. Initially he had over-the-counter Covid test which was negative, he tried taking over-the-counter medication and repeated his Covid test which came back positive. He called our office to get the Covid test on 9/10 recently been positive. Patient reports he has intermittent severe cough and sometimes noted difficulty in swallowing food. Denies any chest pain or shortness of breath but does report getting short of breath when he coughs. Denies headache, abdominal pain or swelling in the legs. Patient also noticed loose bowel movement this morning. Patient had both doses of COVID vaccine in March. He didn't take his regular medication in last few days due to feeling sick. ED to Hosp-Admission Discharged 9/13/2021 - 9/14/2021 (22 hours) Hospital - Acute respiratory failure with hypoxia DETAILS OF HOSPITAL STAY Presenting Problem/History of Present Illness/Reason for Admission Hypoxemia Acute respiratory failure with hypoxia COVID-19 virus infection Hospital Course Patient is an 70 y.o. male with past medical history of hypertension, hyperlipidemia, hypothyroidism presented to the emergency room with 1 week history of cough, generalized fatigue and shortness of breath. Patient was noted to be hypoxic at 87% at room air at PCPs office and sent over here. Initially patient was on 2 L of oxygen via nasal cannula. Patient was diagnosed with COVID-19 last Thursday but having symptoms for at least 10 days. After initiation of remdesivir and steroid we were able to wean patient off oxygen and today patient saturating 94 to 95% at room air and was able to ambulate without any symptoms. Though his cough is still persisting. Blood culture did not grow any organism. Patient is stable from our standpoint to be discharged home on p.o. steroid for another 10 days. I recommend patient to come back to hospital if worsening symptoms including fever
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- 09/13/21 2320 Respiratory virus detection panel Collected: 09/13/21 1836 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Detected Chlamydophila pneumoniae Not Detected Parainfluenza Not Detected COVID-19 SARS-CoV-2 Overall Result DetectedCritical Enterovirus/Rhinovirus Not Detected Coronavirus Not Detected Respiratory Syncytial Virus Not Detected Influenza A Not Detected Bordetella pertussis Not Detected Influenza B Not Detected Bordetella parapertussis Not Detected Metapneumovirus Not Detected 09/10/21 1959 COVID-19 (SARS CoV-2,RNA Molecular Amplification) Collected: 09/10/21 1022 | Final result | Specimen: Swab from Nasopharynx COVID-19 SARS-CoV-2 Overall Result DetectedCritical 09/10/21 1959 COVID-19 PCR Collected: 09/10/21 1022 | Final result | Specimen: Swab from Nasopharynx Procedure Component Value Ref Range Date/Time X-ray chest 1 view - Portable Resulted: 09/14/21 0713 Order Status: Completed Updated: 09/14/21 0713 Narrative: Single view portable chest INDICATION: Sepsis, cough, pneumonia, encounter initial Frontal portable chest film. Comparison 2015. Patchy bilateral lower lobe peripheral infiltrates are seen suspicious for Covid 19 infection. No effusion or pneumothorax. No congestive failure, cardiomegaly, or acute osseous finding. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Respiratory Asthma Sinusitis Acute respiratory failure with hypoxia (HCC) Pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Circulatory Essential hypertension Digestive Malignant neoplasm of colon ( HCC) Gastroenteritis due to COVID-19 virus Genitourinary Kidney cyst, acquired Benign prostatic hyperplasia without lower urinary tract symptoms Endocrine/Metabolic Hypercholesterolemia Hypothyroidism Hypokalemia Hematologic Leukopenia Other Impotence of organic origin High glucose
- Andere Medikamente
- dexAMETHasone (DECADRON) 6 mg tablet FLAXSEED OIL (LINSEED OIL MISC) fluticasone (FLONASE) 50 mcg/actuation nasal spray gemfibroziL (LOPID) 600 mg tablet glucosamine/chondr su A sod (OSTEO BI-FLEX ORAL) levothyroxine (SYNTHROID) 75 mcg
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 15.09.2021
- Impfdatum
- 17.03.2021
- Beginn
- 01.09.2021
- Tage bis Beginn
- 168,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Hypoxia
SARS-CoV-2 test positive
Symptomtext
Patient admitted as inpatient on 9/1 due to acute respiratory failure with hypoxia due to COVID pneumonia. Patient was tested for COVID-19 and was positive on 9/1.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 12,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- amLODIPine, finasteride, gabapentin, Omeprazole
- Allergien
- Statins-hmg-coa Reductase Inhibitors, Codeine, Dilantin, Fentanyl, Ibuprofen, Niacin, Lipitor [Atorvastatin], Pravastatin, Simvastatin, Rosuvastatin
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 15.09.2021
- Impfdatum
- 18.02.2021
- Beginn
- 08.08.2021
- Tage bis Beginn
- 171,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute respiratory failure
Atrial fibrillation
COVID-19
Chest X-ray abnormal
Cyanosis
Oxygen saturation decreased
Pneumonia
Pneumonia viral
Positive airway pressure therapy
Pulmonary embolism
Respiratory symptom
SARS-CoV-2 test positive
Symptomtext
Patient here with acute hypoxic respiratory failure, improved with respiratory support via BiPAP. He is hemodynamically stable, awake and alert. He patient has voiced clearly to myself and to multiple nursing staff, Members at the bedside that patient would not wish to be intubated and placed on mechanical ventilation should his respiratory status further deteriorate. Patient had very little oxygen reserve with desaturations very quickly into the high 70s on room air when transitioned from stretcher into bed. He has no prior history of cardiac or pulmonary disease. Presentation highly suspicious for COVID-19, which was confirmed with diagnostic testing here today. Bilateral pneumonia noted on chest XR. Likely viral in nature. Patient presented to the emergency room at this facility by ambulance which had been summoned to his house by his sister whom happens to be a nurse practitioner. Apparently the patient had developed upper respiratory symptoms for the last 5 days or so and at his sister had called in the prescription for Zithromax and a Medrol Pak about 3 days ago. Apparently she went to check on him today and found him cyanotic. When EMS arrived to assess the patient they found his oxygen saturations to be 55% on room air. The patient was placed on a non-rebreather and improved to mid 80s and he was then placed on CPAP with improvement to the low 90s. Upon arrival to the emergency room he was placed on a BiPAP and he has remained stable in terms of oxygenation. Patient reports receiving 2 doses of Pfizer vaccine. He reported not being aware of sick contacts. I had received a call from reading radiologist the reported and small burden of blood clot in the right upper lobe of the lung besides findings compatible with pneumonia. Patient had also been found to be in atrial fibrillation with moderate ventricular response.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- SARS COV2 COVID 19 PCR (Positive) 08/08/2021
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- HTN, Hypercholesteremia
- Andere Medikamente
- ASA, Zithromax, Crestor, Diovan, Losartan, Medrol Dosepak, Met, Zetia
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 15.09.2021
- Impfdatum
- 18.02.2021
- Beginn
- 08.08.2021
- Tage bis Beginn
- 171,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute respiratory failure
Atrial fibrillation
COVID-19
Chest X-ray abnormal
Cyanosis
Oxygen saturation decreased
Pneumonia
Pneumonia viral
Positive airway pressure therapy
Pulmonary embolism
Respiratory symptom
SARS-CoV-2 test positive
Symptomtext
Patient here with acute hypoxic respiratory failure, improved with respiratory support via BiPAP. He is hemodynamically stable, awake and alert. He patient has voiced clearly to myself and to multiple nursing staff, Members at the bedside that patient would not wish to be intubated and placed on mechanical ventilation should his respiratory status further deteriorate. Patient had very little oxygen reserve with desaturations very quickly into the high 70s on room air when transitioned from stretcher into bed. He has no prior history of cardiac or pulmonary disease. Presentation highly suspicious for COVID-19, which was confirmed with diagnostic testing here today. Bilateral pneumonia noted on chest XR. Likely viral in nature. Patient presented to the emergency room at this facility by ambulance which had been summoned to his house by his sister whom happens to be a nurse practitioner. Apparently the patient had developed upper respiratory symptoms for the last 5 days or so and at his sister had called in the prescription for Zithromax and a Medrol Pak about 3 days ago. Apparently she went to check on him today and found him cyanotic. When EMS arrived to assess the patient they found his oxygen saturations to be 55% on room air. The patient was placed on a non-rebreather and improved to mid 80s and he was then placed on CPAP with improvement to the low 90s. Upon arrival to the emergency room he was placed on a BiPAP and he has remained stable in terms of oxygenation. Patient reports receiving 2 doses of Pfizer vaccine. He reported not being aware of sick contacts. I had received a call from reading radiologist the reported and small burden of blood clot in the right upper lobe of the lung besides findings compatible with pneumonia. Patient had also been found to be in atrial fibrillation with moderate ventricular response.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- SARS COV2 COVID 19 PCR (Positive) 08/08/2021
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- HTN, Hypercholesteremia
- Andere Medikamente
- ASA, Zithromax, Crestor, Diovan, Losartan, Medrol Dosepak, Met, Zetia
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 10.09.2021
- Impfdatum
- 28.02.2021
- Beginn
- 10.08.2021
- Tage bis Beginn
- 163,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Death
Endotracheal intubation
Exposure to SARS-CoV-2
Extubation
SARS-CoV-2 test positive
Symptomtext
Patient admitted on 8/10/2021 with acute respiratory failure secondary to COVID pneumonia. She was COVID positive on 7/22/2021 following a family gathering. She had been hospitalized for 3 days previously (8/4 - 8/7/2021) and seen in the ED on 8/8/2021. This current admission, she was intubated and required high dose dexamethasone. After 20 days, she was converted to comfort care and compassionate extubation was performed. She passed away comfortably soon after this.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 20,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Multiple sclerosis
- Andere Medikamente
- Ocrelizumab
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 86,0
- Geschlecht
- M
- Eingang
- 08.09.2021
- Impfdatum
- 01.02.2021
- Beginn
- 05.09.2021
- Tage bis Beginn
- 216,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Symptomtext
client fully vaccinated, patient died 09/05/2021-Cause: Complications of COVID-19
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 01.09.2021
- Impfdatum
- 23.02.2021
- Beginn
- 23.08.2021
- Tage bis Beginn
- 181,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Acute respiratory failure
Adenovirus test
Angiogram pulmonary abnormal
Blood potassium decreased
Bordetella test negative
COVID-19
COVID-19 pneumonia
Chlamydia test negative
Computerised tomogram abnormal
Computerised tomogram thorax abnormal
Convalescent plasma transfusion
Coronavirus test negative
Cough
Dyspnoea
Enterovirus test negative
Human metapneumovirus test
Human rhinovirus test
Symptomtext
Cough, Acute hypoxemic respiratory failure ED to Hosp-Admission Discharged 8/23/2021 - 8/28/2021 (5 days) Hospital covid, hypoxia, htn Presenting Problem/History of Present Illness/Reason for Admission COVID-19 virus infection Hospital Course 60-year-old female presented with acute respiratory insufficiency secondary to COVID-19 pneumonia with bilateral infiltrates on CT scan and negative for PE She was placed on oxygen had convalescent plasma and a 5-day course of remdesivir and she started on dexamethasone 6 mg daily Her oxygen was weaned to room air but needs 6 L with exertion and sleep and she is on room air with being awake at rest She has essential hypertension she presented with severe hypokalemia the potassium was 2.6 her blood pressures were on the low side we held her blood pressure medication she had AKI as well her losartan was held as well The AKI resolved the hypokalemia resolved with replacement and we restarted her on her blood pressure medications amlodipine and losartan but hold the hydrochlorothiazide which she might restart at home depending on what her blood pressures are. The blood pressure at the time of discharge is 130/80 with a heart rate of 70
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 5,0
- Labordaten
- 08/23/21 2046 Respiratory virus detection panel Collected: 08/23/21 1946 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Detected Chlamydophila pneumoniae Not Detected Parainfluenza Not Detected COVID-19 SARS-CoV-2 Overall Result DetectedCritical Enterovirus/Rhinovirus Not Detected Coronavirus Not Detected Respiratory Syncytial Virus Not Detected Influenza A Not Detected Bordetella pertussis Not Detected Influenza B Not Detected Bordetella parapertussis Not Detected Metapneumovirus Not Detected Procedure Component Value Ref Range Date/Time CT angiogram chest pulmonary embolism with and without contrast Resulted: 08/30/21 0802 Order Status: Completed Updated: 08/30/21 0802 Narrative: CTA CHEST PULMONARY EMBOLISM W WO CONTRAST IMPRESSION: 1. Limited exam for the assessment of pulmonary embolism. No large central embolism present. 2. Findings characteristic for COVID related lung disease. END OF IMPRESSION: INDICATION: Shortness of breath and cough, COVID positive, assess for pulmonary artery embolism. TECHNIQUE: Enhanced helical CT scan of the chest was performed from the lung apices to below the diaphragm. 2 mm axial reconstruction with MPR coronal, oblique and sagittal images were created. 3D shaded surface images also created on a separate workstation and permanently stored. Images were obtained without and with contrast. CONTRAST: 80mL of IODIXANOL 320 MG IODINE/ML INTRAVENOUS SOLUTION administered INTRAVENOUS. Quality of contrast opacification was inadequate. COMPARISON: 12/13/2012. FINDINGS: Exam is limited by poor opacification of the pulmonary arteries. No large central embolism is identified in the main pulmonary arteries. The heart, aorta, and main pulmonary artery are within normal limits in size. Calcified plaque is noted in the aorta and coronary arteries. There is moderate predominantly peripheral patchy groundglass opacity bilaterally, characteristic for COVID-19 lung disease. No endobronchial lesions are identified. No pleural effusion nor pneumothorax is present. No acute findings are identified in the upper abdomen. There is mild degenerative change in the spine. There are no acute bone findings.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Nervous LLQ pain Circulatory Hypertension Digestive Constipation Diverticulitis of colon Diverticulosis Infectious/Inflammatory COVID-19 virus infection Other Epidermal inclusion cyst Bloating
- Andere Medikamente
- albuterol HFA (PROVENTIL;VENTOLIN) 90 mcg/actuation inhaler amLODIPine (NORVASC) 10 mg tablet atorvastatin (LIPITOR) 40 mg tablet benzonatate (TESSALON) 100 mg capsule dexAMETHasone (DECADRON) 6 mg tablet losartan (COZAAR) 100 mg table
- Allergien
- Sulfamethoxazole-trimethoprim
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 30.08.2021
- Impfdatum
- 08.03.2021
- Beginn
- 11.08.2021
- Tage bis Beginn
- 156,0
- Dosis
- 1
- Route/Site
- SYR / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19
Death
Infection
Symptomtext
breakthrough Covid infection, acute resp failure, patient died
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 30.08.2021
- Impfdatum
- 20.03.2021
- Beginn
- 10.08.2021
- Tage bis Beginn
- 143,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute respiratory failure
COVID-19
Infection
Respiratory disorder
SARS-CoV-2 test positive
Symptomtext
Breakthrough Covid infection, acute respiratory failure
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 9,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 28.08.2021
- Impfdatum
- 23.08.2021
- Beginn
- 24.08.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute respiratory failure
Computerised tomogram thorax abnormal
Infection
Interstitial lung disease
Lung opacity
Oedema
Pneumonia
Symptomtext
admitted next day with Acute respiratory failure
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- CXR done 1 hour prior to vaccination as apart of routine visit with normal results on 08.23.21 chest CT Diffuse extensive bilateral groundglass opacities with multifocal areas of consolidation is nonspecific. Differential considerations are multifocal pneumonia/infection, acute interstitial pneumonia, organizing pneumonia, edema or inflammatory process, neoplastic process unlikely but recommend follow-up to resolution. on 08.25.21
- Aktuelle Erkrankungen
- CLL in remission, GVHD, CKD 3a, h/o colon ca, anemia
- Vorgeschichte
- as above
- Andere Medikamente
- Prednisone, Lasix, Gabapentin, simvastatin, alendronate , Zanaflex, zolpidem, Ruxolitinib
- Allergien
- nkda
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 24.08.2021
- Impfdatum
- 03.02.2021
- Beginn
- 14.08.2021
- Tage bis Beginn
- 192,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Symptomtext
Vaccinated hospitalized patient expired 8/14/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 21.08.2021
- Impfdatum
- 01.02.2021
- Beginn
- 08.02.2021
- Tage bis Beginn
- 7,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Dyspnoea
Heart rate increased
Migraine
Muscle spasms
Nausea
Oxygen saturation decreased
Pulmonary embolism
Pulse abnormal
Respiratory failure
Thrombolysis
Symptomtext
During the week following the first Covid 19 2/1/21 I had a couple of days with Migraine and the ?normal symptoms ? but increasingly feeling winded and nauseous. I also had a couple of days at the end of the week where I had severe leg cramps. I found myself with low blood oxygen and high resting pulse so on Monday 2/8/21, after a phone conference with Dr. she sent me to the ER At Hospital , where they kept me until the following Thursday. I had a Pumonary Embolus and respiratory failure. They preformed Trombolysis.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- Poly Myalgia Rheumatica PMR, Sciatica, Osteoporosis.
- Vorgeschichte
- PMR and Osteoporosis
- Andere Medikamente
- Prednisone, Calcium, C vitamin.
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 20.08.2021
- Impfdatum
- 18.02.2021
- Beginn
- 27.04.2021
- Tage bis Beginn
- 68,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Anticoagulant therapy
Computerised tomogram
Condition aggravated
Deep vein thrombosis
Echocardiogram
Electrocardiogram
Laboratory test
Peripheral swelling
Pulmonary embolism
Symptomtext
I started experiencing a swelling of my left foot and ankle; my lower and upper left leg were swollen. I had a kidney stone operation in August of 2020 and one month later after that surgery I was first diagnosed with DVT and Pulmonary Embolism in September of last year. When it popped up again here, they don't know the reason why. I went to hospital ER after calling my doctor office. I was hospitalized for three days and two nights. They prescribed Eliquis for me. I had been given that last year but for 60 days only. But now that I have it again it will be for life. They monitored my heart and kept me an additional night because of testing that showed it may have initially strained my heart but everything was fine and they let me go. I can't tell if my blood clot has gone away. They still found evidence of a blood clot when they did the last test after I have been released from the hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 3,0
- Labordaten
- A whole battery of tests: Pulse; blood pressure; EKG and echo-cardiogram of leg; CT scan. Diagnosed me with DVT and Pulmonary Embolism.
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Diabetes type 2; Kidney stone operation in August 2020 and a month after that I was diagnosed with Pulmonary Embolism and Deep Vein Thrombosis and took Eliquis for 60 days.
- Andere Medikamente
- Metformin; Lantis; Novolog; Atorvastatin; Lisinopril; Jardians; Doxycycline; Trazadone
- Allergien
- Penicillin and any antibiotics that end in "cillin"
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 20.08.2021
- Impfdatum
- 25.02.2021
- Beginn
- 08.08.2021
- Tage bis Beginn
- 164,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Asthenia
Blood creatinine normal
Blood glucose decreased
COVID-19
COVID-19 pneumonia
Chest X-ray
Cough
Dyspnoea
Encephalopathy
Fall
Hypoglycaemia
Hypophagia
Hypoxia
Lethargy
Physical deconditioning
SARS-CoV-2 test positive
Symptomtext
CHIEF COMPLAINT: Weakness, shortness of breath, and a cough of several days' duration. HISTORY OF PRESENT ILLNESS: The patient is an 84-year-old with history of paroxysmal atrial fibrillation, on Warfarin, chronic kidney disease, diabetes mellitus, coronary artery disease status post stents, hypothyroidism, and osteoarthritis, who tested positive on 08/20/2021. Wife was also positive. He has been at home, but has had gotten increasingly weak with very poor oral intake. He has had several falls at home and refused to come in. Today, he had another fall and wife convinced him to have a rescue squad was called in and he was then brought to the ER. When they presented, he had a rhonchorous cough and was also hypoxic and quite deconditioned. Currently, patient is not providing much history. He admits to the cough. He states he usually gets around with a walker or a cane. Other questions asked like loss of smell or taste, the patient is unable to provide. He is selective with some of his answers. In the ER, found to be hypoxic, requiring 4-6 liters of oxygen and we were asked to admit the patient. The patient did get his COVID vaccination. Wife was taking care of him at home, but she states she is unable to cope, which is why she brought him to the hospital. The patient is hypoglycemic with a blood sugar of 45. Wife had stated to the ER that though he had poor oral intake she still gave him his Insulin because he had previously had some hyperglycemia. ASSESSMENT AND PLAN: 1. COVID infection, his creatinine clearance is about 30, which is borderline so will hold remdesivir We will put him on steroids at this time. Continue oxygen supplementation. He is already on Warfarin. We will continue this for anticoagulation. 2. Some acute encephalopathy. I am not sure whether he is just weak and involves an effort to answer questions or just some lethargy. He has had this history of falls and he is on Coumadin. We will get a CT of his head. 3. Acute hypoxic respiratory failure, likely from COVID pneumonia. CXR findings is not classic at this time. We will repeat a chest x-ray in the morning. Continue to monitor patient, wean the oxygen as needed. We will get a baseline ABG Due to lethargy to ascertain if he has hypercapnia. He may need BiPAP. Contains critical data CORONAVIRUS (COVID 19) PCR Order: 274006261 Status: Final result Specimen Information: NASOPHARYNGEAL SWAB 0 Result Notes Ref Range & Units 8/8/21 2010 CORONAVIRUS SARS COV 2 PCR (RESP) NEGATIVE POSITIVEPanic PATIENT STILL HOSPITALIZED AS OF 8/20/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 16.08.2021
- Impfdatum
- 01.03.2021
- Beginn
- 08.08.2021
- Tage bis Beginn
- 160,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute myocardial infarction
Symptomtext
NSTEMI (non-ST elevated myocardial infarction) (CMS/HCC). PFIZER Lots # EL 9269, EN6200.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 90,0
- Geschlecht
- M
- Eingang
- 13.08.2021
- Impfdatum
- 23.03.2021
- Beginn
- 25.07.2021
- Tage bis Beginn
- 124,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Anaemia
Asthenia
Azotaemia
Blood thyroid stimulating hormone normal
Chest X-ray abnormal
Chills
Confusional state
Cough
Decreased appetite
Diarrhoea
Dyspnoea
Electrocardiogram normal
Glycosylated haemoglobin normal
Hyperchloraemia
Hypernatraemia
Hypophagia
Leukocytosis
Symptomtext
Upon arrival to the emergency department, patient was found to have acute hypoxemic respiratory failure. Chest x-ray was concerning for mild left basilar infiltrate. He was also noted to have leukocytosis, anemia, hypernatremia, hyperchloremia, uremia, and elevated troponin. Renal function seems to be at baseline. 07/25/2021tested positive 7/28/2021 discharged 91-year-old male with past medical history of prostate cancer 30 years ago status post surgical removal, coronary artery disease, and stage 3 chronic kidney disease who is also a DNR presented to the emergency department with worsening weakness and confusion. Patient is unable to provide any history himself. Patient's daughter was contacted directly. Per her reports, patient was his usual state of health until approximately few months ago when his wife died. Patient has not been himself since then. He was admitted approximately 1 month ago due to changes in mental status. He was discharged and went to rehab facility. Patient went home approximately 1.5 weeks ago and at that time, per the daughter's report, he was doing very well. Patient was able to take care of himself for the most part. Mental status was also intact. After about 1-2 days, patient started having weakness, poor oral intake, and lack of interest in food. Patient also had poor appetite. During this time frame, patient had multiple episodes of chills along with cough and shortness of breath. He also had nausea and vomiting along with diarrhea 5 days ago. Patient only lives with his daughter. Patient was accident for COVID-19 in April 2021. Over the last 5-6 days, patient has had barely anything to eat and has been very weak. This morning, he was unable to bear his own weight therefore, his daughter brought him to the emergency department for further evaluation. Upon arrival to the emergency department, patient was found to have acute hypoxemic respiratory failure. Chest x-ray was concerning for mild left basilar infiltrate. He was also noted to have leukocytosis, anemia, hypernatremia, hyperchloremia, uremia, and elevated troponin. Renal function seems to be at baseline. Elevated troponin also seems to be lower than baseline. EKG independently reviewed and negative for any ST elevations or depressions. No new T-wave inversions noted. Urinalysis negative. Patient was discharged approximately 1 month ago after being presented with similar symptoms. At that time, patient has metabolic encephalopathy was deemed of unclear etiology. MRI brain was negative for any acute findings. Carotid ultrasound was also negative. Hemoglobin A1c was 5.3. TSH was unremarkable. Lipid panel was also negative. Patient was evaluated by Neurology and his mental status changes were deemed most likely secondary to toxic metabolic encephalopathy. There was no clear source of infection identified. Chest x-ray and UA were negative. Also negative for COVID-19. CT abdomen was also negative. During the hospitalization, patient did have an episode of aspiration pneumonia and was treated appropriately. Modified barium swallow was recommended however, daughter refused at that time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- prostate cancer , coronary artery disease, and stage 3 chronic kidney disease, atrial fibrillation on Xarelto, CAD with history of cardiac stents, congestive heart failure of unknown type, dementia, prostate cancer, hyperlipidemia, gout, hypertension
- Andere Medikamente
- -
- Allergien
- antihistamines
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 12.08.2021
- Impfdatum
- 28.01.2021
- Beginn
- 09.08.2021
- Tage bis Beginn
- 193,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Death
Symptomtext
fully vaccinated, covid-19 death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 04.08.2021
- Impfdatum
- 16.02.2021
- Beginn
- 26.07.2021
- Tage bis Beginn
- 160,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Dyspnoea
SARS-CoV-2 test positive
Symptomtext
admitted to the service of Im at Sh BL on 7/26/2021 with SOB secondary to COVID pneumonia, acute hypoxemic respiratory failure. PMHx significant for CKD III, DM II, CAD, GERD.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 5,0
- Labordaten
- COVID-19 PCR Order: 331228255 Status: Final result Visible to patient: Yes (MyChart) Dx: Suspected COVID-19 virus infection Specimen Information: Nasopharynx; Swabbed Collection
- Aktuelle Erkrankungen
- Pneumonia
- Vorgeschichte
- Acute embolic stroke (HCC) ? Acute left PCA stroke (HCC) ? Chronic diastolic heart failure (HCC) ? Dyslipidemia associated with type 2 diabetes mellitus ? S/P CABG x 3 1995 ? Hypertension associated with diabetes (HCC) ? Mixed hyperlipidemia ? Type 2 diabetes mellitus without complication, without long-term current use of insulin (HCC) ? Coronary artery disease involving native heart without angina pectoris, unspecified vessel or lesion type ? Obesity ? GERD (gastroesophageal reflux disease) ? Chronic left shoulder pain ? Benign prostatic hyperplasia without lower urinary tract symptoms ? Spinal stenosis, lumbar region, without neurogenic claudication ? Fatty liver
- Andere Medikamente
- Acetaminophen 650 mg Oral 2 times daily Aspirin 325 mg Oral Daily Blood Glucose Monitoring Suppl Accu-chek Nano Meter (dispense one kit, refill prn), Test strips, Fast Clix Lancets and Device, test solution; Length of need: 99 months, Tes
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 04.08.2021
- Impfdatum
- 03.03.2021
- Beginn
- 08.03.2021
- Tage bis Beginn
- 5,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Death
Malignant melanoma
Rash
Sepsis
Symptomtext
death rash following vaccination sepsis N17.9 - Acute kidney failure, unspecified multiple mylenoma
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 04.08.2021
- Impfdatum
- 10.04.2021
- Beginn
- 16.05.2021
- Tage bis Beginn
- 36,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Death
Pulmonary embolism
Seizure
Symptomtext
death Other pulmonary embolism without acute cor pulmonale Unspecified convulsions
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 31.07.2021
- Impfdatum
- 25.02.2021
- Beginn
- 11.03.2021
- Tage bis Beginn
- 14,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Anaemia
Blood disorder
Cardiac disorder
Computerised tomogram
Liver disorder
Pain in extremity
Pulmonary embolism
Renal disorder
SARS-CoV-2 test
Syncope
Symptomtext
Acute Massive Pulmonary Embolism detected via CT scan; Syncope; Severe anemia; Leg pain; Negatively impacted cardiac, liver, and kidney function; Negatively impacted cardiac, liver, and kidney function; Negatively impacted cardiac, liver, and kidney function; Long term effects require continuous use of blood thinners; This is a spontaneous report received from a contactable consumer or other non-health care professional. A 34-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot Number: EN6200), via an unspecified route of administration, administered in Arm Left on 25Feb2021 at 09:00 (at the age of 34-years-old) as Dose 1, Single for COVID-19 immunization. Medical history included none. Concomitant medications included desogestrel, ethinylestradiol (APRI) taken for an unspecified indication, start and stop date were not reported. Patient received vaccine Facility in: Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, patient has been tested for COVID-19. Event occurred on 11Mar2021, exactly two weeks following 1st dose of COVID vaccine. Acute Massive Pulmonary Embolism detected via CT scan following sudden leg pain and syncope. Negatively impacted cardiac, liver, and kidney function. Long term effects require continuous use of blood thinners. Presently experiencing severe anaemia treated through infusion treatments. Continued follow up required with Gastroenterology, Cardiology, Pulmonology, Hematology, and Gynecology. Patient visited Emergency room/department or urgent care. The events assessed as serious (Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage). Treatment was received for the events as infusion. Patient admitted in hospital for 4 days. The patient underwent lab tests and procedures which included computerised tomogram: acute massive pulmonary embolism and acute massive pulmonary embolism detected via CT scan following sudden leg pain and syncope, sars-cov-2 test: negative on 11Mar2021 Nasal Swab. The outcome of the events was reported as recovering.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 4,0
- Labordaten
- Test Date: 20210311; Test Name: CT scan; Result Unstructured Data: Test Result:Acute Massive Pulmonary Embolism; Comments: Acute Massive Pulmonary Embolism detected via CT scan following sudden leg pain and syncope.; Test Date: 20210311; Test Name: COVID test; Test Result: Negative ; Comments: Nasal Swab
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: Other medical history: None
- Andere Medikamente
- APRI
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 86,0
- Geschlecht
- M
- Eingang
- 30.07.2021
- Impfdatum
- 02.02.2021
- Beginn
- 23.07.2021
- Tage bis Beginn
- 171,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
COVID-19 pneumonia
Death
SARS-CoV-2 test positive
Symptomtext
Admitted to hospital 7/23/21 with covid pneumonia requiring high flow nasal cannula. Respiratory status never improved and patient transitioned to hospice care. Expired 7/30/31
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- covid + 7/23/21
- Aktuelle Erkrankungen
- CKD stage IV, hypertension, BPH, dementia
- Vorgeschichte
- CKD stage IV, hypertension, BPH, dementia
- Andere Medikamente
- albuterol inhaler, aspirin, cilostazol, furosemide, hydrocodone/acetaminophen, humalog mix 75/25, magnesium oxide, omeprazole, pravastatin, pregabalin, quetiapine, flomax
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 29.07.2021
- Impfdatum
- 01.03.2021
- Beginn
- 13.07.2021
- Tage bis Beginn
- 134,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cerebrovascular accident
Facial paresis
Neurological symptom
Symptomtext
R29.90 - Stroke-like symptom I63.9 - Cerebrovascular accident aborted by administration of thrombolytic agent (CMS/HCC) R29.810 - Facial weakness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 29.07.2021
- Impfdatum
- 03.03.2021
- Beginn
- 28.07.2021
- Tage bis Beginn
- 147,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute myocardial infarction
Death
Symptomtext
death I21.4 - NSTEMI (non-ST elevated myocardial infarction) (CMS/HCC)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 28.07.2021
- Impfdatum
- 31.01.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 29,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Abdominal pain upper
Arterial stent insertion
Blood test abnormal
Electrocardiogram normal
Eructation
Myocardial infarction
Myocardial necrosis marker increased
X-ray
Symptomtext
first signs of were in last week of February and first week of march. approximately 5 times between Feb 21 and April 15 I had what I thought to be indigestion, constant belching with a little pain in center of stomach area, these symptoms disapeared after a few hours and tums. All started in early morning around 630 am. On April 15 it happened again but continued all day, went to urgent care at around 330n they did egg which was fine but advised going to emergency room for better tests,
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocardial infarction
- Hospital-Tage
- 2,0
- Labordaten
- April 15 after urgent care went to hospital emergency . They took blood samples, x- rays blood pressure around 5 x and ekg; everything checked out before the blood test came back. when that came the cardiac enzyme was 94 which the doctor said indicated a heart attack. I was admitted and 2 stents in one artery were done
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- slight copd
- Andere Medikamente
- Synthroid, alfuzosin, low dose aspirin, symbicort
- Allergien
- possibly penicillin
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 28.07.2021
- Impfdatum
- 05.03.2021
- Beginn
- 09.07.2021
- Tage bis Beginn
- 126,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cerebral infarction
Death
Symptomtext
death I63.9 - Cerebral infarction, unspecified
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 19.07.2021
- Impfdatum
- 26.03.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 102,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Death
Pneumonia
Symptomtext
death - Pneumonia due to infectious organism, unspecified laterality, unspecified part of lung - Acute kidney failure, unspecified
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 92,0
- Geschlecht
- M
- Eingang
- 14.07.2021
- Impfdatum
- 16.02.2021
- Beginn
- 18.02.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Contusion
Death
Electrocauterisation
Exsanguination
Haemorrhage
Penile haemorrhage
Platelet count decreased
Skin laceration
Symptomtext
PER SPOUSE, HE HAD A CUT ON HIS LEG THAT DID NOT STOP BLEEDING. THEY WENT TO CLINIC TO GET IT CAUTERIZED. DAY LATER HIS BODY HAD MULTIPLE BRUISES, THEN HE WAS EVEN BLEEDING FROM HIS PENIS. AT HOSPITAL THEY TOLD HIM HE HAD LOW PLATELETS AND WAS BLEEDING OUT. HE WENT INTO HOSPICE AND PASSED AWAY ON 5/8/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 14.07.2021
- Impfdatum
- 02.04.2021
- Beginn
- 22.05.2021
- Tage bis Beginn
- 50,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cerebrovascular accident
Symptomtext
suffered a stroke
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- atrial flutter, hypothyroidism
- Andere Medikamente
- tirosint, diltiazem, aspirin , mirtazapine, vit d, vit c
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 08.07.2021
- Impfdatum
- 27.02.2021
- Beginn
- 19.06.2021
- Tage bis Beginn
- 112,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Cerebrovascular accident
Symptomtext
I63.9 - CVA (cerebral vascular accident) I63.9 - Cerebrovascular accident (CVA), unspecified mechanism
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 08.07.2021
- Impfdatum
- 26.03.2021
- Beginn
- 15.05.2021
- Tage bis Beginn
- 50,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Acute myocardial infarction
Symptomtext
N17.9 - Acute kidney failure, unspecified I21.4 - NSTEMI (non-ST elevated myocardial infarction) (CMS/HCC)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 06.07.2021
- Impfdatum
- 20.03.2021
- Beginn
- 25.06.2021
- Tage bis Beginn
- 97,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Pulmonary embolism
Symptomtext
I26.99 - Pulmonary embolus (CMS/HCC)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 06.07.2021
- Impfdatum
- 25.03.2021
- Beginn
- 21.05.2021
- Tage bis Beginn
- 57,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Death
Hyponatraemia
Hypoosmolar state
Symptomtext
death - Hypo-osmolality and hyponatremia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 06.07.2021
- Impfdatum
- 02.03.2021
- Beginn
- 14.06.2021
- Tage bis Beginn
- 104,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cerebrovascular accident
Death
Hyponatraemia
Symptomtext
death I63.9 - CVA (cerebral vascular accident) E87.1 - Hyponatremia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 06.07.2021
- Impfdatum
- 06.03.2021
- Beginn
- 06.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Abdominal pain
Death
Pneumonia
Symptomtext
death J18.9 - Pneumonia, unspecified organism abdominal pain
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 92,0
- Geschlecht
- M
- Eingang
- 01.07.2021
- Impfdatum
- 18.02.2021
- Beginn
- 31.03.2021
- Tage bis Beginn
- 41,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Death
Unevaluable event
Symptomtext
Patient was hospitalized multiple times within 60 days of receiving a COVID vaccine series and then passed away
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 92,0
- Geschlecht
- M
- Eingang
- 01.07.2021
- Impfdatum
- 18.02.2021
- Beginn
- 31.03.2021
- Tage bis Beginn
- 41,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Death
Unevaluable event
Symptomtext
Patient was hospitalized multiple times within 60 days of receiving a COVID vaccine series and then passed away
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 30.06.2021
- Impfdatum
- 03.03.2021
- Beginn
- 20.06.2021
- Tage bis Beginn
- 109,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Cerebrovascular accident
Symptomtext
I63.9 - CVA (cerebral vascular accident)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 30.06.2021
- Impfdatum
- 20.02.2021
- Beginn
- 21.06.2021
- Tage bis Beginn
- 121,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cerebrovascular accident
Symptomtext
I63.9 - CVA (cerebral vascular accident) I63.9 - Acute CVA (cerebrovascular accident)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 30.06.2021
- Impfdatum
- 01.03.2021
- Beginn
- 20.06.2021
- Tage bis Beginn
- 111,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Blood test
Chest pain
Computerised tomogram abnormal
Dyspnoea
Oxygen saturation decreased
Pulmonary embolism
Thrombectomy
Symptomtext
Pulmonary embolism - significant drop in pulse ox, short of breath, pain in chest Thrombectomy - six clots removed, remained in hospital four days
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 4,0
- Labordaten
- CT Scan, multiple blood tests
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- long-covid, asthma, migraine, heart palpitations
- Andere Medikamente
- gabapentin, symbicort, albuterol, singulair, metoprolol, famotidine, ortho-novum1-35 vitamin C, zinc, calcium, vitamin D, multivitamin, fiber allegra D, tylenol, excedrin, ibuprofen, robitussin
- Allergien
- Dimetapp
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 30.06.2021
- Impfdatum
- 21.02.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 8,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Death
Unevaluable event
Symptomtext
Patient was hospitalized multiple times within 60 days of receiving a COVID vaccine series and later passed away
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 30.06.2021
- Impfdatum
- 21.02.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 8,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Death
Unevaluable event
Symptomtext
Patient was hospitalized multiple times within 60 days of receiving a COVID vaccine series and later passed away
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 29.06.2021
- Impfdatum
- 10.03.2021
- Beginn
- 02.05.2021
- Tage bis Beginn
- 53,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory distress syndrome
Death
Intensive care
Mechanical ventilation
Pneumonia
Symptomtext
SKYLINE ICU DOD 5/2/21 VENT REQUIRED14 DAYS, PNEUMONIA, ARDS, HX OF HTN, CAD, THROMBOCYTOPENIA, HYPOCALCEMIA, HX of TIA and Cereb Infarc with resid dysphgagia, Major Depressive Disorder single episode unspecified
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- CAD, TIA, HTN
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 29.06.2021
- Impfdatum
- 01.03.2021
- Beginn
- 04.06.2021
- Tage bis Beginn
- 95,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute myocardial infarction
Symptomtext
I21.4 - NSTEMI (non-ST elevated myocardial infarction) (CMS/HCC)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 29.06.2021
- Impfdatum
- 24.03.2021
- Beginn
- 09.06.2021
- Tage bis Beginn
- 77,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute myocardial infarction
Symptomtext
I21.4 - NSTEMI (non-ST elevated myocardial infarction) (CMS/HCC)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 28.06.2021
- Impfdatum
- 03.03.2021
- Beginn
- 10.05.2021
- Tage bis Beginn
- 68,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Death
Pneumonia
Symptomtext
Death J18.9 - Pneumonia, unspecified organism N17.9 - Acute kidney failure, unspecified
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 24.06.2021
- Impfdatum
- 19.02.2021
- Beginn
- 21.02.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Breast mass
Breast pain
Gynaecomastia
Lymphadenopathy
Magnetic resonance imaging
Mammogram
Ultrasound scan
Symptomtext
Small, hard mass started 2 days after the 2nd vaccine shot in left breast and turned into a mass the size of a golf ball after 3-4 weeks, that is painful and has not gone down in size.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Gynaecomastia
- Hospital-Tage
- -
- Labordaten
- Saw dermatologist, then internist, who ordered mammogram, ultrasound and MRI. Results were several enlarged axial lymph nodes and gynecomastia.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- multivitamins
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 97,0
- Geschlecht
- F
- Eingang
- 24.06.2021
- Impfdatum
- 15.02.2021
- Beginn
- 21.04.2021
- Tage bis Beginn
- 65,0
- Dosis
- 2
- Route/Site
- SYR / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Chest X-ray abnormal
Death
Hypopnoea
Hyporesponsive to stimuli
Mydriasis
Pulse absent
Pupil fixed
Respiratory arrest
SARS-CoV-2 test positive
Vomiting
Symptomtext
PMH Afib, BiV PPM, HTN, pHTN, hypothyroidism, hemorrhoids, hearing loss, macular degeneration, squamous cell carcinoma, Parkinsons brought to ED after her caregiver found her in bed in AM w/a "dark substance in her bed" and minimally responsive. On admission vomiting x1, no cough, no SOB, abnormal CXR, covid+ Admission originally planned by IMS, but CCM asked to take over due to rapid decline.Pt w/ shallow breathing, guarded prognosis.In the morning on May 1, 2021 around 830 in the morning patient found to be without any pulse or breathing. DNR DNI with pupils fixed and dilated without any spontaneous breathing. No pulse palpated.pronounced dead at 8:30 a.m.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 11,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Cardiovascular disease Chronic Lung Disease ( Asthma or COPD) Hypertension Former Smoker
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 31,0
- Geschlecht
- M
- Eingang
- 22.06.2021
- Impfdatum
- 17.02.2021
- Beginn
- 03.05.2021
- Tage bis Beginn
- 75,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cardiomyopathy
Death
Depressed level of consciousness
Lethargy
Symptomtext
Woke that morning very lethargic and hard to arouse. Mom states had been doing very well, exercising and losing weight. States he felt good up until that day. DEATH
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Death certificate states cardiomyopathy
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- None
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 16.06.2021
- Impfdatum
- 20.02.2021
- Beginn
- 25.02.2021
- Tage bis Beginn
- 5,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Anticoagulant therapy
Blood test
Catheterisation cardiac normal
Chest pain
Computerised tomogram
Electrocardiogram
Intracardiac thrombus
Myocardial infarction
Symptomtext
5 days later went to ER with severe chest pain. Determined it was a heart attack due to blood clot. Was in the hospital for 2 days. EKG, catheter to heart, cat scan, blood tests
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocardial infarction
- Hospital-Tage
- 2,0
- Labordaten
- No heart damage or blockage found. Dr determined it had to be a blood clot so prescribed Plavix and aspirin.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- High blood pressure, high cholesterol
- Andere Medikamente
- Lipitor Protonix Metoprolol Aspirin Losartan Unison Buspar Norco Nevrontin
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 15.06.2021
- Impfdatum
- 19.02.2021
- Beginn
- 22.02.2021
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Cerebral thrombosis
Cerebrovascular accident
Investigation
Symptomtext
stroke; blood clot occurring in the brain; This is a spontaneous report from a contactable consumer. A 70-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6200), dose 1 via an unspecified route of administration, administered in arm left on 19Feb2021 11:00 (at the age of 70-year-old) as single dose for COVID-19 immunization. The patient's medical history included 50% blockage of artery, thyroid disorder, hyperlipidemia. No known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications the patient received within 2 weeks of vaccination included statin and thyroid. The patient experienced stroke on 22Feb2021 00:30 with blood clot occurring in the brain. On a scale of 1-10, it was a 1 or 1.5 per physician and originated in speech area. AEs resulted in emergency room/department or urgent care, and hospitalization (1 day). Patient received Clotbuster as treatment. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovered in 2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 1,0
- Labordaten
- Test Date: 20210222; Test Name: blood clot occurring in the brain scale; Result Unstructured Data: Test Result:1 or 1.5; Comments: originated in speech area
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Coronary artery disease; Hyperlipidemia; Thyroid disorder
- Andere Medikamente
- THYROID
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 10.06.2021
- Impfdatum
- 20.02.2021
- Beginn
- 27.04.2021
- Tage bis Beginn
- 66,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Foetal death
Symptomtext
Fetal demise at 16 weeks
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Foetal death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Colitis
- Andere Medikamente
- prenatal vitamins
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 09.06.2021
- Impfdatum
- 27.02.2021
- Beginn
- 03.03.2021
- Tage bis Beginn
- 4,0
- Dosis
- UNK
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Anaphylactic shock
Loss of consciousness
SARS-CoV-2 test
Symptomtext
severe anaphylactic shock; Unconscious; This is a spontaneous report from a contactable consumer (patient). This 73-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in the right arm on 27Feb2021 (at the age of 73-year-old) (Batch/Lot Number: EN6200) as single dose (unknown if first or second dose) for COVID-19 immunisation and bendamustine from an unspecified date, 5th dose in what was to be a series of 12, for Waldenstrom's macroglobulinaemia. Relevant medical history included Waldenstrom's macroglobulinaemia. The patient's concomitant medications were not reported. The patient previously took bendamustine for Waldenstrom's macroglobulinaemia (the patient received 12 doses over 6 months 2 years ago). On 03Mar2021, the patient experienced severe anaphylactic shock and loss of consciousness; the events were considered serious as life-threatening. The patient specified that 5 days after the vaccine, the patient was undergoing chemotherapy with bendamustine. He had Waldenstrom's macroglobulenemia. This was his 5th dose in what was to be a series of 12. He had received 12 doses over 6 months 2 years prior to this report. During the treatment, the patient went into severe anaphylactic shock. He was unconscious in about 10 seconds from the onset of his first symptoms. He was treated on site and transferred to an E.R. The severity of the event and the fact that both drugs were playing around with his immunoglobulins led him to file this report. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient underwent a nasal swab on an unspecified date which was negative. He recovered from the events on an unspecified date.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic shock
- Hospital-Tage
- -
- Labordaten
- Test Name: Nasal Swab; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Waldenstrom's macroglobulinaemia
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 02.06.2021
- Impfdatum
- 23.02.2021
- Beginn
- 28.05.2021
- Tage bis Beginn
- 94,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute myocardial infarction
Symptomtext
I21.4 - NSTEMI (non-ST elevated myocardial infarction)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 02.06.2021
- Impfdatum
- 26.03.2021
- Beginn
- 23.05.2021
- Tage bis Beginn
- 58,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Acute myocardial infarction
Symptomtext
I21.4 - NSTEMI (non-ST elevated myocardial infarction) (CMS/HCC) N17.9 - Acute kidney injury (CMS/HCC)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 02.06.2021
- Impfdatum
- 01.03.2021
- Beginn
- 24.05.2021
- Tage bis Beginn
- 84,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cerebrovascular accident
Symptomtext
I63.9 - CVA (cerebral vascular accident) (HCC) I63.9 - Acute CVA (cerebrovascular accident) (HCC)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 02.06.2021
- Impfdatum
- 27.02.2021
- Beginn
- 21.05.2021
- Tage bis Beginn
- 83,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cerebrovascular accident
Facial paresis
Symptomtext
I63.9 - CVA (cerebral vascular accident) (CMS/HCC) R29.810 - Facial weakness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 02.06.2021
- Impfdatum
- 25.03.2021
- Beginn
- 23.05.2021
- Tage bis Beginn
- 59,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Death
Hyponatraemia
Symptomtext
death weakness E87.1 - Hyponatremia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 01.06.2021
- Impfdatum
- 01.02.2021
- Beginn
- 14.05.2021
- Tage bis Beginn
- 102,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Autopsy
Cardio-respiratory arrest
Death
Endotracheal intubation
Pulmonary embolism
Pulse absent
Respiratory arrest
Resuscitation
Syncope
Tracheal haemorrhage
Symptomtext
Abrupt syncope with cessation of pulse and respirations at 11:15AM at main office. CPR was started by the workers present. 911 activated and code was activated by EMS and continued during transport and arrival at ER. All resuscitation efforts failed to restore breathing and cardiac activity. A large amount of blood was encountered upon intubation, so Dr. informed next of kin that cause of death was likely a large pulmonary embolus.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardio-respiratory arrest
- Hospital-Tage
- -
- Labordaten
- A complete autopsy was performed with results pending. A death certificate has been issued but the listed cause of death is unknown at this time.
- Aktuelle Erkrankungen
- lumbar DJD
- Vorgeschichte
- lumbar DJD
- Andere Medikamente
- oxycodone/tylenol 10/325 one TID PRN
- Allergien
- No known drug, food, or environmental allergy
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 01.06.2021
- Impfdatum
- 10.04.2021
- Beginn
- 21.05.2021
- Tage bis Beginn
- 41,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Acute myocardial infarction
Death
Symptomtext
death Non-ST elevation (NSTEMI) myocardial infarction Acute kidney failure, unspecified
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 31.05.2021
- Impfdatum
- 09.02.2021
- Beginn
- 10.03.2021
- Tage bis Beginn
- 29,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Angiogram pulmonary abnormal
Anticoagulant therapy
Arthralgia
Back pain
Chest pain
Dyspnoea
Echocardiogram
Fibrin D dimer increased
Pain in extremity
Pulmonary embolism
Thrombosis
Ultrasound Doppler abnormal
Symptomtext
Within 1 week of receiving COVID vaccine,I started having left leg pain that lasted until hospitalization. I?ve had sciatica before and thought it was this. After second COVID vaccine(03/02/2021),started getting shortness of breath that continued to get worse. Finally, in mid-April, along with the shortness of breath and left leg pain, I started getting right,mid back pain that radiated to right chest and shoulder. On April 21,2021, I could no longer tolerate the chest and back pain and drove myself to ER and Urgent Care. The Dr. ordered a CT Angio of chest and determined I had bilateral pulmonary embolism and sent me by ambulance to Hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 4,0
- Labordaten
- Cardiac Echo, venous Doppler left leg, given oxygen and blood thinners. On 4/22/2021- clot in left leg. Labs showed elevated D dimer.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Omeprazole, Bupropion, Pravastatin, Trazadone(for sleep), Vit.D3.
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 21.05.2021
- Impfdatum
- 05.03.2021
- Beginn
- 03.05.2021
- Tage bis Beginn
- 59,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Death
Hyponatraemia
Pneumonia
Symptomtext
Death E87.1 - Chronic hyponatremia N17.9 - AKI (acute kidney injury) (CMS/HCC) J18.9 - Pneumonia of right lower lobe due to infectious organism
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 17.05.2021
- Impfdatum
- 26.03.2021
- Beginn
- 04.05.2021
- Tage bis Beginn
- 39,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Death
Symptomtext
This 73 year old female patient received the Covid shot on 3/26/21 died on 5/4/21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 17.05.2021
- Impfdatum
- 24.03.2021
- Beginn
- 01.05.2021
- Tage bis Beginn
- 38,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Symptomtext
This 83 year old woman received the 2nd dose of vaccine on 3/24/21 and died early May 2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 38,0
- Geschlecht
- M
- Eingang
- 16.05.2021
- Impfdatum
- 30.04.2021
- Beginn
- 06.05.2021
- Tage bis Beginn
- 6,0
- Dosis
- UNK
- Route/Site
- SYR / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Asthenia
Cerebral haemorrhage
Cerebrovascular accident
Computerised tomogram head abnormal
Diplopia
Dizziness
Dysarthria
Eye patch application
Fatigue
Headache
Magnetic resonance imaging head abnormal
Symptomtext
Brother felt dizzy and saw double vision with left side body fatigue which was diagnosed as a stroke. He has bleeding in the back of his brain. Went to the ER at Hospital and took a CT Scan and MRI which showed bleeding. Brother had normal blood pressure and everything was fine with him but the stroke happened after a week of his 2nd Covid-19 vaccine dose. He lost strength in his left part of the body and had a speech slur and double vision. He had to wear an eye patch and had a headache. Hospital said no surgery was needed and transfered him to Rehab for rehab. He is currently there getting treatment.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebral haemorrhage
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Multi-vitamins
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 15.05.2021
- Impfdatum
- 06.04.2021
- Beginn
- 01.04.2021
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Cerebral haemorrhage
Symptomtext
Brain hemorrhage; This is a spontaneous report from a contactable consumer (patient). This 56-year-old male patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number En6200) at single dose on 06Apr2021 13:00 via an unknown route in left arm for Covid-19 immunization. Medical history included hospitalization and vaccine received during existing hospitalization. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient had no known allergies. Concomitant drug was not provided. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced brain hemorrhage on an unknown date in Apr2021. The event resulted in emergency room/department or urgent care, prolongation of existing hospitalization, disability or permanent damage. The report was reported as serious with seriousness criteria of prolonged hospitalization (hospitalization days were 37 days) and disabling. Outcome of the event was unknown. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebral haemorrhage
- Hospital-Tage
- 37,0
- Labordaten
- -
- Aktuelle Erkrankungen
- Hospitalization (vaccine received during existing hospitalization)
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 14.05.2021
- Impfdatum
- 22.02.2021
- Beginn
- 15.03.2021
- Tage bis Beginn
- 21,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Acute myocardial infarction
Chest pain
Dyspnoea
Respiratory distress
Symptomtext
Non-ST elevation (NSTEMI) myocardial infarction Acute kidney failure, unspecified SHORTNESS OF BREATH CHEST PAIN RESPIRATORY DISTRESS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 13.05.2021
- Impfdatum
- 23.02.2021
- Beginn
- 02.03.2021
- Tage bis Beginn
- 7,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: unbekannt
Erholt: nein
Cerebrovascular accident
Dysarthria
Facial paralysis
Gait disturbance
Hemiparesis
Magnetic resonance imaging head abnormal
Symptomtext
Pontine stroke causing dysarthria, right facial droop, right arm weakness, and unsteady gait.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 1,0
- Labordaten
- MRI brain 3/3/2021 showed a stroke
- Aktuelle Erkrankungen
- Hypertension, Hyperlipidemia, prior prostate cancer, and osteopenia
- Vorgeschichte
- as above
- Andere Medikamente
- Amlodipine, Rosuvastatin, Alendronate, Losartan, vitamin D
- Allergien
- Lisinopril
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 103,0
- Geschlecht
- M
- Eingang
- 13.05.2021
- Impfdatum
- 22.02.2021
- Beginn
- 01.05.2021
- Tage bis Beginn
- 68,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 12.05.2021
- Impfdatum
- 25.03.2021
- Beginn
- 10.05.2021
- Tage bis Beginn
- 46,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Cerebrovascular accident
Symptomtext
I63.9 - Cerebrovascular accident (CVA) determined by clinical assessment
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 11.05.2021
- Impfdatum
- 27.01.2021
- Beginn
- 22.04.2021
- Tage bis Beginn
- 85,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Arrhythmia
Arteriosclerosis
Arteriosclerosis coronary artery
Atelectasis
Atrioventricular block second degree
Bladder catheterisation
Bradycardia
Bundle branch block left
Bundle branch block right
COVID-19
Cardiac arrest
Cardiac pacemaker insertion
Catheterisation cardiac
Cerebral atrophy
Cerebral small vessel ischaemic disease
Chest X-ray abnormal
Colonoscopy
Computerised tomogram abdomen abnormal
Symptomtext
cardiac arrest
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- 8,0
- Labordaten
- Admission diagnosis: Primary Admission Diagnosis Medical Problems Hospital Problems POA * (Principal) Sinus bradycardia Yes Vitamin D deficiency Yes Overview Signed 8/21/2018 11:06 AM by, LPN will monitor; COVID-19 virus infection Yes 04/13/21 1532 Influenza/RSV/COVID PCR Collected: 04/13/21 1325 | Final result | Specimen: Swab from Nasopharynx Influenza A Not Detected Respiratory Synctial Virus Not Detected Influenza B Not Detected COVID-19 SARS-CoV-2 Overall Result DetectedCritical X-ray chest 2 views Result Date: 4/21/2021 XR CHEST 2 VW IMPRESSION: Cardiac device in position with lead tips in the projection of the right heart. Negative for pneumothorax. END OF IMPRESSION: INDICATION: Confirm pacemaker lead position. TECHNIQUE: PA and lateral views of the chest are acquired. COMPARISON: None available. FINDINGS: Cardiac device in the left chest wall is noted with lead tips in the projection of the right heart. The cardiomediastinal silhouette is unremarkable. No consolidation, effusion, or pneumothorax identified. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT head without contrast Result Date: 4/14/2021 CT HEAD WO CONTRAST IMPRESSION: Mild diffuse atrophic changes the brain without evidence of acute intracranial hemorrhage or midline shift is noted. A subtle area of decreased attenuation left basal ganglia may represent an age-indeterminate area of infarction. For further delineation MRI would be recommended to assess for acuity. Appropriate follow-up as clinically directed. END OF IMPRESSION: INDICATION: Patient is status post cardiac arrest. COVID-19 positive. Dizziness. TECHNIQUE: The patient was scanned from the skull base to the vertex using 5 mm increments. No intravenous contrast was used. CONTRAST: No contrast administered. COMPARISON: None available. FINDINGS: Examination revealing there is mild periventricular hypoattenuation consistent with chronic small vessel ischemic change. There is no midline shift appreciated. No evidence of acute hemorrhage is noted. There is no evidence of intra-axial or extra-axial fluid collection identified. Subtle area of decreased attenuation of the left basal ganglia may represent an age-indeterminate area of prior ischemic event. Further delineation with MRI is recommended to assess for acuity. The mastoid air cells are clear. The visualized paranasal sinuses are grossly clear. Ocular structures are unremarkable. Patient is intubated. Incompletely assessed. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT abdomen pelvis with contrast Result Date: 4/17/2021 CT ABDOMEN PELVIS W CONTRAST IMPRESSION: 1. Small to moderate-sized right pleural effusion and a small left pleural effusion, mildly increased since the prior study. 2. Air-fluid level in the left colon and rectum, indicating diarrhea. Clinical correlation is recommended. 3. Small cortical renal cysts and bilateral parapelvic renal cysts. No hydronephrosis is identified. END OF IMPRESSION: INDICATION: Positive COVID test. Rule out intra-abdominal process. TECHNIQUE: 3 mm axial images from the upper abdomen to the symphysis pubis. Images were obtained with IV contrast. Images were also viewed in sagittal and coronal 2D reconstructions. IV CONTRAST: 80 mL of IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION administered intravenously. COMPARISON: Enhanced CT abdomen and pelvis 4/14/2021. FINDINGS: CT ABDOMEN: LUNG BASE: Small left effusion with atelectasis, increased since the prior study. Small-to-moderate sized right pleural effusion with postoperative changes of the right lower lobe. LIVER: Normal in size and contour. The 2 cm left hepatic lesion noted on the prior study is less prominent. It may represent a hemangioma or flow-related artifact. SPLEEN: Normal. PANCREAS: Normal. ADRENAL GLANDS: Normal. GALLBLADDER/BILIARY: Surgically absent. There is no intra- or extrahepatic ductal dilation. KIDNEYS AND URETERS: Bilateral small cortical renal cysts and parapelvic renal cysts. No evidence of hydronephrosis. ADENOPATHY: None. ASCITES: None. AORTA: No aneurysm or dissection. There is mild atherosclerotic plaque noted. HERNIA: None. CT PELVIS: BLADDER: Foley catheter in place. GI SYSTEM: Air-fluid levels are noted in the rectosigmoid colon, indicating diarrhea. No acute findings in the abdomen or pelvis. OTHER PELVIC ORGANS: Normal. ADENOPATHY: None. FREE FLUID: None. BONES: Stable chronic compression fracture of the T12 vertebral body. Stable incomplete fractures in the bilateral lower chest. There are mild to moderate degenerative changes of the lumbar spine. SOFT TISSUE: Unremarkable. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT abdomen pelvis with contrast Result Date: 4/14/2021 CTA CHEST PULMONARY EMBOLISM W WO CONTRAST, CT ABDOMEN PELVIS W CONTRAST IMPRESSION: 1. No evidence of aortic dissection or pulmonary embolism. 2. Mild groundglass densities in the bilateral lungs are nonspecific. It may represent atelectasis or infiltrate. 3. Small right effusion with postoperative change of right lower lobe and mild left basilar atelectasis. 4. Incomplete fractures involving right 2nd to 8th and left 3rd to 7th ribs. No pneumothorax is identified. 5. The 2 cm lesion in the left hepatic lobe, hemangioma is most likely. Correlation with liver ultrasound is recommended. 6. Benign cortical renal cysts in bilateral kidneys. 7. Stable compression fracture of T12 vertebral body and chronic changes in thoracolumbar spine. END OF IMPRESSION: INDICATION: Status post cardiac arrest with chest compression. TECHNIQUE: Enhanced helical CT scan of the chest was performed from the lung apices to below the diaphragm. 2 mm axial reconstruction with MPR coronal, oblique and sagittal images were created. 3D shaded surface images also created on a separate workstation and permanently stored. Enhanced CT abdomen and pelvis were obtained sequently. Images were obtained with contrast.. IV CONTRAST: 80mL of IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION administered intravenously. COMPARISON: Unenhanced CT chest 11/19/2020. FINDINGS: CT CHEST: THYROID: Unremarkable. ET and NG tubes identified. LUNG/PLEURAL: Small right effusion with postoperative change of right lower lobe. Mild groundglass densities are noted in the lung parenchyma. There is mild left basilar opacity, atelectasis is most likely. MEDIASTINUM/HILA/AXILLA/SUPRACLAVICULAR: No adenopathy is noted. PULMONARY ARTERIES: Unremarkable. HEART: Unremarkable. Mild coronary artery calcification noted. AORTA: No aneurysm or dissection. Mild atherosclerotic plaque noted. CT ABDOMEN: LIVER: A 2.2 cm irregular shaped, irregular enhancing lesion identified in the medial segment of left hepatic lobe, suspicious for a hemangioma. No second lesion is identified. SPLEEN: Normal. PANCREAS: Normal. ADRENAL GLANDS: Normal. GALLBLADDER/BILIARY: Surgically absent. Mild intra and extrahepatic ductal dilatation is within normal limits after cholecystectomy. KIDNEYS AND URETERS: Multiple small cortical renal cysts are noted bilaterally. There is no evidence of hydronephrosis or obstructing kidney stones. ADENOPATHY: None. ASCITES: None. AORTA: No aneurysm or dissection. Mild atherosclerotic plaque noted. HERNIA: None. CT PELVIS: BLADDER: Foley catheter in place. GI SYSTEM: No acute findings. OTHER PELVIC ORGANS: Uterus and adnexa are unremarkable. ADENOPATHY: None. FREE FLUID: None. BONES: Incomplete fracture is identified involving right second 2nd to 8th and left 3rd to 7th ribs Severe compression fracture of T12 vertebral body, unchanged since the prior study. No evidence of metastases. There are mild degenerative changes of thoracic and lumbar spine. SOFT TISSUE: Unremarkable. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Cardiac catheterization Result Date: 4/20/2021 Clinical History: This patient had a recent cardiac arrest requiring pacemaker placement. And a mildly elevated troponin level. As such catheterization was recommended. Access: Right radial artery LHC findings: Left Ventriculogram: Normal contractility with dyssynchronous contraction, EF 50 to 55%. LMT: Normal. LAD: Angiographically normal LCx: Angiographically normal RCA: Dominant vessel, angiographically normal Impression: 1. No significant coronary obstructive disease. 2. Normal LV function. Cardiac catheterization Result Date: 4/13/2021 Cardiac Catheterization Procedure Report Summary 4/13/2021 Indication High grade AVB Cardiac arrest secondary to torsades de pointes Procedures -temporary pacemaker placement Procedure Technique Under local lidocaine anesthesia, a 6 Fr sheath was placed in the right IJ vein using direct ultrasound guidance and a micropuncture kit. Next, a balloon tipped pacemaker catheter was placed in the RV apex and pacing thresholds were established. The device lost capture at 0.4 mA. Therefore, a backup rate of 60 bpm was set with an output of 5 mA and the device was secured in place. The patient was transferred to the ICU in stable medical condition. Complications No intraprocedural complications. Impression Successful temporary pacemaker placement via the right internal jugular vein Recommendations Device care per protocol Further care per ICU team, 8:32 PM. X-ray chest 1 view, Portable Result Date: 4/19/2021 XR CHEST 1 VW PORT IMPRESSION: Grossly adequate pacemaker placement. Chronic interstitial changes of the lungs. No evidence of pneumothorax appreciated. Appropriate follow-up, as clinically directed. END OF IMPRESSION: INDICATION: Post pacemaker. TECHNIQUE: AP upright portable examination of the chest. COMPARISON: Prior examination of April 14, 2021. FINDINGS: Heart size is within normal limits. Newly introduced cardiac pacemaker. There is no definite evidence of pneumothorax. Chronic interstitial changes are noted. No definite pleural effusion is appreciated. Osseous skeleton revealing degenerative changes of the thoracic spine. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view, Portable Result Date: 4/14/2021 XR CHEST 1 VW PORT IMPRESSION: Mild right basilar atelectasis. END OF IMPRESSION: INDICATION: placement of pacer wire. Covid 19. TECHNIQUE: AP projection of the chest is acquired. COMPARISON: Radiographs of 4/13/2021. FINDINGS: The cardiomediastinal silhouette is unchanged. The endotracheal and nasogastric tubes remain in satisfactory position. Right internal jugular temporary pacing lead terminates overlying the right ventricle. There is mild right basilar atelectasis. The left lung is clear. No evidence of pneumothorax. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view - STAT Result Date: 4/14/2021 XR CHEST 1 VW IMPRESSION: Increased interstitial markings in the left hemithorax may represent evidence of compressions with contusion or congestion. The endotracheal tube position cannot be adequately assessed due to overlying monitoring device obscuring the positioning of the trachea and carina. Orogastric tube is in the stomach, but the last sidehole is at the gastroesophageal junction. Recommend advancement when appropriate. Right IJ line with the tip overlying the lower cardiac margin, most likely within the right ventricle. Recommend appropriate clinical correlation. No definite evidence of pneumothorax is noted, but this study is performed as a supine image, which limits evaluation. Findings, as discussed in the body of the report. Appropriate follow-up, as clinically directed. END OF IMPRESSION: INDICATION: OTHER - Post temporary pacemaker. Cardiac temporary pacemaker placement. TECHNIQUE: AP supine examination of the chest. COMPARISON: Prior examination of April 13, 2021. FINDINGS: Heart size is within normal limits. Bilateral lung zones demonstrate haziness, particularly over the left hemithorax. Patient with history of recent chest compressions. Contusion or congestion must be considered. Patient also COVID+. The endotracheal tube cannot be adequately assessed due to overlying leads, which obscure positioning of the trachea and carina. Orogastric tube extending into the stomach, but the last sidehole is at the gastroesophageal junction. Right IJ cardiac pacer with the tip overlying the region of the right ventricle. Recommend clinical correlation for positioning. No evidence of pneumothorax is noted. However, this study is performed in a supine fashion, which limits evaluation. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view, Portable Result Date: 4/13/2021 XR CHEST 1 VW PORT IMPRESSION: Increased interstitial markings in the left hemithorax and the right upper lung zone. Due to the repetitively development and the history of chest compressions this may represent pulmonary parenchymal congestion or contusion. No definite evidence of pneumothorax is appreciated. Findings as discussed in the body of the report. Appropriate follow-up as clinically directed. END OF IMPRESSION: INDICATION: Post chest compressions . TECHNIQUE: AP semiupright portable examination of the chest. COMPARISON: Prior examination of April 13, 2021. FINDINGS: Heart size is within normal limits. Increased interstitial markings extending throughout the left hemithorax and the right upper lobe. This has newly developed as compared with prior imaging of the same date and I suspect may be due to congestion or contusion due to the patient's history of chest compressions. No definite evidence of pleural effusion or obvious pneumothorax is appreciated on this examination. Mild S-shaped scoliosis of the thoracolumbar spine. No evidence of pneumothorax is appreciated. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view - Portable Result Date: 4/13/2021 XR CHEST 1 VW PORT IMPRESSION: Shift of the trachea to the patient's right which is unchanged from the comparison study dated March 4, 2019. This likely represents chronic volume loss although there is a rotational component seen. No acute cardiopulmonary disease. END OF IMPRESSION: INDICATION: SOB, arrhythmia. TECHNIQUE: AP projection of the chest is acquired. COMPARISON: March 4, 2019 FINDINGS: Lungs are symmetrically inflated. No significant interval change. The trachea and mediastinum is shifted to the patient's right. While there is a rotational component to this this also likely represents chronic volume loss in the right side. This is unchanged from the comparison study. No focal infiltrate is seen. No pleural effusion or pneumothorax is identified. The heart and pulmonary vasculature are within normal limits and unchanged. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Electrophysiology Procedure Result Date: 4/20/2021 Patient, Implantable Cardioverter Defibrillator-Cardiac Re-Synchronization Therapy Implant Report Procedures: ICD implant: [33249] Additional Left ventricular lead placement [33225] Procedure date: April 19, 2021 Implanting physician: , MD Implant indications: 2: 1 AV block secondary to Mobitz 2 AV block. Cardiac arrest History: Patient had a cardiac arrest about a week ago. Very puzzling presentation. She went to a GI suite to have a routine colonoscopy. She was noted to have 2: 1 AV block. Her baseline EKG shows a right bundle branch block and a left anterior fascicle block and she was in 2: 1 AV block on presentation. She was asymptomatic from this. However she was sent to the hospital and admitted. After admission she was on the floor and because of the bradycardia she developed torsade the point and was resuscitated with CPR and countershock. Transvenous right internal jugular vein temporary pacing was applied. She spiked low level troponin level--probably related to the cardiac arrest and CPR/countershock. However she did have a coronary angiogram [immediately preceding this device implant] and no coronary artery disease was noted and ventricular function is normal. The patient's history becomes a little more puzzling as follows: She has a history of lung cancer but recovered and there is no evidence of recurrence. And she has a baseline right bundle branch block. In December 2020, she and her husband developed COVID-19. COVID-19 test was done as an outpatient and she recovered at home. She did not require hospitalization. She had a COVID-19 immunization in February 2021. However, on presentation with this 2: 1 AV block [in the ER] another COVID-19 test was done and it is again positive. There is no COVID-19 symptoms. HOWEVER: A literature search found several reports of infra his CN Mobitz 2 AV block and complete heart block in patients with acute COVID-19 infection. Whether or not this patient's AV block is related to COVID-19 is entirely uncertain. Again she has absolutely no other symptoms of Covid at this point. I refer the reader to the 4/14/2021 infectious disease consult note. The consultant recommended convalescent plasma and monoclonal antibodies for a presumed reinfection although admittedly infection was not certain. At any rate she comes to the EP lab for ICD implant and removal of the temporary pacemaker wire addendum: With respect of longevity: expected noncardiovascular longevity is over one year. Addendum: Functional class = New York Heart Association functional class I Neuroendocrine blockade is not indicated. Ventricular function is normal And the patient and I discussed thoroughly pacemaker versus ICD. She definitely has an indication for pacemaker because the trifascicular heart block that preexisted her 2: 1 AV block may be the underlying rhythm problem and not Covid. Therefore pacemaker is definitely indicated. Whether or not preventing bradycardia will eliminate chance for another cardiac arrest is substantially less certain. So our SHARED DECISION was to implant an ICD. Because of the high likelihood of progression of this conduction system disease, I am going to implant a CRT device Procedure Note Details: Findings: 1. Venous access site: Cephalic vein for the right atrial and right ventricular ICD lead. Left ventricular lead was a left bundle pacing lead and that was placed through an axillary venous entry 2. Cardiac Placement Sites (Right Sided Leads): Right atrial appendage. Active fixation lead. Right ventricular distal septum. Please note: The right ventricular ICD lead was extremely difficult to place. I repositioned at least 4 times because of suboptimal sensing. Capture was always more than adequate. But the sensing was as lowest 1-2 mV. Eventually we had successful lead placement. 3. Rather than implant a left ventricular venous epicardial lead, I elected to place a left bundle pacing lead: 4. Left bundle pacing area was mapped and the lead was successfully deployed. EKGs are below. We were able to record a left bundle electrogram on the lead.: 5. Total Contrast: About 30 mL of Visipaque 6. Defibrillation Threshold: Was not pursued 7. A bioabsorbable antibiotic impregnated fabric [Medtronic Tyrx?] was implanted in the pocket for further bacterial chemoprophylaxis. The fabric was placed between the skin incision & the patient's ICD generator but was not placed around the generator or leads. 8. 9. ICD PROGRAMMING: 10. BRADYCARDIA PACING: DDD with mode switching. Lower rate = 60. Upper tracking rate = 130. The AV delays are programmed to allow for intrinsic conduction with the AV delay was set to about 230 ms. If conduction is longer than that, there will be P wave synchronous or AV sequential paced rhythm. MVP was not activated TACHYCARDIA ARRHYTHMIA DETECTION: Patient had torsade the point. Therefore, the programming here was recommendations from heart rhythm Society regarding programming Medtronic device for primary prevention: Ventricular tachycardia/ventricular fibrillation = 188 beats per minute; 30 of 40 intervals to detect there is antitachycardia pacing in the both zones. This is followed by ICD shocks. All shocks are maximal 11. Conscious sedation time: About about 120 minutes . Please refer to the electrophysiology laboratory data sheets/nurse's notes which will document the exact time of the start and stop of conscious sedation. 12. The following are EKGs showing the implanted left bundle pacing lead The first EKG has a lot of motion artifact but what is shown is VVI pacing followed by termination of pacing and resumption of the patient's AV conduction which is a very similar right bundle branch block. This would represent fairly classic left bundle branch pacing. This next EKG shows P wave synchronous left bundle pacing ______________________________________________________________ 12. Implanted Hardware: Procedure Note Details Prior to incision, the patient had been sedated and intravenous antibiotics were administered prior to the procedure. Continuous oxygen saturation was measured as well as blood pressure monitoring was conducted throughout the procedure. Local anesthesia was obtained with 1% lidocaine. An incision about 5-10 cm in length was made in the infraclavicular region of the shoulder parallel to the clavicle. With sharp and blunt dissection, incision was taken down to the pre-pectoral fascia. Medial to the incision, a ICD pocket was fashioned. Cephalic vein entry: The cephalic vein was isolated in the deltopectoral groove and ligated distally. The vein was opened with sharp scissors. A guidewire was placed into the vein and passed and coursed through the superior veins to the level of the right atrium. Over this retained a guidewire, peel-away sheathes were placed followed by the ICD ventricular lead and atrial leads respectively. Axillary vein entry: Left arm/axillary vein venogram was performed. The axillary vein was then entered using a micro-needle/wire & a modified Seldinger technique after which a guidewire was placed and coursed through the superior veins to the level of the right atrium. Over the retained a guidewire left bundle pacing lead was placed. Right ventricular ICD: The lead was manipulated toward the right ventricular apex. As discussed above, it was extremely difficult to manipulate this lead. It would not settle in the right ventricular apex. I tried multiple spots in the apex and along the mid and distal septum. Over the course of the procedure, I needed to reposition this lead because of decreased sensitivity at least 4 times. Eventually we found the site in the distal apical septum which seem to be stable. At that point capture and sensing thresholds were good. The lead was actively fixed. The lead was sutured to the pectoralis with 0 silk on the sewing sleeve. Atrial lead: The atrial lead was manipulated to the right atrial appendage. Capture and sensing thresholds were good. The lead was actively fixed. The lead was sutured to the pectoralis with 0 silk on the sewing sleeve. After the dual-chamber ICD was implanted we paced atrially to assess AV conduction. There was 2: 1 AV block with a paced rate of 100 bpm. I decided to implant a CRT device. LEFT BUNDLE BRANCH PACING LEAD PLACEMENT I deployed a Medtronic His bundle lead using its specific delivery sheath (pacing lead = model 3830 Select Secure? lead). The delivery sheath was placed through a short hemostatic sheath and was advanced over a guidewire to the right atrioventricular groove near the His bundle. Guidewire was removed. The Medtronic Select Secure? lead was then advanced through the sheath and mapping around the AV groove in the region of the His bundle was conducted.The area of the His bundle was mapped. We found his potential, marked with fluoroscopy save and move forward with left bundle pacing. : We proceeded to map the right ventricular septum with plans to deliver the lead across the interventricular septum to the area of the left bundle. This procedure is described in the Heart Rhythm Journal [June 2019]. And Journal of Cardiovascular Electrophysiology. 2019:1-6. ADDITIONALLY: JACC vol 24 #24 page 3039-3049 The model 3830 select secure lead and the non-deflectable his sheath were advanced towards the right ventricular septum. We mapped around on the right ventricular septum to find the typical QRS morphology of the mid RV septum [basically a RSR pattern in precordial lead V1 forming a "W" pattern. Contrast was injected into the sheath to confirm that we were on the interventricular septum. The QRS morphology on the 6-lead EKG was also analyzed to be certain we were not in the outflow tract. Once we found that W pattern and we confirmed interventricular septal placement of the sheath, I proceeded to deploy the lead into the interventricular septum. Initial placement was with about 6 turns of the lead test as described in the manuscript above. We then proceeded to advance the lead one turn at a time while measuring lead resistances and assessing the QRS morphology. The goal is a satisfactorily narrow QRS [indicating successful capture of the left bundle and ideally, a left bundle potential preceding the local QRS. Although while we are measuring lead resistances to be certain it is within satisfactory range. Once we achieved a satisfactorily narrow QRS, the delivery sheath was removed. The lead was sutured to the pectoralis with 0 silk on the sewing sleeve. Capture and sensing thresholds were remeasured all 3 leads. At that point the repositioning of the ICD lead was repeatedly needed but eventually successful. After we successfully achieved a placement for the ICD lead: And that lead had been sewn to the pectoralis with 0 silk on the sewing sleeve, all the lead capture and sensing thresholds were acceptable. The incision was then copiously irrigated with antibiotic solution. A purse string suture was placed around the venous access site for hemostasis. The generator was attached to the leads and the leads and generator were implanted in the pocket. A bioabsorbable antibiotic impregnated fabric [Medtronic Tyrx?] was implanted in the pocket for further bacterial chemoprophylaxis. The fabric was placed between the skin incision & the patient's ICD generator but was not placed around the generator or leads. Appropriate pacemaker & ICD function was noted once the generator was connected. The incision was closed in three layers. The patient was then taken to the recovery room. During incision closure, device based ICD testing was conducted. Ventricular fibrillation however was NOT induced. Please see the result section and the attached electrophysiology lab data sheet that discusses and displays the high voltage in low-voltage lead impedance measurements, and the capture and sensing thresholds. At the end of the procedure, the patient was taken to the recovery room. Transthoracic echo (TTE) limited Result Date: 4/14/2021 FINALIZED REPORT TWO-DIMENSIONAL ECHOCARDIOGRAPHIC FINDINGS LEFT VENTRICLE: Normal LV size with normal wall thickness. Dyssynchronous contraction pattern. RIGHT VENTRICLE: Normal size and function. Echodensities in the right heart consistent with device leads AORTIC VALVE: Trileaflet MITRAL VALVE: Normal TRICUSPID VALVE: Mild regurgitation PULMONIC VALVE: Normal LEFT ATRIUM: Normal size RIGHT ATRIUM: Normal size INTERATRIAL SEPTUM: Intact AORTIC ROOT: Normal PERICARDIUM: No effusion IVC: Normal AORTIC ARCH: Not well seen COLOR AND SPECTRAL DOPPLER: Normal PA systolic pressure Doppler evidence decreased LV compliance FINAL IMPRESSIONS: Normal LV size with normal wall thickness. Dyssynchronous contraction pattern. Preserved function. EF in the range of 50-55 % Normal RV size and function Echodensities in the right heart consistent with device leads Mild tricuspid regurgitation Doppler evidence decreased LV compliance Definity was utilized to help enhance endocardial border definition Cardiac device check - remote Result Date: 4/20/2021 Reason: Pt initiate- no call from pt w/ symptoms Action: monitor Device: ICD-CRT Managing Provider: Fazio Brady Parameters: DDD 60 Pacing: AP 0.5% BiVP 5.9% Dependent: no Presenting EGM: AS/VS Arrhythmia: AT/AF 0%, no SVT/VT/VF, ASA 325 Lead impedance, sensing, capture: appear stable Battery: initializing Future appts: site check Initials: ccm CT angiogram chest pulmonary embolism with and without contrast Result Date: 4/14/2021 CTA CHEST PULMONARY EMBOLISM W WO CONTRAST, CT ABDOMEN PELVIS W CONTRAST IMPRESSION: 1. No evidence of aortic dissection or pulmonary embolism. 2. Mild groundglass densities in the bilateral lungs are nonspecific. It may represent atelectasis or infiltrate. 3. Small right effusion with postoperative change of right lower lobe and mild left basilar atelectasis. 4. Incomplete fractures involving right 2nd to 8th and left 3rd to 7th ribs. No pneumothorax is identified. 5. The 2 cm lesion in the left hepatic lobe, hemangioma is most likely. Correlation with liver ultrasound is recommended. 6. Benign cortical renal cysts in bilateral kidneys. 7. Stable compression fracture of T12 vertebral body and chronic changes in thoracolumbar spine. END OF IMPRESSION: INDICATION: Status post cardiac arrest with chest compression. TECHNIQUE: Enhanced helical CT scan of the chest was performed from the lung apices to below the diaphragm. 2 mm axial reconstruction with MPR coronal, oblique and sagittal images were created. 3D shaded surface images also created on a separate workstation and permanently stored. Enhanced CT abdomen and pelvis were obtained sequently. Images were obtained with contrast.. IV CONTRAST: 80mL of IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION administered intravenously. COMPARISON: Unenhanced CT chest 11/19/2020. FINDINGS: CT CHEST: THYROID: Unremarkable. ET and NG tubes identified. LUNG/PLEURAL: Small right effusion with postoperative change of right lower lobe. Mild groundglass densities are noted in the lung parenchyma. There is mild left basilar opacity, atelectasis is most likely. MEDIASTINUM/HILA/AXILLA/SUPRACLAVICULAR: No adenopathy is noted. PULMONARY ARTERIES: Unremarkable. HEART: Unremarkable. Mild coronary artery calcification noted. AORTA: No aneurysm or dissection. Mild atherosclerotic plaque noted. CT ABDOMEN: LIVER: A 2.2 cm irregular shaped, irregular enhancing lesion identified in the medial segment of left hepatic lobe, suspicious for a hemangioma. No second lesion is identified. SPLEEN: Normal. PANCREAS: Normal. ADRENAL GLANDS: Normal. GALLBLADDER/BILIARY: Surgically absent. Mild intra and extrahepatic ductal dilatation is within normal limits after cholecystectomy. KIDNEYS AND URETERS: Multiple small cortical renal cysts are noted bilaterally. There is no evidence of hydronephrosis or obstructing kidney stones. ADENOPATHY: None. ASCITES: None. AORTA: No aneurysm or dissection. Mild atherosclerotic plaque noted. HERNIA: None. CT PELVIS: BLADDER: Foley catheter in place. GI SYSTEM: No acute findings. OTHER PELVIC ORGANS: Uterus and adnexa are unremarkable. ADENOPATHY: None. FREE FLUID: None. BONES: Incomplete fracture is identified involving right second 2nd to 8th and left 3rd to 7th ribs Severe compression fracture of T12 vertebral body, unchanged since the prior study. No evidence of metastases. There are mild degenerative changes of thoracic and lumbar spine. SOFT TISSUE: Unremarkable. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1-2 vw
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Nervous Migraine headache Brachial neuritis Carpal tunnel syndrome Intervertebral disc disorder of cervical region with myelopathy Low back pain Lumbar radiculopathy Neck pain Skin sensation disturbance Respiratory Primary adenocarcinoma of lower lobe of right lung (CMS/HCC) Circulatory Sinus bradycardia Digestive Vitamin D deficiency Genitourinary Nephrolithiasis Cyst of kidney, acquired Musculoskeletal Age-related osteoporosis without current pathological fracture Degeneration of cervical intervertebral disc Degeneration of lumbar intervertebral disc Displacement of cervical intervertebral disc without myelopathy Neck sprain Scoliosis of lumbar spine Infectious/Inflammatory COVID-19 virus infection Other Living will in place History of lung cancer
- Andere Medikamente
- butalbital-aspirin-caffeine (FIORINAL) 50-325-40 mg capsule cholecalciferol, vitamin D3, (VITAMIN D3) 2,000 unit tablet tablet cyclobenzaprine (FLEXERIL) 10 mg tablet melatonin 10 mg metoprolol succinate XL (TOPROL-XL) 25 mg 24 hr tablet mu
- Allergien
- PenicillinsHives / Urticaria, Rash SulfamethoxazoleRash
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 11.05.2021
- Impfdatum
- 23.02.2021
- Beginn
- 08.03.2021
- Tage bis Beginn
- 13,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute myocardial infarction
Pneumonia
Symptomtext
I21.4 - NSTEMI (non-ST elevated myocardial infarction) J18.9 - Pneumonia, unspecified organism
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 11.05.2021
- Impfdatum
- 25.03.2021
- Beginn
- 07.04.2021
- Tage bis Beginn
- 13,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Cerebral infarction
Cerebrovascular accident
Facial paresis
Symptomtext
I63.9 - Stroke (CMS/HCC) I63.9 - Cerebral infarction, unspecified N17.9 - Acute kidney failure, unspecified R29.810 - Facial weakness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 10.05.2021
- Impfdatum
- 24.03.2021
- Beginn
- 04.04.2021
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Cerebral haemorrhage
Symptomtext
I61.9 - ICH (intracerebral hemorrhage) (CMS/HCC)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebral haemorrhage
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 92,0
- Geschlecht
- M
- Eingang
- 10.05.2021
- Impfdatum
- 23.02.2021
- Beginn
- 03.05.2021
- Tage bis Beginn
- 69,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute myocardial infarction
Chest pain
Symptomtext
This 92 year old white male received the Covid shot on 2/23/21 and went to the ED and admitted on 5/3/21 and again to ED and admitted on 5/5/21 with the following diagnoses listed below. I21.4 - NSTEMI (non-ST elevated myocardial infarction) (CMS/HCC) CHEST PAIN
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 10.05.2021
- Impfdatum
- 26.03.2021
- Beginn
- 21.04.2021
- Tage bis Beginn
- 26,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Acute myocardial infarction
Pyrexia
Thrombocytopenia
Vomiting
Symptomtext
This 71 year old male received the Covid shot on 3/26/21 and went to the ED on 4/21/21 and was admitted on 4/21/21 with the following diagnoses listed below. I21.4 - Non-ST elevation (NSTEMI) myocardial infarction N17.9 - Acute kidney failure, unspecified D69.6 - Thrombocytopenia, unspecified Fever Vomiting
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 08.05.2021
- Impfdatum
- 20.02.2021
- Beginn
- 10.04.2021
- Tage bis Beginn
- 49,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Aphasia
Cerebrovascular accident
Symptomtext
This 81 year old white male received the Pfizer Covid shot on 2/20/21 and went to the ED on 4/10/21 and was admitted on 4/10/21 with the following diagnoses listed below. I63.9 - CVA (cerebral vascular accident) (CMS/HCC) unable to speak
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 08.05.2021
- Impfdatum
- 17.02.2021
- Beginn
- 27.01.2021
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Computerised tomogram
Exposure during pregnancy
Pulmonary embolism
Ultrasound scan
Symptomtext
Pulmonary embolism; Is pregnant: yes; This is a spontaneous report from a contactable healthcare professional (patient). A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 27Jan2021 14:00 (Batch/Lot Number: EL3249) and dose 2 via an unspecified route of administration, administered in Arm Left on 17Feb2021 14:00 (Batch/Lot Number: EN6200); both as single dose for covid-19 immunisation. Medical history included pregnancy, allergies to penicillin and Covid prior to vaccination. The patient's concomitant medications were not reported. The patient has no other vaccine in four weeks. The patient experienced pulmonary embolism on 18Apr2021 16:00 which resulted in doctor or other healthcare professional office/clinic visit. CT scan and ultrasound were done, and patient was given lovenox injections. The patient is pregnant with last menstrual cycle on 20Jan2021; delivery date will be on 05Nov2021. The patient was not tested for Covid post vaccination. The outcome of the event pulmonary embolism was not recovered.; Sender's Comments: A causal association between BNT162B2 and the reported event Pulmonary embolism cannot be excluded based on a compatible temporal relation. The contribution of pregnancy to thromboembolic events should also be considered. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- -
- Labordaten
- Test Name: CT scan; Result Unstructured Data: Test Result:unknown result; Test Name: ultrasound; Result Unstructured Data: Test Result:unknown result
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: COVID-19; Penicillin allergy; Pregnancy
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 08.05.2021
- Impfdatum
- 17.03.2021
- Beginn
- 17.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Balance disorder
Cerebellar haemorrhage
Cerebrovascular accident
Computerised tomogram
Dizziness
Blood test
Intensive care
Magnetic resonance imaging
Heart rate
Heart rate irregular
Infarction
Investigation
Symptomtext
Stroke; Caller reported that one of the CT scans that he got showed a brain bleed/he had a small bleed in the cerebellum.; Caller reported that the minor infarct on his first CT scan performed after his stroke; Irregular heartbeat; Lost balance; Dizzy; This is spontaneous report from a contactable consumer (patient). A 76-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7534), second dose via an unspecified route of administration, administered in Arm Left on 17Mar2021 08:30 (at 76 years old), single dose for covid-19 immunisation. Medical history included ongoing Low thyroid, Possible atrial fibrillation, there was a question of whether he had atrial fibrillation in years past but it was never determined with certainty whether the caller actually had atrial fibrillation. He went to see a cardiologist years ago for the possible atrial fibrillation but the tests came back negative; Knees were so painful. Every time his family went overseas, he got tetanus, typhoid, diphtheria, and other vaccines. The vaccines were all done in military facilities. He received these vaccines somewhere between the ages of 0 and 15 years old. Patient's tetanus and diphtheria booster in 2007 caused a sore arm. The shingles vaccine in 2012 caused a sore arm. The Prevnar-23 vaccine in 2013 or 2014 caused a sore arm. He was adopted so he doesn't know his family history. He heard anecdotal evidence that his mother suffered a stroke and died at 61 but that his father lived apparently well into his 90's.The patient had his first dose of bnt162b2 for COVID-19 immunisation on 23Feb2021, left arm, lot number: EN6200. Concomitant medications included levothyroxine; vitamin c [ascorbic acid]; chondroitin sulfate sodium, glucosamine hydrochloride; colecalciferol (VITAMIN D3); aspirin [acetylsalicylic acid]. Patient experienced 15 hours after he received his second dose of the Covid-19 vaccine on 17Mar2021, he had a stroke.Stroke occurred at 11:30 PM on 17Mar2021. He was admitted on 18Mar2021 as the stroke occurred so late on 17Mar2021. He was discharged late in the afternoon on 22Mar2021. He has vastly improved. He is not 100% recovered but that he has made great strides and great improvements. He was in great shape before the stroke on 17Mar2021. For a guy his age, he has the vitals of a 19 year old. he was walking 2 to 3 miles or biking for 30-45 minutes daily, lifting weights three times a week, and doing yoga before the stroke. He was in good shape and that he thinks that may have had a part in bringing him back quickly from the stroke. we are only a month in post-stroke, and that he is not 100% but he is very close, probably 90% back.He was started on Atorvastatin and Clopidogrel after his stroke. He takes the vitamins as a prophylactic for overall health. The glucosamine and chondroitin seems to have helped his knee pain immensely. He has been wearing a heart monitor since his stroke on 17Mar2021. He noted an irregular heartbeat once when he woke up about a week ago. The irregular heartbeat occurred maybe on 15Apr2021. There was just one episode of irregular heartbeat. All of his stroke assessments kept improving and getting better while he was hospitalized after his stroke on 17Mar2021.The hospital was performing CT scans and MRIs practically daily while in the hospital.One of the CT scans that he got showed a brain bleed. He thinks the CT scan that showed a brain bleed was after tPA, tissue plasminogen activator, had been administered. The repeat CT scans and MRIs were because the medical staff wanted to ensure that there was no further damage or bleed after the tissue plasminogen activator was administered.One CT scan showed that he had a small bleed in the cerebellum. The bleed in his cerebellum was probably because of the tissue plasminogen activator that was administered but it doesn't seem to have any lasting effects.Caller queried for product details of tissue plasminogen activator but he was unable to provide as it was administered in the hospital.His balance is back, he is riding a bike again, he is going for walks, and he does not feel dizzy.His balance returned probably about 2 weeks ago.On 17Mar2021, he was so dizzy that he couldn't raise himself up in bed. the dizziness was slow to resolve and probably resolved in the last week.The minor infarct on his first CT scan performed after his stroke on 17Mar2021 may have occurred previously.The hospital staff performed a CT scan after the patient arrived at the hospital following his 17Mar2021 stroke.Hospital staff administered the tissue plasminogen activator after the first CT scan and that another CT scan was performed 12 hours later after tissue plasminogen activator administration. The CT after the tissue plasminogen activator administration showed the small bleed in his cerebellum. He has had video visits with occupational therapy, physical therapy, his neurologist, and he had one scheduled for a speech therapist but she didn't want to talk to him.His therapists and physician say that he is ok and there is no reason for them to see the caller again. He had one follow up with his occupational therapist and the therapist told the caller that she didn't see any reason to see the caller again. The outcome of the event Stroke was recovering; Cerebellar bleeding, infarction was unknown, other events was recovered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 4,0
- Labordaten
- Test Date: 202103; Test Name: CT scan; Result Unstructured Data: Test Result:Minor infarct right occipital lobe; Test Date: 202103; Test Name: CT scan; Result Unstructured Data: Test Result:Small bleed in cerebellum; Comments: Caller reported that the CT after the tissue plasminogen activator administration showed the small bleed in his cerebellum.; Test Name: heartbeat; Result Unstructured Data: Test Result:Irregular; Test Name: tests; Result Unstructured Data: Test Result:Unknown result; Test Date: 202103; Test Name: MRI; Result Unstructured Data: Test Result:Unknown result
- Aktuelle Erkrankungen
- Hypothyroidism (Verbatim: Low thyroid)
- Vorgeschichte
- Medical History/Concurrent Conditions: Atrial fibrillation (Verbatim: Possible atrial fibrillation); Pain in knee
- Andere Medikamente
- LEVOTHYROXINE; VITAMIN C [ASCORBIC ACID]; GLUCOSAMINE/CHONDROITIN [CHONDROITIN SULFATE SODIUM;GLUCOSAMINE HYDROCHLORIDE]; VITAMIN D3; ASPIRIN [ACETYLSALICYLIC ACID]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 07.05.2021
- Impfdatum
- 17.02.2021
- Beginn
- 27.04.2021
- Tage bis Beginn
- 69,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Angiogram
Deep vein thrombosis
Pain in extremity
Pulmonary embolism
Ultrasound Doppler normal
Symptomtext
Feb 17 - second pfizer shot. Shortly after second dose, was instructed to stop warfarin (for h/o VTE, pt with IVC filter) March 3rd - ultrasound of legs both clear ~April 27th - c/o leg pain May 6 - admitted to hospital with DVT, PE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- -
- Labordaten
- ultrasound, CT angio
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- hypothyroidism, anxiety, chronic pain, hypertension, gerd, vitamin d deficiency, blood clots
- Andere Medikamente
- fioricet, hydrocodone, ativan, gabapentin, levothyroxine, amlodipine, pantoprazole, vitamin d2, warfarin (stopped right after second shot)
- Allergien
- penicillin
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 06.05.2021
- Impfdatum
- 16.03.2021
- Beginn
- 17.04.2021
- Tage bis Beginn
- 32,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cardio-respiratory arrest
Coronary arterial stent insertion
Intracardiac thrombus
Myocardial infarction
Resuscitation
Vascular stent occlusion
Symptomtext
My father suffered a heart attack due to blood clots clogging the artery to his heart. He coded and was resuscitated and had four stents installed after the blockage was cleared. He had a second heart attack several days later when the stents clogged and had to be cleared. He was hospitalized for several days for each heart attack.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardio-respiratory arrest
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 06.05.2021
- Impfdatum
- 27.02.2021
- Beginn
- 08.04.2021
- Tage bis Beginn
- 40,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
Sepsis
Shock
Symptomtext
J96.01 - Acute respiratory failure with hypoxia R57.9 - Shock A41.9 - Sepsis, unspecified organism
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 06.05.2021
- Impfdatum
- 18.03.2021
- Beginn
- 05.05.2021
- Tage bis Beginn
- 48,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Alanine aminotransferase increased
Angiogram abnormal
Angiogram pulmonary abnormal
Anion gap
Anticoagulant therapy
Aspartate aminotransferase increased
Back pain
Blood albumin decreased
Blood bicarbonate increased
Blood calcium
Blood chloride normal
Blood glucose normal
Blood lactic acid
Blood potassium decreased
Blood urea normal
Blood urine present
Brain natriuretic peptide normal
Chest pain
Symptomtext
BRIEF OVERVIEW: Primary Care Provider at Discharge: DO Admission Date: 5/5/2021 Discharge Date:5/6/2021 Active Hospital Problems Diagnosis Date Noted POA ? Essential hypertension 05/06/2021 Yes ? Pulmonary embolism on right (HCC) 05/05/2021 Yes ? Right flank pain 05/05/2021 Yes ? Hypokalemia 05/05/2021 Yes ? Uncomplicated alcohol dependence (HCC) 05/05/2021 Yes Resolved Hospital Problems No resolved problems to display. CONSULTS: None INPATIENT PROCEDURES: None DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Patient is a 83 y.o. male with Hx of HTN who presents today with complaint of right sided flank pain, with radiations into the right side of his back and right side of his chest. The pain is worse with movement and deep inspiration. He denies palpitations and shortness of breath. He has no previous HX of VTE. He denies fever, chills, cough, nasal congestion, and sore throat. He denies abdominal pain, N/V, and changes in bowel movements. The patient is a limited historian. He is oriented x4 on admission, but states that he has had difficulty with his memory over the past 2-3 years. He lives alone in an apartment. In the emergency department the patient's vital signs were stable. Labs revealed a potassium of 3.3. AST was 52 and ALT 61. White blood cell count was 11.13. Troponin was negative and BNP was within normal limits. Lactic acid was 1.5. UA showed trace blood. EKG showed normal sinus rhythm with PACs. CTA the thorax abdomen and pelvis showed acute pulmonary emboli involving the segmental subsegmental arteries of the upper and lower lobes. There is no evidence of heart strain. He was admitted for observation due to severe pain, and was given IV fentanyl. Echocardiogram showed: The left ventricular ejection fraction is 67%. No regional wall motion abnormalities noted. The right ventricular size, thickness, and function are normal. The estimated right ventricular systolic pressure is 36 mmHg. The inferior vena cava was not visualized during the exam. There is no comparison study available. He was started on Eliquis 10 mg bid for 7 days, than 5 mg bid for total of 3 months. He should follow up with PCP in 1 week and should check CBC and BMP on 5/10/21. He should also follow up with pulmonologist in 2-3 months. He had Pfizer COVID-19 vaccine on 2/18/21 and 3/18/21. There is remote possibility that this PE could be related to COVID-19 vaccine, so this was reported to Vaccine Adverse Event Reporting System (VAERS). He had mild hypokalemia due to HCTZ, and required K-dur supplement. HCTZ was switched to Maxzide 25/37.5 mg daily. Rechecked K was normal 3.9. BMP should be checked in 1 week. Also he is drinking little bit too much alcohol, 4 alcoholic drinks every night. He was instructed to cut alcohol drinking to </=2 alcoholic drink a day. His daughter was updated over the phone.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 2,0
- Labordaten
- Lab Results Component Value Date WBC 9.87 05/06/2021 RBC 3.85 (L) 05/06/2021 HGB 13.7 (L) 05/06/2021 HCT 39.9 (L) 05/06/2021 MCV 103.6 (H) 05/06/2021 PLATELET 237 05/06/2021 NEUTABSOLU 7.09 05/05/2021 Lab Results Component Value Date GLUCOSE 103 (H) 05/06/2021 BUN 10 05/06/2021 CREATININE 0.74 05/06/2021 SODIUM 137 05/06/2021 POTASSIUM 3.9 05/06/2021 CHLORIDE 100 05/06/2021 HCO3 31 (H) 05/06/2021 ANIONGAP 6 (L) 05/06/2021 CALCIUM 8.5 (L) 05/06/2021 ALBUMIN 3.1 (L) 05/05/2021
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- ? HTN (hypertension) ? Lower extremity edema ? Psoriasis
- Andere Medikamente
- hydrochlorothiazide ixekizumab triamcinolone cream
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 04.05.2021
- Impfdatum
- 04.03.2021
- Beginn
- 27.04.2021
- Tage bis Beginn
- 54,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Pulmonary embolism
Symptomtext
I26.99 - Pulmonary embolism (CMS/HCC)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 04.05.2021
- Impfdatum
- 13.03.2021
- Beginn
- 30.04.2021
- Tage bis Beginn
- 48,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Pulmonary embolism
Symptomtext
Pulmonary embolism, bilateral
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 03.05.2021
- Impfdatum
- 26.02.2021
- Beginn
- 02.05.2021
- Tage bis Beginn
- 65,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 03.05.2021
- Impfdatum
- 24.02.2021
- Beginn
- 29.04.2021
- Tage bis Beginn
- 64,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute myocardial infarction
Chronic kidney disease
Death
Symptomtext
Death Non-STEMI (non-ST elevated myocardial infarction) (CMS/HCC) Chronic renal failure
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 30.04.2021
- Impfdatum
- 13.03.2021
- Beginn
- 10.04.2021
- Tage bis Beginn
- 28,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
Cardiac failure acute
Cerebral infarction
Confusional state
Death
Dyspnoea
Fluid overload
Hypercapnia
Hyponatraemia
Symptomtext
This 77 year old white female received the Covid shot on 03/13/21 and went to the ED on 4/10/21 and was admitted on 4/10/21 with hyponatremia with excess fluid volume, acute respiratory failure with hypercapnia, transient confusion, acute heart failure, shortness of breath and went to the ED again on 4/18/21 with cerebral infarction and died on 4/29/21 . Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 29.04.2021
- Impfdatum
- 24.02.2021
- Beginn
- 13.03.2021
- Tage bis Beginn
- 17,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cardiac arrest
Cardiac assistance device user
Cyanosis
Implantable defibrillator insertion
Intensive care
Heart rate
Investigation
Near death experience
Pulse absent
Resuscitation
SARS-CoV-2 test
Skin discolouration
Symptomtext
cardiac arrest; on the ground turning purple and lifeless/ immediate risk of death from the event; she had no pulse; on the ground turning purple and lifeless; This is a spontaneous report received from a contactable consumer. A 53-year-old female patient (reporter's mother) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EN6200), administered in left arm on 24Feb2021 (at the age of 53-year-old) at single dose for COVID-19 immunisation. The vaccination facility type was reported as other. The patient was not pregnant. The patient's medical history was reported as none. No known allergies were reported. The patient had not had COVID prior vaccination. The patient's concomitant medications were not reported. No other vaccine was administered in four weeks. It was reported that on 13Mar2021 08:15 exactly 17 days after reporter's mother received her first Pfizer vaccine she had a cardiac arrest, luckily reporter was with her when this happened and he/she called immediately and followed the steps of cardiopulmonary resuscitation (CPR) etc. When the emergency team arrived she had no pulse and they used the defibrillator on her 4 times. The entire day they did not know if she would survive. She was sedated and tested, they got the news that she had survived and there was not brain damage. The doctors had no clue what the cardiac arrest was caused by, she had no prior health conditions and the tests show nothing to what could have caused this event (no blood clots, no clogged arteries etc.). The only thing that changed leading up to the event was her receiving her first vaccine. Luckily reporter was there when this happened or else she would in fact be dead. She now had a defibrillator implanted and reporter had a post-traumatic stress from the traumatic event and witnessing his/her mom on the ground turning purple and lifeless. They need answers. The events resulted in emergency room/department or urgent care. The events were reported as serious since resulted in hospitalization and life-threatening illness (immediate risk of death from the event). Treatments were received for the events and they were reported as multiple lifesaving treatments, tests, and defibrillator implant. The patient underwent lab tests and procedure which included COVID test (negative) on unspecified date post vaccination. The outcome of the events was resolved for the event "she had no pulse" and resolved with sequel (reported as recovered with lasting effects) for all other events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210313; Test Name: Pulse; Result Unstructured Data: Test Result:No Pulse; Test Name: test; Result Unstructured Data: Test Result:Unknown results; Test Name: Covid test; Test Result: Negative ; Comments: post vaccination
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 29.04.2021
- Impfdatum
- 24.02.2021
- Beginn
- 13.03.2021
- Tage bis Beginn
- 17,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Cardiac arrest
Cardiac assistance device user
Cyanosis
Implantable defibrillator insertion
Intensive care
Heart rate
Investigation
Near death experience
Pulse absent
Resuscitation
SARS-CoV-2 test
Skin discolouration
Symptomtext
cardiac arrest; on the ground turning purple and lifeless/ immediate risk of death from the event; she had no pulse; on the ground turning purple and lifeless; This is a spontaneous report received from a contactable consumer. A 53-year-old female patient (reporter's mother) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EN6200), administered in left arm on 24Feb2021 (at the age of 53-year-old) at single dose for COVID-19 immunisation. The vaccination facility type was reported as other. The patient was not pregnant. The patient's medical history was reported as none. No known allergies were reported. The patient had not had COVID prior vaccination. The patient's concomitant medications were not reported. No other vaccine was administered in four weeks. It was reported that on 13Mar2021 08:15 exactly 17 days after reporter's mother received her first Pfizer vaccine she had a cardiac arrest, luckily reporter was with her when this happened and he/she called immediately and followed the steps of cardiopulmonary resuscitation (CPR) etc. When the emergency team arrived she had no pulse and they used the defibrillator on her 4 times. The entire day they did not know if she would survive. She was sedated and tested, they got the news that she had survived and there was not brain damage. The doctors had no clue what the cardiac arrest was caused by, she had no prior health conditions and the tests show nothing to what could have caused this event (no blood clots, no clogged arteries etc.). The only thing that changed leading up to the event was her receiving her first vaccine. Luckily reporter was there when this happened or else she would in fact be dead. She now had a defibrillator implanted and reporter had a post-traumatic stress from the traumatic event and witnessing his/her mom on the ground turning purple and lifeless. They need answers. The events resulted in emergency room/department or urgent care. The events were reported as serious since resulted in hospitalization and life-threatening illness (immediate risk of death from the event). Treatments were received for the events and they were reported as multiple lifesaving treatments, tests, and defibrillator implant. The patient underwent lab tests and procedure which included COVID test (negative) on unspecified date post vaccination. The outcome of the events was resolved for the event "she had no pulse" and resolved with sequel (reported as recovered with lasting effects) for all other events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210313; Test Name: Pulse; Result Unstructured Data: Test Result:No Pulse; Test Name: test; Result Unstructured Data: Test Result:Unknown results; Test Name: Covid test; Test Result: Negative ; Comments: post vaccination
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 28.04.2021
- Impfdatum
- 27.02.2021
- Beginn
- 20.04.2021
- Tage bis Beginn
- 52,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute respiratory failure
Death
Symptomtext
Acute respiratory failure with hypoxia Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 27.04.2021
- Impfdatum
- 19.02.2021
- Beginn
- 04.03.2021
- Tage bis Beginn
- 13,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Death
Symptomtext
Patient was seen in the ED/hospitalized within 6 weeks of COVID vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 27.04.2021
- Impfdatum
- 19.02.2021
- Beginn
- 04.03.2021
- Tage bis Beginn
- 13,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Death
Symptomtext
Patient was seen in the ED/hospitalized within 6 weeks of COVID vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 21.04.2021
- Impfdatum
- 20.02.2021
- Beginn
- 27.03.2021
- Tage bis Beginn
- 35,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Anaemia
Death
Dyspnoea
Hyponatraemia
Metastatic neoplasm
Pleural effusion
Pneumonia
Symptomtext
This 72 year old male hospice patient received the Covid shot on 2/20/21 and went to the ED on 3/27/21 and was admitted on 3/27/21 with shortness of breath, pneumonia, hyponatremia, anemia, bilateral pleural effusion, metastatic cancer and died on 4/17/21. Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 21.04.2021
- Impfdatum
- 23.03.2021
- Beginn
- 04.04.2021
- Tage bis Beginn
- 12,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Symptomtext
This 75 year old white female received the Covid shot on 3/23/21 and died on 4/4/21. Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 21.04.2021
- Impfdatum
- 25.02.2021
- Beginn
- 13.04.2021
- Tage bis Beginn
- 47,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Death
Myocardial infarction
Symptomtext
This 70 year old white female received the Covid shot on 2/25/2021 and died of a heart attack on 4/13/21. Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 16.04.2021
- Impfdatum
- 12.03.2021
- Beginn
- 04.04.2021
- Tage bis Beginn
- 23,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal discomfort
Condition aggravated
Death
Malaise
Myocardial infarction
Pain in extremity
Symptomtext
My Dad was healthy no symptoms on first shot . On Second shoot just slight pain in arm , he felt sick on Sunday the 4 of April at around 7pm he had a upset stomach. He got worse at night. in the morning Monday the 5 April we decided it was time to take him to the hospital. Due to the covid 19 restriction we were not able to go in with him He was stable until 1 pm when he suffered 4 heart attacks . He Died . He was healthy he exercise and was active every day . We were told to report this because it was close to dates of vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 1,0
- Labordaten
- We have not received the medical records yet they were requested to the hospital. Corner will se him on Tuesday
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 15.04.2021
- Impfdatum
- 05.03.2021
- Beginn
- 20.03.2021
- Tage bis Beginn
- 15,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Atypical pneumonia
Hyperglycaemia
Pulmonary embolism
Sepsis
Symptomtext
I26.99 - Pulmonary emboli (CMS/HCC) J18.9 - Atypical pneumonia N17.9 - Acute kidney injury (CMS/HCC) R73.9 - Hyperglycemia A41.9 - Sepsis (CMS/HCC)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 14.04.2021
- Impfdatum
- 17.02.2021
- Beginn
- 12.03.2021
- Tage bis Beginn
- 23,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Death
Thrombotic thrombocytopenic purpura
Symptomtext
Hospitalized 03-13-2021, Diagnosed with Thrombotic Thrombocytopenic Purpura, Died 03-16-2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- CML (>20 yrs ago), Rheumatoid Arthritis
- Andere Medikamente
- Prednisone 5mg, Fluconazole, Valtrex 1x day
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 14.04.2021
- Impfdatum
- 09.04.2021
- Beginn
- 10.04.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Fatigue
Hypophagia
Myalgia
Sudden cardiac death
Symptomtext
Timeline of events: o No concerns in the past month. o Usual state of health on Friday 4/9/2021 o Received Pfizer vaccine at event on 4/9/2021 o Fatigue, poor PO intake and myalgia on Saturday, 4/10/2021; Received Tylenol at 1 pm o Texted Primary Community Nurse (PCN) (not on call), on Saturday, to share above. PCN followed up Sunday morning and reassured them. o Last seen alive Sunday night, not well from vaccine but does not seem like family was concerned enough to page on call team o Monday morning- found dead in rigor mortis o Cause of death: deemed sudden cardiac death. Etiology unclear. o Unexpected death.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- HTN, Hyperlipidemia, eczema, chronic shoulder pain, obesity, seizures
- Andere Medikamente
- (ASA, Carvedilol, Lisinopril, spironolactone) (atorvastatin)(ammonium lactate)Keppra was stopped in 2019
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 92,0
- Geschlecht
- M
- Eingang
- 14.04.2021
- Impfdatum
- 24.02.2021
- Beginn
- 07.04.2021
- Tage bis Beginn
- 42,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 14.04.2021
- Impfdatum
- 25.03.2021
- Beginn
- 05.04.2021
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute myocardial infarction
Cardiac arrest
Death
Dialysis
End stage renal disease
Hyperkalaemia
Symptomtext
Death Cardiac arrest Hyperkalemia NSTEMI (non-ST elevated myocardial infarction) (CMS/HCC) ESRD needing dialysis (CMS/HCC)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 14.04.2021
- Impfdatum
- 19.02.2021
- Beginn
- 08.04.2021
- Tage bis Beginn
- 48,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Unevaluable event
Symptomtext
Patient was hospitalized x 3 and died within 60 days of receiving a COVID vaccine series
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ND
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 13.04.2021
- Impfdatum
- 16.02.2021
- Beginn
- 18.02.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Bacterial infection
Blood thyroid stimulating hormone normal
Brain natriuretic peptide normal
COVID-19 pneumonia
Chest tube insertion
Chronic obstructive pulmonary disease
Clostridium test negative
Computerised tomogram abnormal
Cortisol increased
Death
Diarrhoea
Dizziness
Ear discomfort
Endotracheal intubation
Fatigue
Fibrin D dimer increased
Full blood count normal
Symptomtext
Two days after receiving vaccine patient and family reports patient developed nausea and headache. symptoms seemed to worsen over time and not improve. was evaluated on 3/3/2021 where patient reported weakness, body aches, slight ear discomfort, slight headache. Seen again on 3/8/2021 by other provider reports symptoms of fatigue, dizziness, weakness, diarrhea, nausea. Admitted on 3/11/2021 for COPD exacerbation, treated and sputum cultures grew pseudomonas readmitted on 3/18/2021 due to recurrence of symptoms, diagnosed with Covid pneumonia, increasing oxygen requirements. complication of subcutaneous emphysema with small bilateral pneumothorax from continuous noninvasive ventilation and eventually with worsening hypoxia on 100% FiO2 was intubated and chest tube placed. 4/4/2021 removal of invasive care, comfort care. patient passed away inpatient Prior to covid vaccine patient did have several co morbidities and then subsequently covid that resulted in her death, family is adamant that her decline in health started after her covid vaccine and requested adverse reaction report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 23,0
- Labordaten
- Urgent Care Visit 3/3/2021 - group a strep (-), covid antigen (-), CBC - normal except for WBC (3.2) MCV 101.5, CMP normal except for eGFR 51, troponin 0.005 Walk In Clinic Visit 3/8/2021 - vit b12 (713), c diff (-) ER Visit - Admission for acute hypoxemic respiratory failure and acute on chronic COPD exacerbation, 3/11/2021 - 3/14/2021 CBC normal except for wbc (3.0), RBC (3.52) hemocrit (34.5%), platelet (138) lymph absolute (0.2) troponin (0.007), bnp (10), d-dimer (1.25), cortisol random (15.7) TSH (1.20), UA normal except for (specific gravity >1.040, trace protein. CT impression - 1. No PE. 2. New patchy reticular and groundglass opacities in the lung bases bilaterally consistent with an infectious or inflammatory etiology. 3. There are 3 new pulmonary nodules not seen on the PET/CT dated 10/23/2020 measuring 8 x 4 mm in the left upper lobe, 4 mm in the superior segment of the left lower lobe, and 3 mm in the right lower lobe. These are likely infectious or inflammatory. Follow-up chest CT in 2-3 months recommended to ensure resolution. treated for COPD exacerbation. Sputum cultures growing pseudomonas discharged on cipro. Readmitted 3/18/2021 Acute hypoxic respiratory failure: Secondary to covid pneumonia died 4/4/2021
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- low grade b cell lymphoma, hypertension, abdominal aortic aneurysm without rupture, allergic rhinitis, hiatal hernia, COPD, anxiety, depression, hyperlipidemia, reflux
- Andere Medikamente
- zoloft 50 mg daily, lopressor 25 mg twice a day. losartan 25 mg daily, azithromycin 250 mg daily, trelegy 1 puff daily, albuterol inhaler 2 puffs every 4 hours, flonase 2 sprays once a day. crestor 20 mg daily. aspirin 81 mg daily
- Allergien
- penicillin, niacin, inaspine, zyrtec. rituxan
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 13.04.2021
- Impfdatum
- 05.03.2021
- Beginn
- 07.03.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anticoagulant therapy
Blood test normal
Bundle branch block left
Chest X-ray normal
Chest discomfort
Computerised tomogram
Computerised tomogram thorax abnormal
Dizziness
Dyspnoea
Echocardiogram abnormal
Electrocardiogram abnormal
Fatigue
Fibrin D dimer increased
Left ventricular hypertrophy
Pulmonary embolism
Ultrasound Doppler normal
Symptomtext
To summarize our conversation, you stated that you received the second Pfizer vaccine on 3/4/21. Three days later, on 3/7/21, you began to have fatigue, shortness of breath, dizziness and chest pressure. Because all symptoms continued for 24 hours, on the evening of 3/8/21, you took yourself to the Emergency Department. Your ER work-up included a CXR (negative), an EKG (showing a left bundle branch block), serum bloodwork (negative for MI), however, the D-dimer and spiral CT were both positive for a pulmonary emboli (i.e. a blood clot in your lungs). You were admitted to the hospital and started on the blood thinner, Eliquis. During your 3-day hospital stay, your work-up also included a bilateral lower extremity Doppler study (negative) and an echocardiogram (showing left ventricular hypertrophy). You were discharged on all of your previously prescribed medications (see list below), except for the fish oil. You were also started on Eliquis. Since discharge, you have followed up with your PCP and have been referred to a cardiologist and pulmonologist. To date, you have had no further symptoms. PAST MEDICAL HISTORY: hypertension, hypercholesterolemia, pre-diabetes. PRE-VACCINE MEDICATIONS: losartan, HCTZ, amlodipine, Welchol, fenofibrate, fish oil. POST-ER VISIT MEDICATIONS: losartan, HCTZ, amlodipine, Welchol, fenofibrate, Eliquis.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 1,0
- Labordaten
- To summarize our conversation, you stated that you received the second Pfizer vaccine on 3/4/21. Three days later, on 3/7/21, you began to have fatigue, shortness of breath, dizziness and chest pressure. Because all symptoms continued for 24 hours, on the evening of 3/8/21, you took yourself to the Emergency Department. Your ER work-up included a CXR (negative), an EKG (showing a left bundle branch block), serum bloodwork (negative for MI), however, the D-dimer and spiral CT were both positive for a pulmonary emboli (i.e. a blood clot in your lungs). You were admitted to the hospital and started on the blood thinner, Eliquis. During your 3-day hospital stay, your work-up also included a bilateral lower extremity Doppler study (negative) and an echocardiogram (showing left ventricular hypertrophy). You were discharged on all of your previously prescribed medications (see list below), except for the fish oil. You were also started on Eliquis. Since discharge, you have followed up with your PCP and have been referred to a cardiologist and pulmonologist. To date, you have had no further symptoms. PAST MEDICAL HISTORY: hypertension, hypercholesterolemia, pre-diabetes. PRE-VACCINE MEDICATIONS: losartan, HCTZ, amlodipine, Welchol, fenofibrate, fish oil. POST-ER VISIT MEDICATIONS: losartan, HCTZ, amlodipine, Welchol, fenofibrate, Eliquis.
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- hypertension, hypercholesterolemia, pre-diabetes
- Andere Medikamente
- losartan, HCTZ, amlodipine, Welchol, fenofibrate, fish oil
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- ND
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 13.04.2021
- Impfdatum
- 23.02.2021
- Beginn
- 24.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Cardiac assistance device user
Chills
Death
Diarrhoea
Cardiac arrest
Cardio-respiratory arrest
Gastrointestinal disorder
Pain
Pyrexia
Resuscitation
Syncope
Symptomtext
Clients wife describes onset of temp of 102.6 F the evening of 02/23/2021 followed by chills and fever continuing for 4 days until time of his death at approximately 10;30 PM 02/28/2021; Wife states he had generalized weakness, and profuse diarrhea since 02/23/2021 evening; Complaints of generalized weakness; slept in recliner; 02/28/2021 patient collapsed in bathroom; wife who is a nurse performed CPR; First responders preformed CPR; 2 doses of IV epinephrine; AED did not show any cardiac activity nor a shockable rhythm; pronounced dead by the coroner.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- Aspiration pneumonia diagnosed January 4th 2021; Assessed at a clinic by a doctor on January 4th, 11th and 18th. Refused hospitalization; received IM rocephin and oral antibiotics throughout January and February as reported by his wife. Wife reports that he was feeling better the week prior to receiving his covid vaccine;
- Vorgeschichte
- Non- Insulin dependent diabetes Hypertension
- Andere Medikamente
- Metformin Lisonopril Glipizide
- Allergien
- No medication allergies Mild seasonal hay fever
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 13.04.2021
- Impfdatum
- 17.02.2021
- Beginn
- 10.04.2021
- Tage bis Beginn
- 52,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Cardiogenic shock
Chronic kidney disease
Septic shock
Symptomtext
Multiple comorbidities - Cardiogenic/septic shock, Acute Respiratory failure, AKD stage 3
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 13.04.2021
- Impfdatum
- 19.02.2021
- Beginn
- 23.03.2021
- Tage bis Beginn
- 32,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Abdominal X-ray
Alanine aminotransferase normal
Anion gap
Arthralgia
Aspartate aminotransferase normal
Bilirubin conjugated
Biopsy bone abnormal
Blood albumin decreased
Blood alkaline phosphatase normal
Blood bilirubin decreased
Blood calcium normal
Blood chloride normal
Blood cholesterol normal
Blood creatine increased
Blood folate normal
Blood glucose increased
Blood magnesium normal
Blood phosphorus normal
Symptomtext
DEATH Narrative: Patient passed away after Covid Vaccine. 2/8/21: brought to the ER for evaluation for leg weakness and a recent fall associated. He was in a facility- per patient he fell when standing from the bed, he though he could do it and did not ask for help. He has been with hip and pelvic pain since then. The CT/XR shows evidence of lytic lesions, an IR bone biopsy was done and came positive for metastatic bladder carcinoma. 02/17/21: transferred to the facility for PT and pain management, originally for short stay rehab then changed to hospice care. 02/19/2021: received covid vaccine 03/05/21: discharged from facility on home hospice 03/23/21: pt passed away at home Patient with prior covid infection; tested positive last on 9/25/2020. Vaccine did not likely contribute to patient's death, as he was on hospice due to malignant cancer. No evidence of reaction immediately after vaccination or before date of death.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- RECENT LABS: Specimen Collection Date: Feb 18, 2021 Test name Result units Ref. range Site Code HGB A1C 7.8 H % 4.5 - 5.6 Test name Result units Ref. range Site Code PT 13.6 H SEC 9.4 - 12.5 [67] INR 1.22 H 0.83 - 1.11 Test name Result units Ref. range Site Code VITAMIN B-12 >1921 H pg/mL 213 - 816 [67] FOLATE, SERUM 17.2 ng/mL 7 - 31.4 GLUCOSE 268 H mg/dL 70 - 105 [67] UREA NITROGEN 29 H mg/dL 7-20.6 [67] CREATININE 1.5 H mg/dL 0.7 - 1.3 [67] SODIUM 134 L mEq/L 136 - 145 [67] POTASSIUM 5.3 H mEq/L 3.5 - 5.2 [67] CHLORIDE 103 mEq/L 98 - 109 [67] CO2 22 mmol/L 22 - 31 [67] CALCIUM 9.3 mg/dL 8.4 - 10.6 [67] PO4 3.8 mg/dL 2.3 - 4.3 [67] URIC ACID 7.6 H mg/dL 3.5 - 7.2 [67] CHOLESTEROL 94 mg/dL Ref: <=199 [67] PROTEIN,TOTAL 7.2 g/dL 6.4 - 8.3 [67] ALBUMIN 2.3 L g/dL 2.8 - 4.5 [67] TOTAL BILIRUBIN <0.20 mg/dL 0.16 - 1.25 [67] ALKALINE PHOSPHATASE 111 U/L 40 - 150 [67] MAGNESIUM 1.6 mg/dL 1.6 - 2.6 [67] TRIGLYCERIDE 104 mg/dL 29 - 149 [67] HDL 27 L mg/dL Ref: >=40 [67] ANION GAP 9.0 mEq/L 5 - 18 [67] EGFR 46 L mL/min Ref: >=60 ALT 11 U/L 10 - 55 [67] AST 11 U/L 5 - 34 [67] BILIRUBIN, DIRECT 0.11 mg/dL 0 - 0.4 [67] LDL DIRECT 44 mg/dL Ref: <=99 [67] IRON SATURATION 11.8 L % 20 - 55 [67] FERRITIN 366.3 H ng/mL 22 - 275 [67] TRANSFERRIN 174 mg/dL 163 - 364 [67] IRON 29 L ug/dL 40 - 160 WBC 13.7 H K/cmm 4.2 - 10.3 [67] RBC 3.50 L M/cmm 4.20 - 5.80 [67] HEMOGLOBIN 9.0 L g/dL 13.0 - 17.0 [67] HCT 29.8 L % 39.0 - 50.0 [67] MCV 85.1 fL 80.0 - 100.0 [67] MCH 25.7 L pg 27.0 - 35.0 [67] MCHC 30.2 L g/dL 32.0 - 36.0 [67] RDW 15.7 % 11.3 - 16.5 [67] PLT 421 H K/cmm 150 - 410 [67]
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 98,0
- Geschlecht
- M
- Eingang
- 09.04.2021
- Impfdatum
- 20.02.2021
- Beginn
- 20.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arrhythmia
Bladder catheterisation
Death
Dyspnoea
Dysuria
Focal dyscognitive seizures
Oedema peripheral
Symptomtext
Major Complex Seizure with post-ictal period of 2 hours, occurring 3 hours after receiving injection. 16 days later on March 6, 2021 was unable to void, sustained breathing difficulty with peripheral edema. Received diuretic from Nurse,. Indwelling Catheter was inserted. On day 17, after receiving Corvid Vaccine, DECEASED on March 7, 2021 at home. Sustained Complex Seizure 6 hours prior. Death Certificate ruling Cause of Death as Cardiac Arrhythmias.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- CHF, Partial Seizures-Controlled. Bradycardia, Urinary Tract Infection- E. Coli. Hematemesis.
- Vorgeschichte
- CHF, Partial Seizures, A Fib, GERD. Peptic Ulcers.
- Andere Medikamente
- Lisinopril, Metroprol, Keppra, Aldactone, Prozac, Apixiban, Proscar, Augmentin, Zantac.
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 08.04.2021
- Impfdatum
- 27.02.2021
- Beginn
- 18.03.2021
- Tage bis Beginn
- 19,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Angiogram pulmonary abnormal
Back pain
Computerised tomogram thorax
Paraesthesia
Pulmonary embolism
Symptomtext
Patient presented to ER with R back pain paresthesia. CTA performed:Segmental and subsegmental pulmonary emboli involving the left upper lobe.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 4,0
- Labordaten
- CTA ; treated with heparin and eliquis
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- chronic back pain, HLD, HTN, OSA
- Andere Medikamente
- -
- Allergien
- lipitor
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 07.04.2021
- Impfdatum
- 03.04.2021
- Beginn
- 03.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Dyspnoea
Resuscitation
Unresponsive to stimuli
Symptomtext
On the evening of 4/3/2021 the patient was at home, prone in bed, gasped suddenly and became unresponsive. EMS was called and unable to resuscitate. She expired.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- attempt at CPR by responding EMS
- Aktuelle Erkrankungen
- PTSD
- Vorgeschichte
- BMI 95, HTN, OSA, RAD, GERD, hypothyroidism
- Andere Medikamente
- symbicort 150/4.5, singulair 10mg, pepcid 10mg, amlodipine
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 05.04.2021
- Impfdatum
- 19.02.2021
- Beginn
- 24.03.2021
- Tage bis Beginn
- 33,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Symptomtext
Patient death within 60 days of receiving the COVID vaccine series
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 03.04.2021
- Impfdatum
- 04.03.2021
- Beginn
- 05.03.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Computerised tomogram abnormal
Dyspnoea
Pulmonary embolism
Symptomtext
Pt. presented to ED on 5 Mar, day after vaccine with SOB and CT showed PE. Discharged from hospital on 6 March
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- CHF, HTN, DM type 2
- Vorgeschichte
- CHF, HTN, DM type 2
- Andere Medikamente
- -
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 02.04.2021
- Impfdatum
- 21.02.2021
- Beginn
- 27.03.2021
- Tage bis Beginn
- 34,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Symptomtext
Hospice patient death within 60 days of receiving the COVID vaccine series
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 103,0
- Geschlecht
- M
- Eingang
- 02.04.2021
- Impfdatum
- 21.02.2021
- Beginn
- 27.03.2021
- Tage bis Beginn
- 34,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Symptomtext
Hospice Patient death within 60 days of receiving the COVID vaccine series
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 02.04.2021
- Impfdatum
- 01.03.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Apnoea
Blood glucose
Blood glucose increased
Blood pressure measurement
Death
Cardioversion
Dyspnoea
Respiratory arrest
Hypotension
Unresponsive to stimuli
Vital signs measurement
Resuscitation
Symptomtext
patient died; BP 83/55; no respiration noted; patient unresponsive; blood glucose level of 193; This is a spontaneous report received from a contactable nurse. A 68-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN9581, expiry date: unknown), via an unspecified route of administration in the right arm, on 01Mar2021 13:50, as single dose, for covid-19 immunization, at a public health department. Medical history included diabetes, obesity, hypertension (HTN), myocardial infarction (MI) in 2011, gastroparesis, home oxygen use, motorize scooter use, pulmonary embolism (PE) in Oct2020, and iodine allergy. Concomitant medications included insulin for diabetes and fentanyl patch. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date: unknown) received at age 68 years, on 08Feb2021, for COVID-19 immunization and experienced breathing difficulty. The patient's doctor stopped "Zarello" (as reported) subsequent to the first dose of BNT162B2 vaccine due to breathing difficulty. It was reported that the patient did not have an adverse event following any previous vaccine. On 01Mar2021 at 13:50, the patient received the second dose of the Pfizer COVID-19 vaccine. At 14:18, a nurse was called to the parking lot and observed the patient having difficulties (unspecified). The nurse called for emergency medical services (EMS) and for a crash cart. The patient's vitals were taken and the patient had pressure (BP) 83/55, no respiration noted and the patient was unresponsive. The EMS arrived as 14:22 and look over care. The patient was transported to the hospital at 14:40. Per the EMS, the patient had a blood glucose level of 193. It was reported that the patient died on 01Mar2021. It was not reported if an autopsy was performed. The outcome of the event "patient died" was fatal; and the outcome of the events "BP 83/55", "no respiration noted", "patient unresponsive" and "blood glucose level of 193" was unknown.; Sender's Comments: Based on temporal association and limited information, the causal relationship between BNT162B2 and the events death, hypotension, apnea, unresponsive to stimuli and blood glucose increased cannot be excluded. The contributory role of other pre-existing diseases cannot be excluded as well. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: patient died
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210301; Test Name: Blood glucose level; Result Unstructured Data: Test Result:193; Test Date: 20210301; Test Name: BP; Result Unstructured Data: Test Result:83/85; Test Date: 20210301; Test Name: Vitals; Result Unstructured Data: Test Result:no respiration noted; Comments: no respiration noted, unresponsive
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Diabetes; Gastroparesis; Hypertension; Iodine allergy; Myocardial infarction; Obesity; Oxygen supplementation; Pulmonary embolism; Walking aid user
- Andere Medikamente
- INSULIN; FENTANYL PATCH
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 01.04.2021
- Impfdatum
- 23.02.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 6,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Anaphylactic shock
Blood pressure measurement
Hypertension
Symptomtext
severe anaphylactic shock; High blood pressure; This is a spontaneous report from a contactable consumer (patient). An 84-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in left arm on 23Feb2021 09:30 (Lot Number: EN6200) as single dose for covid-19 immunisation at age 84 years old. Medical history included low thyroid and allergies to grasses. The patient was not pregnant. The patient had no Covid prior to vaccination and was not Covid tested post vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported. No other vaccine taken in four weeks. The patient previously received the first dose of BNT162B2 administered in left arm on 02Feb2021 09:30 AM (lot no: EC9265) for COVID-19 immunization. On 16Mar2021 09:15 AM, 15 minutes after eating usual breakfast: avocado/toast, coffee, almond milk, the patient went into severe anaphylactic shock: extreme itching on palms, red welts on body, explosive diarrhea, dizzy/fainted, extreme blood pressure drop to 60/XX, in/out of consciousnes, loss of bowel/urine. Rushed to ER. High blood pressure 7 days after (Mar2021). The events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, emergency room/department or urgent care and were considered life threatening illness (immediate risk of death from the event). Treatment given in the emergency room includes unknown (as reported), prednisone, Pepcid. Outcome of the event was unknown.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic shock
- Hospital-Tage
- -
- Labordaten
- Test Date: 202103; Test Name: blood pressure; Result Unstructured Data: Test Result:High; Comments: .; Test Date: 20210316; Test Name: blood pressure; Result Unstructured Data: Test Result:drop; Comments: extreme blood pressure drop to 60/XX,
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Grass allergy; Thyroid disorder NOS
- Andere Medikamente
- SYNTHROID
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 01.04.2021
- Impfdatum
- 19.03.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Foaming at mouth
Symptomtext
unspecified event: Death; This is a spontaneous report from a contactable pharmacist through VAERS system. A 81-year-old male patient received first dose of bnt162b2 (COMIRNATY, Solution for injection, Lot number: EN6200, Expiration date: 31Jun2021) via unspecified route on 19Mar2021 between 10:30 to 11:30 Am, in the right arm, deltoid at a single dose for COVID-19 immunization. The patient' 's relevant medical history included Chronic Obstructive Pulmonary Disease acute exacerbation (end date: 20Mar2021), Anemia, unspecified (from 18Mar2021 to 20Mar2021), Acquired Coagulation Factor Deficiency, Thrombocytopenia, unspecified, Hypothyroidism, unspecified, Hyperlipidemia, Sleep apnea, unspecified, Polyneuropathy, unspecified, Hemiplegia with hemiparesis, Esophagitis unspecified without bleeding, Gastroesophageal reflux disease without esophagitis, Unspecified Cirrhosis of the liver, Non-alcoholic steato hepatitis, Other Ascites, Dependence on Supplemental Oxygen all from 18Mar2021 to 20Mar2021, History of Falling on 30Nov2017 to 20Mar2021, Acute and Chronic Respiratory Failure with hypoxia from 18Mar2021 to Unspecified. Concomitant medications, Apixaban (5mg, one tab by mouth two times a day) from 18Mar2021 to 20Mar20201 for DVT prevention, Carvedilol (3.125 mg, one tab by mouth once a day) for hypertension from 19Mar2021 to 20Mar2021, Ezetimibe (10mg tablets one tab by mouth once a day) for hyperlipidemia from 19Mar2021 to 20Mar2021, ferrous Sulfate (325 mg tab, one tab by mouth one time a day for supplement) from 19Mar2021 to 20Mar2021, folic Acid (1mg tablet, one my by mouth one time a day for supplement) from 19Mar2021 to 20Mar2021, Gabapentin (300 mg , capsule one cap by mouth three times a day) for neuropathy from 19Mar2021 to 20Mar2021, levothyroxine (25 mcq, one tab by mouth once a day) for hypothyroidism from 19Mar2021 to 20Mar2021, oxycodone (5 mg tablet; one tab by mouth every four hours as needed) for pain from 19Mar2021 to 20Mar2021 and Ergocalciferol on unspecified dates (order date of 18Mar2021 and to be started on 24Mar2021, so it was probably never started) as supplement. The patient had not taken any previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent and no additional vaccines were administered within 2 weeks. Prior to vaccinations (within 4 weeks) the patient had not taken any vaccinations given for two weeks before. On 20Mar2021 the patient died due to unspecified reason. It was unknown if autopsy was done. It was reported that the patient did not have a severe reaction with anaphylaxis treated with an EpiPen or hospitalization and anaphylaxis not related to a drug. Investigation assessment was unknown. The patient was discharged on 20Mar2021. It was further stated by reporter that she has no idea if any of this is related to the Covid vaccine or not, however her Medical Director wanted her to call and report the event. Reporter's causality was not known.; Sender's Comments: The event of death is assessed as possibly related to the suspect drug BNT162B2 based on strong temporal association, but possible contributory effects from patient's multiple medical history of acute and chronic respiratory failure, chronic obstructive pulmonary disease, hepatic cirrhosis and ascites cannot be completely ruled out. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: unspecified event: Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Acquired coagulation factor deficiency (Verbatim: Acquired Coagulation Factor Deficiency); Acute on chronic respiratory failure (Verbatim: Acute and Chronic Respiratory Failure with hypoxia); Anaemia (Verbatim: Anemia, unspecified); Ascites (Verbatim: Other Ascites); Chronic obstructive pulmonary disease exacerbation (Verbatim: Chronic Obstructive Pulmonary Disease acute exacerbation); Cirrhosis of liver (Verbatim: Unspecified Cirrhosis of the liver); DVT; Esophagitis, unspecified (Verbatim: Esophagitis unspecified without bleeding); Falling (Verbatim: History of Falling); Gastroesophageal reflux disease (Verbatim: Gastroesophageal reflux disease without esophagitis); Hemiplegia (Verbatim: Hemiplegia with hemiparesis); Hyperlipidemia (Verbatim: Hyperlipidemia); Hypertension; Hypothyroidism (Verbatim: Hypothyroidism, unspecified); Neuropathy; Non-alcoholic steatohepatitis (Verbatim: Non alcoholic steato hepatitis); Oxygen supplementation (Verbatim: Dependence on Supplemental Oxygen); Pain; Polyneuropathy (Verbatim: Polyneuropathy, unspecified); Sleep apnea (Verbatim: Sleep apnea, unspecified); Supplementation therapy; Thrombocytopenia (Verbatim: Thrombocytopenia, unspecified)
- Andere Medikamente
- APIXABAN; CARVEDILOL; EZETIMIBE; FERROUS SULFATE; FOLIC ACID; GABAPENTIN; LEVOTHYROXINE; OXYCODONE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 01.04.2021
- Impfdatum
- 19.03.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Foaming at mouth
Symptomtext
unspecified event: Death; This is a spontaneous report from a contactable pharmacist through VAERS system. A 81-year-old male patient received first dose of bnt162b2 (COMIRNATY, Solution for injection, Lot number: EN6200, Expiration date: 31Jun2021) via unspecified route on 19Mar2021 between 10:30 to 11:30 Am, in the right arm, deltoid at a single dose for COVID-19 immunization. The patient' 's relevant medical history included Chronic Obstructive Pulmonary Disease acute exacerbation (end date: 20Mar2021), Anemia, unspecified (from 18Mar2021 to 20Mar2021), Acquired Coagulation Factor Deficiency, Thrombocytopenia, unspecified, Hypothyroidism, unspecified, Hyperlipidemia, Sleep apnea, unspecified, Polyneuropathy, unspecified, Hemiplegia with hemiparesis, Esophagitis unspecified without bleeding, Gastroesophageal reflux disease without esophagitis, Unspecified Cirrhosis of the liver, Non-alcoholic steato hepatitis, Other Ascites, Dependence on Supplemental Oxygen all from 18Mar2021 to 20Mar2021, History of Falling on 30Nov2017 to 20Mar2021, Acute and Chronic Respiratory Failure with hypoxia from 18Mar2021 to Unspecified. Concomitant medications, Apixaban (5mg, one tab by mouth two times a day) from 18Mar2021 to 20Mar20201 for DVT prevention, Carvedilol (3.125 mg, one tab by mouth once a day) for hypertension from 19Mar2021 to 20Mar2021, Ezetimibe (10mg tablets one tab by mouth once a day) for hyperlipidemia from 19Mar2021 to 20Mar2021, ferrous Sulfate (325 mg tab, one tab by mouth one time a day for supplement) from 19Mar2021 to 20Mar2021, folic Acid (1mg tablet, one my by mouth one time a day for supplement) from 19Mar2021 to 20Mar2021, Gabapentin (300 mg , capsule one cap by mouth three times a day) for neuropathy from 19Mar2021 to 20Mar2021, levothyroxine (25 mcq, one tab by mouth once a day) for hypothyroidism from 19Mar2021 to 20Mar2021, oxycodone (5 mg tablet; one tab by mouth every four hours as needed) for pain from 19Mar2021 to 20Mar2021 and Ergocalciferol on unspecified dates (order date of 18Mar2021 and to be started on 24Mar2021, so it was probably never started) as supplement. The patient had not taken any previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent and no additional vaccines were administered within 2 weeks. Prior to vaccinations (within 4 weeks) the patient had not taken any vaccinations given for two weeks before. On 20Mar2021 the patient died due to unspecified reason. It was unknown if autopsy was done. It was reported that the patient did not have a severe reaction with anaphylaxis treated with an EpiPen or hospitalization and anaphylaxis not related to a drug. Investigation assessment was unknown. The patient was discharged on 20Mar2021. It was further stated by reporter that she has no idea if any of this is related to the Covid vaccine or not, however her Medical Director wanted her to call and report the event. Reporter's causality was not known.; Sender's Comments: The event of death is assessed as possibly related to the suspect drug BNT162B2 based on strong temporal association, but possible contributory effects from patient's multiple medical history of acute and chronic respiratory failure, chronic obstructive pulmonary disease, hepatic cirrhosis and ascites cannot be completely ruled out. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: unspecified event: Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Acquired coagulation factor deficiency (Verbatim: Acquired Coagulation Factor Deficiency); Acute on chronic respiratory failure (Verbatim: Acute and Chronic Respiratory Failure with hypoxia); Anaemia (Verbatim: Anemia, unspecified); Ascites (Verbatim: Other Ascites); Chronic obstructive pulmonary disease exacerbation (Verbatim: Chronic Obstructive Pulmonary Disease acute exacerbation); Cirrhosis of liver (Verbatim: Unspecified Cirrhosis of the liver); DVT; Esophagitis, unspecified (Verbatim: Esophagitis unspecified without bleeding); Falling (Verbatim: History of Falling); Gastroesophageal reflux disease (Verbatim: Gastroesophageal reflux disease without esophagitis); Hemiplegia (Verbatim: Hemiplegia with hemiparesis); Hyperlipidemia (Verbatim: Hyperlipidemia); Hypertension; Hypothyroidism (Verbatim: Hypothyroidism, unspecified); Neuropathy; Non-alcoholic steatohepatitis (Verbatim: Non alcoholic steato hepatitis); Oxygen supplementation (Verbatim: Dependence on Supplemental Oxygen); Pain; Polyneuropathy (Verbatim: Polyneuropathy, unspecified); Sleep apnea (Verbatim: Sleep apnea, unspecified); Supplementation therapy; Thrombocytopenia (Verbatim: Thrombocytopenia, unspecified)
- Andere Medikamente
- APIXABAN; CARVEDILOL; EZETIMIBE; FERROUS SULFATE; FOLIC ACID; GABAPENTIN; LEVOTHYROXINE; OXYCODONE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 31.03.2021
- Impfdatum
- 19.02.2021
- Beginn
- 26.02.2021
- Tage bis Beginn
- 7,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Acute kidney injury
Acute myocardial infarction
Alanine aminotransferase normal
Aspartate aminotransferase normal
Blood creatinine increased
Brain contusion
Brain oedema
COVID-19
Cardio-respiratory arrest
Chest pain
Chronic kidney disease
Computerised tomogram head abnormal
Death
Fall
Fibrin D dimer increased
Glomerular filtration rate decreased
Haemorrhage intracranial
Head injury
Symptomtext
FALLS, CHEST PAIN, HEMORRAHAGIC CONTUSION, COVID, PNEUMONIA, HYPOXIC RESPIRATORY FAILURE Narrative: 2/22/2021 Patient presented to hospital with multiple complaints. He was reporting falls, chest pain, his wife was diagnosed with Covid. While he was there, he was found to have hemorrhagic contusion in the right frontoparietal region with minimal surrounding edema, Covid, pneumonia, elevated troponin. He was accepted in transfer by trauma surgeon Dr. and arrives with no complaints. 2/26/2021 Patient died after code blue was called Death Diagnosis: s/p fall with head trauma Focal area right intracranial hemorrhage per initial CT - serial CT head showing stability Acute hypoxic respiratory failure secondary to COVID-19 viral illness COVID-19 viral illness Acute chest pain, improved Elevated troponin, suspected type 2 NSTEMI Elevated D-dimer - V/Q scan with intermittent probability PE Acute kidney injury on CKD, improving unlikely that vaccine contributed to patient's death.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- 12/1/20 SCR 1.5 EGFR 44 ALT 18 AST 20 NOTHING ELSE REMARKABLE
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 31.03.2021
- Impfdatum
- 19.03.2021
- Beginn
- 20.03.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
death; This is a spontaneous report from a contactable pharmacist. A 66-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number: EN6200, via an unspecified route of administration, administered in left deltoid on 19Mar2021 10:30 as single dose for COVID-19 immunisation. Medical history included sepsis, septic shock, acute respiratory failure, acute kidney injury, pneumonia, chronic obstructive pulmonary disease, interstitial lung disease, non-traumatic ischemic infarction of forearm muscle, polyneuropathy, obstructive sleep apnea, anaemia, hyperlipidaemia, cigarette smoker, major depressive disorder, restless legs syndrome, hypertension, gastroesophageal disease, generalized muscle weakness, dysphasia oropharyngeal phase, difficulty in walking, other lack of coordination, cognitive communication deficit, falling, dependence on supplemental oxygen all on 03Mar2021, high cholesterol, edema, neuropathy, pain, allergy, hypokalemia, gastrooesophageal reflux disease and tachycardia. Concomitant medications included atorvastatin taken for blood cholesterol increased from 03Mar2021 to 20Mar2021; ferrous sulfate taken for mineral supplementation from 03Mar2021 to 20Mar2021; fluticasone;formoterol taken for chronic obstructive pulmonary disease from 03Mar2021 to 20Mar2021; furosemide taken for oedema from 16Mar2021 to 20Mar2021; gabapentin taken for neuropathy peripheral from 11Mar2021 to 20Mar2021; albuterol;ipratropium (ALBUTEROL;IPRATROPIUM) taken for chronic obstructive pulmonary disease from 05Mar2021 to 20Mar2021; lidocaine (LIDODERM) taken for pain management from 04Mar2021 to 20Mar2021; magnesium oxide taken for vitamin supplementation from an unspecified start date to 20Mar2021; metoprolol tartrate taken for hypertension, tachycardia from 15Mar2021 to 20Mar2021; montelukast taken for hypersensitivity from 03Mar2021 to 20Mar2021; potassium chloride taken for hypokalaemia from 04Mar2021 to 20Mar2021; omeprazole (PRILOSEC [OMEPRAZOLE]) taken for gastrooesophageal reflux disease from 04Mar2021 to 20Mar2021; paracetamol (TYLENOL) taken for pain from 18Mar2021 to 20Mar2021. The patient died on 20Mar2021. It was not reported if an autopsy was performed.; Reported Cause(s) of Death: death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Acute kidney failure (Verbatim: Acute kidney failure unspecified); Acute respiratory failure (Verbatim: Acute respiratory failure with hypoxia); Allergy; Anemia (Verbatim: Anemia); Chronic obstructive pulmonary disease (Verbatim: Chronic obstructive pulmonary disease); Cigarette smoker (Verbatim: Nicotine dependence cigarettes); Cognitive disorder (Verbatim: Cognitive communication deficit); Dependence on oxygen therapy (Verbatim: Dependence on supplemental oxygen); Difficulty in walking (Verbatim: Difficulty in walking); Dysphasia (Verbatim: Dysphasia oropharyngeal phase); Edema; Falling (Verbatim: History of falling); Gastroesophageal obstruction (Verbatim: Gastroesophageal disease without esophagitis); Generalized muscle weakness (Verbatim: Generalized muscle weakness); GERD; High cholesterol; Hyperlipidemia (Verbatim: Hyperlipidemia); Hypertension (Verbatim: Central primary hypertension); Hypokalemia; Infarction (Verbatim: Non traumatic ischemic infarction of forearm muscle); Interstitial pulmonary fibrosis (Verbatim: Other specified interstitial pulmonary diseases); Lack of coordination (Verbatim: Other lack of coordination); Major depressive disorder (Verbatim: Major depressive disorder, single episode unspecified); Neuropathy; Obstructive sleep apnea syndrome (Verbatim: Obstructive sleep apnea); Pain; Pain management; Pneumonia (Verbatim: Pneumonia unspecified organism); Polyneuropathy (Verbatim: Polyneuropathy unspecified); Restless leg syndrome (Verbatim: Restless leg syndrome); Sepsis (Verbatim: Sepsis, unspecified organism); Septic shock (Verbatim: Severe sepsis with septic shock); Tachycardia
- Andere Medikamente
- ATORVASTATIN; FERROUS SULFATE; FLUTICASONE;FORMOTEROL; FUROSEMIDE; GABAPENTIN; ALBUTEROL;IPRATROPIUM; LIDODERM; MAGNESIUM OXIDE; METOPROLOL TARTRATE; MONTELUKAST; POTASSIUM CHLORIDE; PRILOSEC [OMEPRAZOLE]; TYLENOL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 31.03.2021
- Impfdatum
- 19.03.2021
- Beginn
- 20.03.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
death; This is a spontaneous report from a contactable pharmacist. A 66-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number: EN6200, via an unspecified route of administration, administered in left deltoid on 19Mar2021 10:30 as single dose for COVID-19 immunisation. Medical history included sepsis, septic shock, acute respiratory failure, acute kidney injury, pneumonia, chronic obstructive pulmonary disease, interstitial lung disease, non-traumatic ischemic infarction of forearm muscle, polyneuropathy, obstructive sleep apnea, anaemia, hyperlipidaemia, cigarette smoker, major depressive disorder, restless legs syndrome, hypertension, gastroesophageal disease, generalized muscle weakness, dysphasia oropharyngeal phase, difficulty in walking, other lack of coordination, cognitive communication deficit, falling, dependence on supplemental oxygen all on 03Mar2021, high cholesterol, edema, neuropathy, pain, allergy, hypokalemia, gastrooesophageal reflux disease and tachycardia. Concomitant medications included atorvastatin taken for blood cholesterol increased from 03Mar2021 to 20Mar2021; ferrous sulfate taken for mineral supplementation from 03Mar2021 to 20Mar2021; fluticasone;formoterol taken for chronic obstructive pulmonary disease from 03Mar2021 to 20Mar2021; furosemide taken for oedema from 16Mar2021 to 20Mar2021; gabapentin taken for neuropathy peripheral from 11Mar2021 to 20Mar2021; albuterol;ipratropium (ALBUTEROL;IPRATROPIUM) taken for chronic obstructive pulmonary disease from 05Mar2021 to 20Mar2021; lidocaine (LIDODERM) taken for pain management from 04Mar2021 to 20Mar2021; magnesium oxide taken for vitamin supplementation from an unspecified start date to 20Mar2021; metoprolol tartrate taken for hypertension, tachycardia from 15Mar2021 to 20Mar2021; montelukast taken for hypersensitivity from 03Mar2021 to 20Mar2021; potassium chloride taken for hypokalaemia from 04Mar2021 to 20Mar2021; omeprazole (PRILOSEC [OMEPRAZOLE]) taken for gastrooesophageal reflux disease from 04Mar2021 to 20Mar2021; paracetamol (TYLENOL) taken for pain from 18Mar2021 to 20Mar2021. The patient died on 20Mar2021. It was not reported if an autopsy was performed.; Reported Cause(s) of Death: death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Acute kidney failure (Verbatim: Acute kidney failure unspecified); Acute respiratory failure (Verbatim: Acute respiratory failure with hypoxia); Allergy; Anemia (Verbatim: Anemia); Chronic obstructive pulmonary disease (Verbatim: Chronic obstructive pulmonary disease); Cigarette smoker (Verbatim: Nicotine dependence cigarettes); Cognitive disorder (Verbatim: Cognitive communication deficit); Dependence on oxygen therapy (Verbatim: Dependence on supplemental oxygen); Difficulty in walking (Verbatim: Difficulty in walking); Dysphasia (Verbatim: Dysphasia oropharyngeal phase); Edema; Falling (Verbatim: History of falling); Gastroesophageal obstruction (Verbatim: Gastroesophageal disease without esophagitis); Generalized muscle weakness (Verbatim: Generalized muscle weakness); GERD; High cholesterol; Hyperlipidemia (Verbatim: Hyperlipidemia); Hypertension (Verbatim: Central primary hypertension); Hypokalemia; Infarction (Verbatim: Non traumatic ischemic infarction of forearm muscle); Interstitial pulmonary fibrosis (Verbatim: Other specified interstitial pulmonary diseases); Lack of coordination (Verbatim: Other lack of coordination); Major depressive disorder (Verbatim: Major depressive disorder, single episode unspecified); Neuropathy; Obstructive sleep apnea syndrome (Verbatim: Obstructive sleep apnea); Pain; Pain management; Pneumonia (Verbatim: Pneumonia unspecified organism); Polyneuropathy (Verbatim: Polyneuropathy unspecified); Restless leg syndrome (Verbatim: Restless leg syndrome); Sepsis (Verbatim: Sepsis, unspecified organism); Septic shock (Verbatim: Severe sepsis with septic shock); Tachycardia
- Andere Medikamente
- ATORVASTATIN; FERROUS SULFATE; FLUTICASONE;FORMOTEROL; FUROSEMIDE; GABAPENTIN; ALBUTEROL;IPRATROPIUM; LIDODERM; MAGNESIUM OXIDE; METOPROLOL TARTRATE; MONTELUKAST; POTASSIUM CHLORIDE; PRILOSEC [OMEPRAZOLE]; TYLENOL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 29.03.2021
- Impfdatum
- 23.02.2021
- Beginn
- 08.03.2021
- Tage bis Beginn
- 13,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Symptomtext
Patient expired 3/8/2021 at home. Coroner pronounced time of death at 0415 and assumed cause of death was history of transplant and cardiac.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 29.03.2021
- Impfdatum
- 25.02.2021
- Beginn
- 28.03.2021
- Tage bis Beginn
- 31,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- congestive heart failure, kidney failure, diabetes
- Andere Medikamente
- Unknown
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 29.03.2021
- Impfdatum
- 16.02.2021
- Beginn
- 10.03.2021
- Tage bis Beginn
- 22,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Dysarthria
Facial paralysis
Hemiparesis
Ischaemic stroke
Symptomtext
Patient presented to the ED on 3/4/2021 with left facial droop, left-sided weakness, and dysarthria that started upon awakening that morning. Patient found to have an ischemic stroke and ultimately admitted to hospice. Patient expired on 3/10/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 29.03.2021
- Impfdatum
- 05.03.2021
- Beginn
- 17.03.2021
- Tage bis Beginn
- 12,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Septic shock
Symptomtext
Acute renal failure (ARF) (CMS/HCC) Septic shock (CMS/HCC)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Septic shock
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 90,0
- Geschlecht
- M
- Eingang
- 29.03.2021
- Impfdatum
- 26.02.2021
- Beginn
- 26.03.2021
- Tage bis Beginn
- 28,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Bradycardia
Death
Mental status changes
Rhabdomyolysis
Troponin increased
Symptomtext
ALTERED MENTAL STATUS Bradycardia Elevated troponin Non-traumatic rhabdomyolysis Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 29.03.2021
- Impfdatum
- 11.03.2021
- Beginn
- 13.03.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood test
Cardiac failure
Computerised tomogram
Respiratory arrest
Symptomtext
PATIENT RECIEVED FIRST SHOT ON FEBRUARY 18TH AND SHOWED NO OBVIOUS SIGNS, SYMPTOMS, OR ISSUES. PATIENT RECIEVED THE SECOND SHOT ON MARCH 11TH SHOWED NO IMMEDIATE SIGNS OR SYMPTOMS UNTIL A DAY AND A HALF LATER ON MARCH 13TH WHEN PATIENT SUDDENLY STOPPED BREATHING AND WENT INTO CARDIAC FAILURE FOR NO APPARENT REASON.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Respiratory arrest
- Hospital-Tage
- 4,0
- Labordaten
- PATIENT UNDERWENT MULTIPLE CT SCANS, BLOOD TESTING DURING HER HOSPITAL STAY BETWEEN THE DATES OF 03/13/21 - 03/15/21.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- COPD, ATHSMA
- Andere Medikamente
- IRON 65mg, B12 50 mcg, OMEPRAZOLE 40mg CAPSULE, SUCRALFATE 1 gm TABLET, CALCIUM CITRATE + D3, IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE INHALATION SOLUTION 0.5 mg/ 3 mg PER 3 ml, SYMBICORT INHALER, HYDROCHLOROTH IAZIDE 12.5 mg TABLET, ARTH
- Allergien
- NO FOOD OR MEDICATION ALLERGIES
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 25.03.2021
- Impfdatum
- 23.02.2021
- Beginn
- 11.03.2021
- Tage bis Beginn
- 16,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Deep vein thrombosis
Pulmonary embolism
Symptomtext
multiple bilateral DVTs; pulmonary embolus; This is a spontaneous report from a contactable Physician (Patient). A 66-year-old male patient received second dose of bnt162b2 (BNT162B2, Solution for injection, Lot number: EN6200, Expiration date was not reported), via an unspecified route of administration, in Arm Left on 23Feb2021 13:15 as single dose, the first dose via an unspecified route of administration, a in Arm Left on 02Feb2021 13:15 as single dose for covid-19 immunization. Medical history included Subarachnoid hemorrhage (SAH), hypertension (htn), degenerative discs, malignant melanoma and prostatectomy (2 years 3 months). Concomitant medications included atorvastatin calcium and lisinopril taken for an unspecified indication, start and stop date were not reported. The patient previously took cephalosporin for allergies. After receiving the second dose patient experienced pulmonary embolus on an unspecified date in 2021 and multiple bilateral DVTs diagnosed on 11Mar2021. As per the reporter seriousness criteria reported as emergency room/department or urgent care, Life threatening illness (immediate risk of death from the event). Patient did not receive any other vaccine in four weeks. Patient did not have Covid prior vaccination. Patient was not tested Covid post vaccination. Therapeutic measures were taken as a result of pulmonary embolus multiple bilateral dvts. The outcome of the events was not recovered.; Sender's Comments: Based on the temporal relationship, A possible contributory role of the suspect product to the development of Pulmonary Embolus and Deep Vein Thrombosis cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Degenerative disc disease; Hypertension; Malignant melanoma (s/p resection of malignant melanoma (years)); Prostatectomy (s/p prostatectomy(2 years 3 months)); Subarachnoid hemorrhage
- Andere Medikamente
- ATORVASTATIN CALCIUM; LISINOPRIL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 25.03.2021
- Impfdatum
- 18.02.2021
- Beginn
- 12.03.2021
- Tage bis Beginn
- 22,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Symptomtext
Patient death within 60 days of receiving the COVID vaccine series
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 24.03.2021
- Impfdatum
- 15.03.2021
- Beginn
- 17.03.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 24.03.2021
- Impfdatum
- 16.02.2021
- Beginn
- 19.02.2021
- Tage bis Beginn
- 3,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Angiogram pulmonary abnormal
Anti factor V antibody
Antithrombin III
Beta-2 glycoprotein antibody
Blood homocysteine normal
Blood magnesium normal
C-reactive protein increased
Deep vein thrombosis
Dizziness
Dyspnoea
Fatigue
Feeling cold
Fibrin D dimer
Full blood count normal
Hypoaesthesia
Limb discomfort
Lipoprotein (a)
Metabolic function test normal
Symptomtext
The patient is a 41 yo male with a history of seasonal allergic rhinitis who experienced DVT and PE temporally related to Pfizer BioNTech COVID vaccine dose #2 receipt. He is a Service Member and reported high levels of baseline activity, including running 10 miles each Saturday. He received vaccine #1 25 JAN 21 (EN5318) without AE. He received dose #2 on 16 FEB 21, (EN6200). He experienced no immediate symptoms suggestive of IgE event. On day 1 he reports feeling cold, mild fatigue but no other symptoms. On day 2 he was baseline. On day 3 he noted numbness, tightness and discomfort to his right calf. On day 4 (Saturday), his usual long run day, he experienced dyspnea and lightheadedness after running 20-30 feet. He states he noted tightness in his calf and instead walked the track while his wife completed her run. He rested day 5. Day 6 he noted significant edema to his calf, which he describes as double normal in size, and iced it. Day 7, he tried to schedule with PCP and based on triage was sent to ER. ER diagnosed R DVT and bilateral PE's. He was admitted overnight, started anticoagulation therapy. He saw hematology, and the workup was negative for other causes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 1,0
- Labordaten
- 23 FEB 21 CT Pulmonary Angiogram Bilateral lower lobe pulmonary embolisms. 2. Indeterminate 2.1 cm left kidney lesion, suspect complex cyst 23 FEB 21 Ultrasound Doppler RLE Occlusive thrombus in distal right femoral vein. LABS: Fibrin D-Dimer 3618, Trop-T 12.6, CBC, CMP, MG WNL 25 FEB/04 MAR all normal: CRP 3.1, Homocysteine 10.6, lipoprotein 21.4, beta-2 glycoprotein Ab (G,A,M) <9, MTHFR DNA homozygous, protein C 116,antithrombin III 112/ Ag 89, protein S WNL, Factor V 102
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- seasonal allergic rhinitis.
- Andere Medikamente
- Zyrtec Flonase Singulaire fishoil Tumeric B Complex Vitamin C.
- Allergien
- No history of allergy or intolerance to any medications He reports allergy to raw nuts, tropical fruits characterized by oral pruritis He denies a history of intolerance or allergy to natural rubber, latex or stinging insects
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 22.03.2021
- Impfdatum
- 15.02.2021
- Beginn
- 13.03.2021
- Tage bis Beginn
- 26,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute myocardial infarction
Blood creatine phosphokinase MB increased
Endotracheal intubation
Guillain-Barre syndrome
Seizure
Troponin increased
Symptomtext
Patient developed Gilliam Barre after administration of the second dose of Covid vaccine on 2/15/21; After multiple calls, clinic was where patient received vaccine with LOT #EN6200 (expiration date unavailable in computer system per pharmacist); pt then went to a hospital and was diagnosed as above; treated in the ED for several days per notes at the hospital and was not put in a room due to bed shortages so was transferred to another hospital; patient subsequently developed an NSTEMI, seizures, and was intubated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- 9,0
- Labordaten
- CK-MB of 2.5 with troponin of 0.59
- Aktuelle Erkrankungen
- s/p hip replacement, s/p shoulder replacement; blindness in one eye; nicotine dependence
- Vorgeschichte
- none noted
- Andere Medikamente
- rosuvastatin 10 mg daily; clopidogrel 75 mg daily; tadalafil 20 mg up to twice per week; vitamin D3 2000 units Daily; Neurontin 400 mg tid
- Allergien
- None indicated
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 22.03.2021
- Impfdatum
- 23.02.2021
- Beginn
- 23.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Back pain
Chest pain
Dizziness
Fatigue
Loss of consciousness
Myocardial infarction
Pain
Pyrexia
Thrombosis
Vaccination site pain
Symptomtext
chest pains; chest pains; blood clot; light headedness; low fever; blacked out for about 5 minutes; onset of major body ache and fatigue; onset of major body ache and fatigue; Body aches at injection site and into upper back; Body aches at injection site and into upper back; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6200), via an unspecified route of administration, administered in left arm on 23Feb2021 10:30 AM (at age of 67 years old) as single dose for COVID-19 immunisation. Medical history included high cholesterol. Concomitant medications included atorvastatin; levobunolol (eye drops); latanoprost (LATANO). The patient previously received his first dose of BNT162B2 on 05Feb2021 for COVID-19 immunisation (brand=Pfizer; lot number: EL9269; administration time 03:30 PM; vaccine location=Left arm; dose number=1). 6 hours after injection on 23Feb2021, the patient experienced body aches at injection site and into upper back. After 24 hours after injection on 24Feb2021, started light headedness, low fever, blacked out for about 5 minutes, onset of major body ache and fatigue. Spent the next 36hrs in bed. 72hrs after injection recovered back to normal slowly. On 04Mar2021 at 8pm, started with chest pains called, admitted to Hospital with heart attack, immediately taken to Cardiac Cath Lab for coronary catherization in both legs, to partial remove blood clot and insert continuous balloon pump, IV Heparin infusion Troponin 6542.3 ng/l (critical), NO previous health issues for blood clots. Discharged 07Mar2021, Apixiban 5mg twice a day, Clopidogrel 75 mg /day. AE resulted in: Emergency room/department or urgent care, Hospitalization, Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event. Number days hospitalization: 3 days. The outcome of events was unknown.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocardial infarction
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: High cholesterol
- Andere Medikamente
- ATORVASTATIN; LEVOBUNOLOL; LATANO
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 20.03.2021
- Impfdatum
- 26.02.2021
- Beginn
- 20.03.2021
- Tage bis Beginn
- 22,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Blood pressure increased
Computerised tomogram thorax abnormal
Cough
Dyspnoea
Fibrin D dimer normal
Heart rate increased
Pulmonary embolism
Symptomtext
Non-productive cough, shortness of breath, increase in blood pressure (170/90) and increased heart rate (85 bpm). Symptoms began shortly after second dose of vaccine on 2/26/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 2,0
- Labordaten
- 3/5/2021: D-dimer 7.17 mg/L 3/5/2021: CT chest: bilateral pulmonary emboli
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- hypertension, hypercholesterolemia, type 2 diabetes, impaired renal function (GFR 50), Leiden Factor V mutation
- Andere Medikamente
- Losartan, amlodipine, simvastatin, vitamin D3
- Allergien
- penicillin
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 19.03.2021
- Impfdatum
- 20.02.2021
- Beginn
- 02.02.2021
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Aphasia
Apraxia
Cerebral infarction
Cerebrovascular accident
Chest X-ray
Chest pain
Dyspnoea
Electrocardiogram T wave inversion
Gout
Haemorrhagic stroke
Hypertension
Nausea
Prostate cancer
Sinus rhythm
Troponin
Vomiting
Symptomtext
Nausea, vomiting, chest pain and dyspnea Narrative: A 59yo male with a historical ADR of chest pain, dyspnea, nausea and vomiting, after receiving Pfizer's Covid-19 vaccine. The reporting physician, note included the patient was hospitalized at Hospital. The non-agency record summary from Medical Center showed, patient was admitted for chest pain observation and had -ve Troponins, CXR, EKG - NSR at 65 with T wave inversion in I, II, III AVF and V4 - V6" and was cleared for outpatient f/u February 10, 2021 advice line patient reported note stated the reaction started 2 days after receiving Covid vaccine on January 30, 2021 February 24th PCC nurse's f/u note included patient had minimal side effect with the 2nd shot which was administered on February 20, 2021 PMH - Gout, HTN, Chest Pain, Prostate Cancer, Cerebral Infraction, Apraxia due to cerebrovascular accident, Aphasia, Hemorrhagic Stroke
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 18.03.2021
- Impfdatum
- 02.03.2021
- Beginn
- 09.03.2021
- Tage bis Beginn
- 7,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal distension
Blood pressure decreased
Cardiac arrest
Choking
Choking sensation
Cold sweat
Cough
Dehydration
Dyspnoea
Feeding disorder
Feeling abnormal
Fluid intake reduced
Gastrointestinal pain
Lethargy
Pain
Pneumonia
Productive cough
Respiratory arrest
Symptomtext
One week post vaccine, caller's mother started to feel "phlegm-y", coughing up clear phlegm. The next day she was more lethargic, coughing. Called her PCP, recommended Robitussin and Mucinex which she took. Continued to feel worse. No fever although she had cold sweats. She felt a lot of GI pain, fullness, could not eat/drink. Called PCP again by the 4th day of feeling bad. Recommended Augmentin and she took 2 doses. On 3/12 and 3/13, had difficulty breathing, coughing. Called EMS on 3/14 and taken to hospital where she was treated for dehydration and pneumonia with a broad spectrum antibiotic and vancomycin, IV. Given morphine for pain. She tried to take a GI cocktail which she felt like she was choking on. That evening on her BP bottomed out. They continued to give IVFs to raise BP as fast as possible. She was unable to receive chest compressions due to aorta issue and her heart gave out and she stopped breathing on 3/14.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- heart stents, crystallized aorta, recovering from GI bleed, thyroid cancer, Hodgkins stage 2B, heart and lung problems, fibromyalgia, lupus like disorder
- Andere Medikamente
- levothyroxine, omeprazole, diltiazem, fenofibrate, atorvastatin, iron, ativan, vitamins
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 93,0
- Geschlecht
- F
- Eingang
- 18.03.2021
- Impfdatum
- 27.02.2021
- Beginn
- 12.03.2021
- Tage bis Beginn
- 13,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 18.03.2021
- Impfdatum
- 05.02.2021
- Beginn
- 17.03.2021
- Tage bis Beginn
- 40,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 17.03.2021
- Impfdatum
- 21.02.2021
- Beginn
- 24.02.2021
- Tage bis Beginn
- 3,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Angiogram pulmonary abnormal
Antinuclear antibody
Computerised tomogram abnormal
Computerised tomogram thorax abnormal
Cough
HIV test
Hepatitis B virus test
Hepatitis C virus test
Interstitial lung disease
Legionella test
Lung opacity
Lymphadenopathy
Pneumonia
Pulmonary embolism
Pulmonary granuloma
Rheumatoid factor
SARS-CoV-2 test negative
Scan with contrast
Symptomtext
Patient has a progressive dry cough and dyspnea on exertion that started a few days after receiving the second dose of the COVID vaccine. He received a 10 day course of doxycycline for CAP as an outpatient without any improvement, hence he was admitted to the hospital for further workup. CT scan was performed revealing findings concerning for ILD. Of note a CT done in 2018 shows some possible early signs of ILD. Pulmonology is seeing the patient and he was started on steroids today (3/17/2021).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 1,0
- Labordaten
- 3/8/2021: 2 view CXR 3/9/2021: COVID swab negative 3/16/2021: respiratory virus detection panel (including COVID) negative, urine Legionella antigen negative 3/16/2021: 1 view CXR, CTA chest PE with and without contrast 3/17/2021: HIV, hepatitis B, hepatitis C, ANA, rheumatoid factor, anti-CCP pending 3/17/2021: CT high resolution chest without contrast showing reticulation and ground-glass opacities possibly due to NSIP, no definite honeycombing however UIP may be a possibility; prior granulomatous disease noted in the left lower lobe, left hilum, and spleen; mildly enlarged lymph node in the left mediastinum with no associated findings noted
- Aktuelle Erkrankungen
- Left knee replacement on 1/7/2021
- Vorgeschichte
- Coronary artery disease with right coronary artery stent placement in 2018, paroxysmal atrial fibrillation with history of pulmonary vein isolation in 2019, hypertension, mixed hypercholesterolemia, iron deficiency anemia, history of bilateral hip replacement
- Andere Medikamente
- Aspirin 81 mg daily, dofetilide 500 mcg twice daily, apixaban 5 mg twice daily, lisinopril 5 mg daily, rosuvastatin 40 mg daily
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 17.03.2021
- Impfdatum
- 01.03.2021
- Beginn
- 03.03.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Dyspnoea
Lethargy
Pain in extremity
Pulmonary embolism
Pyrexia
Symptomtext
Patient received 2nd dose on 3/1 and self-reported experiencing fever and lethargy for 3 days. Two days post dose, patient complained of her left leg hurting to her daughter. Daughter inspected leg and did not notice any swelling or warmth. Two days after that symptom started (4 days post dose), patient's leg felt better but she now had shortness of breath which she claims worsened for two weeks before presenting to the hospital where patient was diagnosed with a pulmonary embolism.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 16.03.2021
- Impfdatum
- 06.02.2021
- Beginn
- 12.03.2021
- Tage bis Beginn
- 34,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 15.03.2021
- Impfdatum
- 22.02.2021
- Beginn
- 03.03.2021
- Tage bis Beginn
- 9,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Autopsy
Cardiomegaly
Death
Symptomtext
Client found dead by a family member.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Per family member autopsy showed cause of death as an enlarged heart.
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- COPD, High Blood Pressure
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 12.03.2021
- Impfdatum
- 01.03.2021
- Beginn
- 02.03.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 12.03.2021
- Impfdatum
- 23.02.2021
- Beginn
- 23.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
I was alerted on 3.11.21 by the patient's wife that patient had passed away the night after having received the vaccine. The wife informed me that she did not wake up the next morning.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 11.03.2021
- Impfdatum
- 21.02.2021
- Beginn
- 21.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arthralgia
Asthenia
Chills
Diarrhoea
Headache
Feeling cold
Myocardial infarction
Neck pain
Oral pain
SARS-CoV-2 test
Vomiting
Symptomtext
extreme weakness; joint pain in neck; mouth pain; severe heart attack; 10 hrs after shot severe chills; 1 hr later explosive diarrhea; vomiting; severe joint pain in ankles, knees, hips, elbows; severe headache; This is a spontaneous report from a contactable nurse report for self. A 55-year-old female (not pregnant) patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6200), intramuscular in left arm on 21Feb2021 10:45 AM at single dose for covid-19 immunisation. The patient's medical history was not reported. No COVID prior vaccination. Concomitant medications in two weeks included atorvastatin, aspirin [acetylsalicylic acid], ergocalciferol (VIT D), cetirizine hydrochloride (ZYRTEC). No other vaccine in four weeks. Patient was allergy to morphine. Patient received first dose of bnt162b2 (lot number=EL9263) intramuscular in left arm on 30Jan2021 09:30 AM. On 21Feb2021, 1 hr later patient experienced explosive diarrhea and vomiting 1 time, severe joint pain in ankles, knees, hips, elbows, severe headache. 10 hrs after shot patient had severe chills. Next day joint pain in neck and mouth pain along with severe heart attack. On 23Feb2021 had extreme weakness. No treatment received. Patient was recovered from the events. Nasal Swab Covid test post vaccination on 22Feb2021 was Negative.; Sender's Comments: Based on the limited information provided it is unlikely that heart attack was related to suspect product in this patient on atorvastatin and aspirin. Case will be reassessed when additional information is received. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocardial infarction
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210222; Test Name: B D Veritor; Test Result: Negative ; Test Date: 20210222; Test Name: Nasal Swab; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- ATORVASTATIN; ASPIRIN [ACETYLSALICYLIC ACID]; VIT D; ZYRTEC [CETIRIZINE HYDROCHLORIDE]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 11.03.2021
- Impfdatum
- 21.02.2021
- Beginn
- 21.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arthralgia
Asthenia
Chills
Diarrhoea
Headache
Feeling cold
Myocardial infarction
Neck pain
Oral pain
SARS-CoV-2 test
Vomiting
Symptomtext
extreme weakness; joint pain in neck; mouth pain; severe heart attack; 10 hrs after shot severe chills; 1 hr later explosive diarrhea; vomiting; severe joint pain in ankles, knees, hips, elbows; severe headache; This is a spontaneous report from a contactable nurse report for self. A 55-year-old female (not pregnant) patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6200), intramuscular in left arm on 21Feb2021 10:45 AM at single dose for covid-19 immunisation. The patient's medical history was not reported. No COVID prior vaccination. Concomitant medications in two weeks included atorvastatin, aspirin [acetylsalicylic acid], ergocalciferol (VIT D), cetirizine hydrochloride (ZYRTEC). No other vaccine in four weeks. Patient was allergy to morphine. Patient received first dose of bnt162b2 (lot number=EL9263) intramuscular in left arm on 30Jan2021 09:30 AM. On 21Feb2021, 1 hr later patient experienced explosive diarrhea and vomiting 1 time, severe joint pain in ankles, knees, hips, elbows, severe headache. 10 hrs after shot patient had severe chills. Next day joint pain in neck and mouth pain along with severe heart attack. On 23Feb2021 had extreme weakness. No treatment received. Patient was recovered from the events. Nasal Swab Covid test post vaccination on 22Feb2021 was Negative.; Sender's Comments: Based on the limited information provided it is unlikely that heart attack was related to suspect product in this patient on atorvastatin and aspirin. Case will be reassessed when additional information is received. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocardial infarction
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210222; Test Name: B D Veritor; Test Result: Negative ; Test Date: 20210222; Test Name: Nasal Swab; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- ATORVASTATIN; ASPIRIN [ACETYLSALICYLIC ACID]; VIT D; ZYRTEC [CETIRIZINE HYDROCHLORIDE]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 10.03.2021
- Impfdatum
- 20.02.2021
- Beginn
- 21.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cerebrovascular accident
Fatigue
Headache
Hypoaesthesia
Muscular weakness
Vaccination site pain
Symptomtext
having a small stroke; weakness in her right hand and arm; Right arm was really sore; really tired; Headache; having issues with her right hand being numb/1st 2 fingers on her right hand were numb; The initial safety information received was reporting only non-serious adverse drug reactions, Upon receipt of follow-up information on 01Mar2021, this case now contains serious adverse reaction. Information processed together. This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6200, expiry date was not reported) (at 59 years of age), via an unspecified route of administration in the right arm on 20Feb2021 15:49 at a single dose for COVID-19 immunisation. The patient's medical history and family medical history were none. The concomitant medications were not reported. Historical vaccine included PFIZER BIONTECH COVID 19 VACCINE, 1st dose, lot number: EL9263, injection in right arm on 30Jan2021 (at 59 years of age). There was no other vaccines administered on same date with the Pfizer vaccine and there was no any other vaccinations within four weeks prior to the first administration date of the vaccine. The patient stated that she is not an HCP, but she does work in a mental health. She stated that she is concerned. She got her 2nd dose of the vaccine on Saturday and was having weakness in her right hand and arm. She asked if this was expected. She added that when she got up yesterday, her right arm was really sore, she was extremely tired, and she had a headache. She went to bed early that night at around 5:30pm, and she woke up around 8 or 9pm that night and tried to pick up her phone and couldn't. She stated that the 1st 2 fingers on her right hand were numb. When she got up today it was fine. They are working from home, so she was typing some notes and then it felt like her fingers went numb, it felt like her 1st finger was like rubber. She stated that the numbness comes and goes. She mentioned that she doesn't have a headache right now, but it felt like it could come back. The events did not require emergency room or physician visit. On 01Mar2021, it was reported that the patient was having issues with her right hand being numb and the representative that she spoke with recommended she follow up with her PCP, which she did, and they diagnosed her with having a small stroke and also referred her to a neurologist as well. She said that her primary care provider she saw was a nurse practitioner. She said that she also saw a neurologist. It was not reported if the patient received treatment for 'having a small stroke' while no treatment received for all other events. The outcome of having a small stroke was unknown; 'weakness in her right hand and arm' was not recovered; while 'Right arm was really sore' and 'really tired' was recovering. The outcome of Headache and 'having issues with her right hand being numb/1st 2 fingers on her right hand were numb' was recovered on an unknown date.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 08.03.2021
- Impfdatum
- 04.03.2021
- Beginn
- 05.03.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Feeling abnormal
Unresponsive to stimuli
Symptomtext
Information provided by facility director. Resident told medical provider on 3/3/21 at routine visit that he had not felt right since receiving vaccine on 2/11/21. No specific complaints and no findings reported by provider. No specific complaints reported prior to nurse at facility finding resident unresponsive and breathing at approximately 6AM on 3/5/21. 911 initiated. EMS, police and coroner responded.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- schizophrenia
- Andere Medikamente
- Iron, Lamctal 100mg,Olanzapine 10mg,Omeprazole; Spiriva inhal Tums, OTC; Advair 250 inhaler; Aspirin 81mg; Docusate Sodium 100mg; Ergocalciferol 125mg on Friday; Fluoxetine hcl 40 mg; Haloperiodol 10mg; Hydrochlorothiazide 25mg. Medication
- Allergien
- None reported
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 04.03.2021
- Impfdatum
- 15.02.2021
- Beginn
- 15.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood pressure measurement
Cerebrovascular accident
Headache
Heart rate
Neck pain
Feeling abnormal
Malaise
Nervousness
Nightmare
Oxygen saturation
Neurological symptom
Symptomtext
Like I'm having a stroke; neck ache; nightmares; nervousness; Felt terrible with bad headache; This is a spontaneous report from a contactable consumer (patient). An 86-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EN6200) via an unspecified route of administration on 15Feb2021 13:00 at single dose in left arm for COVID-19 immunisation. She received the first dose of BNT162B2 (lot number: EL9262) on 18Jan2021 13:00 in left arm for COVID-19 immunisation. The patient medical history was not reported. The patient was not pregnant at the time of vaccination. The patient was allergic to Formaldehyde, Coumadin. Concomitant medication included levothyroxine sodium (LEVOXYL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 15Feb2021, the patient felt terrible with bad headache. On 18Feb2021 also felt terrible. On 17Feb2021 08:00, Like she was having a stroke. Headache, neck ache, nightmares, nervousness. Blood pressure was ok. Oxygen was ok. Pulse was ok. No treatment received for the adverse events. Events outcome was not recovered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210217; Test Name: Blood pressure; Result Unstructured Data: Test Result:ok; Test Date: 20210217; Test Name: Pulse; Result Unstructured Data: Test Result:ok; Test Date: 20210217; Test Name: Oxygen; Result Unstructured Data: Test Result:ok
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- LEVOXYL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 04.03.2021
- Impfdatum
- 15.02.2021
- Beginn
- 15.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood pressure measurement
Cerebrovascular accident
Headache
Heart rate
Neck pain
Feeling abnormal
Malaise
Nervousness
Nightmare
Oxygen saturation
Neurological symptom
Symptomtext
Like I'm having a stroke; neck ache; nightmares; nervousness; Felt terrible with bad headache; This is a spontaneous report from a contactable consumer (patient). An 86-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EN6200) via an unspecified route of administration on 15Feb2021 13:00 at single dose in left arm for COVID-19 immunisation. She received the first dose of BNT162B2 (lot number: EL9262) on 18Jan2021 13:00 in left arm for COVID-19 immunisation. The patient medical history was not reported. The patient was not pregnant at the time of vaccination. The patient was allergic to Formaldehyde, Coumadin. Concomitant medication included levothyroxine sodium (LEVOXYL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 15Feb2021, the patient felt terrible with bad headache. On 18Feb2021 also felt terrible. On 17Feb2021 08:00, Like she was having a stroke. Headache, neck ache, nightmares, nervousness. Blood pressure was ok. Oxygen was ok. Pulse was ok. No treatment received for the adverse events. Events outcome was not recovered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210217; Test Name: Blood pressure; Result Unstructured Data: Test Result:ok; Test Date: 20210217; Test Name: Pulse; Result Unstructured Data: Test Result:ok; Test Date: 20210217; Test Name: Oxygen; Result Unstructured Data: Test Result:ok
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- LEVOXYL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 03.03.2021
- Impfdatum
- 24.02.2021
- Beginn
- 25.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Cerebrovascular accident
Dysphagia
Gastrointestinal tube insertion
Sensory disturbance
Symptomtext
Right dorsal medullary stroke leading to dysphagia and left-sided sensation changes. First noticed symptoms on 2/25 but did not present to emergency room until 2/27/2021. Patient was hospitalized 2/27/2021; anticipate discharge 3/4 or 3/5 2021. Patient lost ability to swallow; requires tube feeding.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Type 2 diabetes, atherosclerosis of the aorta, MGUS
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 03.03.2021
- Impfdatum
- 25.02.2021
- Beginn
- 26.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cardiac arrest
Death
Symptomtext
Cardiac arrest- death
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- -
- Labordaten
- Squad called by wife on 2/26/2021, wife found patient in full cardiac arrest, patient was transported to Hospital for treatment, please see records for additional information
- Aktuelle Erkrankungen
- none reported
- Vorgeschichte
- A-fib, DM
- Andere Medikamente
- -
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 03.03.2021
- Impfdatum
- 15.02.2021
- Beginn
- 01.02.2021
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Chills
Decreased appetite
Near death experience
Pain
Pyrexia
Vaccination site pain
Vaccination site swelling
Symptomtext
Chills; Fever; aches and pains; no appetite; felt weak as a kitten; injection site got swollen; having pain where the injection occurred; she had felt like she was at death's door; This is a spontaneous report from a contactable consumer (patient). An 80-year-old female patient received the first dose on BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number: EN6200) solution for injection, via an unspecified route of administration in right arm on 15Feb2021 at a single dose for Covid-19 immunization. Medical history included allergies, hip surgery, and foot surgery three times. Concomitant medications included unspecified medications. Patient reported she has been so sick. She got the shot on Monday 15Feb2021, and that same day she got so sick, it was horrible. Patient had chills, fever, aches and pains, and if someone named it, it was there. She stated that before Monday she was 183 pounds, didn't know if it has changed as she has not been on a scale, but she was sure it has because hasn't eaten since Monday, as she has had no appetite. Her appointment was at 07:45, and she went right when she got up, so she did not really have anything to eat on Monday. Patient stated that on Tuesday, she did not eat anything until the evening when she had one piece of pizza. Today, patient has only had a yogurt. Today was the first time she has gotten out of bed and even felt like getting dressed and putting her contacts in, since Monday. The last few days, patient stated that after getting up and going to the bathroom she would walk downstairs and felt weak as a kitten (15Jan2021). Patient stated that she was at least 80% better, because she had felt like she was at death's door (Feb2021), and she was not a wimp, it was just horrible. Patient mentioned that she was on a lot of medicine, probably 10, but this was the first time she was receiving this vaccine. She stated that she was still having pain where the injection occurred (Feb2021), like when her shirt touches it, she can tell it was there. But patient stated that she had the nicest nurse and the injection itself did not hurt, it was just later, and the injection site got swollen (Feb2021). Outcome of the event she had felt like she was at death's door, chills, fever, aches and pains, felt weak as a kitten was recovering; no appetite was not recovered; while the other events was unknown. No follow-up activities are needed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Near death experience
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Allergy; Foot surgery; Hip surgery
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 02.03.2021
- Impfdatum
- 27.02.2021
- Beginn
- 28.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abnormal sensation in eye
Activated partial thromboplastin time normal
Angiogram cerebral normal
Arteriogram carotid normal
Blood magnesium normal
Cerebrovascular accident
Chest X-ray normal
Computerised tomogram head normal
Computerised tomogram neck
Dreamy state
Dyskinesia
Echocardiogram normal
Electroencephalogram
Full blood count normal
Glycosylated haemoglobin normal
Haemoglobin normal
Headache
International normalised ratio normal
Symptomtext
I had my 2nd does of the Pfizer vaccine on February 27, 2021. The next morning I awoke with a very bad headache. I took and Advil. My husband was making breakfast. I came downstairs, ate, had a cup of coffee, then got a glass of water and an ice pack and sat on a recliner in the living room. I don't remember much of the rest. It was like a dream. My husband said I let out a yell, my arms flailed and my eyes were very strange. I lost muscle strength in my lift side mimicking a stroke. He called 911. I was taken to Emergency facility where I gained consciousness. I was then transferred to Hospital. So far every test has come back negative. I have an EEG scheduled for this Thursday.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 2,0
- Labordaten
- MRI Brain Scan Echocardiogram EEG (will be completed soon) Hemoglobin A1C PT/INR/PTT CBC Basic Metabolic Profile Magnesium NCoronovirus PCR XR Chest AP Portable ECG 12-LEAD CT aniography head neck with iv contrast CT head without iv contrast CBC and Differential
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- High Cholesterol
- Andere Medikamente
- Previstatin
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 98,0
- Geschlecht
- F
- Eingang
- 02.03.2021
- Impfdatum
- 16.02.2021
- Beginn
- 24.02.2021
- Tage bis Beginn
- 8,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Computerised tomogram
Death
Diarrhoea
Myocardial infarction
Pain in extremity
Respiratory arrest
Symptomtext
Minor arm pain on 2nd day of each vaccine Diarrhea 3 days after 2nd vaccine Massive heart attack (left ventricle) 8 days (2/24/21) after vaccine Home hospice 3:30pm 2/24/21 Stopped breathing 5:45 am, pronounced dead at 8:22 am on 2/25/21
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- CT scan 2/24/21
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- High blood pressure Stroke 2017 and 2019
- Andere Medikamente
- Aspirin Simvastatin Omeprazole Amlodipine
- Allergien
- Shrimp Hydrochlorothiazide
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 01.03.2021
- Impfdatum
- 23.02.2021
- Beginn
- 23.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Blood glucose
Chills
Death
Decreased appetite
Electrocardiogram
Fatigue
Flank pain
Gait inability
Pyrexia
Resuscitation
Symptomtext
1. Fatigue ? day 1 - Tuesday 2. Loss of appetite ? day 1 Tuesday 3. Fever 102.0 ? day 2 - Wednesday 4. Chills ? day 2 - - Wednesday 5. Weak ? day 2 - - Wednesday 6. Non-ambulatory (unusual) ? day 2 - - Wednesday 7. Two emergency service ambulance assessment ? day 2 - - Wednesday 8. Symptoms improved ? day 3 - Thursday 9. Ambulatory - day 3 - Thursday 10. Symptoms worsened ? day 4 - Friday 11. Chills ? day 4 - Friday 12. Non-ambulatory again ? day 4 - Friday 13. Fever 102.0 ? day 4 - Friday 14. Left side flank pain ? day 4 - Friday 15. CPR and declared decease at home by paramedics - day 5 - Saturday morning @ 1:32am
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- 1. 2/24/2021 at 18:35 ? 12-Lead EKG ? Paramedics 2. 2/24/2021 at 18:30 ? Vital Signs ? Paramedics 3. 2/24/2021 at 13:06 ? Vital Signs ? Paramedics 4. 2/24/2021 at 13:11 ? 12-Lead EKG ? Paramedics 5. 2/24/2021 at 13:06 ? Glucose Check ? Paramedics 6. 2/27/2021 at 01:32 ? Cardiac Arrest Protocol - Paramedics
- Aktuelle Erkrankungen
- No new or acute illnesses reported within the last month
- Vorgeschichte
- 1. Multiple myeloma 2. Atrial Fibrillation 3. COPD ? Emphysema/Asthma 4. Congested Heart Failure 5. Macular degeneration 6. Normal Sp02 ? 90%-92%
- Andere Medikamente
- 1. Xarelto 20mg 2. Digoxin 125mcg 3. Aterbastatin 10mg 4. Escitalopram 10mg 5. Lopressor 50mg 6. Spironolactone 25mg 7. Lasix 20mg 8. Gabapentin 200mg 9. Diazepam 5mg 10. Lisinopril 2.5mg 11. Tylenol 800mg 12. Breoellieta 200/25 13. Spiriva
- Allergien
- 1. Entresto
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 90,0
- Geschlecht
- F
- Eingang
- 01.03.2021
- Impfdatum
- 23.02.2021
- Beginn
- 24.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Cerebrovascular accident
Neurological symptom
Symptomtext
Stroke like symptoms and treated for CVA with Altapace
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- unknown
- Allergien
- Cipro PCN
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 25.02.2021
- Impfdatum
- 17.02.2021
- Beginn
- 18.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood lactic acid increased
Brain natriuretic peptide increased
C-reactive protein increased
Clostridium difficile colitis
Colitis
Computerised tomogram abdomen abnormal
Computerised tomogram thorax abnormal
Cough
Death
Dyspnoea
Endotracheal intubation
Full blood count abnormal
Metabolic function test abnormal
Pneumonia
Sepsis
Symptomtext
Began having SOB and cough on 2/18/21, the day after his first vaccine. Had a routine physician appointment for diabetes on 2/15/21 with no documentation of these complaints. Presented to the hospital on 2/23, soon after required intubation. Admitted with severe pneumonia, diffuse colitis, and sepsis. Condition continued to worsen until patient passed away on 2/24/21 @ 1632.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Nearly all of CMP and CBC abnormal, lactic acid 24.8, CRP 241, BNP >3000. CT of chest/abdomen reveals pneumonia, acute colitis, cirrhosis.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Essential hypertension, benign ? Other and unspecified hyperlipidemia ? Hypertrophy of prostate without urinary obstruction and other lower urinary tract symptoms (LUTS) ? Injury of left rotator cuff ? Adhesive capsulitis of left shoulder ? Suppurative otitis media of both ears ? Bronchitis, acute ? Acute myeloid leukemia in remission ? Type 2 diabetes mellitus without complication ? Acute midline low back pain without sciatica ? Sinistrocardia ? Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene, with long-term current use of insulin ? Thrombocytopenia ? Splenomegaly ? Cirrhosis of liver without ascites ? Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene, with long-term current use of insulin ?
- Andere Medikamente
- Metformin, Lisinopril, Atorvastatin, Aspirin, Dulaglutide, Insulin Glargine, Loratadine, Fenofibrate, Fluticasone, Multivitamin
- Allergien
- Cat hair extract, Pollen extract, Mold and Smuts
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 25.02.2021
- Impfdatum
- 17.02.2021
- Beginn
- 23.02.2021
- Tage bis Beginn
- 6,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Resuscitation
Unresponsive to stimuli
Symptomtext
Resident found unresponsive, CPR initiated and EMS called. EMS called time of death after arrival.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Acute Kidney Failure
- Vorgeschichte
- Cognitive communication deficit, dysphagia, gout, hyperlipidemia, other abnormalities of gait and mobility, personal history of TI and cerebral infarction without residual deficits, unspecified osteoarthritis, benign prostatic hyperplasia with lower urinary tract symptoms, constipation, essential hypertension, history of falling, obstructive and reflux uropathy, overactive bladder, unspecified dementia without behavioral disturbance.
- Andere Medikamente
- Plavix, allopurinol, amlodipine, aspirin, Colace, donepezil, finasteride, losartan potassium, oxybutynin, polyethylene glycol, rosuvastatin, vitamin d, Tamsulosin,
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 25.02.2021
- Impfdatum
- 17.02.2021
- Beginn
- 21.02.2021
- Tage bis Beginn
- 4,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Resuscitation
Unresponsive to stimuli
Symptomtext
Resident found unresponsive in his room. CPR performed and patient expired.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- Not Applicable
- Aktuelle Erkrankungen
- ACUTE ON CHRONIC SYSTOLIC (CONGESTIVE) HEART FAILURE, HYPERTENSIVE CHRONIC KIDNEY DISEASE WITH STAGE 1 THROUGH STAGE 4 CHRONIC KIDNEY DISEASE, OR UNSPECIFIED CHRONIC KIDNEY DISEASE, PARKINSON'S DISEASE, ATHEROSCLEROTIC HEART DISEASE OF NATIVE CORONARY ARTERY WITHOUT ANGINA PECTORIS, CHRONIC KIDNEY DISEASE, STAGE 3 UNSPECIFIED
- Vorgeschichte
- ACUTE ON CHRONIC SYSTOLIC (CONGESTIVE) HEART FAILURE, HYPERTENSIVE CHRONIC KIDNEY DISEASE WITH STAGE 1 THROUGH STAGE 4 CHRONIC KIDNEY DISEASE, OR UNSPECIFIED CHRONIC KIDNEY DISEASE, PARKINSON'S DISEASE, ATHEROSCLEROTIC HEART DISEASE OF NATIVE CORONARY ARTERY WITHOUT ANGINA PECTORIS, CHRONIC KIDNEY DISEASE, STAGE 3 UNSPECIFIED,
- Andere Medikamente
- Pradaxa, Amiodarone, Vitamin C, Atorvastatin, Bumex, Colace, Vitamin B12, ferrous sulfate, Flomax, Flonase, Lyrica, Mag Oxide, Metroprolol Succinate, Potassium, Caridopa-Levadopa, Ultram,
- Allergien
- Ropinirole
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 88,0
- Geschlecht
- M
- Eingang
- 24.02.2021
- Impfdatum
- 22.02.2021
- Beginn
- 23.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Atrial fibrillation
Blood creatinine increased
Blood potassium increased
Blood urea increased
Cerebrovascular accident
Computerised tomogram head normal
Full blood count normal
Hemiparesis
International normalised ratio normal
Muscle twitching
Seizure like phenomena
Symptomtext
Patient brought to emergency department at 2210 with concern for stroke d/t left sided weakness. Upon arrival patient appeared to have seizure like activity and was given 2mg of ativan and keppra 1000mg. Patient remained able to converse with providers during episode. Seizure activity/muscle twitching resolved after ativan/keppra administration. At the time of filing this report the patient is being admitted to the hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- CT of head did not show any acute changes. POC chem 8 with elevated potassium at 5.6, SCr 1.5 (pt baseline 0.9-1.1), BUN 48. CBC wnl INR of 1.2 (pt is on apixaban for afib)
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- hypertension, hyperlipidemia, coronary artery disease, atrial fibrillation, rheumatoid arthritis, h/o SDH (10/2020)
- Andere Medikamente
- allopurinol, amantadine, apixaban, vitamin C, atorvastatin, flonase, folic acid, mucinex, atrovent, irbesartan, multivitamin, methotrexate, metoprolol, montelukast, vitamin E
- Allergien
- mold
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 23.02.2021
- Impfdatum
- 19.02.2021
- Beginn
- 22.02.2021
- Tage bis Beginn
- 3,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Anaphylactic shock
Blood glucose normal
Chills
Diarrhoea
Dizziness
Electrocardiogram
Fatigue
Headache
Loss of consciousness
Nausea
Pain in extremity
Pallor
Paraesthesia
Pulse abnormal
Rash erythematous
Rash papular
Rash pruritic
Seizure
Symptomtext
Anaphylactic shock? Shortly after receiving the vaccine my arm was sore and I had a severe headache. Approximately 24-48 hours after I received the vaccine I started developing a red, hot, itchy raised rash on my ears and buttocks which became more prevalent and peaked around 80-90 hours later. Approximately 82 hours after I received the vaccine, I began to feeI nauseous, dizzy, and fatigued so I stood up to get ready for bed early. While brushing my teeth, I went pale white and felt like I was going to vomit. I put the toothbrush down and got on floor. My pulse felt like it had stopped. I tried to check my pulse and I could only detect one beat every other second. I called for my spouse and by the time he got to bathroom I was passed out. I came back to after about 30 seconds and was convulsing from chills. He put a blanket on me and grabbed my Apple Watch to try to get my pulse which read in the 50s (so I assume it was much lower when I passed out). My hands and feet were tingly and I stayed on the floor until my pulse got back up. I then had diarrhea. At this point in time the rash was most prevalent and was present mostly on my buttocks but also on my ears, scalp, pointer finger on right hand, thighs, and hips. I went to doctor the following morning an my vitals, blood sugar, EKG, urine screen were stable and indicated no issues. 106 hours later I still have the rash on all areas mentioned and am dizzy, nauseous, and fatigued.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic shock
- Hospital-Tage
- -
- Labordaten
- Around 10:30-11:00 am on 2/23/21 I went to the doctor where my vitals, blood sugar, EKG, urine screen were checked and deemed stable and indicated no issues. and was prescribed prednisone.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Omeprazole, Aleve
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 31.05.2023
- Impfdatum
- 05.03.2021
- Beginn
- 06.07.2022
- Tage bis Beginn
- 488,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Adrenal mass
COVID-19
Condition aggravated
Coronavirus test negative
Deep vein thrombosis
Haematuria
Metastases to adrenals
Metastases to lung
Pulmonary mass
Renal mass
Renal vessel disorder
Urogram abnormal
Vaccine breakthrough infection
Vena cava filter insertion
Symptomtext
BREAKTHROUGH COVID: FULLY VACCINATED 66 YR OLD 1. Coronavirus disease 2019 - resolved s/p Paxlovid, completed 7 days of ceftriaxone. Initial diagnosis was on 06/29/2022 and repeat test on July 6 is negative. He does not have any pulmonary symptoms and is not requiring any supplemental oxygen. Gross hematuria, History of deep venous thrombosis, has been on anticoagulation, Leukocytosis, Pulm nodules-s/o metastatic disease, S/P cystoscopy evacuation of blood clots, transurethral prostate vaporization and fulguration 7/7/2022, NEW DX OF DVT - Left Lower Extremity, IVC filter placement 7/13. CT urogram suggestive of large left renal mass with renal vein invasion and metastatic nodules to adrenal and lungs.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- UNKNONWN
- Vorgeschichte
- Diabetes Mellitus,Atrial-Fib,factor II deficiency ,hematuria and clot retention
- Andere Medikamente
- UNKNOWN
- Allergien
- CIPROFLOXACIN, CLINDAMYCIN, KENALOG, LATEX, PENICILLIN
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 31.05.2023
- Impfdatum
- 05.03.2021
- Beginn
- 06.07.2022
- Tage bis Beginn
- 488,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Adrenal mass
COVID-19
Condition aggravated
Coronavirus test negative
Deep vein thrombosis
Haematuria
Metastases to adrenals
Metastases to lung
Pulmonary mass
Renal mass
Renal vessel disorder
Urogram abnormal
Vaccine breakthrough infection
Vena cava filter insertion
Symptomtext
BREAKTHROUGH COVID: FULLY VACCINATED 66 YR OLD 1. Coronavirus disease 2019 - resolved s/p Paxlovid, completed 7 days of ceftriaxone. Initial diagnosis was on 06/29/2022 and repeat test on July 6 is negative. He does not have any pulmonary symptoms and is not requiring any supplemental oxygen. Gross hematuria, History of deep venous thrombosis, has been on anticoagulation, Leukocytosis, Pulm nodules-s/o metastatic disease, S/P cystoscopy evacuation of blood clots, transurethral prostate vaporization and fulguration 7/7/2022, NEW DX OF DVT - Left Lower Extremity, IVC filter placement 7/13. CT urogram suggestive of large left renal mass with renal vein invasion and metastatic nodules to adrenal and lungs.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- UNKNONWN
- Vorgeschichte
- Diabetes Mellitus,Atrial-Fib,factor II deficiency ,hematuria and clot retention
- Andere Medikamente
- UNKNOWN
- Allergien
- CIPROFLOXACIN, CLINDAMYCIN, KENALOG, LATEX, PENICILLIN
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 19.04.2023
- Impfdatum
- 06.10.2021
- Beginn
- 01.01.2022
- Tage bis Beginn
- 87,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Blood test
Computerised tomogram
Diaphragmatic paralysis
Dyspnoea
Magnetic resonance imaging
Surgery
X-ray
Symptomtext
See my comment above
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diaphragmatic paralysis
- Hospital-Tage
- 10,0
- Labordaten
- X-rays, fluorescent X-ray, CAT scan, MRI, 6 minute walks, and many more from April 2022 thru February 2023. Too many blood tests to list here
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- I began struggling with breathing issues in January 2022. April 4, 2022 I complained to by primary care doctor about difficulties breathing. By May 2022 I was diagnosed with a paralyzed diaphragm. October 13,2022 I had first surgery. January 2023 I had a secon open body surgery. I am breathing better but still struggling in recovery
- Andere Medikamente
- Atorvastatin, Venlafaxine, Ramipril, Clopidogrel, Levothyroxine, and Metformin.
- Allergien
- Dog dander and Phyzer booster shot(3rd vaccination)
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 17.04.2023
- Impfdatum
- 23.01.2021
- Beginn
- 01.01.2022
- Tage bis Beginn
- 343,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bronchial disorder
Eye pruritus
Lacrimation increased
Prostate cancer
Prostatic specific antigen
Pulmonary congestion
Sneezing
Thrombosis
Symptomtext
Allergies - seasonal sneezing, itchy watery eyes has Continued All year; affects bronchial problems, seem to be much more susceptible to upper lung congestions /concerns big uptick in PSA test results relating to Prostrate cancer; strange blood clotting with hair follicles;
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- PSA- 2020, 2021, 2022
- Aktuelle Erkrankungen
- none / light cold
- Vorgeschichte
- none
- Andere Medikamente
- see list
- Allergien
- non realized
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 21.02.2023
- Impfdatum
- 01.02.2021
- Beginn
- 17.10.2022
- Tage bis Beginn
- 623,0
- Dosis
- 3
- Route/Site
- SYR / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Back pain
Chest pain
Laboratory test abnormal
Myocarditis
Pain in extremity
Symptomtext
Arms, chest & back began to ache. No signs prior, felt fine, standing checking into my Dr.?s office for a regular checkup. . I was sent to urgent care & then to hospital . Many tests were given. Diagnosis was myocarditis. My Heart Dr. issued another text & the result is apparently it has healed itself. Very odd considering I have been extremely healthy only bring in a hospital 3 times. Which were elective. No heath issues whatsoever.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- -
- Labordaten
- All are documented with my primary Dr. Too many tests to text. I was in the hospital from the 10/17/22 & discharged 10/18/22.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Alprazolam, Celexa, Flonase, Zyrtec, simvastatin
- Allergien
- Some antibiotics., that?s it
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 21.02.2023
- Impfdatum
- 23.03.2021
- Beginn
- 20.01.2023
- Tage bis Beginn
- 668,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Syncope
Symptomtext
Hospitalization: 1/20/2023 - 1/22/2023 (2 days) Presentation to the ED: syncopal episode COVID + date: 1/20/2023 Treatment: no treatment required. Discharge to: HOME. EN6200 3/1/2021 EN6199 3/23/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- DEMENTIA, HTN, AFIB, alcohol dependence
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 04.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 01.01.2023
- Tage bis Beginn
- 257,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asymptomatic COVID-19
Presyncope
SARS-CoV-2 test positive
Symptomtext
Hospitalization: 1/1/2023 - 1/2/2023 (30 hours). Presentation to the ED: near syncopal episode. COVID + date: 1/1/2023 Treatment: asymptomatic; NO TREATMENT INDICIATED. Discharge to: home. EN5318 1/29/2021 EN6200 2/19/2021 PAA173697 11/5/2021 FK9893 4/19/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- CAD.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 21.12.2022
- Impfdatum
- 06.02.2021
- Beginn
- 05.10.2022
- Tage bis Beginn
- 606,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anticoagulant therapy
Atrial fibrillation
COVID-19
Cardioversion
Imaging procedure abnormal
Intensive care
Peripheral artery stenosis
SARS-CoV-2 test positive
Surgery
Symptomtext
This is a 75y.o. female with history of PAD with difficulty ambulating who presented on 10/5/2022 for surgery. Findings on imaging consistent with left popliteal artery stenosis. Pt underwent procedure listed above which they tolerated well without complication, see operative report for full details. She went into afib with RVR in the PACU requiring ICU admission. She was started on a cardizem gtt and converted to NSR. She was then started on a heparin gtt and transitioned to Eliquis. Patient recovered well. Hospital course significant for afib with RVR.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- -
- Labordaten
- 10/5 SARS-CoV-2 -COVID-19 by NAA, Micro -- detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 09.12.2022
- Impfdatum
- 18.02.2021
- Beginn
- 08.11.2022
- Tage bis Beginn
- 628,0
- Dosis
- 3
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Arthralgia
COVID-19
Discoloured vomit
Intensive care
Lethargy
Mental status changes
Productive cough
Respiratory distress
SARS-CoV-2 test positive
Symptomtext
Pt to ED 11/8 for AMS, lethargy. Pt COVID+ 11/8. 11/9 pt in resp distress, transfer to ICU. 11/12 pt coughing up a moderate amount of brown/tan Phlegm, thick. Also emesis noted small amount times one dark green in color. 11/15 Pt a/o x4, room air, complaints of chronic pain in left hip, vital signs stable, afebrile. Pt discharged 11/21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 14,0
- Labordaten
- see above
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Acute respiratory failure with hypoxia (CMS/HCC) Acute respiratory failure with hypoxia (CMS/HCC) Oropharyngeal dysphagia Pneumonia due to COVID-19 virus Acute respiratory failure with hypoxemia (CMS/HCC) Nausea and vomiting Morbid obesity with BMI of 50.0-59.9, adult (CMS/HCC) Cellulitis of right lower extremity Pain Bradycardia Morbid obesity (CMS/HCC) Toxic metabolic encephalopathy Acute renal failure with tubular necrosis (CMS/HCC) Hyperkalemia, diminished renal excretion Metabolic acidosis, increased anion gap Atrial fibrillation with RVR (CMS/HCC) UTI due to extended-spectrum beta lactamase (ESBL) producing Escherichia coli Wounds, multiple Acute blood loss anemia Acute deep vein thrombosis (DVT) of right upper extremity (CMS/HCC) Septic shock (CMS/HCC) COVID-19 virus infection Hypomagnesemia Hyperkalemia Acute renal failure with acute tubular necrosis superimposed on stage 3a chronic
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG PO Tab apixaban acetaminophen (TYLENOL) 500 MG PO Tab apixaban (ELIQUIS) 5 MG PO Tab bumetanide (BUMEX) 2 MG PO Tab calcitriol (ROCALTROL) 0.5 MCG PO Cap chlorthalidone (HYGROTON) 25 MG PO Tab cyclobenzaprine
- Allergien
- Codeine
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 06.11.2022
- Impfdatum
- 01.03.2021
- Beginn
- 01.04.2021
- Tage bis Beginn
- 31,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Arthralgia
Blood test abnormal
Dyspnoea
Electromyogram abnormal
Guillain-Barre syndrome
Muscle enzyme increased
Muscular weakness
Nerve injury
Symptomtext
Muscle weakness and joint pain and shortness of breath started after second vax ..got better then got 1st booster in November 2021 and all symptoms became worse and still have them 1 year later...neurologist diagnosis is GBS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Guillain-Barre syndrome
- Hospital-Tage
- -
- Labordaten
- Numerous bloodtest show elevated muscle enzymes EMG show some nerve damage
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 07.09.2022
- Impfdatum
- 18.02.2021
- Beginn
- 06.06.2021
- Tage bis Beginn
- 108,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: ja
Blood test normal
Chest discomfort
Computerised tomogram abnormal
Dizziness
Dyspnoea
Gait disturbance
Pulmonary hypertension
Pulmonary thrombosis
SARS-CoV-2 test
Thromboembolectomy
Ultrasound Doppler
Symptomtext
For a couple of weeks prior to event, I was short of breath and occasionally light headed. That day I had a very difficult time breathing, pressure in my chest, and too dizzy to walk. Ambulance took me to emergency room where a scan showed a six inch blood clot across the saddle of my lungs. A specialist was able to go into my lungs through my groin and suck out the clot. Three doctors told me I was lucky to be alive.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary thrombosis
- Hospital-Tage
- 4,0
- Labordaten
- Covid testing, Full body CT scan, leg sonogram, and blood tests were done in the hospital and again a few weeks after discharge. Even more extensive blood tests were done. Everything showed normal. No explanation for the clot formation. It also caused pulmonary hypertension.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- high blood pressure
- Andere Medikamente
- lisinopril, pravastatin, potassium, multivitamin, coq10, omega3
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 07.09.2022
- Impfdatum
- 25.03.2021
- Beginn
- 01.04.2022
- Tage bis Beginn
- 372,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Anticoagulant therapy
Pain in extremity
Peripheral swelling
Thrombosis
X-ray abnormal
Symptomtext
Blood clot in left leg. Left leg was extremely swollen and in pain. Initially admitted into Hospital. The hospital administered and IV and took X-rays to verify the blood clot. The doctor advised it was a ?very rare blood clot? and was further told I ?should never have gotten this blood clot? and there was ?no reason?.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- 1,0
- Labordaten
- After Hospital, I went back home to see my primary care doctor- Dr. He prescribed a blood thinner. I was then referred to hematologist Dr. Confirmed blood clot with no reason or explanation. I continue to have a swollen and sore leg. I was advised to continue taking a blood thinner for 3 more months.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- High blood pressure medication, statin medication, acid reflux medication
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 25.02.2021
- Beginn
- 22.08.2022
- Tage bis Beginn
- 543,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
Memory impairment
Oropharyngeal pain
SARS-CoV-2 test positive
Seizure like phenomena
Unresponsive to stimuli
Symptomtext
Pt to ED 8/18 for intermittent periods of becoming unresponsive. Pt having seizure like activity. 8/20 No seizure like activity, patient denies any chest pain/SOB, denies pain. Stated that lately she has become "more forgetful". Patient is A&O x 4, no S/S of acute distress noted. 8/21 no seizure like activity, VSS and no S/S of acute distress. 8/22 pt COVID+, not a candidate for antiviral therapy. 8/24 pt with sore throat. Pt discharged 8/25.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure like phenomena
- Hospital-Tage
- 8,0
- Labordaten
- see above
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- OSA on CPAP ...OSA on CPAP Preop cardiovascular exam Coronary artery disease involving native heart Obesity (BMI 35.0-39.9 without comorbidity) Mixed hyperlipidemia Essential hypertension Peripheral edema Status post cardiac catheterization OA (osteoarthritis) of knee S/P total knee arthroplasty, left Anxiety H/O: gout HLD (hyperlipidemia) Activity somewhat limited Acute blood loss anemia Elevated serum creatinine Syncope AMS (altered mental status) Fever Seizure disorder (CMS/HCC) AKI (acute kidney injury) (CMS/HCC) Ischemic cardiomyopathy Breakthrough seizure (CMS/HCC)
- Andere Medikamente
- amLODIPine (NORVASC) 10 MG PO Tab ...amLODIPine (NORVASC) 10 MG PO Tab aspirin 81 MG PO Chew Tab latanoprost (XALATAN) 0.005 % OPHTH Solution levETIRAcetam (KEPPRA) 1000 MG PO Tab meclizine (ANTIVERT) 25 MG PO Tab NUTRITIONAL SUPPLEMENTS PO
- Allergien
- Penicillins
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 42,0
- Geschlecht
- M
- Eingang
- 22.07.2022
- Impfdatum
- 14.03.2021
- Beginn
- 20.07.2022
- Tage bis Beginn
- 493,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood test abnormal
Deep vein thrombosis
Symptomtext
DVT Right leg. Mid Femoral Vein all the way down to mid Calf past triforcation and superficial gastroc.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- 1,0
- Labordaten
- 7/21/22: ER blood tests. positive for DVT.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 26.02.2021
- Beginn
- 18.05.2022
- Tage bis Beginn
- 446,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
Chest injury
Dyspnoea
Epistaxis
Haemoptysis
International normalised ratio increased
SARS-CoV-2 test positive
Syncope
Symptomtext
Patient admitted 5/18 with complaint of SOB, epistaxis, and had a syncopal episode while at PCP office. Injury to lower left anterior ribs and INR was elevated. COVID test came back positive 5/18. Patient continues to have occasional nose bleeds and continues to cough up scant amount of blood. Patient was seen and started on remdesivir and also on ceftriaxone. Patient did complain of cough and shortness of breath denied any chest pain no nausea no vomiting no frequency urgency no dysuria hematochezia hematemesis melena no dizziness no diaphoresis no bleeding and no rash 5/23. Discharged home 5/25.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- 8,0
- Labordaten
- see above
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- COPD, CAP ... CAP (community acquired pneumonia) Chronic obstructive pulmon Chronic obstructive pulmonary disease with acute exacerbation (CMS/HCC) Hematemesis TIA (transient ischemic attack) Chest pain Low back pain Multiple-type hyperlipidemia Coronary artery disease involving native heart Benign essential hypertension Fall Hypotension Severe major depression, single episode (CMS/HCC) Anxiety Palpitation S/P angioplasty with stent Chronic systolic CHF (congestive heart failure) (CMS/HCC) Ejection fraction < 50% S/P cardiac cath Drug-induced hypokalemia Obesity (BMI 30-39.9) STEMI (ST elevation myocardial infarction) (CMS/HCC) Acute chest pain Pulmonary embolism, unspecified chronicity, unspecified pulmonary embolism type, unspecified whether acute cor pulmonale present (CMS/HCC) HFrEF (heart failure with reduced ejection fraction) (CMS/HCC) Anemia Acute respiratory distress Supratherapeutic INR
- Andere Medikamente
- albuterol (2.5 MG/3ML) ... albuterol (PROVENTIL, VENTOLIN, PROAIR) HFA 108 (90 Base) MCG/ACT INHAL Aero Soln ALPRAZolam (XANAX) 1 MG PO Tab atorvastatin (LIPITOR) 40 MG PO Tab clopidogrel (PLAVIX) 75 MG PO Tab ferrous sulfate 325 (65 Fe) MG
- Allergien
- penicillins, seafood
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 25.02.2021
- Beginn
- 17.05.2022
- Tage bis Beginn
- 446,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Abdominal pain lower
COVID-19
Chest pain
Cholelithiasis
Nausea
Pain
Syncope
Ultrasound abdomen abnormal
Vomiting
Symptomtext
Patient admitted 5/17. The patient complains of left and right lower abdominal pain associated with nausea and vomiting. She was evaluated in the ED and was found to have COVID-19 infection 5/17. Patient also complained of having chest pain. Patient describes that her chest pain started before the nausea and vomiting and feels like a sting and then the nausea and vomiting started. She describes having a syncopal event PTA. Patient does have a history of chronic abdominal pain. The patient underwent an ultrasound of the abdomen, which revealed findings consistent with cholelithiasis, no evidence of cholecystitis. No fevers, no chills. Dishcharged home 5/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- 6,0
- Labordaten
- see above
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- asthma, Mallory-Wiess tear, Acute focal neurological deficit Syncope Epistaxis, recurrent Symptomatic anemia Obesity (BMI 30-39.9) Chest pain NSTEMI (non-ST elevated myocardial infarction) S/P CABG (coronary artery bypass graft) Coronary artery disease involving native heart Essential hypertension Hyperlipidemia SOB (shortness of breath) CAD (coronary artery disease) Hematochezia Acute renal failure (ARF) Hematuria Essential hypertension, malignant
- Andere Medikamente
- albuterol (PROVENTIL, VENTOLIN, PROAIR), albuterol (PROVENTIL, VENTOLIN, PROAIR) HFA 108 (90 Base) MCG/ACT INHAL Aero Soln amLODIPine (NORVASC) 10 MG PO Tab Ascorbic Acid 500 MG PO Tab aspirin (HALFPRIN) 81 MG PO Tablet Delayed Response ato
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 11.05.2022
- Impfdatum
- 24.02.2021
- Beginn
- 10.02.2022
- Tage bis Beginn
- 351,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Presyncope
SARS-CoV-2 test positive
Symptomtext
02/10/22 presents to ED for "Pre-syncope". PMHx of "hypothyroidism, dyslipidemia, history of CVA and dementia"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- 02/11/22 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 02.05.2022
- Impfdatum
- 16.02.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 258,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal distension
Aspartate aminotransferase increased
Blood alkaline phosphatase increased
Blood lactic acid decreased
COVID-19
COVID-19 pneumonia
Cardiac failure congestive
Chest X-ray abnormal
Computerised tomogram thorax abnormal
Dyspnoea
Dyspnoea exertional
Hypertension
Hypertransaminasaemia
Hypervolaemia
Hypoxia
Laboratory test abnormal
Lactic acidosis
Leukopenia
Symptomtext
COVID Vaccine Breakthrough Case Pfizer Dose 1 2/16/21 (EN6200) COVID Positive 11/6/21 11/6/21: Patient is a 85 year old male who presented to ED via EMS with complaints of shortness of breath. Patient has been experiencing increased shortness of breath since February of this year, with bilateral lower extremity swelling. His symptoms have progressively worsened over the past several days. His daughter is at bedside and notes that he has had increased abdominal bloating for the past several days. He has had increased dyspnea with exertion and while lying flat. He was seen by pulmonology October 24th with no definitive diagnosis for his fluid overload. He has been taking Lasix 20 mg daily. He had a high-resolution CT on November 5th which showed bilateral pleural effusions and pericardial effusion, with possible superimposed multilobar pneumonia or viral pneumonitis. He denies any recent fevers. He does endorse a productive cough with some mucus production, especially while lying flat. He denies any recent nausea, vomiting or diarrhea. No chest pain. He has been fully COVID-19 vaccinated. He does not currently wear any home oxygen. He has a past medical history significant for hyperlipidemia, BPH and history of PE anticoagulated on Eliquis. On arrival to ED the patient was hypertensive 160/48 and hypoxic on room air at 87%. The patient was put on 5 L nasal cannula with improvement oxygen saturations to 95%. Laboratory findings were significant for transaminitis AST 66 and ALP 192. Lactic acidosis 2.5. ProBNP 772. Troponin 0.03. Leukopenia 2.11. Chest x-ray shows findings suggestive of CHF with bibasilar airspace disease most suggestive of pulmonary edema. Rocephin and Zithromax were initiated in ED. DuoNeb treatment given. Lasix 40 mg IV given in ED. 11/27/21: An 85-year-old gentleman presented to the emergency room with worsening shortness of breath. Patient reports some subjective fever. He tested positive for COVID, eventually admitted COVID-19 pneumonia. Patient was noted to be hypoxic, was treated with dexamethasone, remdesivir, empiric antibiotic therapy. The patient's condition progressively improved. Currently he is down to 3 L of oxygen via nasal cannula. He is deconditioned, and will be discharged to skilled for further physical conditioning.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary oedema
- Hospital-Tage
- 22,0
- Labordaten
- -
- Aktuelle Erkrankungen
- edema renal stone SOB HLD BPH h/o PE anticoagulated on Eliquis
- Vorgeschichte
- edema renal stone SOB HLD BPH h/o PE anticoagulated on Eliquis
- Andere Medikamente
- acetaminophen 500 mg PO QID PRN ascorbic acid 1 tab PO QD furosemide 20 mg PO BID KCl 20 mEq PO BID zinc 1 tab PO QD
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 24.03.2022
- Impfdatum
- 01.03.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: ja
Erholt: nein
Bell's palsy
Symptomtext
partial paralysis of the right side of my face/Bells Palsy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 22 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 01Mar2021 (Lot number: EN6200) at the age of 22 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1; lot EL9265), administration date: 08Feb2021, when the patient was 22 years old, for COVID-19 immunization. The following information was reported: BELL'S PALSY (disability) with onset 01Mar2021, outcome "recovered with sequelae", described as "partial paralysis of the right side of my face/Bells Palsy". The event "partial paralysis of the right side of my face/bells palsy" was evaluated at the physician office visit and emergency room visit. Therapeutic measures were taken as a result of bell's palsy included doxycycline, and methylprednisolone. Additional information: It was reported that the patient had no covid prior vaccination and was not covid tested post vaccination. Patient had no known allergies. It was reported that after her second dose, she had partial paralysis of the right side of her face. The day after she got the second dose, she called her dermatologist and they told her to go to the ER. Once she arrived, the stroke team ruled out having a stroke. She was diagnosed with having Bells Palsy and the doctors believed it was caused by the Pfizer vaccine. The patient had no other vaccine in 4 weeks and no other medications in 2 weeks. The patient received 3rd dose of Pfizer vaccine on 28Dec2021 (lot FJ1611). No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: Other medical history: No
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 18.03.2022
- Impfdatum
- 23.02.2021
- Beginn
- 01.05.2021
- Tage bis Beginn
- 67,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: ja
ER: ja
Erholt: nein
Anticoagulant therapy
Back pain
Blood test
Immunisation reaction
Magnetic resonance imaging normal
Malaise
Pain
Pain in extremity
Peripheral artery thrombosis
Pyrexia
Thrombosis
Ultrasound scan abnormal
Symptomtext
Second dose 3/15/21. Lot #EN6204. I got sick from the second shot and had 104 fever, horrible back ache and general body aches for 24 hours. A couple of week after the second shot I started getting leg pain behind my knee. I was concerned it was something and kept an eye on it. It kept getting worse and I was worried it was a blood clot. This went on for months. I had an ultra sound and they found a lesion and ordered an MRI. The MRI said the lesion was gone. Then the problem kept getting worse. I decided it was a muscle and went to rub it out. When I did It felt like a garden hose in my leg so I felt confident it was a blood clot. I went to urgent care and told them I thought I had a blood clot. They said they didn't think so and refused to do an ultrasound. That was Saturday Monday I went to my primary physician and there was a purple line where my vein was. They said they didn't think it was a blood clot but sent me to my cardiologist to verify. My cardiologist verified it was a blood clot. I had them in both lets from my ankles to my groin and 50% of my femoral artery. I was put on permanent blood thinners and had several tests done. I went to a vein specialist and they could not determine what it was from. My primary felt it was associated with the vaccine since the vascular doctor felt it had been accumulating over time. I do have heterzygos Factor V Leiden. I had a PE with no known DVT in 2007 and a heart attack in 2013
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Peripheral artery thrombosis
- Hospital-Tage
- -
- Labordaten
- Ultrasound, MRI Ultrasound. various blood tests
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- High blood pressure being treated, coronary artery disease, , anxiety
- Andere Medikamente
- Metroprolol, pantaprolol, clopidigril, aspain, Alive 55+ Vitamin, praulent, welbuterine, zyrtec
- Allergien
- celery, shrimp
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 07.03.2022
- Impfdatum
- 29.09.2021
- Beginn
- 25.02.2022
- Tage bis Beginn
- 149,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Abnormal loss of weight
Adult failure to thrive
Anaemia
Biopsy
Blood lactic acid normal
Blood potassium decreased
Blood sodium decreased
COVID-19
COVID-19 pneumonia
Computerised tomogram abdomen abnormal
Computerised tomogram thorax abnormal
Condition aggravated
Cough
Decreased appetite
Dehydration
Diarrhoea
Fatigue
Fluid balance positive
Symptomtext
Hospitalized (2.25.22 - 3.5.22); COVID positive; Fully vaccinated PLUS booster Discharge Provider: MD Primary Care Provider: DO Admission Date: 2/25/2022 Discharge Date: Mar 5, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Unintentional weight loss Pneumonia due to COVID-19 virus COVID-19 HOSPITAL COURSE: 70-year-old female with past medical history for follicular lymphoma status post chemotherapy (last treatment 12/2021), depression, history of Roux-en-Y bypass. She presented to emergency department with failure to thrive, nausea, diarrhea, inability to tolerate oral intake. Incidentally tested positive for COVID-19 pneumonia. Patient was vaccinated and boosted. On arrival to emergency department she is hemodynamically stable and breathing comfortably on room air. Labs notable for leukopenia (stable), mild anemia, thrombocytopenia as expected. Metabolic profile showed hypokalemia, indeterminate procalcitonin, normal lactic acid. She was given some potassium and admitted to a HCF for assessment management. Hematology-Oncology were consulted recommended supportive management. Felt failure to thrive was related to COVID-19 pneumonia. However patient did not develop worsening symptoms for COVID and still despite that had poor oral intake and weight loss. A CT abdomen pelvis showed findings of mild positive fluid balance otherwise no acute findings in abdomen pelvis. Speech therapy evaluated patient, recommended VFSS which showed esophageal dysmotility. Gastroenterology was consulted patient underwent EGD which was relatively unremarkable. Biopsies were taken and pending at the time of discharge. During her stay in the hospital patient did receive Corpak in tube feeds, tolerated these well. Corpak was removed and nutrition was monitored. She was started on Remeron. Patient was able to meet caloric intakes by oral intake. Nausea diarrhea had resolved. Patient was also hospitalized for syncope/orthostatic hypotension. Improved with supportive measures, hydration. She was started on Florinef with improvement in her symptoms. She is being discharged in stable and improved condition with instructions follow-up with primary care physician and primary hematologist. Of note patient's sodium did rise towards the end of her hospital stay, attributed to tube feeds that were previously running. Recommended patient encourage oral hydration/intake and outpatient follow-up with blood work. She expressed understanding.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- 8,0
- Labordaten
- -
- Aktuelle Erkrankungen
- 2.7.22; Called local Infectious Diseases Office - Patient contacted the agency with reports of testing positive for Covid on January 20th. Patient reports continued mild symptoms; Fatigue, Cough, and occasional HA. Reviewed OTC medication to treat symptoms. Offered sick visit but patient declined at this time. Patient is immunocompromised so reviewed 20 day quarantine. Reviewed when to seek further evaluation. Patient agrees with plan. 2.23.22: PET CT Torso (thorax abdomen pelvis) - 1. No definite FDG evidence of active lymphoma, but there are number of confounding findings limiting metabolic evaluation. 5PS=2. 2. Central mesenteric fat stranding with associated marked avidity is presumed inflammatory, but could reflect an atypical presentation of lymphoma, and limits evaluation of the region. 3. Diffuse groundglass densities throughout the lungs are new from 9/10/2021, and are suspicious for pneumonia; this is a typical presentation of COVID. Likely associated reactive bone marrow and splenic uptake. 4. Diffuse colonic activity with liquid stool is likely inflammatory associated with diarrhea. 2.25.22: Family Medicine appt: Pneumonia due to COVID-19 virus (Primary Dx); Dehydration; Anorexia; Gastroesophageal reflux disease, unspecified whether esophagitis present; Esophageal thickening; Gastritis without bleeding, unspecified chronicity, unspecified gastritis type; Follicular lymphoma of intra-abdominal lymph nodes, unspecified follicular lymphoma type (CMS/HCC)
- Vorgeschichte
- Vitamin D deficiency Urge incontinence Thyroid adenoma Seasonal allergies Depression Overactive bladder Osteoporosis Malignant neoplasm of skin Iron deficiency anemia Hypertension Follicular lymphoma of intra-abdominal lymph nodes (HCC) GERD (gastroesophageal reflux disease) Cold thyroid nodule Kidney stones Unspecified severe protein-calorie malnutrition (HCC) Goals of care, counseling/discussion Cancer-related pain Nausea
- Andere Medikamente
- acyclovir (ZOVIRAX) 400 MG tablet alendronate (FOSAMAX) 70 MG tablet calcium citrate (CALCITRATE) 950 (200 Ca) MG tablet cholecalciferol (VITAMIN D3) 25 MCG (1000 UT) tablet Cyanocobalamin (VITAMIN B 12 PO) fludrocortisone (FLORINEF) 0.1 MG
- Allergien
- Environmental NsaidsOther
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 28.02.2022
- Impfdatum
- 27.02.2021
- Beginn
- 27.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Aphasia
Breath odour
Bundle branch block left
Chest X-ray
Computerised tomogram head
Congestive cardiomyopathy
Diplopia
Dyspnoea
Echocardiogram
Ejection fraction
Electrocardiogram
Feeding disorder
Intensive care
Left ventricular failure
Magnetic resonance imaging head
Oesophagogastroduodenoscopy
Oropharyngeal pain
Pharyngeal cyst
Symptomtext
The same day I got vaccination I was sitting down, and I was having vision problems. I briefly twice within 5-10 mins I realized that I could see perfectly but if I had two eyes open, I had double vision. I drove like that to the ER, I started to get a sore throat while I was there, they did brain scan EKG, brain MRI, chest X-ray, Blood vessel of the head, CT scans of my brain EDG, Echo brain. The next day they diagnosed me with left BBB, that was the cause that attacked my heart, and also with dilated with chariot mythology. They sent me home even with a sore throat. It got to the point that I couldn't talk, eat or even breath. I had bad breath when I woke up. I went back to the hospital a couple of days after. They did some neck scans, CT scans and gave me antibiotics through an IV. They found 3 cysts on my throat which is affecting my voice box. They admitted me to a critical care floor for a couple of days. They said my condition was retropharyngeal. A couple of month later they found heart failure of left side with ingestion fracture 31/40 percent.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 5,0
- Labordaten
- Brain scan, EKG, brain MRI, chest X-ray, Blood vessel of the head, CT scans of my brain, EDG, Echo brain.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Shingles
- Andere Medikamente
- Acyclovir
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 21.02.2022
- Impfdatum
- 05.03.2021
- Beginn
- 03.09.2021
- Tage bis Beginn
- 182,0
- Dosis
- 2
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Anticoagulant therapy
Aortic occlusion
Arteriogram coronary abnormal
COVID-19
COVID-19 pneumonia
Cough
Endotracheal intubation
Fibrin D dimer increased
Haemoglobin abnormal
Hypoxia
Muscular weakness
Pain
Respiratory distress
SARS-CoV-2 test positive
Surgery
Thrombectomy
Symptomtext
Presents for cough, body aches, BLE weakness; COVID + 1wk PTA. Found to be hypoxic in ER. Admit for COVID & respiratory distress. Tx: O2 (intubated for emergent surgical procedure but extubated on hospital day 2 to high flow O2), abx, steroids, vit c, vit d, zinc, remdesivir, barcitinib. Elevated d-dimer & CTA shows acute aortic occlusion; emergent thrombectomy performed on hospital day 1. For the COVID pneumonia she was treated with IV steroids remdesivir and barcitinib. and blood thinners restarted after hemoglobin stable. For the COVID pneumonia she was treated with IV steroids remdesivir and barcitinib. weaned off oxygen down to 2 L. DC'd to Home w/ Home Health.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Respiratory distress
- Hospital-Tage
- 18,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 93,0
- Geschlecht
- F
- Eingang
- 18.02.2022
- Impfdatum
- 12.01.2021
- Beginn
- 06.01.2022
- Tage bis Beginn
- 359,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Aggression
Blood creatinine increased
Blood culture
Blood gases
Blood pH decreased
Brain natriuretic peptide increased
C-reactive protein
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Condition aggravated
Cough
Dyspnoea
Electrocardiogram ST segment depression
Electrocardiogram abnormal
Extra dose administered
Fatigue
Haemoglobin decreased
Symptomtext
Pt to ED for respiratory distress and cough. Oxygen saturation on room air was less than 50%, improving to 81% on 12 L of non-rebreather and 100% on 15 L non-rebreather. In severe respiratory distress with rhonchi and had some peripheral edema. Labs showed a creatinine of 1.25. WBC count of 19.0, hemoglobin 9.1. ABG showed a pH of 7.28, PO2 264. BNP level was 406. Chest x-ray showed pleural and parenchymal opacity in the right lung base suggesting a combination of a small pleural effusion and right lower lobe infiltrate. A 12-lead EKG was reviewed showing sinus tachycardia with diffuse ST-segment depressions. Admitted for management of pneumonia COVID + 1/6/21. Found to have troponin elevation. Discharged.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Respiratory distress
- Hospital-Tage
- 12,0
- Labordaten
- see above
- Aktuelle Erkrankungen
- 2/21/21 to 3/31/21 ED for increasing SOB associated with 2 cough and fatigue. Evaluation in the emergency room included a COVID screen which was negative. A subsequent chest x-ray revealed chronic parenchymal changes and she was noted to have chronic nonhealing ulcer of the heel, which was suspected to have osteomyelitis. So, she was admitted for further care and Infectious Disease and Podiatry were consulted. She was placed on broad-spectrum antibiotic therapy. Subsequently, Podiatry evaluated the patient and find no evidence of osteomyelitis and they recommended continuing wound care and obtained blood cultures, sedimentation rate and CRP to evaluate further. Infectious Disease also evaluated the patient. Subsequent imaging failed to reveal any signs of osteomyelitis and she was symptomatically treated. During the course of the hospitalization, she also was seen to have aggressive behavior as part of her vascular dementia, which were treated with initiation of risperidone. she was discharged home via ambulance.
- Vorgeschichte
- Acute encephalopathy,Bilateral pneumonia Chest pain,CVA (cerebral vascular accident); Essential hypertension Hypokalemia Hypomagnesemia Hypoxia Ischemic cardiomyopathy Normochromic normocytic anemia Obesity (BMI 30-39.9) Osteomyelitis Sepsis SIRS (systemic inflammatory response syndrome) UTI (urinary tract infection)
- Andere Medikamente
- amLODIPine (NORVASC) , atorvastatin (LIPITOR); Cholecalciferol (VITAMIN D-1000 MAX ST PO) ferrous sulfate 325 (65 Fe) MG PO Tab furosemide (LASIX) 20 MG PO Tab lisinopril (PRINIVIL, ZESTRIL) 10 MG PO Tab magnesium oxide (MAG-OXIDE) 400 MG P
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 15.02.2022
- Impfdatum
- 10.11.2021
- Beginn
- 02.02.2022
- Tage bis Beginn
- 84,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Anticoagulant therapy
Asymptomatic COVID-19
Blood sodium decreased
COVID-19
Eye injury
Eye operation
Eye pain
Eye swelling
Facial bones fracture
Fall
Hyponatraemia
Intraocular pressure test normal
Orbital haematoma
SARS-CoV-2 test positive
Syncope
Symptomtext
Patient states she had a syncopal episode getting out of the shower 01/25/2022. Had a mild prodrome. Fell striking her right eye. Was seen at an outside facility where imaging showed zygomatic fractures. Ocular pressure stable. Also incidentally found COVID positive the same date. Asymptomatic. Is fully vaccinated. Has been following with Ophthalmology. As of this morning had increasing right eye swelling and pain so presented for cares. Imaging here showed retro-orbital hematoma. Warfarin reversed with Kcentra and 10 mg of vitamin K. Seen by Ophthalmology who performed Right lateral canthotomy/cantholysis. Eyedrops prescribed. Patient was also found to be hyponatremic at 123. She has run slightly hypo
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 08.02.2022
- Impfdatum
- 26.02.2021
- Beginn
- 26.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Angiogram
Arthralgia
Asthenia
Chest pain
Echocardiogram
Electrocardiogram
Hypotension
Myocarditis
Troponin
Symptomtext
Chest pain, joint pain, low blood pressure, weakness starting at 5pm. Symptoms continued to worsen until 3/1/2021 went to the hospital. Treated for myocarditis.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- 3,0
- Labordaten
- Troponin 3/1/21 Angiogram 3/1/21 Echocardiogram 3/1/21 EKG 3/1/21 Troponin 3/2/21 Troponin 3/3/21
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma
- Andere Medikamente
- None
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 07.02.2022
- Impfdatum
- 27.02.2021
- Beginn
- 21.01.2022
- Tage bis Beginn
- 328,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Amnesia
COVID-19
Cerebral small vessel ischaemic disease
Computerised tomogram
Computerised tomogram head normal
Computerised tomogram spine
Demyelination
Dyspnoea
Loss of consciousness
Magnetic resonance imaging head abnormal
Migraine
SARS-CoV-2 test positive
Vasculitis
Symptomtext
Patient is fully vaccinated and boosted 10/8/2021. COVID + 1/14/2022. 61-year-old with no significant past medical history, presented due to complaint of passing out; she states she was diagnosed with COVID last Friday, has been having some shortness of breath. She notes that she went down to the bathroom to take shower and next thing she remembered was being in the hospital and getting CAT scan, she cannot recall any other symptoms, denies any seizure-like activity, has not taken any antibiotics for her COVID. Today, denies any chest pain. CT head/cervical spine has been reviewed, negative for any acute findings.MRI Reviewed; Mild burden of nonspecific subcortical and periventricular white matter signal changes which could be on the basis of small vessel ischemic changes with demyelination, chronic migraines, and vasculitis also in the differential. Discharged home.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 02.02.2022
- Impfdatum
- 15.02.2021
- Beginn
- 15.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cold sweat
Hypotension
Nausea
Pain in extremity
Palpitations
Syncope
Symptomtext
cold sweats, nausea, faintness, terrible pain in injection arm, heart palpitations, and blood pressure went low.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Heart Valve Replacement
- Andere Medikamente
- Warfarin
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 25.01.2022
- Impfdatum
- 04.03.2021
- Beginn
- 19.03.2021
- Tage bis Beginn
- 15,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Fall
Seizure
Skull fracture
Symptomtext
Pt. states that after receiving the 1st dose of Phizer 03/04/2021, started experiencing symptoms 03/19/2021 of seizure activity. Fractured frontal skull do to fall during seizure activity, Emergency Transportation to Medical Center resulting in admission for observation/discharged 03/21/2021. Primary follow-up with recommendation prescription for Keppra for treatment.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- 2,0
- Labordaten
- Unknown 03/19/2021
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- HBP
- Andere Medikamente
- Hydrocodone
- Allergien
- Aspirin, Lisinopril
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 94,0
- Geschlecht
- M
- Eingang
- 19.01.2022
- Impfdatum
- 24.02.2021
- Beginn
- 15.01.2022
- Tage bis Beginn
- 325,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute pulmonary oedema
COVID-19
Feeling abnormal
SARS-CoV-2 test negative
SARS-CoV-2 test positive
Symptomtext
Felt poorly and admitted for flash pulmonary edema.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute pulmonary oedema
- Hospital-Tage
- 5,0
- Labordaten
- 01/15/2022 - SARS-CoV-2 Antigen (-) 01/18/2022 SARS_CoV-2 PCR (++)
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- CAD s/p CABG; HFrEF, mod-severe Mitral regurgitation; GI Bleed, A fib; hypertension, prostate carcinoma, anemia, ischemic cardiomyopathy
- Andere Medikamente
- metoprolol 25 mg po BID Atorvastatin 20 mg po daily Warfarin 2.5 mg po daily Digoxin 0.125 mics every other day Furosemide 10 mg po daily
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 55,0
- Geschlecht
- M
- Eingang
- 14.01.2022
- Impfdatum
- 06.03.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Cranial nerve disorder
Deafness unilateral
Diplopia
Headache
Lumbar puncture abnormal
Cranial nerve palsies multiple
Deafness
Magnetic resonance imaging
Magnetic resonance imaging head abnormal
Noninfective encephalitis
Paralysis
Tinnitus
SARS-CoV-2 test
Symptomtext
cranial nerve inflammation/palsy; brain inflammation; hearing loss in my right ear; severe headache behind my right eye; loud high pitched ringing in both ears; double-vision; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 56 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 06Mar2021 (Lot number: EN6200) at the age of 55 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CRANIAL NERVE PALSIES MULTIPLE (disability, medically significant) with onset 06Mar2021, outcome "recovering", described as "cranial nerve inflammation/palsy"; NONINFECTIVE ENCEPHALITIS (disability, medically significant) with onset 06Mar2021, outcome "recovering", described as "brain inflammation"; DEAFNESS (disability, medically significant) with onset 06Mar2021, outcome "not recovered", described as "hearing loss in my right ear"; HEADACHE (disability) with onset 06Mar2021, outcome "not recovered", described as "severe headache behind my right eye"; TINNITUS (disability) with onset 06Mar2021, outcome "not recovered", described as "loud high pitched ringing in both ears"; DIPLOPIA (disability) with onset Mar2021, outcome "recovered" (Apr2021), described as "double-vision". The events "cranial nerve inflammation/palsy", "brain inflammation", "hearing loss in my right ear", "severe headache behind my right eye", "loud high pitched ringing in both ears" and "double-vision" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: magnetic resonance imaging: (06Mar2021) a spinal tap which confirmed brain inflammation; sars-cov-2 test: (unspecified date) unknown result. Therapeutic measures were taken as a result of cranial nerve palsies multiple, noninfective encephalitis, deafness, headache, tinnitus, diplopia. Clinical course: Patient experienced a very severe headache behind his right eye that continued for approximately 2 months along with loud high pitched ringing in both ears. Treated initially with an ENT who also diagnosed hearing loss in his right ear, prescribed steroids, and recommended that he should not receive the 2nd dose of the vaccine. Three weeks post vaccine he began to experience double-vision and treated with both a neurologist and an ophthalmologist. Patient received two MRIs and a spinal tap which confirmed brain inflammation. Based on these findings - with input from his initial ophthalmologist and a neuro-ophthalmologist - the diagnosis became cranial nerve inflammation/palsy. Patients symptoms had improved greatly and, thankfully, the double-vision resolved after three weeks and the headaches have diminished. Patient still suffer from very loud tinnitus, hearing loss, and headaches. No other vaccine was taken within four weeks of covid vaccine. Post vaccination patient was tested for covid. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paralysis
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210306; Test Name: received two MRIs; Result Unstructured Data: Test Result:a spinal tap which confirmed brain inflammation; Test Name: covid tested; Result Unstructured Data: Test Result:Unknown result
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- RI
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 07.01.2022
- Impfdatum
- 15.04.2021
- Beginn
- 22.04.2021
- Tage bis Beginn
- 7,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Burning sensation
COVID-19
Dehydration
Eye pain
Fatigue
Feeling hot
Full blood count
Haematemesis
Headache
Hypoaesthesia
Lymph node pain
Nausea
Pain
SARS-CoV-2 test positive
Seizure
Tinnitus
Vomiting
Symptomtext
On 04/20/2021 I had a pain a couple days before my event happened. I had a pain in my left side where my lymph nodes are. I thought this was menstrual cramps and I took Ibuprofen, and it didn't go away and that was strange, so I just moved on. On the day 4/22/2021 I woke up with my entire left arm numb. Could not feel it at all and I had this ringing in my ears and the most incredible headache/eye pain that I've ever felt in my whole life. Felt like the back of my eyeballs. I also had gotten Covid this past October 2021 and that was the exact pain I had felt before. So, I got up and felt nauseous and I did take an ibuprofen and tried to put food in my body. I began to vomit violently, and it was vomit like I had eaten piles of food and I just woke up. It was bile liquid and blood. Husband came and I came out and sat down, and I lost use of my limbs and collapsed, and I said the headache was so bad. And I just kept throwing up and throwing up blood. I tried to sit up in my bed and I tried to drink water. I tried to take care of it, and I just couldn't. I was sitting in bed, and I was just really hot and sharp shooting pain in my body. I could describe it as if I was burning from the inside. I just kept throwing up blood and we finally got a hold of my doctor. Asked if I had a fever or if I was around anyone with Covid. He prescribed anti-nausea medicine and said to take fluids. And I had a breakthrough seizure which I haven't had in years. That was scary. I had the seizure, and I was throwing up again and doctor said to call EMS. The ambulance came and checked my vitals, and they weren't too helpful. I never stopped throwing up blood and went to the ER and was checked and they left me. Still throwing up blood. Covid patients were everywhere so we actually left the ER. I went home and rode it out at home. Took fluids and took anti-nausea medication. This went from 6AM and went to about 2-3PM and took any type of pain medicine that I could. Sleeping and waking up and passing out. At about 10PM at night after passing out again. I woke up and felt like I had a hangover, and I went to the bathroom. Drank more fluids, ate, got up the next morning and had a headache and had a cup of coffee and crackers. I was dehydrated and tired. The whole day was just me doing a little bit and taking a nap and keep taking in fluids as much as I could. Light foods. I kept doing that as much as I could. I went to the doctor for follow up and they did a bunch of tests, and everything was normal. Gave me omeprazole for the stomach lining for 6 days. I wasn't better until maybe Saturday or Sunday later that week where I could function. Follow up with doctor, he said that was scary, but we got through it. Called Neurologist about it as well and that I had a seizure and she said that other patients were having seizures as well. Was told to take it easy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- CBC panel normal.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Partial complex seizures; Migraines; Asthma
- Andere Medikamente
- Lamotrigine ER; Ibuprofen; Albuterol Sulfate
- Allergien
- Sulfa; Percocet; Azithromycin Intolerance; Peanuts; Shellfish
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 07.01.2022
- Impfdatum
- 17.04.2021
- Beginn
- 03.01.2022
- Tage bis Beginn
- 261,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Abnormal behaviour
Acute kidney injury
Angiogram cerebral
Anticoagulant therapy
Arthralgia
Asthenia
Back pain
Blood creatinine increased
Blood thyroid stimulating hormone normal
Bradyphrenia
Breath sounds abnormal
COVID-19
COVID-19 pneumonia
Chest X-ray normal
Chronic kidney disease
Chronic obstructive pulmonary disease
Computerised tomogram head normal
Computerised tomogram neck
Symptomtext
Hospitalized (1.3.22 - still admitted currently); COVID-19 positive (1.3.22); Fully vaccinated -pfizer x2 H&P: History and Physical HOSPITALIST Chief complaint Fall and weakness. Problem List Principal Problem: COVID-19 Active Problems: COPD (chronic obstructive pulmonary disease) Chronic kidney disease (CKD), stage III (moderate) CAD (coronary artery disease) Diabetes mellitus, type II Hypertension Chronic respiratory failure with hypoxia Fall from ground level Hyperlipidemia Hypothyroidism OSA treated with BiPAP Assessment and Plan Medical Decision Making This is an 84 years old lady who was presented to the emergency department because of generalized weakness and fall. She has been complaining of intermittent confusion also in the last week. She was found to have COVID-19 infection without evidence of pneumonia on the chest x-ray. She does not have hypoxia but the patient has history of asthma and chronic obstructive pulmonary disease and uses home O2 overnight only 1 liter/minute nasal cannula. 1. Acute kidney injury. Present on admission. Related to poor oral intake and using of Lasix at home. I am holding nephrotoxic medications. Because of the patient COVID infection, will avoid giving IV fluid for now and wait for labs in the morning. 2. COVID-19 infection. Present on admission. The patient does not have any changes in the chronic pattern of her breathing, no hypoxia. As baseline she uses 1 L per minute oxygen nasal cannula overnight only. Chest x-ray does not show any acute cardiopulmonary process. The patient has no hypoxia. She denies headaches, sore throat, and coughing. No plan to give steroid for now. Will recheck labs in the morning. Including CRP and D-dimer. We will put the patient on Lovenox for DVT prophylaxis. 3. Chronic obstructive pulmonary disease. No bronchospasm or chronic obstructive pulmonary disease exacerbation. Will continue home medications. No need to give oral or IV steroid. 4. Diabetes mellitus type 2. The patient does not take any medications at home. We will put the patient on 24 hour corrective insulin. 5. Hypertension. Blood pressure is stable and controlled. Will continue Cardizem and metoprolol. I am holding Lasix because of the acute kidney injury. 6. DVT prophylaxis with Lovenox subcutaneous. 7. Protonix for GI prophylaxis. 9. Code status. Because of the patient intermittent confusion, she is on full code by default for now. The patient has intermittent confusion and slow mentation but I try to explain her conditions. This is a virtual admission, history and physical, inpatient status. History of Present Illness History and physical obtained using virtual technology with the assistance of the bedside nurse. Pt. is a 84 y.o. female who presents to hospital with fall and generalized weakness. The patient is known to have history of multiple comorbidities including anxiety, asthma, GERD, chronic obstructive pulmonary disease, diabetes mellitus type 2, hypertension, and obstructive sleep apnea. The patient is a poor historian and the informations about her were taken from the emergency department staff physician, documentations, and bedside nursing staff. The patient has slow mentation and confusion at times. In the last week, the patient has not been feeling well and experiencing progressive decline of strength and her generalized weakness and fatigue. Recently the patient had a mechanical fall, almost a week ago, and she has been experiencing right hip pain and lower back pain since then. She did not lose consciousness no had a head trauma. The patient denies chest pain, abdominal pain, nausea, vomiting. She told me that she has some difficulty breathing which is chronic likely. The patient has home O2 1 L nasal cannula oxygen supplement at night. Her family has been experiencing cold symptoms. At the emergency department, the patient was found to have evidence of acute kidney injury with creatinine 1.3, baseline creatinine 0.9. Her appetite has been declining lately. The patient PCR rapid COVID-19 test came back positive. The patient chest x-ray did not show any evidence of acute cardiopulmonary process. Regarding her fall, the patient CT scan of the cervical spine and CT scan of the head without contrast where unremarkable for any evidence of fracture or acute intracranial process. The patient right hip x-ray did not show any fracture. However her lumbar spine x-ray mild L2 superior endplate height loss which is a new comparing to the prior study in 2018. The patient is being admitted to the hospital for further evaluation treatment. Review of Systems Review of Systems Constitutional: Positive for activity change (Because of generalized weakness.), appetite change ( decreased appetite.) and fatigue. Negative for fever. HENT: Negative for sore throat and hoarse voice. Respiratory: Positive for shortness of breath ( Mild difficulty breathing.). Negative for chest tightness. Cardiovascular: Negative for chest pain and leg swelling. Gastrointestinal: Negative for nausea, vomiting, abdominal pain, diarrhea, rectal bleeding and blood in stool. Genitourinary: Negative for hematuria. Musculoskeletal: Positive for back pain ( Chronic lower back pain.), gait problem ( Baseline using a walker to ambulate.) and falls ( Mechanical fall.). Negative for neck pain and edema. Psychiatric/Behavioral: Negative for hyperactivity. Slow mentation and confusion at time.. Objective BP 117/66 | Pulse 92 | Temp 37 ?C (Oral) | Resp 18 | Ht 1.397 m | Wt 58 kg | SpO2 94% | BMI 29.72 kg/m? Physical Exam Vitals and nursing note reviewed. Constitutional: General: She is in acute distress. Appearance: She is ill-appearing. She is not toxic-appearing. Cardiovascular: Rate and Rhythm: Regular rhythm. Heart sounds: No murmur heard. Pulmonary: Effort: Respiratory distress (Mild.) present. Breath sounds: Rales ( Sporadic.) present. No wheezing. Musculoskeletal: Right lower leg: No edema. Left lower leg: No edema. Skin: Coloration: Skin is not jaundiced. Neurological: Mental Status: She is alert. She is confused. Motor: Weakness present. Psychiatric: Behavior: Behavior is slowed. 1/6/22 progress note: CHIEF COMPLAINT: COVID-19 Assessment/Plan ASSESSMENT / PLAN: 1. COVID-19 viral pneumonia 2. COPD 3. Chronic hypoxia -Remains on baseline -no indication for Decadron at this time -Continue home bronchodilators; prn nebs 4. Stroke-like symptoms -Stroke code called on 1/522; CTH/CTA head and neck/CTP reviewed. MRI brain w/o acute ischemia. Echo EF 72% -Discussed with stroke neurology; will obtain virtual visit consult -DAPT x 30 days; statin 5. Benign essential HTN -bp well controlled on Cardizem and Metoprolol 6. DM2 -monitor poc glucose checks, SSI as needed to maintain euglycemia 7. Generalized weakness -PT/OT input appreciated -SLP pending -Likely need SAR 8. CKD III -stable; avoid nephrotoxins and dose adjust medications 9. Mild LFT elevation -monitor 10. Hypothyroidism -continue levothyroxine; tsh wnl 11. UTI -continue Rocephin; cultures NGTD per discern Subjective SUBJECTIVE: No new issues noted. Patient said she still feels weak. No chest pain. Afebrile. Review of Systems As per the HPI Objective OBJECTIVE: BP 133/74 | Pulse 92 | Temp 36.9 ?C (Oral) | Resp 22 | Ht 1.397 m | Wt 60.3 kg | SpO2 93% | BMI 30.90 kg/m? Physical Exam General: NAD, non-toxic appearing but generally unwell appearing Eyes: EOM-I no scleral icterus HENT: NCAT; CV: Slightly tachycardic; regular rhythm Lungs: non-labored respirations, decreased breath sounds but no WRR Abd: soft/nt/nd Ext: no joint swelling or TTP Neuro: flattened nasolabial folds, slumping in bed, no ataxia, sensory intact Psych: flat affect
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Respiratory distress
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Past Medical History: Diagnosis Date ? Acute on chronic respiratory failure ? Adenovillous polyp of colon ? Anemia ? Anxiety ? Arthritis ? Asthma ? Barrett's esophagus ? Bilateral edema of lower extremity 6/15/2016 ? Cataract of both eyes ? Chronic restrictive lung disease ? Chronic sinusitis ? Community acquired pneumonia ? COPD ? Depression ? Diabetes ? Diabetes mellitus, type II ? Diaphragmatic hernia ? Diverticulosis 11/16/2018 ? DJD (degenerative joint disease) scoliosis ? Emphysema of lung ? Environmental allergies ? Esophageal reflux ? GERD (gastroesophageal reflux disease) ? Hypercholesteremia ? Hypertension ? Hypothyroidism ? Incisional hernia, without obstruction or gangrene 3/19/2019 ? Lung nodule ? Macular degeneration 2010 ? Menopause roughly age 50 ? Myositis ? OSA (obstructive sleep apnea) 11/27/07, 12/13/07 AHI 26, 87% O2 nadir, 12 ? Osteopenia ? Osteoporosis ? Other osteoporosis, unspecified pathological fracture presence 7/20/2017 ? Restrictive lung disease ? Rhinitis ? Tachycardia ? Tendonitis Past Surgical History: Procedure Laterality Date ? HX CATARACT REMOVAL Right 09/21/2015 ? HX COLECTOMY Right 2017 ? HX ELBOW SURGERY 2008 Left ? HX HEART CATHETERIZATION ? HX HERNIA REPAIR ? HX HYSTERECTOMY ? HX PARTIAL HYSTERECTOMY 2003
- Andere Medikamente
- Medication Sig ? acetaminophen (TYLENOL) 500 MG tablet Take 1,000 mg by mouth every 8 hours as needed for Pain. ? albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler Take 2 puffs by inhalation every 6 hours
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 23.12.2021
- Impfdatum
- 15.03.2021
- Beginn
- 16.12.2021
- Tage bis Beginn
- 276,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Intensive care
Kidney infection
Pyrexia
Renal disorder
SARS-CoV-2 test positive
Symptomtext
fully vaccinated on 3/15/2021. admitted to hospital with kidney infection. Tested (+) COVID 12/16/2021. Only symptom was a fever > 100.4. Wife reported hospitalized due to kidney issues. Remains in ICU as of 12/23/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 16,0
- Labordaten
- -
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- chronic kidney condition, COPD
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 08.12.2021
- Impfdatum
- 19.02.2021
- Beginn
- 20.11.2021
- Tage bis Beginn
- 274,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Chest X-ray abnormal
Cough
Diarrhoea
Lung opacity
Oropharyngeal pain
Pain in extremity
Rhinitis
SARS-CoV-2 test positive
Superficial vein thrombosis
Ultrasound Doppler abnormal
Varicose vein
Symptomtext
Narrative: COVID infection following COVID vaccine series 01/28, Pfizer, dose #1 02/19, Pfizer, dose #2 06/01 CR impression: 1. Nonspecific subtle left suprahilar increased opacity. 2. Similar left rib deformities. 07/03 Extremity impression: 1. No sonographic evidence of deep venous thrombosis in the left lower extremity. 2. Superficial thrombosis involving the left lesser saphenous vein. 3. Varicose veins involving the left mid thigh and left mid calf. The above results were communicated to PA at 1:42 PM on 7/3/2021 with read back verification. 08/23 Extremity Impression: 1. No LEFT femoropopliteal venous system deep vein thrombosis. 2. Previously noted superficial venous thrombosis of the left lesser saphenous vein is no longer visualized. 3. Patent superficial varicosities in the left mid calf in the area of reported pain. 11/22 COVID swab, result; detected 11/20 pt cc: cough, diarrhea, rhinitis, sore throat exposure: unknown 11/22 SARS-COV-S Variant Sequencing result: pending
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Superficial vein thrombosis
- Hospital-Tage
- -
- Labordaten
- 06/01 CSR impression: 1. Nonspecific subtle left suprahilar increased opacity. 2. Similar left rib deformities. 07/03 Extremity impression: 1. No sonographic evidence of deep venous thrombosis in the left lower extremity. 2. Superficial thrombosis involving the left lesser saphenous vein. 3. Varicose veins involving the left mid thigh and left mid calf. The above results were communicated to PA at 1:42 PM on 7/3/2021 with read back verification. 08/23 Extremity Impression: 1. No LEFT femoropopliteal venous system deep vein thrombosis. 2. Previously noted superficial venous thrombosis of the left lesser saphenous vein is no longer visualized. 3. Patent superficial varicosities in the left mid calf in the area of reported pain. 11/22 COVID swab, result: detected 11/20 pt cc: cough, diarrhea, rhinitis, sore throat exposure: unknown 11/22 SARS-COV-S Variant Sequencing result: pending
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 06.12.2021
- Impfdatum
- 20.02.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 9,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Amnesia
Disturbance in attention
Dyspnoea
Gait disturbance
Hypoaesthesia
Laboratory test
Memory impairment
Mental impairment
Presyncope
Trance
Symptomtext
A few days prior to 03/02/2021, I was feeling like I was in a trance. I could not think, I could not concentrate, I could not remember. On 03/02/2021- I went into see my cardiologist for an annual check up. I was not able to walk very far. It felt like I was going to collapse. The cardiologist put me on oxygen. They checked my oxygen level and my oxygen was below 85. On Saturday, I got real numb in my arm and legs and I called my husband and he took me to the hospital. We thought I was having a stroke. On Saturday, 03/06/2021- at about 2:00PM ET, My husband took me to the Hospital Emergency Room and they admitted me to the hospital. The hospital thought I was having a stroke, but that was not the problem. They never did find out what the problem was. Doctor saw me in the hospital, my pulmonary doctor had all kinds of tests done, and exhausted all the test he needed to be done on me, but did not know what happened to me. They discharged me from the hospital on Tuesday afternoon. Treatment: oxygen, they had to increase from 2 to 4. It took about 5 or 6 months for me to stop having the memory, concentration, and forgetfulness. Those symptoms slowly came back, but my breathing did not get any better with the oxygen.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- 4,0
- Labordaten
- Hospital has those records
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Asthma
- Andere Medikamente
- Synthroid 150 mg Pravastatin 40 mg od Lexapro 20 mg od Amitriptyline 2 tablets 10 mg ea B-12 shot once a month 1000 mcg Plavix 75 mg od / Singulair 10 mg od Turmeric od Magnesium 800 mg od Fluticasone 50 mcg spray through nostrils
- Allergien
- Cannot take Tylenol because of my liver
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 03.12.2021
- Impfdatum
- 22.02.2021
- Beginn
- 02.05.2021
- Tage bis Beginn
- 69,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Anticoagulant therapy
Deep vein thrombosis
Pain
Swelling
Symptomtext
Narrative: Following the second dose of COVID-19 vaccine (2/22), patient was seen at a hospital emergency room on 5/2/2021 for a DVT in the right leg. Initially treated starting on 5/3/21 with Apixaban 10 mg BID x 7 days and is completing 3 months of treatment with Apixaban 5 mg BID. As of 6/17/2021, swelling and pain is resolving, but not completely gone.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 03.12.2021
- Impfdatum
- 22.02.2021
- Beginn
- 25.02.2021
- Tage bis Beginn
- 3,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Cardiac aneurysm
Cardiac discomfort
Catheterisation cardiac abnormal
Chest X-ray abnormal
Chest pain
Catheterisation cardiac
Computerised tomogram thorax
Electrocardiogram
Computerised tomogram abnormal
Dyspnoea
Magnetic resonance imaging heart
Myocarditis
COVID-19
Cardiac disorder
Computerised tomogram
Inflammation
Laboratory test
Ultrasound scan
Symptomtext
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 72 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Feb2021 16:00 (Lot number: EN6200) at the age of 72 years as dose 2, single and administered in arm left, administration date 29Jan2021 (Lot number: EL9265) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Onions" (unspecified if ongoing), notes: Known allergies: Onions. There were no concomitant medications. The following information was reported: CARDIAC DISORDER (hospitalization, disability, life threatening), INFLAMMATION (hospitalization, disability, life threatening) all with onset 25Feb2021 12:00, outcome "not recovered" and all described as "Major heart inflammation"; MYOCARDITIS (hospitalization, disability, life threatening) with onset 25Feb2021 12:00, outcome "not recovered", described as "Myocarditis"; CARDIAC ANEURYSM (hospitalization, disability, life threatening) with onset 25Feb2021 12:00, outcome "not recovered", described as "FIVE heart Aneurysms"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 05Nov2021, outcome "unknown" and all described as "covid test date=05Nov2021, covid test result=Positive". The patient was hospitalized for cardiac disorder, inflammation, myocarditis, cardiac aneurysm (hospitalization duration: 2 day(s)). The events "major heart inflammation", "major heart inflammation", "myocarditis" and "five heart aneurysms" were evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: computerised tomogram: (unspecified date) unknown result; sars-cov-2 test: (05Nov2021) positive, notes: Nasal Swab; x-ray: (unspecified date) unknown result. Therapeutic measures were taken as a result of cardiac disorder, inflammation, myocarditis, cardiac aneurysm. Clinical Course: Facility type vaccine: Doctor's office/urgent care. Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage. No follow-up attempts are possible. No further information was expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- 2,0
- Labordaten
- Test Name: CT Scan; Result Unstructured Data: Test Result:Unknown result; Test Date: 20211105; Test Name: COVID rapid; Test Result: Positive ; Comments: Nasal Swab; Test Name: XRAY; Result Unstructured Data: Test Result:Unknown result
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Food allergy (Known allergies: Onions)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 30.11.2021
- Impfdatum
- 17.02.2021
- Beginn
- 22.02.2021
- Tage bis Beginn
- 5,0
- Dosis
- 1
- Route/Site
- SYR / -
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Anticoagulant therapy
Blood test
Cerebral venous thrombosis
Computerised tomogram
Condition aggravated
Cough
Headache
Hypoaesthesia
Impaired work ability
Lumbar puncture
Magnetic resonance imaging
Migraine
Mobility decreased
Nasal congestion
Nasopharyngitis
Night sweats
Oropharyngeal pain
Pain
Symptomtext
I received my vaccine at my work place, on February 17, 2021. Once I received the injection, my arm was sore and I had cold like symptoms (stuffy nose, sore throat, etc) for a few days. Body aches started the following week along with a cough and sinus drainage and night sweats. Headaches started that Friday and progressed into what I thought were migraines over the weekend. Monday, March 1, 2021, I couldn't lift my upper body out of bed. I couldn't move my head from side to side. The headache pain was as if I had been hit in the back of the head with a hammer behind my right ear. I called out of work that morning and had an online doctor's visit. The doctor urged me to go to the ER thinking I had meningitis since I couldn't touch my chin to my chest. Once I arrived to the ER, my right leg went numb. I couldn't lift it during my exam. They performed MRI, CT, Spinal, along with blood tests, etc and found I had blood clots in my brain. They administered heparin but I had an allergic reaction to it.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebral venous thrombosis
- Hospital-Tage
- 3,0
- Labordaten
- I was in the hospital from 3/2-3/5. I have a cerebral venous thrombosis and I'm currently on warfarin after trying 4 other blood thinners to no avail.
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- MIGRAINES
- Andere Medikamente
- BIRTH CONTROL PILL SYNTHROID DAILY VITAMIN
- Allergien
- GLUTEN
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 29.11.2021
- Impfdatum
- 24.11.2021
- Beginn
- 25.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Back pain
Blood test
Chest pain
Computerised tomogram normal
Dyspnoea
Electrocardiogram normal
Fibrin D dimer increased
Pain
Pain in extremity
Painful respiration
Pericarditis
Symptomtext
24 hours after receiving vaccine, I began getting severe chest pain and shortness of breath. At 48 hours post vaccine, I called my PCP who advised me to go the the ER. I had pain in my arm (where the shot was given) and pain in my chest on the left side. It radiated to my back. It hurt to take a breath in. At the ER, I was put on the EKG machine, blood word done, chest xray. My d-dimmer was 660. That was the only number that was not within normal limits. They did a CT scan with and without contrast of my chest to look for a possible blood clot. Nothing was found. I was sent home with Naproxen and told to follow up with a cardiologist 3-5 days after. I went to the cardiologist 4 days after the ER, he diagnosed pericarditis most likely due to the covid booster vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pericarditis
- Hospital-Tage
- -
- Labordaten
- 11/26 - tons of blood work at ER, d-dimmer, several ekg's, chest xray, ct scan with and without contrast. all negative except for the d-dimmer number was 660. 11/29 - Follow up with cardiologist who diagnosed pericarditis most likely due to covid vaccine.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- diabetes
- Andere Medikamente
- Metformin 500 mg 2x day, cymbalta 120mg, trazodone 100mg, tradjenta 5mg, klonipin .5mg, incassa (birth control) 1 pill per day progesterone only.
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 26.11.2021
- Impfdatum
- 25.03.2021
- Beginn
- 16.11.2021
- Tage bis Beginn
- 236,0
- Dosis
- 2
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Angiogram pulmonary abnormal
Arteriosclerosis coronary artery
Asthenia
Blood culture negative
Bronchial wall thickening
Cardiomegaly
Cerebral calcification
Chest X-ray abnormal
Computerised tomogram head abnormal
Condition aggravated
COVID-19
COVID-19 pneumonia
Cardiac dysfunction
Cardiac failure
Cardiac failure congestive
Culture urine positive
Dyspnoea
Echocardiogram
Symptomtext
Patient discharged after (7) day inpatient stay from 11/16-11/23/2021. 87-year-old female presenting to our institution with 1 week of shortness of breath and productive cough. She also had progressive fatigue and weakness. She was identified to be febrile at the urgent care, and directed to the emergency department for further evaluation. Patient is vaccinated for COVID-19, but had not had her booster. In the ER she was found to have a COVID-19 positive test and a hemoglobin of 6.7. She received 1 unit packed red blood cells and was admitted to the hospitalist service. In regards to her anemia, she was seen in consultation with Hematology who recommended that the patient received as needed transfusions, and follow-up as an outpatient for possible bone marrow biopsy after she recovers from COVID-19. In regards to her COVID-19, she initially was on room air not requiring oxygen. She received monoclonal antibody infusion. Chest x-ray did show developing infiltrates, and the patient rapidly deteriorated, requiring high-flow nasal cannula. She was placed on remdesivir and dexamethasone. CT angiogram thorax was obtained, which ruled out pulmonary embolism but showed evidence of COVID-19 pneumonia and suspected CHF with pulmonary edema and small bilateral pleural effusions. Patient was noted to have progressing left-sided infiltrates, with a significant rise in procalcitonin. There is concern for bacterial superinfection, and the patient was started on cefepime and vancomycin. Patient continued to have increased oxygen needs, and ultimately elected to discharge home with hospice goals of care. She would like to be with her family. She will complete 5 additional days of dexamethasone at discharge. Given the finding of new congestive heart failure, the patient was started on intravenous diuretic therapy. She diuresed well. Echocardiogram was obtained, showing a ejection fraction of 40% with moderate dysfunction and minor regional variations. She was noted to have an echodensity in the right atrium measuring 1.1 x 1.3 cm. She was started on losartan as well as Coreg. She was seen in consultation with Cardiology, they recommended anticoagulation, and repeat echocardiogram however the patient elected for hospice goals of care. Patient also identified to have uncomplicated urinary tract infection, with E coli likely CAUTI. This was treated to completion during hospital course. She signed up with Hospice was discharged home in stable condition with hospice
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary oedema
- Hospital-Tage
- 7,0
- Labordaten
- Procedure Component Value Ref Range Date/Time DR CHEST SINGLE VIEW Resulted: 11/21/21 1110 Order Status: Completed Updated: 11/21/21 1112 Narrative: EXAMINATION: Single View Chest EXAM DATE: 11/21/2021 10:56 AM TECHNIQUE: Single AP portable semiupright chest INDICATION: Shortness of Breath COMPARISON: 11/18/2021 ENCOUNTER: Not applicable _________________________ FINDINGS: No supporting lines or tubes. There is no evidence of pneumothorax. Grossly stable cardiomegaly. Pulmonary vasculature appears slightly increased in prominence. Hilar regions grossly symmetric. Stable aorta and superior mediastinum. Bilateral infiltrates mildly improved in the central right lung and increased in the left parahilar region central left lung. Persistent mild basilar opacities. No definite evidence of pleural effusion. Osseous structures are unchanged. _________________________ Impression: Bilateral pulmonary opacities are mildly improved on the right and increased on the left since 3 days ago. CT HEAD WITHOUT IV CONTRAST Resulted: 11/19/21 1847 Order Status: Completed Updated: 11/19/21 1849 Narrative: EXAMINATION: CT Head without Contrast EXAM DATE: 11/19/2021 6:37 PM TECHNIQUE: Multiple axial images of the brain obtained from the skull base to the vertex without contrast enhancement. Coronal and sagittal reformations are provided. INDICATION: Headache, intracranial hemorrhage suspected. COMPARISON: CT head from 1/11/2019. ENCOUNTER: Not applicable HAND DOMINANCE: Unknown _________________________ FINDINGS: No acute intracranial hemorrhage, extra-axial fluid collection, midline shift or mass effect is seen. No space-occupying lesion is demonstrated. Sulcal and ventricular prominence is compatible with intracranial volume loss. Areas of diminished attenuation within the supratentorial white matter are noted. While nonspecific, they likely reflect chronic microvascular ischemic change. No CT evidence of an acute ischemic event. There are scattered intracranial vascular calcifications. Mucosal thickening is present within the paranasal sinuses. The mastoids are well aerated. ___________________________ Impression: 1. No CT evidence of an acute intracranial hemorrhage or acute ischemic event. 2. Intracranial volume loss and probable superimposed chronic microvascular ischemic change. CV Echo Limited with Contrast Collected: 11/19/21 1440 Order Status: Completed Updated: 11/19/21 1618 Narrative: Hospital LIMITED ECHOCARDIOGRAPHY REPORT Name: Patient Study Date: 11/19/2021 MRN: Patient Location: Hospital DOB: Patient Class: Inpatient Gender: Female Ordering Physician: Doctor Age: 87 yrs Height: 152 cm Performed By: Weight: 74 kg Resting HR: 89 BSA: 1.7 m2 Resting BP: 155/79 mmHg Reason For Study: Cardiomyopathy suspected, . History/Symptoms: Syncope, Hypertension, Vertigo, Covid-19 Infection Electronically signed by: Doctor on 11/19/2021 04:17 PM Interpretation Summary The left ventricle is normal in size. There is normal left ventricular wall thickness. The left ventricular ejection fraction is 40%. Moderate global left ventricular systolic dysfunction with minor regional variation is noted. The right ventricular size, thickness, and function are normal. The left atrium is mildly dilated. Echodensity measuring 1.1 x 1.3 cm noted within the right atrial cavity which appears mobile. Redundant eustachian valve or abnormal mass cannot be ruled out. There is mild mitral regurgitation. Today's study was compared to one performed on 01/12/2019. The LVEF was 59% on the prior report. STUDY PERFORMED/QUALITY: AORTIC VALVE: A two-dimensional transthoracic The aortic valve is not well echocardiogram with color flow and visualized. There is no aortic valve spectral flow Doppler was performed in stenosis. limited views only. A limited two- dimensional transthoracic MITRAL VALVE: echocardiogram was performed (2D). The Structurally normal mitral valve. technical quality of the exam was There is mild mitral regurgitation. fair. Due to limited acoustic windows, Definity was administered. Location: Portable. TRICUSPID VALVE: The tricuspid valve is not well LEFT VENTRICLE: visualized. There is trace tricuspid The left ventricle is normal in size. regurgitation. There is normal left ventricular wall thickness. The left ventricular PULMONIC VALVE: ejection fraction is 40%. The LV The pulmonic valve is not well ejection fraction was determined visualized. utilizing visual estimation. Moderate global left ventricular systolic dysfunction with minor regional variation is noted. LEFT ATRIUM: The left atrium is mildly dilated. RIGHT ATRIUM: Right atrial size is normal. Echodensity measuring 1.1 x 1.3 cm noted within the right atrial cavity which appears mobile. Redundant eustachian valve or abnormal mass cannot be ruled out. RIGHT VENTRICLE: The right ventricular size, thickness, and function are normal. PERICARDIUM/PLEURAL: No pericardial effusion. No pleural effusion. INFERIOR VENA CAVA: The inferior vena cava is normal in size, with a normal collapsibility. Left Ventricle Great Vessels EDV(MOD-sp4): 163.0 ml IVC diam: 1.8 cm ESV(MOD-sp4): 73.5 ml IVSd: 1.0 cm LVPWd: 1.2 cm LVIDd: 4.3 cm LVIDs: 3.4 cm ESV(MOD-sp2): 86.5 ml ______________________________________________________________________________ Reference Table: Normal Mild ModerateSevere Men LVEF > 52% 41-51% 30-40% <30% Women LVEF > 54% 41-53% 30-40% <30% Men LVIDd 4.2-5.8 5.9-6.3 6.4-6.8 >6.8 Women LVIDd 3.8-5.2 5.3-5.6 5.7-6.1 >6.1 LA Volume (ml/m^2) < 34 35-41 42-48 >48 ______________________________________________________________________________ Electronically signed by: Doctor on 11/19/2021 04:17 PM All sources of data reside in the Cardiology PACS EJECTION FRACTION ECHO Collected: 11/19/21 1440 Order Status: Completed Updated: 11/19/21 1618 EJECTION FRACTION ECHO 40 % CT ANGIO THORAX WITH IV CONTRAST Resulted: 11/18/21 2201 Order Status: Completed Updated: 11/18/21 2203 Narrative: EXAMINATION: CT Angiography of the Thorax EXAM DATE: 11/18/2021 9:22 PM TECHNIQUE: Standard protocol CT angiogram images were obtained through the chest following the administration of intravenous contrast. Coronal and sagittal MIP 3-D reformations were performed. CONTRAST: The amount and type of contrast are recorded in the medical record. QPP DOCUMENTATION: At least one of the following dose reduction techniques was utilized: Iterative reconstruction, and/or Automatic Exposure Control, and/or mA/kV adjustment based on body size. INDICATION: PE suspected, high prob. COMPARISON: CTA chest 4/29/2016 ENCOUNTER: Not applicable ____________________ FINDINGS: Base of Neck & Axillae: There is no lymph node enlargement. Heterogeneous right thyroid nodule. Remotely stable. Mediastinum & Hila: Prominent likely reactive mediastinal lymph nodes. Cardiovascular: The heart is enlarged and atherosclerotic plaque is present on the coronary arteries. There is no pericardial effusion. The thoracic aorta is not aneurysmal and there is no dissection. There is no evidence for right heart strain. Pulmonary Arteries: No pulmonary embolism is present. Lungs & Airways: Patchy bilateral airspace consolidations compatible with reported history of gout infection. There is also superimposed intralobular septal thickening suggesting a component of pulmonary edema/heart failure. Pleural Space: Small bilateral pleural effusions. There is no pneumothorax. Upper Abdomen: Included portions of the upper abdomen are unremarkable. Chest Wall & Musculoskeletal: There is multilevel thoracic degenerative disc disease. ____________________ Impression: 1. No evidence of pulmonary embolus. 2. Confluent bilateral airspace opacities compatible with reported history of Covid infection. 3. Cardiomegaly, septal thickening, and small bilateral effusions suggesting a component of superimposed CHF and pulmonary edema. DR CHEST SINGLE VIEW Resulted: 11/18/21 0910 Order Status: Completed Updated: 11/18/21 0912 Narrative: EXAMINATION: Single View Chest EXAM DATE: 11/18/2021 8:20 AM TECHNIQUE: Single view chest INDICATION: Shortness of Breath COMPARISON: 11/16/2021 ENCOUNTER: Not applicable _________________________ FINDINGS: Stable appearance of the cardiac mediastinal silhouette. Interval development of a right upper and mid lobe opacity compared to the prior examination. Left perihilar opacity. There is bronchial wall thickening. No significant pleural effusion or pneumothorax. Low lung volumes bilaterally. _________________________ Impression: Interval development of bilateral opacities, right greater than left, which may represent underlying infectious process. DR CHEST SINGLE VIEW [353328496] Resulted: 11/16/21 2104 Order Status: Completed Updated: 11/16/21 2106 Narrative: EXAMINATION: Single View Chest EXAM DATE: 11/16/2021 8:11 PM TECHNIQUE: Single view chest INDICATION: Cough and shortness of breath COMPARISON: Chest radiograph 9/15/2020. CT angiogram of the thorax 3/10/2017 ENCOUNTER: Not applicable _________________________ FINDINGS: There is suboptimal inspiration. Within this limitation, the lungs appear clear without evidence of infiltrate. There is no pleural effusion or pneumothorax. The heart size and pulmonary vascularity are normal. Convexity along the right mediastinal border is stable and consistent with elongated tortuous ascending aorta also demonstrated on prior CT angiogram of the thorax. _________________________ Impression: No acute abnormalities. Procedure Component Value Ref Range Date/Time Legionella Antigen, Urine (Normal) Collected: 11/22/21 0921 Order Status: Completed Specimen: Urine, clean catch Updated: 11/22/21 1232 Legionella Ag Urine Negative Negative Streptococcus Pneumoniae Antigen, Urine [354047121] (Normal) Collected: 11/22/21 0921 Order Status: Completed Specimen: Urine, Voided Updated: 11/22/21 1232 STREPTOCOCCUS PNEUMONIAE ANTIGEN Negative Negative, Invalid MRSA Screen PCR (Normal) Collected: 11/21/21 2350 Order Status: Completed Specimen: Swabbed Collection from Nares, Bilateral Updated: 11/22/21 0936 MRSA Screen PCR Not Detected Not Detected Narrative: This screen determines MRSA carrier status. When negative, it predicts the absence of MRSA lower respiratory tract infection. When positive, infection due to MRSA is possible, yet cultures from the site of infection must be used to guide diagnosis and therapy. Peripheral Blood Culture Collected: 11/16/21 2107 Order Status: Completed Specimen: Blood, Venous Updated: 11/21/21 2301 Cult Blood Peripheral No bacteria or yeast isolated Peripheral Blood Culture Collected: 11/16/21 2125 Order Status: Completed Specimen: Blood, Venous Updated: 11/21/21 2301 Cult Blood Peripheral No bacteria or yeast isolated Sputum Culture Collected: 11/18/21 1948 Order Status: Completed Specimen: Body Fluid from Sputum Updated: 11/21/21 0832 Bacterial culture, sputum Normal Upper Respiratory Flora, no MRSA or Pseudomonas aeruginosa isolated Gram stain Many WBCs Moderate Gram Positive Cocci Few Gram Negative Rods Urine Culture (Abnormal) Collected: 11/18/21 2309 Order Status: Completed Specimen: Urine, clean catch Updated: 11/20/21 1059 Bacterial culture, urine >=100,000 CFU/mL Escherichia coli Abnormal Susceptibility Escherichia coli Not Specified Ampicillin Susceptible Ampicillin/sulbactam Susceptible Cefazolin Susceptible 1 Ceftriaxone Susceptible Ciprofloxacin Susceptible Gentamicin Susceptible Nitrofurantoin Susceptible Tobramycin Susceptible Trimethoprim/Sulfamethoxazole Susceptible 1 For uncomplicated UTIs due to E. coli, K. pneumoniae, and P. mirabilis, cefazolin predicts susceptibility to oral cephalosporins including cephalexin, cefpodoxime, cefprozil, cefdinir, and cefuroxime. Linear View COVID-19 PCR (Abnormal) Collected: 11/16/21 2018 Order Status: Completed Specimen: Swabbed Collection from Nasopharynx Updated: 11/16/21 2130 COVID-19 PCR Detected Abnormal
- Aktuelle Erkrankungen
- Megaloblastic anemia due to alcoholism
- Vorgeschichte
- Respiratory Pneumonia due to COVID-19 virus Circulatory Acute systolic (congestive) heart failure (HCC) Digestive Class 1 obesity in adult Gastroesophageal reflux disease with esophagitis without hemorrhage Infectious/Inflammatory UTI (urinary tract infection), uncomplicated Hematologic Symptomatic anemia MDS (myelodysplastic syndrome) (HCC)-Suspected Nervous Headache Toxic metabolic encephalopathy Endocrine/Metabolic Hyperkalemia Other Depression S/P total knee arthroplasty Weakness Possible Right atrial mass vs redundent eustacian valve
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG tablet acetaminophen (TYLENOL) 650 MG suppository bisacodyl (DULCOLAX) 10 MG suppository dexamethasone (DECADRON) 6 MG tablet escitalopram (LEXAPRO) 10 MG tablet furosemide (LASIX) 20 MG tablet haloperid
- Allergien
- Sulfamethoxazole W-trimethoprimHives Amoxicillin DuloxetineOther
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 20.11.2021
- Impfdatum
- 26.02.2021
- Beginn
- 23.03.2021
- Tage bis Beginn
- 25,0
- Dosis
- UNK
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Arthralgia
Electric shock sensation
Inflammation
Magnetic resonance imaging abnormal
X-ray abnormal
Symptomtext
After second dose on March 19, 2021 I started getting shocking sensations in my lower legs and feet, mostly on the left side then shortly thereafter I started getting extremely painful left hip pain when in a sitting position and trying to stand. It started occasionally and then progressed to happening more often. I went for therapy and seemed to improve but now is worse than even and an almost constant ache. No amount of medications or exercise seem to help long term. Seems to be getting worse. Never had these issues before the vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Electric shock sensation
- Hospital-Tage
- -
- Labordaten
- Xray and MRI in October 2021. Shows inflammation
- Aktuelle Erkrankungen
- lupus
- Vorgeschichte
- lupus
- Andere Medikamente
- Plaquenil and hydrocodone for years
- Allergien
- sulfer, z pack
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 12.11.2021
- Impfdatum
- 05.03.2021
- Beginn
- 19.03.2021
- Tage bis Beginn
- 14,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Computerised tomogram
Fall
Gait inability
Ischaemic stroke
Magnetic resonance imaging
Ultrasound Doppler
Symptomtext
The morning of 03/19/2021 I woke up in the middle of the night having a stroke. I could not walk. I flapped around like a fish. When I fell, I fell onto the bed. I was able to get up to the bed. We did not call 911 because they recommended to not go to the hospital unless it was for COVID-19. I was able to get up and get back on the bed, where I stayed until we got a hold of the doctor who said come in and I will see you. He saw me that day. I was in a wheelchair because I could not walk. My husband was helping me. They did an MRI, CAT scan, Doppler on my legs that I had been scheduled for because the podiatrist could not get a reading on my left leg a week prior. We took everything one day at a time. He sent me to a neurologist, who saw me right away. He did more tests and determined I had an ischemic stroke. That was the first one. I started taking a blood thinner. I was seen by my cardiologist who determined it was not a heart event. A month and a half later, the first week in May I had another stroke. At that point I was already doing physical therapy to try and regain control of my walking and my arms. Since then, everything has intensified. I did not call 911 because I did not want to go to the hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ischaemic stroke
- Hospital-Tage
- -
- Labordaten
- MRI CAT scan Doppler- Ischemic stroke
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Diabetes Multiple sclerosis in 2000 Fibromyalgia
- Andere Medikamente
- Insulin Pantoprazole Famotidine Voltaren
- Allergien
- Certain medications Almonds Pineapple
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- -
- Geschlecht
- F
- Eingang
- 23.10.2021
- Impfdatum
- 19.02.2021
- Beginn
- 19.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Skin hyperpigmentation
Syncope
Vaccination site erythema
Vaccination site induration
Vaccination site warmth
Urticaria
Symptomtext
Hives; This is a spontaneous report from a contactable physician. A 47-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6200) intramuscularly, administered in Arm Left on 19Feb2021 17:00 (at the age old 47-year-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included major depressive disorder from 1990 ongoing (Stable with medication (and dose irrelevant), ADHD (attention deficit hyperactivity disorder) from 1974 ongoing (Stable with medication), Seasonal Allergies, and possible eczema from 1977 ongoing (Cetirizine and Zyrtec) controls symptoms well). Family medical history asthma Father- Asthma, severe seasonal allergies (but respond well to medication), Brother- Moderate to severe seasonal allergies (respond well to medication), Nephew (Brother's son)- Moderate to severe seasonal allergies (respond well to medication). Concomitant medication(s) included PROZAC DURAPAC orally taken for depression from 1995 and ongoing; WELLBUTRIN orally taken for depression from 2013 and ongoing; ADDERALL orally taken for attention deficit hyperactivity disorder from 2019 and ongoing; CETIRIZINE orally taken for allergies from 2019 and ongoing; IBUPROFEN orally taken for headache from 1983 and ongoing as needed. The patient previously took first dose of covid-19 vaccine on 29Jan2021 11:00 for covid-19 immunisation. The patient experienced hives on 19Feb2021 18:00. No treatment received. The outcome of event was recovered. Follow-up attempts completed. No further information expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: ADHD; Asthma (Father- Asthma, severe seasonal allergies; Major depressive disorder; Seasonal allergy;
- Andere Medikamente
- PROZAC DURAPAC; WELLBUTRIN; ADDERALL; CETIRIZINE; IBUPROFEN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 20.10.2021
- Impfdatum
- 01.10.2021
- Beginn
- 01.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Condition aggravated
Confusional state
Disorientation
Extra dose administered
Fall
Hyperhidrosis
Influenza like illness
Loss of consciousness
Nausea
Scratch
Shock
Tendon injury
Symptomtext
2nd shot 24 hours of fever, aches, flu-ish symptoms; BOOSTER #3 - 10 hours after had fluish symptoms again. Got up in the night at 3 AM....went into shock blacking out and collapsing onto the floor for who knows how long (I live alone). Very disoriented upon waking. Limbs were mangled under me....feeling for where I was in the dark. Suddenly felt like vomiting yet didn't - sudden profuse sweating - need to get to the toilet and was able to manage that. Back in bed confused for a while. Twisted and stretched tendon all up back of left leg. Scratch on right thigh assuming from left toenail. Mainly the fact that I SUDDENLY blacked out and had symptoms of being in shock. I have a history with trazadone and nitroglycerine taking me into anaphylaxis.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- I did not go to the doctor or even notify the doctor but thought it was of importance to add this to research.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Atorvastatin, Clopidogrel, Levothyroxine, Losartan, Progesterone
- Allergien
- Trazadone, Nitroglycerine
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 31,0
- Geschlecht
- M
- Eingang
- 18.10.2021
- Impfdatum
- 22.09.2021
- Beginn
- 24.09.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- SYR / AR
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Blood creatine phosphokinase
Brain natriuretic peptide
C-reactive protein
Chest X-ray
Chest pain
Differential white blood cell count
Echocardiogram
Electrocardiogram
Extra dose administered
Fibrin D dimer
Full blood count
Metabolic function test
Myalgia
Myocarditis
Pyrexia
SARS-CoV-2 test
Troponin I
Symptomtext
I received a 3rd dose of the Pfizer-BioNTech COVID-19 vaccine on the afternoon of Wednesday (9/22/21). I experienced some muscle aches and fever on Thursday (9/23/21) and Friday (9/24/21). On the evening of 9/24/21 at around 9:00 PM, I experienced some chest pain. By the morning of 9/25/21, the pain had become severe and I visited the emergency room. After being evaluated in the emergency room as described below, I was admitted to the hospital. A number of tests and diagnostics (also described below) was conducted. I was diagnosed with acute myocarditis / perimyocarditis. I was prescribed Colchine (3 months), Prednisone (tapering over 14 days), Ibuprofen (as required to treat inflammation), and Famotidine (as a prophylactic for my stomach). Follow up appointments with cardiologist and a clinician were scheduled for 10/5 and 10/6. Follow-up lab ordered as described below. Follow up with doctor scheduled in December.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- 3,0
- Labordaten
- 9/25/21 ? 9/27/21 Troponin I Trend (Tested at 6-Hour Intervals) Several Electrocardiograms Several Echocardiograms 9/25/21: Creatine Kinase Test High Sensitivity C-Reactive Protein Test for Cardiac Risk Assessment B-Type Natriuretic Peptide Test D-Dimer Test Comprehensive Metabolic Panel Complete Blood Count Test with Auto Differential Chest and Lateral X-Ray SARS-CoV-2 Screening 9/26/21 Comprehensive Metabolic Panel Complete Blood Count Test with Auto Differentia 10/5/21 Troponin I Test
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Ibuprofen Diphenhydramine Creatine Monohydrate Nature's Way Men's Alive Multivitamin
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- DE
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 18.10.2021
- Impfdatum
- 10.02.2021
- Beginn
- 17.04.2021
- Tage bis Beginn
- 66,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Blood test
Computerised tomogram
Electrocardiogram
Magnetic resonance imaging
Myocarditis
Syncope
Tachycardia
Symptomtext
Myocardist, tachycardia, syncope
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- 3,0
- Labordaten
- Ekg, ecg, blood work, mri, CT started in March 2021 to current
- Aktuelle Erkrankungen
- Chronic crohns disease, asthma
- Vorgeschichte
- -
- Andere Medikamente
- Entivo, zoloft,advair,Spiriva, tylenol
- Allergien
- Latex, aspirin
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 18.10.2021
- Impfdatum
- 20.02.2021
- Beginn
- 20.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SYR / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Dizziness
Presyncope
Symptomtext
Felt like I was going to faint. Had to lie on the floor. Was taken to emergency room where it was stated that I had a vaso vagil reaction
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- citalopram, nortriptylene, lorazapam, Vitamin B, Vitamin d
- Allergien
- codeine
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 17.10.2021
- Impfdatum
- 01.02.2021
- Beginn
- 22.02.2021
- Tage bis Beginn
- 21,0
- Dosis
- UNK
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chest pain
Palpitations
Pericarditis
Vaccine positive rechallenge
Symptomtext
pericarditis; presented with chest pain, palpitations. mild after 1st dose. prompted ED visit after 2nd. took several weeks to resolve.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pericarditis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- anxiety, migraine
- Andere Medikamente
- -
- Allergien
- apples, almonds, pitted fruits, hayfever
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 12.10.2021
- Impfdatum
- 01.03.2021
- Beginn
- 01.05.2021
- Tage bis Beginn
- 61,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Hypertension
Thrombosis
Symptomtext
Blood clots, joint pain, hypertension
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Asthma
- Vorgeschichte
- Asthma
- Andere Medikamente
- Albuterol, Trelegy, Allegra, Xosted
- Allergien
- Codeine, Solumedrol
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 07.10.2021
- Impfdatum
- 04.03.2021
- Beginn
- 06.03.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Generalised tonic-clonic seizure
Symptomtext
2 grand mal seizures; This is a spontaneous report from a contactable consumer reported for herself. An 86-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at the age of 86-years-old, via an unspecified route of administration, administered in Arm Left on 04Mar2021 10:00 (Batch/Lot Number: EN6200) as dose 1, single for COVID-19 immunization. The patient was not pregnant. Medical history included heart attack, pacemaker, stroke, non epileptic episodes. Concomitant medications included metoprolol succinate; escitalopram; and omeprazole; all taken for an unspecified indication, start and stop date were not reported. The patient previously took Codeine and experienced allergies. The patient experienced 2 grand mal seizures on 06Mar2021 13:00 (within 5 days after). The events resulted in emergency room/department or urgent care visit, and no treatment received. The patient had no prior vaccination and did not test post vaccination. The outcome of the events was recovered with sequelae. Follow-up attempts are completed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Generalised tonic-clonic seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Heart attack; Non-epileptic seizure; Pacemaker insertion (cardiac); Stroke.
- Andere Medikamente
- Metoprolol Succinate; Escitalopram; Omeprazole
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 04.10.2021
- Impfdatum
- 24.02.2021
- Beginn
- 09.09.2021
- Tage bis Beginn
- 197,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Adenovirus test
Angiogram pulmonary abnormal
Anion gap
Asthenia
Atrioventricular block first degree
Blood bicarbonate
Blood chloride decreased
Blood glucose increased
Blood lactic acid
Blood pH normal
Blood potassium normal
Blood sodium decreased
Bordetella test negative
Bradycardia
COVID-19 pneumonia
Chest X-ray abnormal
Chlamydia test negative
Computerised tomogram thorax abnormal
Symptomtext
ED to Hosp-Admission Discharged 9/8/2021 - 9/22/2021 (14 days) Last attending ? Treatment team Acute respiratory failure with hypoxia Presenting Problem/History of Present Illness/Reason for Admission Shortness of breath Hypoxia Elevated troponin DKA, type 2, not at goal Hospital Course Patient presented to the hospital on 9/9 with weakness, ambulatory dysfunction and shortness of breath. Patient was found to have new onset oxygen requirement and lab work was concerning for increased glucose, anion gap and beta hydroxybutyrate. Ultimately, it was believed patient was in euglycemic DKA secondary to SGL 2 inhibitor use and he was admitted to the hospital for further management. Euglycemic DKA Believed to be in the setting of SGLT2 inhibitor use. With initiation of insulin and IV fluids patient's gap closed and beta hydroxybutyrate returned to normal. Patient was maintained in the hospital to initiate insulin in order to optimize home insulin regimen. His insulin requirement for mealtime was increased due to initiation of steroids and treatment of Covid pneumonia. At the time of discharge she was well managed on 35 units Lantus nightly and lispro 23 units 3 times daily. He will need continued titration of insulin in the outpatient setting as he has completed his dexamethasone course. Anticipate lessening mealtime coverage required. COVID pneumonia & OSA Patient did have weakness and shortness of breath with a new oxygen requirement on the hospital. Initial respiratory viral panel, chest x-ray and CT scan showed no evidence of Covid pneumonia. CT scan did show signs of asbestos exposure. Patient was in the process of being placed secondary to amatory dysfunction and had asymptomatic Covid swab performed which was positive. Repeat CT scan showed that patient was now showing signs of Covid pneumonia. With his hypoxia and new oxygen requirement he met criteria to receive inpatient treatment for Covid pneumonia. He was initiated on dexamethasone x10 days, remdesivir x5 and received convalescent plasma x1. He was discharged after receiving the full course of all these agents on 2 L NC. The 10-day quarantine timeframe from time of positive test is 9/13-9/23. Throughout his hospital stay he did receive CPAP at nighttime as he has OSA. This is an aerosolizing procedure which the facilities were not comfortable with during his Covid positive timeframe. Options were to send him with oxygen alone versus await 10-day mark when he could go with CPAP. To ensure this was a safe discharge with oxygen alone to get him to rehab sooner a nocturnal oximetry was performed which showed overnight on oxygen alone nocturnal oximetry shows patient spent 98% of the night above 90% SpO2 on 3 L NC. He was found to be appropriate for discharge to rehab with transition back to CPAP on 9/24. Asymptomatic bradycardia Patient was on metoprolol tartrate 50 mg once daily upon admission. He had a profound bradycardia to the 40-50s. His metoprolol was reduced to 25 mg and subsequently was held altogether. This did not alter his heart rate and it remained in the 40s to 50s. An EKG was performed which did show a profound first-degree AV block with PR interval of 280. No history of Lyme disease but has had tick exposure. This was not further investigated as patient was asymptomatic throughout. Brachytherapy & side effects Patient noticed he had started being incontinent of stool during his admission status post brachytherapy placement on 9/7. This is likely proctitis related to radiation which can be ongoing. We recommended he reach out to his radiation oncologist for further information regarding the time course of this. He has mild abdominal pain which is improving daily. Ambulatory dysfunction Patient was noted to have falls at home prior to admission. This was believed to be in the setting of above illness but patient was unsafe to return home where he lives by himself. Social work was able to find placement at encompass. a 73 y.o. male presenting with generalized weakness and shortness of breath. Admitted from the ED with lab findings consistent with diabetic ketoacidosis, which has improved with fluids, as well as new oxygen requirement of uncertain etiology. Plans Principal Problem: Shortness of breath #. Metabolic acidosis likely secondary to ketoacidosis #. Type 2 diabetes Possibly related to diabetic ketoacidosis given that patient has elevated beta hydroxybutyrate and UA positive for ketones as well as blood sugar of 286. This may also be contributing to his generalized weakness. ?Repeat BMP pending. Repeat VBG within normal limits. ?Blood glucose checks every 2 hours ?Start low-dose sliding scale as patient is not on insulin at home. ?IV fluids: Normal saline 100 mL/h #. Hypoxia with new O2 requirement Patient states that he has been short of breath for the last 2 days. CT the of the lungs did show evidence of exposure to asbestos, but this would be unlikely to cause acute hypoxia. Given chest x-ray and CT findings, low suspicion for pneumonia. Though it sounds as if patient may be wheezing when listening to him breathe without the stethoscope, on auscultation lungs are clear bilaterally with no wheezing patient has not received any breathing treatments since arriving at the hospital. ?Continue supplemental O2 as needed, wean as tolerated ?Continuous pulse ox ?Albuterol nebulizer or DuoNeb every 2 hours as needed per respiratory therapy protocol. #. Prostate cancer #. S/p brachytherapy seed placement 9/7 Some concern for possible side effects due to onset of symptoms shortly following brachytherapy seed placement. ?Consult to radiation oncology. #. Urinary frequency UA was positive for nitrites, blood, glucose, and ketones. ?Urine culture pending. #. Hyperlipidemia ?Continue home colesevelam 625 mg daily ?Continue ezetimibe 10 mg daily #. Hypertension ?Continue home losartan 100 mg nightly ?Continue home metoprolol tartrate 50 mg daily ?Continue home felodipine 10 mg daily #. Chronic back pain ?Continue home gabapentin 300 mg twice daily ?Continue home duloxetine 30 mg daily #. Gout ?Continue home allopurinol 100 mg daily Diet: Consistent carb DVT Prophylaxis: Lovenox Disposition: Pending clinical improvement CODE STATUS (LOI): Prior Patient was discussed who is in agreement with the plan. Subjective Chief Complaint Shortness of Breath and Fatigue History of Present Illness a 73 y.o. male with PMH of prostate cancer status post placement of brachytherapy seeds 2 days ago, type 2 diabetes, hypercholesterolemia, HTN, OSA on CPAP, GERD, history of kidney stone who presents with 1 day of generalized weakness and 2 days of shortness of breath.. Patient states that he presented to the hospital because he was getting out of bed at noon yesterday and when he went to stand up he collapsed because he felt that his legs could not support him. He tried to get back up and was unable to do so. He crawled to the bathroom. He said that when he fell he did hit the back of his head, but he did not lose consciousness and remembers the entire event. He does have a bit of a headache still, but says he has not had any confusion or vision changes since the fall. His primary complaint is this generalized weakness. During encounter, patient is on 2 L nasal cannula and clearly short of breath with increased work of breathing. When asked about his shortness of breath, he says that it started 2 days ago since his procedure for brachytherapy seed placement. He denies fevers, chills, increased cough, chest pain, palpitations. Further denies lightheadedness, dizziness. Says that when he stands up he falls backwards, but that this is related to weakness in his body rather than a feeling like he is going to pass out. Since his brachytherapy procedure, he has been having urinary frequency which he says was not an issue for him so much before. States that he needs to urinate every hour. He was initially having dysuria, but was given a medication for this (most likely Pyridium) which turned his urine orange but caused the dysuria to resolve. He is unable to see if there is blood in his urine due to urine coloration. Denies issues with incomplete voiding. Patient denies smoking, alcohol, illicit drug use. Ambulates without any assistive devices at home. Has never needed supplemental oxygen before. He currently lives alone and is retired, but formerly worked as a plumber. His primary contact and POA if he were to become unable to make decisions as his brother. ED Course: Patient brought in by EMS. Per ED report, patient had a temperature of 100.6 per EMS, but was afebrile on arrival in the ED. Also on arrival had heart rate 103, respirations 20, blood pressure 162/83, satting 93% on 2 L nasal cannula. Per ED report, he was satting in the high 80s on room air prior to this. Since initial arrival heart rate has been in the 80s to 90s. CBC showed no leukocytosis and normal hemoglobin. BMP significant for blood glucose of 282, sodium 131 corrected to 134, potassium 3.9, chloride 96, bicarb 19, anion gap 16. Lactate 1.2. UA positive for nitrites, moderate blood, glucose, and ketones. Blood culture and urine culture pending. I-STAT showed pH 7.39, PCO2 34. Troponin 0.03. EKG negative for ischemia but suggestive of first-degree heart block with prolonged PR interval and some regularity in heart rate with possible PAC noted. D-dimer 5.91, but CT scan negative for PE. CXR showed no acute cardiopulmonary process. In the ED patient has received 1 L bolus of NS, but no other medications thus far. Family medicine consulted for admission of patient with new O2 requirement and generalized weakness.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- 14,0
- Labordaten
- 09/13/21 1916 Respiratory virus detection panel Collected: 09/13/21 1705 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Detected Chlamydophila pneumoniae Not Detected Parainfluenza Not Detected COVID-19 SARS-CoV-2 Overall Result Detected Critical Enterovirus/Rhinovirus Not Detected Coronavirus Not Detected Respiratory Syncytial Virus Not Detected Influenza A Not Detected Bordetella pertussis Not Detected Influenza B Not Detected Bordetella parapertussis Not Detected Metapneumovirus Not Detected 09/13/21 1403 COVID-19 (SARS CoV-2,RNA Molecular Amplification) Collected: 09/13/21 1233 | Final result | Specimen: Swab from Nasopharynx COVID-19 SARS-CoV-2 Overall Result Detected Critical 09/13/21 1403 COVID-19 PCR - Communal Living / SNF Placement (Asymptomatic) Collected: 09/13/21 1233 | Final result | Specimen: Swab from Nasopharynx Procedure Component Value Ref Range Date/Time CT chest without contrast [3302586241] Resulted: 09/14/21 1409 Order Status: Completed Updated: 09/14/21 1409 Narrative: CT CHEST WO CONTRAST IMPRESSION: New subtle peripheral right lower lobe airspace disease concerning for possible development of early COVID-19 pneumonia. Persistent bilateral calcified and noncalcified pleural plaques related to changes of prior asbestos exposure. Fatty liver disease. END OF IMPRESSION: INDICATION: COVID-19 positive with increasing oxygen requirement. TECHNIQUE: Helical CT scan of the chest without contrast was performed from the lung apices to below the diaphragm with 3 mm axial reconstruction. MPR coronal and sagittal images were created. CONTRAST: No contrast was administered. COMPARISON: September 9, 2021. FINDINGS: Allowing for the limitations of this unenhanced technique, there is no pathologic adenopathy appreciated. No pleural or pericardial effusions are noted. There is scattered coronary artery calcification. Regional soft tissues are grossly intact. Limited evaluation of the upper abdomen demonstrates fatty liver disease. There are stable calcified and noncalcified pleural plaques identified related to prior asbestos exposure. Slight right lower lobe airspace disease concerning for changes of developing COVID-19 pneumonia. Central airways are patent without evidence for endobronchial lesions. Minimal bibasilar dependent changes are noted. Osseous structures are grossly intact. Mild scattered degenerative changes noted. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray foot right 3+ views [3302455217] Resulted: 09/11/21 1811 Order Status: Completed Updated: 09/11/21 1811 Narrative: XR FOOT 3 OR MORE VW RIGHT IMPRESSION: No significant findings. END OF IMPRESSION: INDICATION: unexplain bruising, suspect neuropathic injury. TECHNIQUE: AP, lateral and oblique projections of the right foot were obtained. COMPARISON: None available. FINDINGS: Normal bony mineralization. No definite evidence of fracture or dislocation is seen. The surrounding soft tissues are grossly unremarkable. The joint spaces are within normal limits. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view - Portable [3301992052] Resulted: 09/09/21 0715 Order Status: Completed Updated: 09/09/21 0716 Narrative: XR CHEST 1 VW PORT IMPRESSION: 1. Somewhat low lung volumes limit assessment. 2. Mild cardiomegaly changes. 3. Otherwise no acute cardiopulmonary process. 4. Cannot exclude minimal left basilar atelectasis or infiltrates. END OF IMPRESSION: INDICATION: Sepsis. TECHNIQUE: Single AP projection of the chest is acquired. COMPARISON: Chest radiograph dated December 24, 2016. FINDINGS: Cardiomegaly changes are reidentified. No consolidation, effusion or pneumothorax is identified. Osseous structures are intact. Somewhat low lung volumes limit assessment. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT angiogram chest pulmonary embolism with and without contrast [3302001480] (Abnormal) Resulted: 09/09/21 0450 Order Status: Completed Updated: 09/09/21 0450 Narrative: PROCEDURE INFORMATION: Exam: CTA Chest Without And With Contrast Exam date and time: 9/9/2021 2:53 AM Age: 73 years old Clinical indication: Other: Na; Additional info: Hypoxia, +dimer, SOB. Hypoxia, +dimer, SOB TECHNIQUE: Imaging protocol: Computed tomographic angiography of the chest without and with contrast. 3D rendering (Not supervised by radiologist): MIP and/or 3D reconstructed images were created by the technologist. Radiation optimization: All CT scans at this facility use at least one of these dose optimization techniques: automated exposure control; mA and/or kV adjustment per patient size (includes targeted exams where dose is matched to clinical indication); or iterative reconstruction. Contrast material: OMNI 350; Contrast volume: 80 ml; Contrast route: INTRAVENOUS (IV); COMPARISON: DX XR CHEST 1 VW 9/8/2021 11:41 PM FINDINGS: Pulmonary arteries: Normal. No pulmonary emboli. Aorta: Unremarkable. No aortic aneurysm. No aortic dissection. Lungs: Unremarkable. No consolidation. No masses. Pleural spaces: Multifocal pleural nodularity with calcification scattered throughout the bilateral thorax most consistent with asbestos exposure with calcific plaque along the right hemidiaphragm. Heart: Unremarkable. No cardiomegaly. No pericardial effusion. Lymph nodes: Unremarkable. No enlarged lymph nodes. Liver: Diffuse fatty infiltration of the liver.There are moderate degenerative changes present. Gallbladder and bile ducts: There has been a cholecystectomy. Bones/joints: Unremarkable. No acute fracture. Soft tissues: Unremarkable. Other findings: . IMPRESSION: 1. Findings of asbestos exposure. 2. Hepatic steatosis. THIS DOCUMENT HAS BEEN ELECTRONICALLY SIGNED
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Nervous Chronic bilateral low back pain without sciatica Cervical radiculopathy Hearing loss Respiratory Obstructive sleep apnea of adult Allergic rhinitis Acute respiratory failure with hypoxia (CMS/HCC) Circulatory Essential hypertension Digestive Gastroesophageal reflux disease Genitourinary Prostate cancer (CMS/HCC) Left ureteral stone Musculoskeletal Osteoarthritis, multiple sites Endocrine/Metabolic Type 2 diabetes mellitus without complication (CMS/HCC) Hypercholesterolemia Pure hypercholesterolemia Diabetic ketoacidosis without coma associated with type 2 diabetes mellitus (CMS/HCC) Infectious/Inflammatory COVID-19 virus infection Other Obesity (BMI 30.0-34.9) History of brachytherapy Asbestos exposure Ambulatory dysfunction
- Andere Medikamente
- acetaminophen (TYLENOL) 325 mg tablet albuterol HFA (PROVENTIL;VENTOLIN) 90 mcg/actuation inhaler allopurinoL (ZYLOPRIM) 100 mg tablet aspirin 81 mg tablet azelastine (ASTELIN) 137 mcg (0.1 %) nasal spray colesevelam (WELCHOL) 625 mg t
- Allergien
- Ace InhibitorsAngioedema / Facial Swelling AtorvastatinMyalgia / Muscle Pain LisinoprilAngioedema / Facial Swelling LovastatinMyalgia / Muscle Pain RosuvastatinMyalgia / Muscle Pain CholestyramineConstipation HydrochlorothiazideOther (document details in comments) Nsaids (Non-steroidal Anti-inflammatory Drug)Other (document details in comments) OtherConstipation PiroxicamOther (document details in comments)
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 02.10.2021
- Impfdatum
- 22.01.2021
- Beginn
- 25.05.2021
- Tage bis Beginn
- 123,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Arteriogram coronary abnormal
Asthenia
Blood creatinine
Blood magnesium
Blood urea
Chest X-ray
Chest discomfort
Chest pain
Coronary arterial stent insertion
Coronary artery occlusion
Diagnostic procedure
Dizziness
Echocardiogram
Electrocardiogram
Fibrin D dimer
Full blood count
Intensive care
International normalised ratio
Symptomtext
Queasy, nauseous, lightheaded, chest pressure/pain, weakness during morning, afternoon and evening of May 25, 2021 at home, then in emergency room at a HCF until ambulance took me to be admitted to the Hospital for more intensive care. On May 26th, 2021 about 9:00am had angiogram procedure that inserted stent for 60-70% blockage and low flow in LAD artery. Ultrasound performed on heart. On May 27, 2021 discharged to return home.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 3,0
- Labordaten
- EKG, TroponinI, CBC with Platelets, basic metabolic panel, INR, D Dimer quantitative, XR chest, Scan-cardiac strip, Lipid panel, Magnesium, Creatinine, BUN, CVL Coronary angiogram, Potassium, Sodeium, CBC w PLT NO DIFF, APTT, glucose meter, activated clotting, ECHO Complete, Platelet count, hemoglovin,
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- hiatal hernia, hypothyroidism,glaucoma, occipital neuralgia, arthritis
- Andere Medikamente
- Levothyroxine,Latanoprost, Nortriptyline,Omeprazole,Famotidine calcium citrate, dorzolamine-timolol, ketoconazole shampoo, celecoxib, Miralax, Ocuvite, fishoil-omega 3, SalivaSure lozg, ondansetron, Joint complex of glucosomines, msm, latan
- Allergien
- Codine,brimonnidine, sensitive to kiwi,strawberries,tomatoes
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 01.10.2021
- Impfdatum
- 25.01.2021
- Beginn
- 30.09.2021
- Tage bis Beginn
- 248,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cough
Dizziness
Fatigue
Presyncope
SARS-CoV-2 test positive
Symptomtext
Dizziness, fatigue, cough, and COVID positive on 9/30/21. The patient is a 72 yo male who presents with dizziness and COVID 19 infection. Comorbidities include HTN, hyperlipidemia, prostate cancer s/p radiation (completed May 2019 followed by androgen supression therapy completed Oct 2019, last PSA <0.1 on 5/10/21), peripheral neuropathy, depression, anxiety, and prior ischemic stroke (Oct 2020, no residual deficits) with left carotid artery occlusion s/p right carotid stent placement on 11/2/20. Prior COVID 19 vaccine (Pfizer) completed on 2/24/21. Patient presented to ED due to episode of near syncope earlier today. Patient reported feeling tired, having a cough, and had planned to have a booster dose of vaccine but has not been able to do it yet. While walking to the bathroom this morning, he felt dizzy, had to lower himself to the floor, was diaphoretic, and slow to respond. During this episode patient denied any chest pain, shortness of breath, palpitations, loss of consciousness, and seizures.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- Coronavirus 2 PCR Detect, V symptomatic, POSITIVE.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 14.09.2021
- Impfdatum
- 10.03.2021
- Beginn
- 03.09.2021
- Tage bis Beginn
- 177,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Dyspnoea
Fatigue
Monoclonal antibody immunoconjugate therapy
Presyncope
Pyrexia
SARS-CoV-2 test positive
Symptomtext
Admitted 9/2 due to fatigue, fevers, shortness of breath and near syncope. Tested positive for COVID-19 08/25/2021. Received monoclonal antibody therapy following. Patient is vaccinated for COVID-19.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- 9,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- calcium carbonate 500 mg,cholecalciferol, desipramine
- Allergien
- Amoxicillin, Latex, Minocin [Minocycline], Nickel
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 14.09.2021
- Impfdatum
- 17.02.2021
- Beginn
- 09.09.2021
- Tage bis Beginn
- 204,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Cough
Decreased appetite
Fatigue
Oxygen saturation decreased
Respiratory distress
Symptomtext
Patient is a 79 y.o. male with a history of A fib on chronic anticoagulation, DM type II on insulin, HTN, GERD, obesity and OSA on CPAP who is transferred for after worsening respiratory status despite Remdesivir and dexamethasone treatment for recently diagnosed COVID-19. He arrives and is on high flow O2 80% at 40L/min. He tells me his symptoms began about a week ago. He noticed that he was fatigued despite using his CPAP at night. He also noticed he had lost his appetite. He denies any loss of taste or smell. He says his cough has been ongoing about a week. He denies any N/V, fever or diarrhea. He says he has been eating now, but not as much as normal. His breathing he t
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Respiratory distress
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- dexAMETHasone,dextrose, digoxin, famotidine, finasteride, glucagon, glucose, insulin aspart, insulin glargine
- Allergien
- Allopurinol
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 08.09.2021
- Impfdatum
- 16.02.2021
- Beginn
- 30.03.2021
- Tage bis Beginn
- 42,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Deep vein thrombosis
Joint swelling
Ultrasound Doppler abnormal
Symptomtext
Approx 3 weeks after second shot, pain, swelling behind rt knee. Went to Urgent Care who sent me to ER.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- Positive Doppler for DVT.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hyperthyroidism, PVC?s, RA
- Andere Medikamente
- Atenolol, methimazole, methotrexate, calcium, Vit B complex, Vit C, ACV, MVT
- Allergien
- Sulfa
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 08.09.2021
- Impfdatum
- 24.02.2021
- Beginn
- 30.05.2021
- Tage bis Beginn
- 95,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Computerised tomogram
Thrombosis
Transient ischaemic attack
Symptomtext
Blood Clots found after a Cat Scan and trip to emergency for a series of TIA's.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- Cat Scan, Hospital Emergency June 25th
- Aktuelle Erkrankungen
- Bladder Cancer
- Vorgeschichte
- Bladder Cancer, Parkinson's
- Andere Medikamente
- Linsinopril 5mgx2, Atenolol 25mgx2, Memantine 10mgx2, Donepezil 10mg, Flomax .4mg, Alprazolam.25mg as needed, Levothyroxine 25mg, Rovuvastatin5mg,
- Allergien
- Codine
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 07.09.2021
- Impfdatum
- 23.02.2021
- Beginn
- 06.04.2021
- Tage bis Beginn
- 42,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Bell's palsy
Drooling
Facial paralysis
Magnetic resonance imaging head normal
Symptomtext
Drooping Left side of face. Drooling. Thought by patient to be a stroke.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- 1,0
- Labordaten
- MRI of brain proved inconclusive of stroke. Diagnosed as Bells Palsy
- Aktuelle Erkrankungen
- nil
- Vorgeschichte
- Chondro Malacia Patella
- Andere Medikamente
- Astotvastatin, clopidogrel,metoprolol,amlodipine, multi vitami
- Allergien
- nil
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 07.09.2021
- Impfdatum
- 04.03.2021
- Beginn
- 04.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Bell's palsy
Computerised tomogram
Magnetic resonance imaging
Symptomtext
I developed Bells Palsy affecting the left side of face On 04Jul, 4 months after my 2nd Pfizer vaccine on 04Mar; This is a spontaneous report from a contactable consumer (patient). A 74-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EN6200), via unspecified route of administration, administered in arm left on 04Mar2021 (at the age of 74-years-old and she was not pregnant at the time of vaccination) as Dose 2,Single for COVID-19 immunization. The patient's medical history was none. Other medications in two weeks included atorvastatin calcium (LIPITOR) 10 mg daily. There was no other vaccine in four weeks. There was no covid prior vaccination and not tested COVID post vaccination. There was no known allergies. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EL9265), via unspecified route of administration, administered in arm left on unspecified date as DOSE 2, SINGLE for COVID-19 immunisation at hospital. The patient experienced Bell's Palsy affecting the left side of face on 04Jul2021 at 6:00 AM, 4 months after my 2nd Pfizer vaccine on 04Mar2021. The adverse event resulted into Emergency room visit, Hospitalization for one day. She received treatments for adverse event included CT Scan, MRI, medication. The patient underwent lab tests and procedures included CT Scan, MRI on unspecified date. The outcome of event was not recovered. No follow-up attempts were possible. No further information was expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- 1,0
- Labordaten
- Test Name: CT Scan; Result Unstructured Data: Test Result: UNKNOWN; Test Name: MRI; Result Unstructured Data: Test Result: UNKNOWN.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: Other medical history: None.
- Andere Medikamente
- LIPITOR
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 05.09.2021
- Impfdatum
- 02.04.2021
- Beginn
- 28.08.2021
- Tage bis Beginn
- 148,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Bell's palsy
Computerised tomogram
Ophthalmological examination
Symptomtext
Onset of Bell's Palsy
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- ER Evaluation, CAT scan to eliminate possiblity of stroke, visit to ophthamologist for eye evaluation
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Diabetes, Heart condition (stents, pacemaker), High blood pressure, Prostrate cancer ( in remission, High Colesterol
- Andere Medikamente
- See continuation page
- Allergien
- None known
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 03.09.2021
- Impfdatum
- 08.03.2021
- Beginn
- 13.08.2021
- Tage bis Beginn
- 158,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Angiogram pulmonary normal
Asthenia
Brain natriuretic peptide increased
Bronchitis
COVID-19
Chills
Cholecystitis
Computerised tomogram thorax
Cough
Diastolic dysfunction
COVID-19 pneumonia
Cardiac failure
Cardiac failure acute
Cardiac failure congestive
Chest X-ray abnormal
Dizziness
Dyspnoea
Dyspnoea exertional
Symptomtext
Hospitalized; COVID-19 positive (8.21.21) - hospitalized on 8.28.21 due to COVID (fully vaccinated) Discharge Information: Admission Date: 8/27/2021 Discharge Date: 09/02/2021 Admitting Diagnoses: Pneumonia due to COVID-19 virus PRESENTING PROBLEM: Hypoxia Acute on chronic congestive heart failure, unspecified heart failure type Pneumonia due to COVID-19 virus COVID-19 HOSPITAL COURSE: Patient is a 71 y.o. male who presented to the emergency department with complaints of shortness of breath. He has a past medical history of chronic obstructive pulmonary disease, hypertension, GERD, gout, non-Hodgkin's lymphoma, CKD stage 3, type 2 diabetes, and lymphedema. Patient states that on 08/18/2021, he started having symptoms of COVID-19 including shortness of breath, fatigue, chills, fever, congestion, rhinorrhea, nausea, dizziness and weakness. On 08/21/2021, he presented to the emergency department and COVID-19 was confirmed. He states that since then he has had increasing shortness of breath. Yesterday afternoon, a home health nurse checked his oxygen saturation and found it to be 87% on room air. He presented to the emergency department after realizing he was hypoxic on room air. In the emergency department, patient was febrile, tachypneic, and required 2 liters/minute supplemental oxygen via nasal cannula to maintain a saturation greater than 90%. Complete blood count was unremarkable. BMP was remarkable for chronic kidney disease. BNP was 2261 in the emergency department, and increase from 1296 last week. EKG showed V paced rhythm. Chest x-ray showed few patchy opacities in the right perihilar region and left lower lung along with small bilateral pleural effusions. Echocardiogram from 08/16/2020 shows LVEF of 45% with mild septal hypokinesis. Additionally, it shows diastolic dysfunction stage I. Suspect hypoxia related to COVID-19 pneumonia. Patient has been admitted for further evaluation management of COVID-19 pneumonia and acute on chronic combined systolic and diastolic congestive heart failure. Patient was admitted and diuresed with Lasix. Had echocardiogram done recently on 08/16 was obtained from outpatient and found to have a stable ejection fraction of 40-45%. He diuresed well with improvement of his renal function to his baseline. He was treated with steroids and remdesivir. He was able to be weaned off of oxygen but continued to have persistent dyspnea and exertional shortness of breath with cough. With continued treatment the symptoms eventually improved and was felt he was stable to be discharged home for continued care. He will follow salt and fluid restrictions, and his Lasix was increased to twice daily. He will have a BMP drawn within 1 week and will follow up with tip in the latter more within the next week. He is greater than 10 days from onset of symptoms so he no longer needs to self isolate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- Found to be COVID-19 positive 8.21.21 - ED visit (8.21.21) - SYNCOPE Acute bronchitis - seen in office 7.28.21 (chronic shortness of breath) from ED visit 8.21.21: ED Provider Notes (Physician) ? ? Addiction Medicine Patient was signed out to me by the prior emergency department provider. For original emergency department report details, please see prior note. At the time of sign-out, patient was awaiting a CT angiogram of the thorax to rule out PE in the setting of new COVID infection diagnosis and syncopal episode. Patient was never noted to be hypoxic, but did arrive mildly hypotensive. He was given 2 L of IV fluids prior to sign-out and had responded to fluids nicely with normalization of his blood pressures. Patient does report feeling severe generalized fatigue and cough and assumed he had bronchitis. He does appear mildly fatigued here, but is still satting 97% on room air and has otherwise normal vital signs. His CT scan came back negative for PE but did show signs of congestive heart failure verses airspace disease. Given that patient does have a positive COVID test and also has an elevated BNP, he could certainly have a combination of both heart failure and COVID infection causing these findings on CT scan. I did tell him he should follow up with his PCP about possibly having an echocardiogram at some point. He does have lower extremity edema which he states is not new for him. The CT also commented on a an inflamed appearing gallbladder without gallstones, and I asked the patient if he has had any right upper quadrant abdominal pain, and he denies this. I examined him he had a completely nontender abdomen, in particular nontender in the right upper quadrant. Overall, the patient felt comfortable going home. He states he has a pulse oximeter at home. He ambulated with no difficulty and did not have any desaturation episodes. Ultimately this confirmed that he was appropriate for discharge home and patient was in agreement. He understood follow up instructions and return precautions. All questions are answered and patient is discharged in stable condition
- Vorgeschichte
- History of non-Hodgkin's lymphoma Mild persistent asthma without complication Gastroesophageal reflux disease Gout, unspecified cause, unspecified chronicity, unspecified site Chronic obstructive pulmonary disease, unspecified COPD type Essential hypertension Hyperlipidemia, unspecified hyperlipidemia type Type 2 diabetes mellitus with hyperglycemia, with long-term current use of insulin Sarcoidosis of lung with sarcoidosis of lymph nodes Stage 3a chronic kidney disease Lymphedema Acute bronchitis, unspecified organism Pneumonia due to COVID-19 virus Gout GERD (gastroesophageal reflux disease) COPD (chronic obstructive pulmonary disease) Acute on chronic combined systolic and diastolic congestive heart failure
- Andere Medikamente
- albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler allopurinol (ZYLOPRIM) 100 MG tablet atorvastatin (LIPITOR) 20 MG ta
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 02.09.2021
- Impfdatum
- 05.02.2021
- Beginn
- 19.02.2021
- Tage bis Beginn
- 14,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Back pain
Disturbance in attention
Electric shock sensation
Insomnia
Memory impairment
Pain in extremity
Symptomtext
Not long after the vaccine I began to develop sharp, electrical, stabbing pains all over my body in random places; arms, legs, back, feet. The foot pain is getting worse so I felt I should report it. It feels like someone is driving hot, electrified needles in to my skin. It is not chronic, but it happens sporadically throughout the week and is very painful. I am also having memory issues. My concentration and focus is worse and I am not sleeping as well as I used to.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Electric shock sensation
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None. I already tested positive for COVID in November 2020
- Vorgeschichte
- LBBB, asthma, history of heart failure (caused by Lyrica)
- Andere Medikamente
- Tylenol, Advil, vitamin D, C
- Allergien
- Flagyl, Lyrica
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 31.08.2021
- Impfdatum
- 26.01.2021
- Beginn
- 23.08.2021
- Tage bis Beginn
- 209,0
- Dosis
- 1
- Route/Site
- SYR / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bell's palsy
Feeling abnormal
Symptomtext
August 23. 2021. Woke up with right side of face feeling weird. Went to emergency room at hospital. diagnosed as Bell's Palsy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- Prednisone and Acclovir 8/23/21
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Back pain both lower and upper
- Andere Medikamente
- Xeralto, Famotidine, Atovastatin, Oxicodone pain, Multivitamins
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 30.08.2021
- Impfdatum
- 18.02.2021
- Beginn
- 18.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Fatigue
Loss of consciousness
Nausea
Pyrexia
Symptomtext
I had fever, chills, fatigues, and nausea, I passed out the same night, so the next day I went to the doctor and she stated everything was fine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Metoprolol; Vitamin D
- Allergien
- All sulfur drugs and Metamizole, Neomycin
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 29.08.2021
- Impfdatum
- 01.02.2021
- Beginn
- 27.08.2021
- Tage bis Beginn
- 207,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Activated partial thromboplastin time shortened
Asthenia
Atrioventricular block first degree
Blood bicarbonate decreased
Blood calcium decreased
Blood creatinine increased
Blood culture
Blood urea increased
COVID-19
Chest X-ray abnormal
Cough
Cytopenia
Decreased appetite
Dizziness
Electrocardiogram ST segment abnormal
Electrocardiogram abnormal
Faeces discoloured
Fatigue
Symptomtext
Admitted to hospital for COVID HISTORY OF PRESENT ILLNESS: Patient is a 83 y.o. male with PMH of HTN, CAD, CVA, IFG, h/o alcohol dependency with liver cirrhosis, rectal cancer s/p low anterior resection in 2011, bicytopenia and leukocytosis, recurrent blood in stool, urinary retention with suprapubic catheter in place who presents with increasing fatigue, weakness, presyncope and blood pooling in depends. Patient reports there has been quite a few family members recently d/w COVID-19. States he started feeling weak and fatigue since a week ago. He has also noticed a persistent dry cough around the same time. Around midnight, he feels as though he would pass out after going to the bathroom, which made press the life alert button. He also endorses dark tarry stools for past 3 days but has only noticed significant maroon blood pooling in depends since being in the ER. Appetite has been "so so", states he drinks mainly diet pepsi and eats microwavable meals. Occasionally his daughter in law would bring meals over to his house. Patient admits to chronic bilateral foot edema. Denies suprapubic pain or discharge from suprapubic catheter. Denies noticing blood or dark colored urine. Patient denies any recent fever, chills, sputum producing cough, headache, vision changes, nausea, vomiting, hematemesis, chest pain or pressure, palpitation, shortness of breath, wheezing, abdominal pain, weakness or numbness of the extremities. Patient has been taking NyQuil for symptoms. Otherwise denies current NSAID use, tobacco or alcohol use. Patient does have a h/o alcohol dependency in the past with CT imaging obtained in 2011 suggestive of liver cirrhosis. Of note, patient was seen by Hematology in May of 2021 for evaluation of by cytopenia and leukocytosis with plan for CT A/P to evaluate for hematochezia which was concerning for recurrent rectal cancer. However it seems patient has not obtain CT imaging or follow-up with Hematology since then. It was noted in Hematology note that if rectal cancer recurs, patient would want to forego systemic treatment or chemotherapy. However, when I talked to patient, he also reiterates the reason he did not get the CT scan was because he was not going to pursue treatment if cancer recurs. In the ED, vital signs 146/65, 72 bpm, 97.7F, 96% on RA. Positive orthostatic vitals. Work up significant for bicarb of 19, calcium 7.8, BUN 42, creatinine 1.87 with EGFR 33 (baseline creatinine 1.0). EtOH < 10. INR 1.5, PTT 45. Hemoglobin 6.5 (9.6 in May), WBC 35.3k, platelet 77k. ECG NSR with 1st degree AVB, w/o ST segment changes or TWI. CXR showed stable small b/l pleural effusions. Negative for influenza A/ B and RSV. Unfortunately COVID-19 PCR returned positive. BCx x2 obtained. Patient is receiving 2 units of pRBCs. Hematology was consulted in ER and recommended vitamin K and platelet transfusions. GI was also consulted. Of note, patient is on Plavix for secondary stroke prevention since CVA in 2009. EGD 08/02/2011 - for hematochezia and iron deficiency anemia No Barrett's esophagus Esophageal ring noted Hemorrhagic mucosa in the stomach antrum Normal duodenum Colonoscopy 08/02/2011- for hematochezia and iron deficiency anemia 3 cm ulcerated tumor which occupied 25 - 49% of the circumference of the rectum, 8 cm from the entry site. Pathology returned positive for invasive adenocarcinoma.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- 08/27/2021 COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Essential hypertension Noted: 10/17/2009 Dyslipidemia (Chronic) Noted: 10/17/2009 CVD (cardiovascular disease) Noted: 10/17/2009 History of rectal cancer Noted: 8/24/2011 Urinary retention Noted: 9/15/2011 IFG (impaired fasting glucose) Noted: 6/5/2013 Personal history of other malignant neoplasm of skin Noted: 4/8/2019 CVA, old, ataxia Noted: 4/22/2021
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 28.08.2021
- Impfdatum
- 23.03.2021
- Beginn
- 26.03.2021
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Burning sensation
Electric shock sensation
Symptomtext
Burning sensation intermittently on 3 occasions inside left arm; Burning sensation intermittently on 3 occasions inside left arm. It felt like an electric shock or jolt.; This is a spontaneous report from a contactable other healthcare professional (patient). A 41-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: En6200), via an unspecified route of administration in left arm on 23Mar2021 at 13:00 (at the age of 41-year-old) at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were none. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. No other medications received in two weeks. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021 at 18:00, the patient experienced burning sensation intermittently on 3 occasions inside left arm and it felt like an electric shock or jolt. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No treatment was received for the events. The clinical outcome of the events was recovered in 2021. No follow-up attempts are needed. No further information is expected. Amendment: This follow-up report is being submitted to amend previously reported information: events details added (no treatment received), events were recovered in 2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Electric shock sensation
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 28.08.2021
- Impfdatum
- 15.03.2021
- Beginn
- 15.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Fatigue
Headache
Dysphagia
Lip pruritus
Lip swelling
Throat clearing
Throat irritation
Pain
Pulmonary thrombosis
Thrombosis
Symptomtext
slight headache; weak and tired; weak and tired; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 15Mar2021 (Batch/Lot Number: EN6200) (at age 65-years-old) as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. When the patient received the first dose Pfizer Covid Vaccine on 15Mar2021, she had a severe reaction from it and was taken to the emergency room then discharged. The paramedics had to come to the vaccination site and give the patient mediations there. She was sick for about a week behind the first dose Pfizer Covid Vaccine with slight headache, just weak and tired as soon as the first dose was administered on 15Mar2021. She was in bed for about what seemed like a month or at least three weeks until the patient went to get the second dose of Pfizer Covid Vaccine. Outcome of the event of headache was not recovered while for the remaining events was unknown. Follow-up attempts are completed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary thrombosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 28.08.2021
- Impfdatum
- 15.03.2021
- Beginn
- 15.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Fatigue
Headache
Dysphagia
Lip pruritus
Lip swelling
Throat clearing
Throat irritation
Pain
Pulmonary thrombosis
Thrombosis
Symptomtext
slight headache; weak and tired; weak and tired; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 15Mar2021 (Batch/Lot Number: EN6200) (at age 65-years-old) as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. When the patient received the first dose Pfizer Covid Vaccine on 15Mar2021, she had a severe reaction from it and was taken to the emergency room then discharged. The paramedics had to come to the vaccination site and give the patient mediations there. She was sick for about a week behind the first dose Pfizer Covid Vaccine with slight headache, just weak and tired as soon as the first dose was administered on 15Mar2021. She was in bed for about what seemed like a month or at least three weeks until the patient went to get the second dose of Pfizer Covid Vaccine. Outcome of the event of headache was not recovered while for the remaining events was unknown. Follow-up attempts are completed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary thrombosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 19.08.2021
- Impfdatum
- 13.02.2021
- Beginn
- 14.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Arthralgia
Coagulation test
Deep vein thrombosis
Full blood count
Haemoglobin decreased
Iron deficiency anaemia
Pain in extremity
Peripheral swelling
Transfusion
Ultrasound scan abnormal
Symptomtext
DVT of right popliteal, peroneal, and anterior tibial veins. Pain behind my knee started 2/14 (day after vaccine). Calf eventually was swollen and painful. Saw an orthopedist 3/10 who referred for an ultrasound. An old clot in left popliteal was discovered and a more recent one in the right leg veins. Started on xarelto. - 15 mg bid for 3 weeks then 20 mg SID. Saw a hematologist 4/8. No congenital clotting factors discovered so suspect the dvt?s are secondary to Covid (left leg) and the second vaccine (right leg). On the bloodwork done 4/8 it was discovered that I had severe iron deficient anemia (hgb of 5.1) and was referred to the emergency department for 2 units of blood. I now have had 14 (of 16) iron infusions of ferrlecit in an attempt to bring up both iron levels and hemoglobin. After the initial 8 iron infusions my hgb had dropped to 6.7. Xarelto was switched to enoxaparin during hospital stay.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- 3,0
- Labordaten
- Initial vein ultrasound 3/11, repeated 3/18, 4/15, 4/22, and 6/24. Initial bloodwork for clotting factors 4/8. BW repeated at Hospital 4/14-4/16. Almost weekly CBC?s since.
- Aktuelle Erkrankungen
- None. Covid diagnosed 12/15/2020
- Vorgeschichte
- None - probably had a DVT in left leg during Covid
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 18.08.2021
- Impfdatum
- 16.02.2021
- Beginn
- 16.08.2021
- Tage bis Beginn
- 181,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Condition aggravated
Neurological symptom
SARS-CoV-2 test positive
Seizure
Symptomtext
Presents with Seizure this morning. Per EMS, Pt was increased on Depakote, and hadn't gotten a refill on his prescription which caused back-to-back seizures, each lasting approx 30 seconds and entire episode lasting 3-5 minutes. Pt who has a hx of seizures currently is back to normal and has no complaints or pain at this time. Patient was recently hospitalized at our MC for concerns of possible CVA. He and his wife report that he had a full inpatient workup, including MRI and ultrasounds which were negative for acute stroke. Patient was determined to have had seizure activity leading to his neurological symptoms, and he was increased on his Depakote to 500 mg b.i.d.. Patient's wife states that they have not
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- SARS COV2 COVID 19 PCR 08/16/2021 (INCIDENTAL FINDING)
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Anxiety, back pain, Brain injury with open intracranial wound, CABG, Carotid stenosis, Claudication, Dyslipidemia
- Andere Medikamente
- Hydralazine, Carvedilol, Divalproex, ASA, Jevity, Multivit
- Allergien
- Lisinopril, Statins, PCN
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 97,0
- Geschlecht
- F
- Eingang
- 16.08.2021
- Impfdatum
- 23.02.2021
- Beginn
- 14.08.2021
- Tage bis Beginn
- 172,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Back pain
COVID-19
Fall
Pelvic pain
SARS-CoV-2 test positive
Syncope
Symptomtext
this is a 97-year-old female with past medical history of hypertension, hyperlipidemia dementia, history of CVA, history of colon cancer status post resection currently under remission, DNR, resident of assisted living facility . She came to the hospital with a chief complaint of mechanical fall. Patient reported that she a collapsed on the floor and fell and since then she has been having significant pain in the back and the pelvic region for the last 1 day. History taking limited from the patient due to dementia. Called patient's daughter on the number listed on the face sheet. Most of the history was obtained from her. The patient lives in an assisted living facility and the staff reported that she collapsed and fell and was complaining of some pain so she was sent to the hospital for further evaluation and treatment. Patient herself denies any other symptoms otherwise apart from pelvic pain. 8/14/2021 tested positive
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- hypertension, hyperlipidemia dementia, history of CVA, history of colon cancer status post resection currently under remission
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 13.08.2021
- Impfdatum
- 26.01.2021
- Beginn
- 13.08.2021
- Tage bis Beginn
- 199,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Diarrhoea
Mental status changes
Syncope
Symptomtext
He presented to the ED after having a syncopal episode with altered mental status. Also reports having some loose stools earlier in the day. Denies nausea, vomiting, chest pain or shortness of breath. No prior positive COVID-19 infections.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 13.08.2021
- Impfdatum
- 05.03.2021
- Beginn
- 11.08.2021
- Tage bis Beginn
- 159,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Aphasia
Blood culture
Cerebral amyloid angiopathy
Cerebral atrophy
Chest X-ray
Computerised tomogram
Confusional state
Differential white blood cell count
Encephalopathy
Full blood count
Hallucination
Headache
Hypertension
Hypomagnesaemia
International normalised ratio
Magnetic resonance imaging
Metabolic function test
Paranoia
Symptomtext
Headache, confusion, hypomagnesemia, cerebral amyloid angiopathy, expressive aphasia, hypertension, increasing frequency of seizure activity, acute encephalopathy, paranoia, hallucinations, brain atrophy,
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- MRI, CT, urinalysis, blood cultures, chest xray, troponin, cbc with differential, bmp, PT/INR,
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 13.08.2021
- Impfdatum
- 02.03.2021
- Beginn
- 07.08.2021
- Tage bis Beginn
- 158,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Amnesia
COVID-19
Chills
Condition aggravated
Epistaxis
Head injury
Hypotension
Nasal cavity packing
Nasal cavity packing removal
Nausea
SARS-CoV-2 test positive
Syncope
Symptomtext
This is a 78-year-old female with past medical history of hypertension, hyperlipidemia, type 2 diabetes mellitus insulin dependent, diabetic nephropathy, chronic kidney disease stage 3, myocardial infarction status post 3 stents, permanent atrial fibrillation on chronic anticoagulation with Eliquis, history of multiple episodes of epistaxis, COPD/emphysema, history of CVA with residual deficit in the vision, hypothyroidism, peripheral neuropathy, history of skin cancer status post excision, chronic sinusitis. She came to the hospital with a chief complaint of an episode of syncope this morning. Patient was here in the emergency room last night for epistaxis. Patient underwent nasal 8/7/2021 tested positive This is a 78-year-old female with past medical history of hypertension, hyperlipidemia, type 2 diabetes mellitus insulin dependent, diabetic nephropathy, chronic kidney disease stage 3, myocardial infarction status post 3 stents, permanent atrial fibrillation on chronic anticoagulation with Eliquis, history of multiple episodes of epistaxis, COPD/emphysema, history of CVA with residual deficit in the vision, hypothyroidism, peripheral neuropathy, history of skin cancer status post excision, chronic sinusitis. She came to the hospital with a chief complaint of an episode of syncope this morning. Patient was here in the emergency room last night for epistaxis. Patient underwent nasal packing in the emergency room. She has previous similar episodes of epistaxis. Eliquis was advised to be held. Patient was supposed to see her cardiologist Dr. for decision regarding resuming Eliquis. This morning the patient woke up but she could not really sleep all night due to discomfort in the nasal cavity from the packing. She felt that the packing was too tight. She had some difficulty breathing due to tight packing in the nasal cavity. The patient denied any fevers but did have some chills. Denies any cough. Currently the epistaxis is resolved. Nasal packing is removed. The patient denies any chest pain, shortness of breath, palpitations, abdominal pain, burning or painful urination, diarrhea. She did have some nausea but denies any episodes of vomiting. After the patient got up from the bed this morning she went to the bathroom but she collapsed on the floor, she hit her head, then she suddenly found herself in the bathroom but does not remember how she went there, the episode was unwitnessed. She came to the hospital and had low blood pressure. Nasal packing was removed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- hypertension, hyperlipidemia, type 2 diabetes mellitus insulin dependent, diabetic nephropathy, chronic kidney disease, hypertension, hyperlipidemia, type 2 diabetes mellitus insulin dependent, diabetic nephropathy, chronic kidney disease stage 3, myocardial infarction
- Andere Medikamente
- codeine, benadryl
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 10.08.2021
- Impfdatum
- 21.02.2021
- Beginn
- 04.03.2021
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Anticoagulant therapy
Blood uric acid
Joint swelling
Oedema peripheral
Peripheral swelling
Thrombosis
Ultrasound Doppler abnormal
X-ray limb normal
Symptomtext
10 days after injection, I had edema and swelling in my lower left leg and ankle. 4 days later after a 5 mile hike more extensive edema in entire lower left leg and ankle. At first it was thought the edema was from a case of gout and a 5 day dose of prednisone was prescribed. Seemed to help for a few day along with leg elevation and ice. The in June, after no real improvement, and x-ray was made which discovered no gout. A day later an ultrasound found a blood clot behind my knee.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- uric acid blood test, x-ray, ultrasound,. I have was prescribed Eliquis 5mg for at least 3 months about June 18th
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- High Blood pressure
- Andere Medikamente
- Diltiazem 24H ER(CD) 180 mg Lisinopril 40 mg Hydrochlorothiazide 50 mg Vitamin C 500 mg Mature Multi-Vitamin w/minerals Calcium Citrate Magnesium and Zinc w/Vitamin D3 Fish Oil 1000 mg Glucosamine 1500 mg and Chondroitin 1200mg
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 09.08.2021
- Impfdatum
- 22.02.2021
- Beginn
- 05.08.2021
- Tage bis Beginn
- 164,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Condition aggravated
Dyspnoea
Physical examination abnormal
Respiratory distress
SARS-CoV-2 test positive
Symptomtext
COVID+8/5. Patient is a 72-year-old female with past medical history of COPD, HTN, insomnia, anxiety, hyperlipidemia who was transferred from the outside hospital due to worsening SOB because of active COVID-19. Symptom onset 8/4 and she got tested on 8/5 and was diagnosed with Covid-19. She received 2 shots of Pfizer vaccine in April. At baseline she is on 5 L of oxygen at home, but had to increase to 10 L at home today due to worsening dyspnea. At the exam she was in moderate distress due to SOB.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Respiratory distress
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 07.08.2021
- Impfdatum
- 22.02.2021
- Beginn
- 22.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Cytokine increased
Flushing
Guillain-Barre syndrome
Headache
Hypoaesthesia
Immediate post-injection reaction
Muscle spasms
Muscular weakness
Neurological symptom
Neuropathy peripheral
Pain
Paraesthesia
Rash
Symptomtext
Immediate rash & facial flushing after Pfizer -- passed in first 1-2 hours. Chills and headaches passed in 36 hours. Neurological symptoms occurred 2 hours after shot. Numbness, tingling, paresthesias, stabbing pains, muscle cramping, muscle weakness and mobility issues that worsened over the course of 2-3 weeks following shot. DX: peripheral neuropathies; GBS syndrome.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Guillain-Barre syndrome
- Hospital-Tage
- -
- Labordaten
- Consultations with 3 allergists and couple pf neurologists. Elevated cytokines.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- A-Fib, Asthma
- Andere Medikamente
- KLor-Con, Flonase, calcium citrate, vitamin D
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 05.08.2021
- Impfdatum
- 27.01.2021
- Beginn
- 27.01.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arthralgia
Dysgraphia
Facial paralysis
Hypoaesthesia
Symptomtext
After my first injection, I had numbness on my right extremities (arm and leg) that lasted about 24 hours. After my second injection, I again had numbness but this time it was move severe and on was on my entire right side, including the right side of my face. The evening of my second injection, I also experienced major joint pain that lasted about 12 hours. The numbness on my right side caused me difficulty writing and signing my name. The numbness on my face resulted in the right side of my mouth being slightly droopy. The numbness on my right arm, leg, foot, and face lasted approximately 1.5 days, beginning the evening I had the 2nd shot and subsiding about 36 hours later.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Facial paralysis
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- none
- Allergien
- Ilosone, hydrocodone, Azithromycin, Levaquin, iodine
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 03.08.2021
- Impfdatum
- 23.02.2021
- Beginn
- 13.04.2021
- Tage bis Beginn
- 49,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bell's palsy
Facial paralysis
Symptomtext
Bells Palsy - facial paralysis
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 03.08.2021
- Impfdatum
- 22.02.2021
- Beginn
- 25.07.2021
- Tage bis Beginn
- 153,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Bell's palsy
Blood test
Computerised tomogram
X-ray
Symptomtext
Bells Palsy; This is a spontaneous report from a contactable consumer (patient). A 68-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6200), dose 1 via an unspecified route of administration, administered in Arm Left on 22Feb2021 at 10:00 (at the age of 68-year-old) as dose 1, single for COVID-19 immunization. The patient medical history was not reported. Concomitant medication(s) included lisinopril 20 mg and atorvastatin 10 mg both were taken for an unspecified indication, start and stop date were not reported (Other medications in two weeks). Patient did not receive other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had not been tested for COVID-19. Had no known allergies. Facility type vaccine: Doctor's office/urgent care. Other vaccine same date product: Pfizer COVID 19 vaccine, on 22Feb2021, dose number: 2 administered in Left arm. On 25Jul2021 21:00, patient experienced bells palsy. Patient visited Emergency room/department or urgent care for event. The patient underwent lab tests and procedures which included blood work, Ct scan and x-rays with unknown results on unspecified date. Therapeutic measures were taken as a result of bells palsy. The outcome of event was recovering.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- Test Name: Blood work; Result Unstructured Data: Test Result:unknown results; Test Name: Ct scan; Result Unstructured Data: Test Result:unknown results; Test Name: x-rays; Result Unstructured Data: Test Result:unknown results
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- LISINOPRIL; ATORVASTATIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 29.07.2021
- Impfdatum
- 23.02.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 133,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Facial paresis
Ischaemic stroke
Symptomtext
I63.9 - Acute ischemic stroke (CMS/HCC) R29.810 - Facial weakness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ischaemic stroke
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 13.07.2021
- Impfdatum
- 02.03.2021
- Beginn
- 17.03.2021
- Tage bis Beginn
- 15,0
- Dosis
- 2
- Route/Site
- SYR / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: unbekannt
Erholt: nein
Guillain-Barre syndrome
Symptomtext
dx with AIDP-Acute Inflammatory Demyelinating Polyneuropathy
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Guillain-Barre syndrome
- Hospital-Tage
- 30,0
- Labordaten
- yes
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- suffers from heart problems
- Andere Medikamente
- unknown-takes several meds
- Allergien
- no
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 30.06.2021
- Impfdatum
- 02.03.2021
- Beginn
- 28.06.2021
- Tage bis Beginn
- 118,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Haemorrhagic stroke
Symptomtext
I61.9 - Hemorrhagic stroke (CMS/HCC)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Haemorrhagic stroke
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 29.06.2021
- Impfdatum
- 11.03.2021
- Beginn
- 08.06.2021
- Tage bis Beginn
- 89,0
- Dosis
- 2
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Influenza
Magnetic resonance imaging
Myocarditis
SARS-CoV-2 test
Symptomtext
Myocarditis documented by MRI; Concomitant diagnosis of Type A inflo; This is a spontaneous report from a contactable physician. A 32-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6200; Expiration date was not reported), intramuscular on the right arm on 11Mar2021 (15:45) as a 2nd dose, single, for COVID-19 immunization. Medical history included hereditary haemochromatosis. The patient's concomitant medications were not reported. The patient previously took erythromycin and cefaclor (CECLOR), and had allergies with these medications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL9264; Expiration date was not reported) on 17Feb2021 (13:00) (when the patient was 32 years old) intramuscular on the right arm for COVID-19 immunization. On 08Jun2021, the patient had myocarditis documented by magnetic resonance imaging (MRI), and a concomitant diagnosis of "type A inflo". The events had resulted into a doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient was hospitalized for six days (in Jun2021) due to the reported events, and had received cardvedilol, sacubitril, valsartan (ENTRESTO) and "life vest. diurectics" as treatment for the reported events. The outcome of the events was not recovered. The patient had no COVID-19 prior to vaccination. The patient's COVID-19 nasal swab on 08Jun2021 was negative.; Sender's Comments: Based on the information provided and plausible temporal association, the causality between BNT162B2 and the event myocarditis cannot be excluded. Event influenza based on the known drug safety profile is assessed as unrelated to BNT162B2. The impact of this report on the benefit-risk profile of the Pfizer product and on the conduct of the study is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, ethics committees. and investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- 6,0
- Labordaten
- Test Date: 20210608; Test Name: MRI; Result Unstructured Data: Test Result:documented myocarditis; Test Date: 20210608; Test Name: COVID-19 nasal swab; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Hereditary hemochromatosis
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- -
- Geschlecht
- F
- Eingang
- 24.06.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Myocarditis
Symptomtext
Myocarditis; The initial case was missing the following minimum criteria: ICH-Unspecified AE. Upon receipt of follow-up information on 18Jun2021, this case now contains all required information to be considered valid. This is a spontaneous report received from a contactable consumer (Patient). A 76-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN6200) via an unspecified route of administration on an unspecified date as 2nd dose, single for COVID-19 immunization. No medical history and concomitant medications were reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EL9269) via an unspecified route of administration on an unspecified date as 1st dose, single for COVID-19 immunization and had abnormal side effects. On an unspecified date the patient experienced myocarditis. She mentioned that she was 76-year-old woman not a teenager or 30-year-old man. She stated that she had to run around and spend like 20minutes going through all these menus and was not helpful. Patient doctor wants to call and report that they think patient have Myocarditis. Patient wanted to connect to the medical department so that she can talk to the nurse to know if her problem was the result of the vaccine. The outcome of the event myocarditis is unknown. Information on Lot/Batch number was available. Additional information has been requested.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 21.06.2021
- Impfdatum
- 25.02.2021
- Beginn
- 28.02.2021
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Condition aggravated
Drooling
Epilepsy
Focal dyscognitive seizures
Symptomtext
Complex Partial Seizure. Drool. I have epilepsy. However I was six free on the current medication and I started to have them regularly.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Focal dyscognitive seizures
- Hospital-Tage
- -
- Labordaten
- I had a medication that was working. No tests, just increasing medication dosage. I kept having seizures. and now I have had to change medications.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Epilepsy. Almost 6 months seizure free.
- Andere Medikamente
- Clobazam, Zonegran, Vitamin D, Folic Acid, Synthroid
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 19.06.2021
- Impfdatum
- 20.03.2021
- Beginn
- 03.06.2021
- Tage bis Beginn
- 75,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Alanine aminotransferase normal
Anion gap decreased
Aspartate aminotransferase normal
Basophil count normal
Blood albumin normal
Blood alkaline phosphatase normal
Blood bilirubin normal
Blood calcium normal
Blood chloride normal
Blood creatinine normal
Blood glucose normal
Blood potassium normal
Blood sodium normal
Blood urea normal
Carbon dioxide decreased
Eosinophil count
Full blood count
Glomerular filtration rate decreased
Symptomtext
PAIN IN LOWER RIGHT LEG (STARTED 6/03/2021) CLOTS FOUND VIA ULTRASOUND SCAN (6/08/2021) LOVENOX INJECTIONS FOR 7 DAYS (120MG SUBCU) ELLIQUIS RECOMMENDED FOR 3-6 MONTHS (5MG 2X/DAY ) CURRENTLY STILL UNDER TREATMENT AS OF 6/19/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- DUPLEX DOPPLER ULTRASOUND OF THE RIGHT LOWER EXTREMITY LEG VEINS; 6/8/2021 6:03 PM - There is nonocclusive thrombus present within the right popliteal vein. There is occlusive thrombus present within the proximal to distal right peroneal veins and right mid to distal posterior tibial veins. The anterior tibial veins are patent. COMP. METABOLIC PANEL: SODIUM 137 MEQ/L POTASSIUM 4.0 MEQ/L CHLORIDE 105 MEQ/L CARBON DIOXIDE 22 MEQ/L ANION GAP 10 GLUCOSE 100 mg/dL BUN 18 mg/dL CREATININE 0.74 mg/dL CALCIUM 9.5 mg/dL TOTAL PROTEIN 6.8 G/DL ALBUMIN 4.1 G/DL BILIRUBIN,TOTAL 0.6 mg/dL AST 13 U/L ALK PHOS 63 U/L ALT 13 U/L GFR -- above 60 ML/MIN CBC/PLT/DIFF: WBC 9.7 K/uL RBC 5.43 10*6 HEMOGLOBIN 16.9 GM/DL HEMATOCRIT 50 % MCV 92 MCH 31 MCHC 34 % RDW 13.5 PLATELET COUNT 263 10*3 Neutrophils, Absolute 5.9 K/uL Lymphocytes, Absolute 2.3 K/uL MONOCYTES, ABSOLUTE 1.0 K/uL Eosinophils, Absolute 0.5 K/ul Basophils, Absolute 0.0 K/uL
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- HIGH BLOOD PRESSURE ELEVATED CHOLESTEROL
- Andere Medikamente
- SPIRONOLACTONE LISINOPRIL ROSUVASTATIN UBIQUINOL
- Allergien
- SULFA (SULFONAMIDE ANTIBIOTICS) PENICILLINS
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 17.06.2021
- Impfdatum
- 19.02.2021
- Beginn
- 08.05.2021
- Tage bis Beginn
- 78,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: ja
Erholt: nein
Blood glucose increased
Blood pressure measurement
Condition aggravated
Thyroid function test
Thrombosis
Symptomtext
Blood clot left leg development; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6200), intramuscular at the shoulder/upper arm on 19Feb2021 11:30 (at the age of 69-years-old) as second dose, single for COVID-19 immunization. Medical history included diabetes and hypertension from 2012 and ongoing, and hypothyroidism from 1980 and ongoing. Concomitant medications included metformin taken for diabetes from 2012 and ongoing; thyroid (ARMOUR THYROID) taken for hypothyroidism from 1980 and ongoing; clonidine taken for hypertension from 2019 and ongoing; and liothyronine sodium taken for hypothyroidism from 2015 and ongoing. The patient had no prior vaccinations. The patient previously received BNT16B2 (lot number: EL9265), intramuscular at the shoulder/upper arm on 29Jan2021 11:30 (at the age of 69-years-old) at first dose, single for COVID-19 immunization and experienced severe pain. The patient experienced blood clot left leg development on 08May2021. The event was reported as serious due to persistent/significant disability/incapacity and required physician office and emergency room visit. Therapeutic measure taken as a result of blood clot left leg included Eliquis. Outcome of the event was not recovered.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021218434 same patient/drug, different dose/events
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Diabetes; Hypertension; Hypothyroidism
- Vorgeschichte
- -
- Andere Medikamente
- METFORMIN; ARMOUR THYROID; CLONIDINE; LIOTHYRONINE SODIUM
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 11.06.2021
- Impfdatum
- 27.02.2021
- Beginn
- 05.06.2021
- Tage bis Beginn
- 98,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Guillain-Barre syndrome
Symptomtext
G61.0 - Guillain-Barre syndrome
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Guillain-Barre syndrome
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 11.06.2021
- Impfdatum
- 25.04.2021
- Beginn
- 25.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Angina pectoris
Loss of consciousness
Symptomtext
The patient had a black out within 10 minutes of taking vaccine for both doses. The black out lasted for about 2 minutes. In the first case, the patient fell on the carpet since he was standing. Paramedics attended, observed for 15 minutes and declared that he was doing alright and we took him to a physical examination after that and found everything was normal. After the second shot ensured the patient was sitting on the chair after the shot and he experienced a black out and recovered. In both instances, he complained of heart pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 09.06.2021
- Impfdatum
- 22.03.2021
- Beginn
- 22.04.2021
- Tage bis Beginn
- 31,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Arteriogram coronary abnormal
Cardiac imaging procedure abnormal
Electrocardiogram abnormal
Myocardial necrosis marker
Pericarditis
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pericarditis
- Hospital-Tage
- -
- Labordaten
- EKG, enzymes, angiogram, MRI
- Aktuelle Erkrankungen
- non
- Vorgeschichte
- Hyptertension only
- Andere Medikamente
- Losartan 50mg
- Allergien
- Ampicillin
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 08.06.2021
- Impfdatum
- 18.02.2021
- Beginn
- 19.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Abdominal discomfort
Blood test
Cardiac function test
Computerised tomogram
Diarrhoea
Headache
Loss of consciousness
Magnetic resonance imaging head
Pyrexia
Scan
Syncope
Unresponsive to stimuli
Urinary incontinence
Vomiting
Symptomtext
I had the expected fever and headache the day after the vaccine. I woke up vomiting during the night. I had ongoing GI problems. One week after the vaccine I fainted one day during a walk with my husband. I woke up and I had lost control of my bladder but I was unaware of the fact that I was unresponsive. I lost consciousness for 2-3 minutes. I had Gastrointestinal problems for one month after the second dose of the vaccine. My stomach was upset and I had Diarrhea as well as a raw feeling in my stomach. I have never had those problems before. I recovered after one month approximately .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- Blood Work Brain MRI Abdominal CT scan Carotid Artery Scan Heart tests
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Cancer Survivor-5 years
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 07.06.2021
- Impfdatum
- 10.04.2021
- Beginn
- 15.05.2021
- Tage bis Beginn
- 35,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Seizure
Symptomtext
Unspecified convulsions
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 07.06.2021
- Impfdatum
- 22.03.2021
- Beginn
- 20.04.2021
- Tage bis Beginn
- 29,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Fall
Seizure
Symptomtext
N17.9 - Acute kidney injury (CMS/HCC) SEIZURES FALL
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 86,0
- Geschlecht
- M
- Eingang
- 04.06.2021
- Impfdatum
- 19.02.2021
- Beginn
- 05.03.2021
- Tage bis Beginn
- 14,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: ja
Erholt: nein
Anticoagulant therapy
Blood test
Deep vein thrombosis
Fibrin D dimer increased
Ultrasound Doppler abnormal
Symptomtext
March 5th Ultrasound revealed Severe DVT in left leg. Emergency room March 5th prescribed Eliquis 10mg twice daily. May 24, 2021 blood work showed elevated Ddimer. Dr requested another Ultrasound, May 27, 2021 Severe DVT not responding to blood thinners. May 30, 2021 Dr. switched to Xerelto 20mg. June 3, 2021 Dr. determined that patient has developed Chronic DVT and will continue to follow up with Blood work and Blood thinners. Next appointment is June 11, 2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- Ultrasound of left Leg imaging on March 5, 2021 Emergency room visit March 5, 2021 Ultrasound May 27, 2021
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- High Blood pressure
- Andere Medikamente
- Amilopidine 10mg, Enalapril 5mg, Baby Asprin81mg, Lipitor 5mg, Carvediol 3.125mg, Daily Multi vitamin
- Allergien
- IVP dyes
- Vorherige Impfungen
- -
- Staat
- VT
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 04.06.2021
- Impfdatum
- 21.02.2021
- Beginn
- 22.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Blood test normal
Decreased appetite
Fatigue
Gait inability
Blood test
Computerised tomogram
Contusion
Haematoma
Headache
Malaise
Oedema
Subarachnoid haemorrhage
Syncope
Sleep disorder
Somnolence
Symptomtext
syncope; Acute subarachnoid hemorrhage involving both hemispheres; acute on chronic right subdural hematoma up to 7 mm thick; hemorrhagic contusion with edema; hemorrhagic contusion with edema; fatigue; malaise; HA; This is a spontaneous report from a contactable physician. A 78-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in arm left on 21Feb2021 (Lot Number: EN6200) (at the age of 78-year-old) as single dose for COVID-19 immunisation. Medical history included hypertension (HTN), hyperlipidemia (HDL) and hypothyroidism, all from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Prior to vaccination the patient was not diagnosed with COVID-19 and since the vaccination the patient has not been tested for COVID-19. The patient previously took SSRI, PNC (unknown), sulfa and oxycodone; the patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in arm left on 31Jan2021 (Batch/Lot Number: EL9265) as single dose for COVID-19 immunisation. Within 12 hours of vaccine (on 22Feb2021) the patient developed symptoms of fatigue, malaise, headache (HA) and severe and near syncope. She visited the emergency department (ED) the following day. Work up at that time including blood work and no imaging. She was treated with IVFs and discharged. Symptoms of malaise, fatigue and HA persisted for > 1 week. A computerized tomogram (CT) of the head was performed on 05Mar2021, this CT showed the following: acute subarachnoid hemorrhage involving both hemispheres; acute on chronic right subdural hematoma up to 7 mm thick; 2X3 left front hemorrhagic contusion with edema. The events required emergency room visit and physician office visit. Therapeutic measures were taken as a result of the events and includes conservative measures (as reported). The patient outcome of the event was recovered with sequel.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of reported events cannot be excluded. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- Test Name: Blood work; Result Unstructured Data: Test Result:unknown results; Test Date: 20210305; Test Name: CT of head; Result Unstructured Data: Test Result:Acute subarachnoid hemorrhage involving both hemis; Comments: Acute subarachnoid hemorrhage involving both hemispheres; acute on chronic right subdural hematoma up to 7 mm thick; 2X3 left front hemorrhagic contusion with edema. It is not clear if these findings are related to Covid vaccine.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Hyperlipidemia; Hypertension; Hypothyroidism
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VT
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 04.06.2021
- Impfdatum
- 21.02.2021
- Beginn
- 22.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Blood test normal
Decreased appetite
Fatigue
Gait inability
Blood test
Computerised tomogram
Contusion
Haematoma
Headache
Malaise
Oedema
Subarachnoid haemorrhage
Syncope
Sleep disorder
Somnolence
Symptomtext
syncope; Acute subarachnoid hemorrhage involving both hemispheres; acute on chronic right subdural hematoma up to 7 mm thick; hemorrhagic contusion with edema; hemorrhagic contusion with edema; fatigue; malaise; HA; This is a spontaneous report from a contactable physician. A 78-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in arm left on 21Feb2021 (Lot Number: EN6200) (at the age of 78-year-old) as single dose for COVID-19 immunisation. Medical history included hypertension (HTN), hyperlipidemia (HDL) and hypothyroidism, all from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Prior to vaccination the patient was not diagnosed with COVID-19 and since the vaccination the patient has not been tested for COVID-19. The patient previously took SSRI, PNC (unknown), sulfa and oxycodone; the patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in arm left on 31Jan2021 (Batch/Lot Number: EL9265) as single dose for COVID-19 immunisation. Within 12 hours of vaccine (on 22Feb2021) the patient developed symptoms of fatigue, malaise, headache (HA) and severe and near syncope. She visited the emergency department (ED) the following day. Work up at that time including blood work and no imaging. She was treated with IVFs and discharged. Symptoms of malaise, fatigue and HA persisted for > 1 week. A computerized tomogram (CT) of the head was performed on 05Mar2021, this CT showed the following: acute subarachnoid hemorrhage involving both hemispheres; acute on chronic right subdural hematoma up to 7 mm thick; 2X3 left front hemorrhagic contusion with edema. The events required emergency room visit and physician office visit. Therapeutic measures were taken as a result of the events and includes conservative measures (as reported). The patient outcome of the event was recovered with sequel.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of reported events cannot be excluded. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- Test Name: Blood work; Result Unstructured Data: Test Result:unknown results; Test Date: 20210305; Test Name: CT of head; Result Unstructured Data: Test Result:Acute subarachnoid hemorrhage involving both hemis; Comments: Acute subarachnoid hemorrhage involving both hemispheres; acute on chronic right subdural hematoma up to 7 mm thick; 2X3 left front hemorrhagic contusion with edema. It is not clear if these findings are related to Covid vaccine.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Hyperlipidemia; Hypertension; Hypothyroidism
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 28,0
- Geschlecht
- M
- Eingang
- 27.05.2021
- Impfdatum
- 21.03.2021
- Beginn
- 24.03.2021
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Chest pain
Chills
Condition aggravated
Echocardiogram normal
Ejection fraction normal
Electrocardiogram
Malaise
Myocarditis
Pyrexia
Troponin increased
Vomiting
Symptomtext
"History obtained from: patient Patient is a 28 y.o. male with hx of post-viral myopericarditis in 2013 but otherwise healthy who presents for recurrence of myopericarditis incidentally not long after receiving 2nd COVID vaccine Got the 2nd COVID vaccine on Sunday. Monday felt fevers and chills and malaise all day. Tuesday morning felt some retrosternal chest discomfort that lasted an hour or so and spontaneously went away. Was able to go to work all day and do fine. Works in a garage and lifts heavy tires. Yesterday took kids to day care, felt a little pain that morning which resolved. Picked them up in the evening and was going to hang out with them but had recurrence of pain and this time was quite severe. Tried to take some tylenol but threw this up. Came to the ED and had to wait 1-2 hours to be seen, but the time he was his pain had nearly resolved. Troponin taken around 10000. Cardiology consulted, think this might be reactivation / recurrence of his prior myopericarditis." H&P 3/24/21 "This is a 28 y.o. male with hx of post-viral myopericarditis in 2013 but otherwise healthy who presents for recurrence of myopericarditis incidentally not long after receiving 2nd COVID vaccine # Myopericarditis Had episode of post-viral myopericarditis back in 2013, at which time he had an elevation of Trop I (non-HS variety) to 7.3 and echo showing basal inferolateral, basal inferior and mid inferolateral wall motion abnormalities but otherwise normal LV function. Has been highly functional. Recently got 2nd COVID vaccine and had fevers/chills after that. Recurrent chest pain 3/24 w/o provocation, aborted on its own but has trop elevated to 10,000. EKG does not show STEMI and patient actually asymptomatic in ED. No infectious symptoms. Unclear but wonder if COVID vaccine could have caused recurrence of prior myopericarditis? Cards called in ED, they would like him admitted, to treat with colchicine and advil, repeat TTE and they will consult in the morning." A/P 3/24/21 from admission
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- 1,0
- Labordaten
- Cardiovascular Problem List: 1. Myocarditis A. 8/2013, EF 65% with basal inferolateral hypokinesis and gadolinium enhancement by MR B. 3/2021, EF 60% with normal all motion by echo; MR: gadolinium enhancement of lateral wall increased since 2013 troponin peak 12732
- Aktuelle Erkrankungen
- none reported
- Vorgeschichte
- Past Medical History: Diagnosis Date ? Chronic back pain ? Myocarditis (HCC) 2013 ? Rotator cuff injury
- Andere Medikamente
- ibuprofen (ADVIL,MOTRIN) 800 MG tablet Take 800 mg by mouth every 6 hours as needed.
- Allergien
- ? Augmentin [Amoxicillin] Very Sick ? Augmentin [Clavulanic Acid] Very sick ? Penicillins ? Amoxicillin-Pot Clavulanate Rash and Swelling
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 26.05.2021
- Impfdatum
- 20.02.2021
- Beginn
- 21.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chest pain
Echocardiogram normal
Electrocardiogram abnormal
Exposure during pregnancy
Hyperemesis gravidarum
Induced labour
Pericarditis
Sinus tachycardia
Troponin normal
Weight gain poor
Symptomtext
Pericarditis with chest pain, treated with cochicine on 2/21/2021 Patient was pregnant, induced labor on 4/19 for poor maternal weight gain and hyperemesis
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pericarditis
- Hospital-Tage
- 1,0
- Labordaten
- Troponin was normal EKG with sinus tachycardia Echo normal
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Bipolar Asthma Tobacco use
- Andere Medikamente
- QVAR Seroquel Zoloft Pepcid Reglan
- Allergien
- Lamotrigine
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 25,0
- Geschlecht
- M
- Eingang
- 20.05.2021
- Impfdatum
- 19.05.2021
- Beginn
- 19.05.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Condition aggravated
Head injury
Loss of consciousness
Syncope
Unresponsive to stimuli
Symptomtext
Systemic: Fainting / Unresponsive-Medium, Additional Details: lost conciousness during his 15 min wait (while he was sitting). Bumped his head. I immiediately got his legs elevated and put something under his head. He regained conciousness within a minute, but I had him remain on the ground. The pharmacy tech called 911 right away. EMT services arrived within 10 minutes, although patient was persistent about wanting to leave on his own as he stated he regularly passes out with needles and has in the past as well. Emt evaluated him and let him leave.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 17.05.2021
- Impfdatum
- 20.02.2021
- Beginn
- 14.05.2021
- Tage bis Beginn
- 83,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Deep vein thrombosis
Ultrasound Doppler
Symptomtext
Deep Vein Thrombosis in right leg.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- Venous Doppler 05/14/2021.
- Aktuelle Erkrankungen
- lung transplant in 10/2020
- Vorgeschichte
- lung transplant in 10/2020, HTN
- Andere Medikamente
- Toprol XL 50mg daily; Cellcept 500mg daily; Protonix 40mg daily, Prednisone 10mg daily; Prograf 5mg in AM and 4mg in PM; Valcyte 900g daily; Bactrim DS 1 tab bid
- Allergien
- adhesive tape
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 13.05.2021
- Impfdatum
- 18.02.2021
- Beginn
- 13.05.2021
- Tage bis Beginn
- 84,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bell's palsy
Computerised tomogram
Computerised tomogram head
Laboratory test
Magnetic resonance imaging
Symptomtext
Bells palsy, medication given, not sure of outcome
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- CTA, CT head, MRI, Labs all WNL
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- N/A
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 12.05.2021
- Impfdatum
- 20.02.2021
- Beginn
- 09.05.2021
- Tage bis Beginn
- 78,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Ischaemic stroke
Symptomtext
I63.9 - Acute ischemic stroke
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ischaemic stroke
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 12.05.2021
- Impfdatum
- 02.03.2021
- Beginn
- 05.05.2021
- Tage bis Beginn
- 64,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Seizure
Symptomtext
R56.9 - New onset seizure (CMS/HCC) R56.9 - Unspecified convulsions N17.9 - Acute kidney failure, unspecified
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 10.05.2021
- Impfdatum
- 20.02.2021
- Beginn
- 31.03.2021
- Tage bis Beginn
- 39,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Cerebral artery occlusion
Cerebral artery stenosis
Cerebral infarction
Facial paresis
Lacunar stroke
Symptomtext
I63.81 - Other cerebral infarction due to occlusion or stenosis of small artery R29.810 - Facial weakness I63.81 - Left sided lacunar stroke
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Lacunar stroke
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 10.05.2021
- Impfdatum
- 02.03.2021
- Beginn
- 25.03.2021
- Tage bis Beginn
- 23,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Seizure
Symptomtext
This 73 year old female received the Covid shot on 3/2/21 and went to the ED and admitted on 3/25/21 with the following diagnoses listed below. R56.9 - Seizure R56.9 - Unspecified convulsions N17.9 - Acute kidney failure, unspecified
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 10.05.2021
- Impfdatum
- 20.02.2021
- Beginn
- 22.03.2021
- Tage bis Beginn
- 30,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Cerebral infarction
Ischaemic stroke
Symptomtext
This 74 year old female received the Covid shot on 2/20/21 and went to the ED and was admitted on 3/22/21 with the following diagnoses listed below. I63.9 - Cerebral infarction, unspecified I63.9 - Ischemic stroke
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ischaemic stroke
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 49,0
- Geschlecht
- M
- Eingang
- 08.05.2021
- Impfdatum
- 23.02.2021
- Beginn
- 01.02.2021
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Deep vein thrombosis
Joint injury
Muscle strain
Soft tissue injury
Symptomtext
DVT symptoms occurred after first dose and was undiagnosed; soft tissue injury; muscle pull and ankle strain; muscle pull and ankle strain; This is a spontaneous report from a contactable nurse. A 49-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 intramuscular, administered in the left arm on 23Feb2021 at 13:30 (Batch/Lot Number: EN6200) at a single dose for COVID-19 immunization. Medical history included a family history of diabetes - his mother had diabetes. The patient's concomitant medications were not reported. DVT symptoms occurred in Feb2021 after the first dose and was undiagnosed. He treated it as soft tissue injury and thought it was a muscle pull and ankle strain. The outcome of the events was unknown. Information on the batch/lot number has been requested.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Diabetes (verbatim: His mother had diabetes)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- F
- Eingang
- 08.05.2021
- Impfdatum
- 17.02.2021
- Beginn
- 20.02.2021
- Tage bis Beginn
- 3,0
- Dosis
- UNK
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Arthralgia
Thrombosis
X-ray
Pain in extremity
Symptomtext
This is a spontaneous report from a contactable consumer(Patient). A 83-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection Formulation, Batch/Lot Number: EN6200), via an unspecified route of administration on Arm left on 17Feb2021 10:00 AM as single dose for covid-19 immunisation. Medical history included colitis ulcerative. Concomitant medications included mesalamine (MESALAMINE). Patient had no past drug history. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. post Covid vaccine patient did not test for Covid. The Device Date given was 25Apr2021. The patient received treatment for raised blood thinner as Elequis 5mg. On 20Feb2021 at 10:00 (Three days after injection), the patient suffered severe pain in the right leg. She went to ER next day and blood clot was discovered behind right knee and later she subsequently had been seen by hematologist. The outcome of the events was not recovered. Follow-up attempts are required. Further information was expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Ulcerative colitis (Ulcerative colitis ? Nothing serious)
- Andere Medikamente
- MESALAMINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 07.05.2021
- Impfdatum
- 27.02.2021
- Beginn
- 27.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: ja
Erholt: nein
Asthenia
Burning sensation
Dizziness
Facial pain
Headache
Heart rate increased
Hyperhidrosis
Hypoaesthesia
Joint noise
Laboratory test
Magnetic resonance imaging
Muscle fatigue
Muscular weakness
Pain
Pain in extremity
Paraesthesia
Paraesthesia oral
Paralysis
Symptomtext
Severe pain and weakness in extremities that progressed upwards through legs, hips, arms, back, neck and head; new and sudden onset of popping joints; Temporary paralysis and numbness upon waking up in the morning; Temporary paralysis and numbness upon waking up in the morning; severe muscle fatigue; experiencing pain, weakness, and tingling in upper back, both arms and hands; Heart rate spike to 180; dizziness; sweating; sudden aching and weakness in both hands, progressed upwards through legs, hips, arms, back, neck and head; sudden aching and weakness in both hands; Severe head and facial pain; Severe head and facial pain; Pain, tingling, burning, and weakness in extremities and limbs; Pain, tingling, burning, and weakness in extremities and limbs; Vibrations/tremor-like sensation in upper back; Tingling tongue; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot EN6200, first dose) solution for injection intramuscular in the left arm on 27Feb2021 at 10:00 (at the age of 33-years-old) as a single dose for COVID-19 vaccination. Medical history included SVT (supraventricular tachycardia). Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 27Feb2021, the patient experienced heart rate spike to 180 within first 2-3 minutes of vaccine with dizziness, sweating and sudden aching and weakness in both hands; severe head and facial pain, pain, tingling, burning, and weakness in extremities and limbs; vibrations/tremor-like sensation in upper back; tingling tongue; severe muscle fatigue; experiencing pain, weakness, and tingling in upper back, both arms and hands, sent to ER for monitoring. Continued heart rate spikes for approx. 7 days afterwards. Severe pain and weakness in extremities that progressed upwards through legs, hips, arms, back, neck and head over 1 week period. On 09Mar2021, 10 days after vaccination; two more ER visits. Severe head and facial pain. Pain, tingling, burning, and weakness in extremities and limbs. Vibrations/tremor-like sensation in upper back. Tingling tongue, new and sudden onset of popping joints, temporary paralysis, and numbness upon waking up in the morning. Multiple lab work orders, X-rays, MRIs - all ruled out other causes/conditions in Mar2021. The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, with disability or permanent damage due severity of symptoms required 4 weeks of medical leave from work. Treatment for the events included medication and physical therapy. The outcome of the events was not recovered. Post vaccination, a Nasal Swab, Covid test result was negative in Mar2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paralysis
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210227; Test Name: heart rate spike; Result Unstructured Data: Test Result:180; Test Date: 202103; Test Name: labwork; Result Unstructured Data: Test Result:ruled out other causes/conditions; Test Date: 202103; Test Name: MRI; Result Unstructured Data: Test Result:ruled out other causes/conditions; Test Date: 202103; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative; Test Date: 202103; Test Name: X-rays; Result Unstructured Data: Test Result:ruled out other causes/conditions
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Supraventricular tachycardia
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 31,0
- Geschlecht
- M
- Eingang
- 30.04.2021
- Impfdatum
- 24.02.2021
- Beginn
- 27.02.2021
- Tage bis Beginn
- 3,0
- Dosis
- UNK
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Blood culture
Cardiac disorder
Cardiovascular symptom
Catheterisation cardiac abnormal
Electrocardiogram
Magnetic resonance imaging abnormal
Myocarditis
Ultrasound scan abnormal
Symptomtext
Heart attack symptoms resulting from cardiac event, leading to hospitalization for 4 days. Diagnosed with Myocarditis.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- 4,0
- Labordaten
- Between February 27 and March 2, multiple blood cultures, EKGs, dye catheterization, sonogram, and MRI. All results pointed to inflammation of the heart.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- Carrots, watermelon, food of the peach family (mild)
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 30.04.2021
- Impfdatum
- 01.04.2021
- Beginn
- 22.04.2021
- Tage bis Beginn
- 21,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain in extremity
Peripheral swelling
Thrombosis
Ultrasound scan
Symptomtext
Leg started swelling 4/22 and became painful. Saw Dr. on Monday 4/26 and had venous ultrasound which showed a "blood clot" was started on xarelto
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- Venous ultrasound
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hypertension, BPH, Arthritis
- Andere Medikamente
- Lisinopril, Carvedilol, Alfuzosin, Celebrex, Potassium, B12, Multivitamin, Omeprazole
- Allergien
- Norvasc
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 35,0
- Geschlecht
- M
- Eingang
- 28.04.2021
- Impfdatum
- 25.03.2021
- Beginn
- 09.04.2021
- Tage bis Beginn
- 15,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blood test
Deep vein thrombosis
Pain
Thrombosis
Ultrasound scan
Erythema
Laboratory test
Pain in extremity
Peripheral swelling
Ultrasound Doppler
Urine analysis
X-ray
Symptomtext
DVT blood clot formed in left leg, intense pain started almost 14 days after vaccine. No history of any health concerns with blood clots, healthy 35 year old male who works out and diets. No long drives or sedentary lifestyle.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- they took blood tests/urine/xray for hairline fracture, found using ultrasound under my left lag
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 88,0
- Geschlecht
- M
- Eingang
- 27.04.2021
- Impfdatum
- 24.02.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 5,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Deep vein thrombosis
Symptomtext
DVT; This is a spontaneous report from a contactable consumer reporting for a patient. An 88-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 24Feb2021 (Batch/Lot Number: EN6200) as SINGLE DOSE for covid-19 immunisation, at 88 years old. Medical history included High blood pressure from an unknown date. No COVID prior vaccination. Not tested for COVID post vaccination. No known allergies. The patient received the first dose of BNT162B2 (Lot number el9264) on 03Feb2021 for Covid-19 immunization. Concomitant medication included simvastatin (ZOCOR); terazosin; carvedilol; ranitidine, taken for an unspecified indication, start and stop date were not reported (Other medications in two weeks). Lower right leg swelling was noted beginning approximately on 01Mar2021 without injury or pain that worsened through 04Mar2021. Patient was taken to ER on 05Mar2021 when DVT was diagnosed. Therapeutic measures were taken as a result of DVT includes XARELTO. Outcome of the event was recovering.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Blood pressure high
- Andere Medikamente
- ZOCOR; TERAZOSIN; CARVEDILOL; RANITIDINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 26.04.2021
- Impfdatum
- 16.02.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 13,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Anti-cyclic citrullinated peptide antibody negative
Antinuclear antibody negative
Blood culture negative
C-reactive protein increased
Cardiac imaging procedure abnormal
Cardiomegaly
Central venous pressure increased
Chest X-ray abnormal
Chest pain
Chills
Computerised tomogram abdomen abnormal
Computerised tomogram pelvis abnormal
Computerised tomogram thorax abnormal
Dyspnoea
Echocardiogram
Echocardiogram abnormal
Ejection fraction normal
Electrocardiogram normal
Symptomtext
Patient is a 69-year-old woman with newly diagnosed pericarditis in March 2021, hypertension, hyperlipidemia, and hypothyroidism, who presented to the Emergency Department (ED) with progressively worsening chest pain, dyspnea, and fatigue. Patient was in her usual state of health until 3/1/2021, when she developed sudden-onset pain "across the entire chest". She shares that her symptoms "came out of the blue", as "suddenly one day, everything just hurt". She saw her primary care physician, who initially felt her symptoms were due to acid reflux. As such, the patient started "eating antacids and omeprazole like candy". However, her chest pain persisted, prompting her to follow up with her primary care physician on 3/16/2021. At that time, ECG reportedly showed normal sinus rhythm and no acute changes. CT of the chest, abdomen, and pelvis with contrast showed abnormal enhancement and thickening of the pericardium with trace pericardial fluid, consistent with pericarditis. The patient was therefore started on colchicine and an ibuprofen taper. On 4/5/2021, Patient sent a myVM portal message to her primary care physician and cardiologist, expressing her belief that her chest pain has remained unchanged over the past month. She continues to experience a constant burning sensation throughout her chest, aggravated by deep inspiration and alleviated by lying flat on her back. She shares that walking up the stairs at home leaves her "breathless". Associated symptoms include subjective fevers, chills, and night sweats. Given these symptoms, Patient underwent a chest x-ray, which showed findings consistent with an enlarging pericardial effusion. Patient was then advised to present to the ED for further workup as an inpatient. At time of hospital admission, patient endorses persistent chest pain during inspiration. Prior to 3/1/2021, she has never experienced these symptoms and reports no history of pericarditis. The most strenuous physical activity she has undertaken in the last month include working in the garden and caring light boxes down the stairs. She is most concerned about the fluid around her heart. Patient reports no nausea, vomiting, palpitations, constipation, diarrhea, or abdominal pain. Of note, the patient developed pericarditis 10 days after her second COVID-19 vaccine. Hospital Course # Sub-acute pericarditis with enlarging pericardial effusion Pericarditis initially diagnosed in March 2021, thought to be potentially from her COVID-19 vaccine given time course as no other clear etiology apparent. Pt was hemodynamically stable with an elevated jugular venous pressure at time of admission, with CXR consistent with an enlarging pericardial effusion. Echo 04/05 with small circumferential pericardial effusion but no tamponade physiology. Cardiac MRI on 4/7 with enlargement of moderate-sized pericardial effusion but otherwise negative exam, with no evidence of myocarditis or infiltrative myocardial process. ANA screen negative, rheumatoid factor and anti-CCP not elevated Blood cultures x 2 with no growth - CRP continued to remain > 160 with ibupofen and colchicine. Prednisone 20 mg PO daily was added on 4/7, with subsequent improvement in patient's symptoms. - Discharged on regimen of prednisone 20 mg PO daily and colchicine 0.3 mg PO daily (reduced from 0.6 mg daily that she was taking prior to admission). She will also continue using ibuprofen 800 mg BID. - Follow-up with Dr (cardiology) next week to follow-up on hospitalization and decide upon tapering plan for her medications
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pericarditis
- Hospital-Tage
- 4,0
- Labordaten
- CXR 04/05 with enlarged cardiac silhouette that has developed since the March 1, 2021 exam. Given the visible change in one month a pericardial effusion should be suspected. TTE 04/05 with small circumferential pericardial effusion but no tamponade physiology, EF normal (68%), CVP mildly elevated at 8 Cardiac MRI 04/07 Impression: 1. Compared to 3/16/2021 there has been enlargement in now a moderate-sized pericardial effusion. Findings are nonspecific and could be related to pericarditis but there is no abnormal pericardial thickening. 2. New small bilateral pleural effusions. 3. Otherwise negative exam. No evidence of myocarditis or infiltrative myocardial process.
- Aktuelle Erkrankungen
- Hypertension Alergies Rash
- Vorgeschichte
- Ongoing Allergic rhinitis Anemia Atopic dermatitis Chronic rhinitis Colon adenomas Contusion of right ankle Cough CRP elevated Fever GERD without esophagitis High cholesterol Hypertension Hypothyroid Left-sided chest pain Localized osteoarthritis of ankle Low blood potassium Migraines NONTOXIC MULTINODULAR GOITER Oral herpes Osteopenia Pericardial effusion Pericarditis Pericarditis Skin lesion of hand SPRAIN OF MEDIAL COLLATERAL LIGAMENT OF KNEE. SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES Tubular adenoma of colon
- Andere Medikamente
- As of Jan 28 2021 1. Flonase 1 spray b.i.d. as needed. 2. Levothyroxine 100 mcg daily. 3. Lisinopril 20 mg a day. 4. Omeprazole 40 mg daily. 5. Sumatriptan 25 mg p.r.n. 6. Pravastatin 40 mg daily. 7. Cetirizine 10 mg daily.
- Allergien
- ALLERGIES: CODEINE, SULFA DRUGS.
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 25.04.2021
- Impfdatum
- 04.03.2021
- Beginn
- 04.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood iron
Feeling abnormal
Loss of consciousness
Pain in extremity
Symptomtext
Four hours later he passed out/ Four hours after getting vaccine he was on the floor and out like a light; Sore right arm; goofy; This is a spontaneous report from a contactable consumer. A 58-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose at the age of 58-years-old intramuscular, administered in Arm Right on 04Mar2021 09:30 (Batch/Lot Number: EN6200) as single dose for covid-19 immunisation and prophylaxis. Medical history included high cholesterol, allergy (When pollen is heavy, it is worse) from an unknown date and unknown if ongoing, fractured his shoulder in 05Feb2021, sinus jacked up from an unknown date and unknown if ongoing, covid-19 from Nov2020 to an unknown date, anemic from Dec2020 to an unknown date, nasal surgery on an unknown date, fever blisters from an unknown date and unknown if ongoing, immune system disorder from an unknown date and unknown if ongoing. Concomitant medications included zolpidem tartrate (AMBIEN) taken to help sleep; atorvastatin (LIPITOR) taken for high cholesterol; loratadine taken for allergy; cetirizine hydrochloride (ZYRTEC) taken for allergy; mometasone furoate (FLONASE) taken for allergy; start and stop date were not reported for all; fish oil (OMEGA 3) and selenium (SELENIUM) taken for an unspecified indication, start and stop date were not reported; colecalciferol (VITAMIN D3 1000) taken for immune system disorder; iron (IRON) taken for anaemia; lysine taken for fever blisters ; zinc taken for immune system disorder, start and stop date were not reported for all and multivitamin. It was reported that four hours after getting vaccine on 04Mar2021, he was on the floor and out like a light. This is the first one he received and his doctor said not to get second one. He had the first one and about 4 hours later, he was on the kitchen floor and out like a light. He doesn't know if it was connected to shot or not. He never had problems before. He got the vaccine around 09:30 and around 13:30, his friend came in for lunch and found him on the floor. She freaked out. She said she liked to never got him awake and said he was goofy for a good half hour. He does not know how long he was on the floor. His arm was sore on 04Mar2021 09:30 for about 4 days. The patient underwent lab tests and procedures which included blood iron: so low on an unspecified date. The patient was recovering from passed out and sore arm while recovered from goofy on 04Mar2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- Test Name: iron count; Result Unstructured Data: Test Result:so low
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Allergy; Anemic; COVID-19; Fever blister; Fracture; High cholesterol; Immune system disorder; Sinus congestion; Surgery
- Andere Medikamente
- AMBIEN; LIPITOR [ATORVASTATIN]; LORATADINE; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; FLONASE [MOMETASONE FUROATE]; OMEGA 3 [FISH OIL]; SELENIUM; VITAMIN D3 1000; IRON; LYSINE; ZINC
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 24.04.2021
- Impfdatum
- 22.02.2021
- Beginn
- 02.03.2021
- Tage bis Beginn
- 8,0
- Dosis
- 2
- Route/Site
- SYR / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdomen scan normal
Abdominal distension
Anxiety
Blood test normal
Computerised tomogram normal
Computerised tomogram pelvis
Computerised tomogram thorax
Pain in extremity
Thrombosis
Ultrasound pelvis
Ultrasound scan abnormal
Ultrasound scan normal
Symptomtext
On March 2nd woke up with right calf pain. Thought I had a charley horse in the middle of the night and thought this was the soarness you get afterward. Because I had been on Crestor for approximately 5 weeks I thought that the crestor may be causing muscle pain. After 2 days of calf pain which was subsiding by then I visited Dr. who ordered a right ultrasound and I had 2 blood clots in the right leg (one in calf and one behind the knee). Due to the fact that I did not meet any standards for getting blood clots I was put on blood thinners (Eliquis) and told to see a hematologist.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- March 8th Had ultrasound of leftt leg due to pain in left leg (test was negative). March 8th had ct scan of chest (negative), March 8th had various blood work (negative. All test were performed in the emergency room due to me experiencing left leg pain and becoming very anxious about it. On March 15th had pelvic ultrasound to rule out anything going on in that area due to me having a bloated feeling. On March 25th had appointment with the hematologist who ordered a ct scan of the abdomen and pelvis (negative) and various genetic blood work (negative)
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- HBP GERD
- Andere Medikamente
- Crestor Atacand Norvasc Protonix calcium vit D
- Allergien
- sulfa flexerill skelaxin
- Vorherige Impfungen
- Shingles shot, 2019, 2nd shot had flu like symptoms and slight fever for 24 hours
- Staat
- MO
- Alter
- 46,0
- Geschlecht
- M
- Eingang
- 20.04.2021
- Impfdatum
- 24.02.2021
- Beginn
- 25.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain in extremity
Peripheral artery thrombosis
Peripheral swelling
Ultrasound scan
Symptomtext
Developed left arm pain and swelling after 1st vaccine in left shoulder. Persisted longer than previous reactions. Found to have blood clot in left brachial vein on 4/15/21 on ultrasound after evaluation by me
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Peripheral artery thrombosis
- Hospital-Tage
- -
- Labordaten
- Ultrasound of left upper extremity 4/15/2021 - left brachial vein blood clot
- Aktuelle Erkrankungen
- Chronic right shoulder pain
- Vorgeschichte
- HLD, GERD
- Andere Medikamente
- atorvastatin, flonase nasal spray
- Allergien
- NKMA
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 19.04.2021
- Impfdatum
- 19.02.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 10,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Fibrin D dimer increased
Haematology test normal
Subclavian vein thrombosis
Thrombectomy
Ultrasound Doppler abnormal
Ultrasound scan abnormal
Venogram
Venous angioplasty
Symptomtext
Blood clot in right subclavian vein on March 1.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Subclavian vein thrombosis
- Hospital-Tage
- 3,0
- Labordaten
- 3/1/2021 - D dimer, ultrasound - both positive for clots 3/4/2021 - Hematology tests - all normal 4/2/2021 - venogram, anjiojet thrombectomy, venous angioplasty x 3
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Depression
- Andere Medikamente
- Desvenlafaxine, drospirenone and ethical estradiol, and pantoprazole
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 18.04.2021
- Impfdatum
- 18.01.2021
- Beginn
- 22.03.2021
- Tage bis Beginn
- 63,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Deep vein thrombosis
Thrombosis
Ultrasound scan abnormal
Symptomtext
Developed a blood clot behind the left knee; This is a spontaneous report from a contactable consumer. A 72-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 18Jan2021 16:00 (Batch/Lot Number: EL3246) as SINGLE DOSE, dose 2 via an unspecified route of administration, administered in Arm Left on 17Feb2021 (Batch/Lot Number: EN6200) as SINGLE DOSE for covid-19 immunisation. Medical history included Known allergies: Feathers. Concomitant medication included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported. On 22Mar2021 18:00, the patient Developed a blood clot behind the left Knee. Ae resulted in : [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care]. The patient received treatment for the event: Blood Thinner Meds and Compression Stocking. The outcome of the event was not recovered. The patient did not have covid prior vaccination, and the patient was not COVID tested post vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Allergy to feathers
- Andere Medikamente
- ZYRTEC [CETIRIZINE HYDROCHLORIDE]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 17.04.2021
- Impfdatum
- 03.03.2021
- Beginn
- 08.03.2021
- Tage bis Beginn
- 5,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Deep vein thrombosis
Haematology test normal
Pain in extremity
Peripheral swelling
Ultrasound scan
Symptomtext
Lower leg pain, swelling. Admitted to the emergency room on 03/29/2021. Ultrasound was done. Diagnosis was left leg DVT. Treatment prescribed is 15 mg of Xaralto twice a day. Had a follow up visit with a physicians assistant on 04/09/2021. She prescribed 20mg of Xarelto once a day for the upcoming 2-3 months. Also prescribed Bisoprolol Fumarate 2.5 mg once per day.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- Ultrasound of left leg - 03/21/2021 Hematology - all normal - 03/21/2021
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- Losartan 25mg once a day
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 16.04.2021
- Impfdatum
- 15.03.2021
- Beginn
- 29.03.2021
- Tage bis Beginn
- 14,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Balance disorder
Computerised tomogram head abnormal
Dizziness
Haemorrhagic stroke
Headache
Intensive care
Magnetic resonance imaging head abnormal
Scan with contrast
Vertigo
Symptomtext
03/29/21 - severe headaches started and continued 04/03/21 - balanced/dizziness/vertigo feeling started and continued 04/04/21 - admitted to ICU and diagnosed with Hemorrhagic Stroke
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Haemorrhagic stroke
- Hospital-Tage
- 5,0
- Labordaten
- 2 CT scans w/o contrast, 1 CT scan w/contrast, 1 MRI
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Diabetes II - well controlled
- Andere Medikamente
- losartin, celebrex, atorvastatin, levothyroxine, metFORMAN, mirtazapine, propranol
- Allergien
- Demerol
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 15.04.2021
- Impfdatum
- 04.03.2021
- Beginn
- 04.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Abdominal pain
Lower gastrointestinal haemorrhage
Rectal haemorrhage
Syncope
Symptomtext
Rectal bleeding abdominal pain R55 - Syncope and collapse K92.2 - Lower GI bleeding
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 15.04.2021
- Impfdatum
- 15.04.2021
- Beginn
- 15.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Aphasia
Blood glucose
Dizziness
Generalised tonic-clonic seizure
Musculoskeletal stiffness
Paraesthesia
Postictal state
Tongue disorder
Symptomtext
Soon after receiving shot, PT experienced dizziness and felt like she was going to pass out, medical team arrived to assess. PT was conscious but shortly thereafter, she had a tonic-clonic seizure. This lasted about 2 minutes, then she was post-ictal for about a minute. Then PT was able to answer questions appropriately and knew where she was. V/S were normal including a BP of 105/70, SPO2-100%, HR-70. EMS was called to transport to ER. Over the next several minutes, PT felt dizzy and tingly. She remained stiff in extremities and had a hard time verbalizing, trying to say that her tongue felt stiff. When EMS arrived, they took her blood sugar, which was 120. She was then taken to ER for further evaluation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Generalised tonic-clonic seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 14.04.2021
- Impfdatum
- 25.02.2021
- Beginn
- 08.03.2021
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Bell's palsy
Cold sweat
Computerised tomogram head
Fatigue
Full blood count
Laboratory test
Symptomtext
4 days after vaccine: cold sweats, fatigue; on 3/8 developed Bells palsy
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- clinical exam, CBC, chem panel, CT brain
- Aktuelle Erkrankungen
- dental infection
- Vorgeschichte
- Raynauds, scarring alopecia
- Andere Medikamente
- estradiol, zolpidem
- Allergien
- augmentin, carafate, codeine, erythromycin, diltiazem
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 14.04.2021
- Impfdatum
- 18.02.2021
- Beginn
- 19.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Syncope
Vertigo
Symptomtext
I woke up at 3:30 a.m. lightheaded. I went to the bathroom and on the way back to the bedroom I fainted. I regained consciousness and realized that I was on my knees on the bedroom floor. I felt as though the room was whirling and fainted again. I woke up to find that I was laying down on the bedroom floor. At that point, I heard my husband asking me what happened. I felt him pick me up and put me back in bed. He didn't sleep the rest of the night listening to me to make sure I was breathing, I woke up in the morning feeling fine, no more symptoms. While my episode was going on, I never thought to call for help from my husband. Very unusual for me not to do that. I just didn't think about talking, strange for me.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- MENIERE'S DISEASE
- Andere Medikamente
- SPIRONOLACTONE ROSUVASTATIN CALCIUM CALCIUM WITH VITAMIN D PRESERVISION, AREDS 2 FISH OIL VITAMIN D
- Allergien
- LIPITOR LACTOSE INTOLERANT
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 92,0
- Geschlecht
- F
- Eingang
- 14.04.2021
- Impfdatum
- 18.02.2021
- Beginn
- 25.02.2021
- Tage bis Beginn
- 7,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bell's palsy
Symptomtext
Bell's Palsy - Right side
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- Clinical exam, neurologic exam
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Vitamin A, vitamin C, Fish Oil, Vitamin D,
- Allergien
- Gluten
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 13.04.2021
- Impfdatum
- 26.02.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- 3,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Chills
Deep vein thrombosis
Fatigue
Night sweats
Nightmare
Pain
Pyrexia
Ultrasound Doppler abnormal
Symptomtext
DVT right leg began on evening of Feb 28 but became evident March 1 morning and diagnosed evening at ER
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- Used ultrasound to diagnose. Blood tests ordered a couple weeks later.
- Aktuelle Erkrankungen
- No, only reaction to first shot (slight fever, tired, achy) and second shot (high fever, chills, night sweats, bad dreams, body aches, tired)
- Vorgeschichte
- Hypothyroidism
- Andere Medikamente
- Synthroid, vitamin D and Birth control
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 12.04.2021
- Impfdatum
- 05.04.2021
- Beginn
- 06.04.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Deep vein thrombosis
Gait disturbance
Pain in extremity
Ultrasound Doppler abnormal
Vascular imaging
Vomiting
Symptomtext
12 hours after receiving 2nd vaccine (4-5-21) I started throwing up through Tuesday 4-6-21. Then on 4-7-21, my left leg calf was very sore and hard for me to walk, Got worse, so on 4-9-21 went into Urgent care and through a vascular ultra sound determined I had a very Large blood clot in my calf. (ACUTE THROMBOSIS OF THE LEFT PROXIMAL PERONEAL VEIN)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- LOWER EXTREMITY VENOUS IMAGING VASCULAR
- Aktuelle Erkrankungen
- None- Healthy Got a blood clot 2 days after receiving the shot. Never, Ever, have I had a blood clot. Not after sugeries, having babies or being on birth contraol
- Vorgeschichte
- none
- Andere Medikamente
- trazadone, lomotil, flexeril, xalatan, prevastatin
- Allergien
- oxycodone, amoxicillin morphine terramycin
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 12.04.2021
- Impfdatum
- 05.04.2021
- Beginn
- 05.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Syncope
Symptomtext
Syncopal event shortly after vaccine was administered
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 11.04.2021
- Impfdatum
- 11.03.2021
- Beginn
- 11.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Bell's palsy
Blood test
Dizziness
Electrocardiogram
Facial nerve disorder
Pharyngeal swelling
Hypoaesthesia oral
Nervous system disorder
Optic nerve disorder
Symptomtext
nerve problems behind left eye; nerve problems in face; lips had nerve problems; tongue was numb; throat felt swollen; Bell's palsy; lightheaded and dizzy; This is a spontaneous report received from a contactable consumer (who is also the patient). A 59-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6207), via an unspecified route of administration in the left arm, on 11Mar2021 15:30, as single dose, for covid-19 immunisation. Medical history included known allergies to antihistamine (unspecified) and sulfur drugs. The patient was not pregnant at the time of vaccination. The patient did not have COVID-19 prior the vaccination and was not tested for COVID-19 post vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID); omeprazole; and anastrozole, all taken for unspecified indications, start and stop dates were not reported. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6200) received at age 59 years, via an unspecified route of administration in the left arm, on 18Feb2021 15:45, for COVID-19 immunization. The patient did not receive other vaccines in four weeks. On 11Mar2021 at 15:45, 15 minutes after the second dose, the patient got lightheaded and dizzy. On the same day at 16:15, 45 minutes after the second dose, the patient experienced nerve problems behind left eye, then nerve problems in face, then lips had nerve problems, then tongue was numb, and throat felt swollen. The patient reported the side effects on the hotline, and she was transferred to a nurse who told her to go to the emergency room immediately as she could be getting Bell's palsy from the vaccine. The events resulted to emergency room visit and hospitalization (unspecified date in Mar2021). Treatment for the events included unspecified IV. The patient was hooked up to an EKG and her blood was drawn for checking in Mar2021 (results were unknown). The patient was recovering from the events. Follow-up attempts are completed. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- Test Date: 202103; Test Name: blood checking; Result Unstructured Data: Test Result:Unknown result; Test Date: 202103; Test Name: EKG; Result Unstructured Data: Test Result:Unknown result
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Drug allergy
- Andere Medikamente
- SYNTHROID; OMEPRAZOLE; ANASTROZOLE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 08.04.2021
- Impfdatum
- 24.02.2021
- Beginn
- 03.03.2021
- Tage bis Beginn
- 7,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Muscular weakness
Paralysis
Symptomtext
GRADUAL WEEKNESS IN LEGS, THEN PARALYSIS, HOSPITALIZATION, PHYSICAL THERAPY. DRS PREDICT 2 MONTHS OF REHAB.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paralysis
- Hospital-Tage
- 13,0
- Labordaten
- -
- Aktuelle Erkrankungen
- PARKINSONS DESEASE
- Vorgeschichte
- PARKINSONS
- Andere Medikamente
- CARBO DOPA
- Allergien
- NO
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 08.04.2021
- Impfdatum
- 10.03.2021
- Beginn
- 14.03.2021
- Tage bis Beginn
- 4,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Headache
Ischaemic stroke
Symptomtext
SEVERE HA , DOCTORS SAYS SE HAD ISCHEMIC STROKE , NOT SURE IF RELATED TO THE VACCINE What happened as a result of the adverse event? SAW DOCTOR
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ischaemic stroke
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- pad CHD COPD
- Andere Medikamente
- aspirin calcatrol soletrisol ADVAIR TODORZA
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 08.04.2021
- Impfdatum
- 07.04.2021
- Beginn
- 07.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Syncope
Unresponsive to stimuli
Symptomtext
Systemic: Fainting / Unresponsive-Mild
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 07.04.2021
- Impfdatum
- 10.03.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Discomfort
Fall
Hypokinesia
Incoherent
Loss of consciousness
Weight decreased
Symptomtext
fell out of his bed; her brother was incoherent when he was found by the ambulance staff; her brother was very weak at the time he was found; Her brother wasn't responsive in his hospital bed; her brother tried to get up from the floor and somehow wiggled under his bed and got stuck; had lost a lot of weight before his fall.; brother had some health problems recently; This is a spontaneous report from a contactable consumer. A 70-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number: EN6200; expiration date: Jun2021, via an unspecified route of administration, administered in left arm on 10Mar2021 10:00 as single dose for Covid-19 immunisation. Medical history included hypersensitivity and not feeling well. The patient's concomitant medications were not reported. The patient previously took Aleve and Advil and experienced allergy. It was reported that the patient took his first Pfizer COVID-19 Vaccine on Wednesday, 10Mar2021. On Monday, 15Mar2021, the ambulance staff found the patient, who had fallen on either Friday 12Mar2021 or Saturday 13Mar2021. The patient was very weak and incoherent at the time he was found. The patient was in bed and fell out of his bed. He tried to get up from the floor and somehow wiggled under his bed and got stuck. The ambulance staff estimated the patient was on the floor for 2 days before he was found. The patient doesn't drink, do drugs, or smoke. The patient may have a glass of wine every 6 months. It was reported that there was one time when the patient wasn't responsive in his hospital bed. The hospital staff shook her brother, massaged his hand, and yelled really loud in his ear before he became awake. The patient was discharged to a rehab center on 19Mar2021 and was going to be at the rehab center for 20 days. It was also reported that the patient had lost a lot of weight before his fall. The patient had some health problems recently. The outcome of the events weight loss and general discomfort was unknown. The outcome of other events was recovering. Follow up attempts needed. Further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Allergy (Verbatim: Allergy); Feeling unwell
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 07.04.2021
- Impfdatum
- 01.04.2021
- Beginn
- 04.04.2021
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Bell's palsy
Facial paralysis
Lacrimation increased
Mastication disorder
Symptomtext
On late afternoon of 4/4/2021 spouse noticed slight paralysis on the right side of face (mouth) and sagging of check/neck. No other symptom was felt. On 4/5/2021 paralysis was still obvious and right eye was tearing. Still no other issues. On 4/6/2021 paralysis seems to interrupt chewing on right side. Went to emergency thinking maybe it was a slight stroke. Diagnosis was Bell palsy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 07.04.2021
- Impfdatum
- 17.03.2012
- Beginn
- 18.03.2021
- Tage bis Beginn
- 3.288,0
- Dosis
- 2
- Route/Site
- SC / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Face injury
Loss of consciousness
Malaise
Syncope
Symptomtext
Vasovagal syncope: suddenly felt extremely sick the next morning. Went to bathroom, thought I might vomit. Passed out, hit face on floor, needed stitches in brow and chin, split lip, broke tooth. The sick feeling lasted maybe 10 minutes before passing out. Did not notice it again after regaining consciousness.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Estrogen patch
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 06.04.2021
- Impfdatum
- 18.02.2021
- Beginn
- 14.03.2021
- Tage bis Beginn
- 24,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Blood fibrinogen normal
Blood glucose increased
Blood immunoglobulin A normal
Blood immunoglobulin G increased
Blood immunoglobulin M normal
Blood lactate dehydrogenase increased
Blood lactic acid increased
Brain natriuretic peptide normal
C-reactive protein increased
COVID-19
Cough
Dyspnoea
Fibrin D dimer increased
Insulin therapy
Intensive care
Nasal congestion
Pyrexia
Red blood cell sedimentation rate increased
Symptomtext
NASAL CONGESTION Narrative: PT ADMITTED TO HOSPITAL 4 DAYS AFTER COVID POSITIVE TEST WITH TACHYPNEA, FEVER, COUGHING, SHORTNESS OF BREATH. FOUND TO HAVE ELEVATED TROPONINS. HOSPITALIZED FROM 3/17 TO 3/31/21. He was admitted to the medical ward and started on Treatment with Dexamethasone and IV Remdesivir, was tolerating the treatment well but the corticosteroids lead to a significant increase in his blood sugars; transferred to the MICU on 03/21 for treatment with an insulin drip. In the ICU patient received treatment with Tocilizumab. His clinical condition continued to improve and he was transferred out of the MICU on 03/24. Patient was monitored on the Step down unit and Oxygen was titrated off as tolerated until he was able to wean off completely. He remained in stable condition and subsequently discharged home to complete a Prednisone Taper.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- -
- Labordaten
- O2 SAT 98% ON 4L Specimen Collection Date: Mar 17, 2021@15:20 Test name Result units Ref. range Site Code TROPONIN I 0.039 H* ng/mL Ref: <=0.031 Specimen Collection Date: Mar 17, 2021@15:20 Test name Result units Ref. range Site Code FIBRINOGEN 317 mg/dL 214 - 489 DDIMER 1.48 H mcg/mL 0.27 - 0.49 Specimen Collection Date: Mar 17, 2021@15:20 Test name Result units Ref. range Site Code CRP 3.217 H mg/dL Ref: <=0.5 Specimen Collection Date: Mar 17, 2021@17:15 Test name Result units Ref. range Site Code LDH 296.5 H U/L 125 - 220 Specimen Collection Date: Mar 17, 2021@20:45 Test name Result units Ref. range Site Code BNP 38.1 pg/mL 10 - 100 Specimen Collection Date: Mar 17, 2021@20:45 Test name Result units Ref. range Site Code TROPONIN I 0.056 H* ng/mL Ref: <=0.031 Specimen Collection Date: Mar 18, 2021@04:20 Test name Result units Ref. range Site Code ESR 48 H mm/hr 2 - 21 Specimen Collection Date: Mar 18, 2021@04:20 Test name Result units Ref. range Site Code FIBRINOGEN 284 mg/dL 214 - 489 DDIMER 1.06 H mcg/mL 0.27 - 0.49 Specimen Collection Date: Mar 18, 2021@04:20 Test name Result units Ref. range Site Code TROPONIN I 0.041 H* ng/mL Ref: <=0.031 Specimen Collection Date: Mar 19, 2021@04:10 Test name Result units Ref. range Site Code ESR 56 H mm/hr 2 - 21 Specimen Collection Date: Mar 19, 2021@04:10 Test name Result units Ref. range Site Code IgM 238.9 mg/dL 22 - 293 IgA 325.01 mg/dL 89 - 484 IgG 2071.0 H mg/dL 540 - 1822 Specimen Collection Date: Mar 19, 2021@04:10 Test name Result units Ref. range Site Code FIBRINOGEN 337 mg/dL 214 - 489 DDIMER 1.34 H mcg/mL 0.27 - 0.49 Specimen Collection Date: Mar 20, 2021@04:06 Test name Result units Ref. range Site Code ESR 54 H mm/hr 2 - 21 Specimen Collection Date: Mar 20, 2021@04:06 Test name Result units Ref. range Site Code FIBRINOGEN 387 mg/dL 214 - 489 DDIMER 1.42 H mcg/mL 0.27 - 0.49 Specimen Collection Date: Mar 21, 2021@10:27 Test name Result units Ref. range Site Code GLUCOSE 621 H* mg/dL 70 - 105 Specimen Collection Date: Mar 21, 2021@13:00 Test name Result units Ref. range Site Code LACTIC ACID (PLASMA) 2.50 H mmol/L 0.40 - 2.30 Specimen Collection Date: Mar 21, 2021@13:00 Test name Result units Ref. range Site Code GLUCOSE 481 H mg/dL 70 - 105 Specimen Collection Date: Mar 21, 2021@13:13 Test name Result units Ref. range Site Code WHOLE BLOOD GLUCOSE, POC 442 H mg/dL 70 - 105 Specimen Collection Date: Mar 21, 2021@19:30 Test name Result units Ref. range Site Code WHOLE BLOOD GLUCOSE, POC 166 H mg/dL 70 - 105 Specimen Collection Date: Mar 21, 2021@21:29 Test name Result units Ref. range Site Code WHOLE BLOOD GLUCOSE, POC 113 H mg/dL 70 - 105 Specimen Collection Date: Mar 22, 2021@03:50 Test name Result units Ref. range Site Code ESR 56 H mm/hr 2 - 21 Specimen Collection Date: Mar 22, 2021@03:50 Test name Result units Ref. range Site Code FIBRINOGEN 373 mg/dL 214 - 489 DDIMER 1.10 H mcg/mL 0.27 - 0.49
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- -
- Geschlecht
- M
- Eingang
- 04.04.2021
- Impfdatum
- 19.02.2021
- Beginn
- 13.03.2021
- Tage bis Beginn
- 22,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bell's palsy
Symptomtext
Bells Palsy; This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 19Feb2021 at 13:00 (Lot Number: EN6200) as SINGLE DOSE for covid-19 immunization, received in the Public Health Clinic/Veterans Administration facility. The patient received the first dose on 29Jan2021 at 01:00 for covid-19 immunization. The patient did not receive other vaccines in four weeks. Medical history included kidney transplant from 2016, ongoing hypertension, ongoing high cholesterol. The patient had no COVID prior to vaccination. The patient was not COVID tested post vaccination. Concomitant medications included anti-rejection medication, hypertension and high cholesterol medications; all ongoing. The patient experienced mild bells palsy on 13Mar2021 at 10:00. Event resulted in physician's office visit. The patient received treatment for the event which included Anti viral medication- acyclovir 800mg. Outcome of the event was recovering, almost recovered at the time of report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- High cholesterol; Hypertension
- Vorgeschichte
- Medical History/Concurrent Conditions: Kidney transplant
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 03.04.2021
- Impfdatum
- 13.03.2021
- Beginn
- 14.03.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Body temperature decreased
Burning sensation
Electric shock sensation
Feeling abnormal
Hypoaesthesia
Paraesthesia
Sleep disorder
Throat irritation
Symptomtext
I had extreme burning in my throat and lungs. Later the next day my nerves felt like electricity was running thru my whole body. I was unable to sleep for 6 days. .My body temperature when down 95.3. It felt like my blood was racing thru my veins, both arms and legs where tingling and numb feeling. Then I have had veins rupture on my legs, hands and feet with bruising. These problems are still with me 3 weeks after 1st vaccine. This is awful and painful!!!!!! Hopefully I will go back to normal soon.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Electric shock sensation
- Hospital-Tage
- -
- Labordaten
- I went to Dr. office a week after shot and explained the problems after receiving the vaccine. He gave me a low dose steroid and flexeril (muscle relaxant to take at night). The steroids help with burning lungs and throat but not the other stuff. Flexeril helped me sleep and ease the rushing sensation in my veins and also calmed the tingling /numbness in arms and legs at night. But the next day the same adverse effect come back.. This is 3 weeks now and doesnt seem like it will stop. I want the doctor to test my blood next for any problems.
- Aktuelle Erkrankungen
- Fibromylagia and arthritis.
- Vorgeschichte
- same as item 11
- Andere Medikamente
- No prescription medicine. I take multivitamin, fish oil and vit-d.
- Allergien
- Nickel, methaparben,, ratidine high dose of preidszone
- Vorherige Impfungen
- Tetnus
- Staat
- OH
- Alter
- 24,0
- Geschlecht
- M
- Eingang
- 02.04.2021
- Impfdatum
- 02.04.2021
- Beginn
- 02.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Feeling hot
Syncope
Symptomtext
I did not vaccinate this patient, but I went out to the parking lot when a customer said someone fainted outside. The patient was asked to wait 15 minutes in the store. However his mom was with him and stated that he always faints after injections, so she wanted to put him in the car to lie down. When I arrived the patient was awake and feeling warm. Sitting up
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- None performed. Patient states he is fine and he does this fainting every time. I explained the fainting and that this is a common problem and not usually an allergy. The mom calmed down. She was going to drive to the ER across the street, but did not think they would go in
- Aktuelle Erkrankungen
- None but reports that he faints after every injection
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKDA
- Vorherige Impfungen
- All vaccines
- Staat
- FL
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 02.04.2021
- Impfdatum
- 24.02.2021
- Beginn
- 25.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal pain
Bell's palsy
Glossodynia
Headache
Lymphadenopathy
Mastoid disorder
Myalgia
Neck pain
Symptomtext
onset of symptoms of left-sided Bell palsy (twitching, paralysis, lost of taste/sensation of tongue, lid lag etc). I knew I had Bell palsy; Awakened with brief episode (10 min) severe abdominal pain; Severe muscle aches; Head pain; Neck pain; Developed sore on left side of tongue; Neck/mastoid pain; Swollen gland lasted a few days; This is a spontaneous report from a contactable other HCP (patient). A 63-year-old (non pregnant) female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number: EN6200, Expiry Date: unknown) via an unspecified route of administration in left arm on 24Feb2021 13:30 at single dose for COVID-19 immunisation. Patient had historical vaccine at 63-year-old BNT162B2, lot number: EL9262 at left arm on 03Feb2021 13:30 at SINGLE DOSE for Covid-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient's medical history included penicillin and neomycin allergy. Patient's concomitant medications included ergocalciferol (VIT D), rosuvastatin calcium (CRETOR) (medications the patient received within 2 weeks of vaccination). On 25Feb2021, the patient experienced onset of symptoms of left-sided bell palsy (twitching, paralysis, lost of taste/sensation of tongue, lid lag etc). I knew I had bell palsy, awakened with brief episode (10 min) severe abdominal pain, severe muscle aches, head pain, neck pain, developed sore on left side of tongue, neck/mastoid pain, swollen gland lasted a few days. Event was reported as on 25Feb, patient awakened with brief episode (10 min) severe abdominal pain. Later, severe muscle aches, head and neck pain, lasted until following Wednesday (03Mar). Patient developed sore on left side of tongue, neck/mastoid pain, swollen gland; lasted a few days, then noted onset of symptoms of left-sided Bell palsy (twitching, paralysis, lost of taste/sensation of tongue, lid lag etc). By friday 12Mar she knew she had Bell palsy. Medrol dosepak, OTC pain meds was received as treatment for adverse events. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. The outcome of event was not recovered.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported event of Bell's palsy and other events due to temporal relationship. There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics including Head CT/MRI and viral serology, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Penicillin allergy
- Andere Medikamente
- VIT D; CRETOR
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 02.04.2021
- Impfdatum
- 28.02.2021
- Beginn
- 03.03.2021
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Eyelid disorder
Headache
IIIrd nerve paralysis
Vision blurred
Symptomtext
65yo male presented to ED with left eyelid droop, blurred vision, and headache. Pt reported that HA began 3 days after COVID-19 vaccination (Pfizer); pt presented to ED 10 days after dose #1. Unknown where patient received vaccine, but able to pull lot #, etc. from Shots Registry. Pt discharged from ED, but then returned 3 days later with worsening HA. At this time, he was admitted for 4 days for extensive work-up. Of note, pt with hx of R-sided Bell's palsy in the past. Per discharge summary from Neurology: "Despite extensive work-up, pt ultimately deemed to have a pupil-sparing CN III palsy likely related to either recent COVID vaccination or his history of DM."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- IIIrd nerve paralysis
- Hospital-Tage
- 4,0
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None noted in outpatient note on 2/22/21 (patient presented for routine refills)
- Vorgeschichte
- T2DM, HTN, anxiety, hx of lacunar stroke, CKD, glaucoma, neuromuscular disorder, hx of tobacco use
- Andere Medikamente
- Aspirin 81 mg daily, atorvastatin 40 mg daily, bimatoprost 0.01% ophthalmic solution, butalbital-APAP-caffeine 50-325-40 mg q4h PO PRN, gabapentin 800 mg four times daily, losartan 100 mg daily, multivitamin daily, nifedipine XL 90 mg daily
- Allergien
- Sitagliptin (swelling), amlodipine (swelling, headache)
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 94,0
- Geschlecht
- F
- Eingang
- 02.04.2021
- Impfdatum
- 25.03.2021
- Beginn
- 01.04.2021
- Tage bis Beginn
- 7,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal pain
Bell's palsy
Dizziness
Full blood count normal
Metabolic function test
Nausea
White blood cell count increased
Symptomtext
started with dizziness, nausea, abd pain on 3/29/2021. treated conservatively. seen in office on 3/31/2021. She started improving the morning of 4/1/2021. Developed Left Bells Palsy on the afternoon of 4/1/2021. Seen in office on 4/2/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- Abd Series: normal CBC: WBC borderline high ar 11.3 CMP: normal
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Losartan-HCTZ, Atenolol, Synthroid
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 01.04.2021
- Impfdatum
- 02.02.2021
- Beginn
- 28.03.2021
- Tage bis Beginn
- 54,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Bell's palsy
Symptomtext
No symptoms at the time of injection. Diagnosed with Bell's Palsy on 3.28.21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Depo
- Allergien
- Mangos, bees, adhesive
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 31.03.2021
- Impfdatum
- 01.03.2021
- Beginn
- 02.03.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood pressure increased
Blood pressure measurement
Chills
Dizziness
Feeling abnormal
Headache
Insomnia
Magnetic resonance imaging
Presyncope
Rhinorrhoea
Tinnitus
Visual impairment
Symptomtext
feeling dizzy like going to pass out; feeling dizzy like going to pass out; like I'm going crazy, like I'm losing my mind; it is hard for her to sleep; severe headaches; ringing and "thump thump thump" in her head comes back; blood pressure goes up; chilly; had some sniffles; vision and her blood pressure and everything went up; This is a spontaneous report from a contactable consumer, reporting for herself. A 72-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6200) via an unspecified route of administration, administered in the left arm on 01Mar202 (at the age of 72 years old) at a single dose for COVID-19 immunization. Vaccination was done in a baseball stadium. Vaccine was administered not administered military facility but firefighters and military were the ones giving the vaccine. Medical history included headaches from an unknown date and unknown if ongoing, ongoing cholesterol, ongoing seasonal allergies, ongoing sinus gets stopped up and high blood pressure and severe migraines (gets a shot every three months both from an unknown date and unknown if ongoing. Concomitant medications included cetirizine hydrochloride (ZYRTEC) taken for seasonal allergy and sinus gets stopped up/helps sinuses from Feb2021 and ongoing; lisinopril taken for high blood pressure and atorvastatin taken for cholesterol, both from an unspecified start date and ongoing. It was reported that the patient started taking lisinopril and atorvastatin years ago in her 50s. The patient experienced severe headaches, ringing and "thump thump thump" in her head comes back, blood pressure goes up, chilly, had some sniffles and vision and her blood pressure and everything went up on 02Mar2021, and feeling dizzy like going to pass out, like I'm going crazy, like I'm losing my mind and it is hard for her to sleep on an unspecified date. It was reported that the patient experienced severe headaches she's having was normal after receiving the Pfizer BioNTech COVID-19 vaccine on 01Mar2021 at around 13:00 or 14:00, appointment was between 13:00 and 15:00. She has had these headaches before but these were different since she had her vaccine. The patient stated severely when asked if she still has headaches. She sometimes takes a break from having the headaches, and she writes down medications she takes. Then, headaches will come back. It was not a long break, stated that the ringing and "thump thump thump" in her head comes back. She received her first dose and felt fine afterwards, had no side effects; and waited at the facility for 15 minutes. She left and got something to eat and came home after 4-5 hours. However, on the following Tuesday and Wednesday, the headaches started rolling in and have not stopped since. When she takes something for the headaches, her blood pressure goes up. She was feeling dizzy like she was going to pass out and like she was going crazy, like she was losing her mind. She has tried taking Tylenol and Ibuprofen but it seemed to aggravate it and says everything she takes make it worse. It was also reported that it was hard for her to sleep. She was concerned if she was in any kind of danger with these headaches and would like to know if there was any other medications she can take for it. It was also reported that on the second day, she was kind of chilly and had some sniffles and took a Zyrtec and said that her vision and her blood pressure and everything went up. She said that it seemed like if she takes a Tylenol or anything her blood pressure goes up. Her blood pressure only goes up if she takes something, she gets rush so bad and that blood pressure goes so high. When she feels this, she takes her blood pressure medication. She said that she thought maybe her headache would go away but has not gone away and she had another bad attack of a headache today and she took one of her medicines for headache, Butal-acet-caff 50-325-40 mg which did not make it worse. Also, tried Tylenol and Ibuprofen. She was trying everything all week but scared to take anything else because it brings a rush and feels like she's going to have a blackout. Took Tylenol at 10 o'clock last night, it seemed like she went crazy and it drove her nuts so she went and got high blood pressure medication so she could lay down. Took three Tylenol. She stated that somebody told her to take three, and that it was the worst mistake she made. Stated extra strength Tylenol. She wanted to know what advise she can get, with the virus going on she did not want to go to the emergency room. She also would like to know if it was recommended that she take the second dose of BNT162B2 vaccine following these severe headaches that she was experiencing after receiving her first dose. The patient underwent lab tests and procedures which included blood pressure: up on an unspecified date 2021 and magnetic resonance imaging: no brain damage or anything on 2020. The patient clarified the MRI was last year at some point before receiving vaccine. The outcome of the event severe headaches was not recovered while the outcome of all other events was unknown.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- Test Date: 2021; Test Name: blood pressure; Result Unstructured Data: Test Result:up; Test Date: 2020; Test Name: MRI; Result Unstructured Data: Test Result:no brain damage or anything
- Aktuelle Erkrankungen
- Blood cholesterol abnormal; Seasonal allergy; Sinus congestion
- Vorgeschichte
- Medical History/Concurrent Conditions: Blood pressure high; Headache; Migraine (gets a shot every three months)
- Andere Medikamente
- ZYRTEC [CETIRIZINE HYDROCHLORIDE]; LISINOPRIL; ATORVASTATIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 31.03.2021
- Impfdatum
- 19.02.2021
- Beginn
- 19.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Anaphylactic reaction
Symptomtext
Anaphylaxis, confirmed by ER; This is a spontaneous report from a contactable other healthcare professional (HCP). A 55-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EN6200, expiration date was unknown), intramuscularly, administered in the left arm on 19Feb2021 at 12:15 PM as a single dose for COVID-19 immunization. The vaccination facility type was reported as the hospital. The patient's medical history and concomitant medications were not reported. The patient previously took codeine and hydrocodone bitartrate, paracetamol (VICODIN), from which she had known allergies. The patient was not pregnant at the time of vaccination. The patient had no other vaccine in four weeks. The patient had no COVID prior vaccination. She was not tested for COVID post vaccination. On 19Feb2021 at 12:15 PM, the patient experienced anaphylaxis, confirmed by emergency room (ER). The adverse event (AE) resulted in a doctor or other HCP office/clinic visit and emergency room/department or urgent care visit. Therapeutic measures were taken as a result of anaphylaxis, confirmed by ER, which included epinephrine, steroids, and antihistamines. The patient recovered from the event on an unspecified date.; Sender's Comments: Based on known drug safety profile and temporal association, the causal relationship between bnt162b2 and the event anaphylactic reaction cannot be excluded.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- F
- Eingang
- 31.03.2021
- Impfdatum
- 05.03.2021
- Beginn
- 01.03.2021
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Body temperature
Dyspnoea
Eye pain
Gait disturbance
Incorrect route of product administration
Lung disorder
Muscle tightness
Muscular weakness
Nausea
Nervous system disorder
Pain
Pain in extremity
Paraesthesia
Pruritus
Pyrexia
Rash
Thrombosis
Vaccination site discolouration
Symptomtext
if it was a lung issue or blood issue, such as blood clots; nervous system was affected; weakness on her leg; had very tight calf muscles; eye pain; have difficulty breathing; she was dragging her feet, could not take the next step.; had "such a tight feeling" of the calf, and a little bit of pain to it; nauseous; if it was a lung issue or blood issue, such as blood clots; whether the injection was done in the wrong location; her arm was very itchy and a red papule-like round rash developed, it was pigmented,; her arm was very itchy and a red papule-like round rash developed, it was pigmented,; her arm was very itchy and a red papule-like round rash developed, it was pigmented,; it was "highlighted" and "dot-like"; had a sharp pain, and tingling or pain-like sensation at the fingertips/she was going "through a world of pain", and from the arm down to the side of body.; had a sharp pain, and tingling or pain-like sensation at the fingertips; a fever too, 99.4?F at one time and over 100?F for a day or so; This is a spontaneous report from a contactable consumer. This consumer (patient) reported for self that the female patient of an unspecified age received second dose of bnt162b2 (BNT162B2,PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6200, Expiration Date: 30Jun2021) via an unspecified route of administration on 05Mar2021 at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot#: EL9262, expiration date: 31May2021) for covid-19 immunization for covid-19 immunization, rabies vaccine and experienced pain. The patient experienced if it was a lung issue or blood issue, such as blood clots on Mar2021 with outcome of unknown, nervous system was affected on Mar2021 with outcome of unknown, weakness on her leg on Mar2021 with outcome of unknown, had very tight calf muscles on Mar2021 with outcome of unknown, eye pain on Mar2021 with outcome of unknown, have difficulty breathing on Mar2021 with outcome of unknown , she was dragging her feet, could not take the next step on Mar2021 with outcome of unknown , had "such a tight feeling" of the calf, and a little bit of pain to it on Mar2021 with outcome of unknown, nauseous on Mar2021 with outcome of unknown, if it was a lung issue or blood issue, such as blood clots on Mar2021 with outcome of unknown, whether the injection was done in the wrong location on Mar2021 with outcome of unknown, her arm was very itchy and a red papule-like round rash developed, it was pigmented on Mar2021 with outcome of unknown, her arm was very itchy and a red papule-like round rash developed, it was pigmented on Mar2021 with outcome of unknown, her arm was very itchy and a red papule-like round rash developed, it was pigmented on Mar2021 with outcome of unknown, it was "highlighted" and "dot-like" on Mar2021 with outcome of unknown , had a sharp pain, and tingling or pain-like sensation at the fingertips/she was going "through a world of pain", and from the arm down to the side of body on Mar2021 with outcome of unknown , had a sharp pain, and tingling or pain-like sensation at the fingertips on Mar2021 with outcome of unknown. The patient underwent lab tests and procedures which included body temperature: 99.4 fahrenheit on Mar2021, body temperature: 100 fahrenheit on Mar2021. The consumer reported that "Who makes the vial label? What syringe did they use to give her the vaccine? How big was it? Where is the vaccine administered? Did we make a second batch with "much less" side effects? She thought there was an earlier version which should have more side effects. Did she have to share a vial with other people? Is it multiple doses? How much is the dose of a vaccine?" Consumer stated the lot number was a "so vague looking thing" to come with the Pfizer vial. Upon clarification, said she did not see the lot number on the vial, but on the vaccination card, where the lot number was very small. She would include 5 labels with lot numbers to split to each person who gets the dose from the same vial. The clinical course was reported as follows: She got the second dose of Pfizer's COVID-19 vaccine on 05Mar2021 and has developed side effects. Her nervous system was affected, she has weakness on her leg, had very tight calf muscles, eye pain. When she was working, she started to have difficulty breathing, she was dragging her feet, could not take the next step. This was 2 weeks ago and went away for a while. Today she had "such a tight feeling" of the calf, and a little bit of pain to it, she was nauseous. She was wondering if it was a lung issue or blood issue, such as blood clots. She had a fever too, 99.4?F at one time and over 100?F for a day or so. The first dose didn't give her any side effects. She was also concerned about whether the injection was done in the wrong location, she thought it was in the deltoid, but 10 days later her arm was very itchy and a red papule-like round rash developed, it was pigmented, she wondered if it was a hair, it was "highlighted" and "dot-like". It was located in the 2/3 lower to the elbow from the shoulder, she thought it was "really low" and they missed the deltoid muscle, she had no idea if the nurse didn't know the exact location and putting it "in the skin" was the cause of her symptoms. Stated they put a bandage in the wrong location, there was nothing there. She additionally had a sharp pain, and tingling or pain-like sensation at the fingertips, yesterday she was going "through a world of pain", and from the arm down to the side of body. With the first dose she didn't have any pain, but it was "very weird", afterwards she had some "sharp pain" under the scapula and didn't know why. She thought it was "echo" through the nervous system. Stated when she got the vaccine, she saw 3 dark marks on the syringe and two thirds were filled with the liquid. She wanted to know if this dosage was correct. Mentioned a lot of people had side effects, a lot of times they are given in the wrong location, in an entirely different place. She thought there was an earlier version of the vaccine which should have more side effects. She had a "very bad bad" experience 4 years ago when she got a rabies vaccine, it was given at 45?, the nurse gave the injection "cutaneously", after 5 min she was "so in pain".
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- Test Date: 202103; Test Name: fever; Result Unstructured Data: Test Result:99.4 Fahrenheit; Test Date: 202103; Test Name: fever; Result Unstructured Data: Test Result:100 Fahrenheit
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -